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Abstract	
Influenza	virus	remains	a	familiar	threat	to	public	health	and	continues	to	challenge	
the	 scientific	 community.	 Most	 challenging	 is	 responding	 to	 the	 evolutionary	
adaptability	 of	 influenza	 virus,	 which	 often	 hinders	 effective	 prevention	 or	
treatment.	Furthermore,	current	production	methods	are	logistically	and	technically	
inadequate	 to	 cope	 with	 pandemic	 surges,	 leaving	 a	 considerable	 number	 of	
individuals	unprotected.	
Tandem	 Core	 Virus-Like	 Particles	 (VLPs),	 expressed	 in	 Pichia	 pastoris,	 offer	 an	
exciting	proposition	to	create	a	platform	process	for	a	universal	 influenza	vaccine.	
However,	 as	 with	 all	 novel	 concepts,	 characterisation	 of	 this	 technology	 was	
required	and	process	methodologies	were	developed	accordingly.		
Initially,	 critical	 process	 parameters,	 associated	 with	 production	 of	 novel	 VLP	
constructs,	 were	 identified.	 In	 doing	 so,	 a	 need	 for	 a	 robust,	 high-throughput	
miniaturised	 fermentation	 platform	 was	 recognised.	 To	 accommodate	 such	 an	
approach,	 a	 high-throughput,	 non-contact,	 automated,	 small-scale,	 scalable	
disruption	 tool	was	developed	 to	extract	VLPs	 from	P.	pastoris.	Development	and	
optimisation	of	this	method	led	to	matching	and	even	outperforming	High	Pressure	
Homogenisation	performance.	
Having	 developed	 the	 prerequisite	 tools	 for	 miniaturised	 upstream	 process	
development,	 the	 use	 of	 microtitre	 plates	 for	 studying	 heterologous	 protein	
expression	was	 investigated.	This	proved	 to	be	challenging,	predominantly	due	 to	
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reduced	mass	transfer	capacity	 imposed	by	microtitre	plates	and	the	requirement	
of	controlled	methanol	 feeding.	The	use	of	pectin	digest	as	an	alternative	 indirect	
induction	agent	was	studied.	It	was	found	that	the	use	of	this	novel	media	resulted	
in	 the	 expression	 of	 heterologous	 protein,	 however,	 this	 effect	was	most	 likely	 a	
result	of	methanol	liberation	during	digest	preparation.	Due	to	the	requirements	of	
a	tightly	controlled	induction	process,	it	was	found	that,	microtitre	plates	provided	
an	unsuitable	platform	for	rapid	upstream	process	development	for	methylotrophic	
yeast.		
As	an	alternative	to	microtitre	plates,	the	effects	of	variance	of	previously	identified	
critical	 process	 parameters	 were	 studied	 to	 a	 greater	 extent	 using	 miniaturised	
bioreactors,	 initially	 with	 a	 simplified,	 non-epitope-exposing,	 variant	 of	 Tandem	
Core	 VLP.	 Metabolic	 responses,	 such	 as	 final	 biomass	 concentration,	 required	
significantly	 different	 optimum	 operating	 conditions	 than	 product	 expression	
responses.	 It	 was	 also	 found	 that	maximising	 expression	 of	 heterologous	 protein	
was	not	synonymous	to	maximising	the	production	of	VLPs.	
After	characterising	VLP	expression	in	miniaturised	bioreactors,	these	findings	were	
translated	to	industrially	relevant	universal	influenza	vaccine	production	scenarios.	
This	 was	 accomplished	 by	 investigating	 the	 effects	 of	 scale-up	 and	 variation	 of	
epitope	 inserts	 that	 could	 be	 utilised	 as	 a	 universal	 influenza	 antigens.	 Following	
this,	 the	 scale-up	 of	 fermentation	 processes	 and	 was	 studied.	 It	 was	 found	 that	
mixed	induction	with	glycerol	feeding	not	only	provided	a	better	basis	for	scale-up	
but	also	resulted	in	higher	product	titres	for	more	complex	VLP	constructs.		
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Impact	statement	
Characterising	the	expression	of	Tandem	Core	Virus-Like	Particles	in	P.	pastoris	has	gained:	
• Increased	 understanding	 in	 the	 potential	 and	 limitations	 of	 Tandem	 Core	
technology	 as	 an	 epitope	 scaffold	 for	 customisable	 vaccine	 development.	 This	
knowledge	will	pave	the	way,	not	only	to	a	universal	 influenza	vaccine	production	
process,	but	to	a	universal	production	process	for	vaccines	in	general.	
• Optimised	 and	 scalable	 processes	 for	 Tandem	 Core	 VLP	 production,	 allowing	 for	
scalable	and	maximum	vaccine	production	capacity.	This	is	particularly	beneficial	in	
the	event	of	a	pandemic	surge.		
• Increased	 understanding	 of	metabolic	 effects	 in	P.	 pastoris	 fermentations.	 These	
findings	could	translate	well	to	process	development	of	many	biopharmaceuticals	
• Multiple	 response	 models	 and	 correlations	 that	 can	 be	 used	 to	 predict	
performance	of	cell	disruption	using	high	pressure	homogenisers.	This	knowledge	
extends	to	extraction	of	VLPs	and	biopharmaceuticals	other	than	VLPs.		
• Development	 of	 a	 high-performance,	 high-throughput,	 non-contact,	 automated,	
small-scale,	 scalable	 disruption	 tool	 for	 microbial	 bioprocess	 development.	 The	
utility	of	this	work	means	that,	for	microbial	cultures	with	sizeable	cell	walls,	such	
as	 P.	 pastoris,	 an	 efficient	 scale-down	 tools	 is	 now	 available	 adding	 to	 the	
processing	 tools	 set.	 This	 can	 be	 used	 for	 a	 wide	 range	 of	 applications	 including	
buffer	 development,	 strain	 selection,	 fermentation	 process	 development	 and	
whole	bioprocess	integration.		
	
	
	 																																																																																										Benjamin	A.F.	Bláha	2018	
	 6	
	
	
	
	
	
“We	are	not	going	in	circles,	we	are	going	upwards.		
The	path	is	a	spiral;	we	have	already	climbed	many	steps.”			
-Hermann	Hesse,	Siddhartha	
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Chapter	1 Introduction	
1.1 Background	
The	 Cough	 of	 Perinthus,	 described	 in	 412	 BC	 by	 Hippocrates,	 is	 possibly	 the	 first	
name	 attributed	 to	 what	 is	 now	 known	 as	 influenza	 or	 flu	 (Martin	 and	 Martin-
Granel,	 2006;	 Monto	 and	 Sellwood,	 2013).	 Influenza	 has	 gained	 notoriety	
throughout	 history,	 with	 the	 Spanish	 Flu	 pandemic	 claiming	 more	 lives	 between	
1918	and	1920	than	the	preceding	Great	War	(Monto	and	Sellwood,	2013).	Despite	
many	advances	made	in	the	field	of	vaccine	development,	recent	deadly	outbreaks	
of	flu	variants	serve	as	unfortunate	reminders	that	pandemics	of	1918	proportions	
cannot	be	ruled	out	in	the	future.	Influenza	virus	remains	a	familiar	threat	to	public	
health	and	continues	to	challenge	the	scientific	community.	
Most	 challenging	 is	 responding	 to	 the	evolutionary	adaptability	of	 influenza	virus,	
which	often	hinders	 effective	prevention	or	 treatment	of	 influenza	 (Brooks	et	al.,	
2013).	Furthermore,	current	production	methods	are	logistically	and	technologically	
inadequate	 to	 cope	 with	 pandemic	 surges,	 leaving	 a	 considerable	 number	 of	
individuals	unprotected	during	such	events.	
This	chapter	aims	to	review	current	vaccine	technologies	and	introduce	the	reader	
to	 the	 development	 of	 a	 universal	 influenza	 vaccine	 based	 on	 Tandem	 Core	
technology	expressed	in	the	yeast,	P.	pastoris.	
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1.2 Influenza	Virology	
1.2.1 Viral	composition	
Figure	1.1	shows	a	general	structure	of	influenza	virus.	The	virus	is	pleomorphic	and	
is	approximately	100-150	nm	in	diameter.	Excluding	influenza	virus	C,	the	influenza	
genome	 consists	 of	 8	 sections1,	 encoding	 for	 ten	 genes2	(Brooks	 et	 al.,	 2013;	
Haaheim	and	Oxford,	2013).		
The	 virus	 particle	 is	 surrounded	 by	 a	 lipid	 bilayer,	 derived	 from	 the	 host	 cell’s	
plasma	membrane	and	consisting	of	a	variety	of	transmembrane	proteins	including	
hemagglutinin	(HA),	neuraminidase	(NA),	and	matrix	protein	2	(M2).	Supporting	the	
lipid	 bilayer	 is	 a	 matrix,	 composed	 of	 matrix	 1	 proteins	 (M1),	 that	 holds	 viral	
ribonucleoproteins	 (vRNPs).	 The	 vRNPs	 are	 composed	 of	 RNA,	 wrapped	 in	
nucleoprotein	 (NP)	 and	 relatively	 small	 amounts	 of	 nuclear	 export	 protein	 (NEP)	
also	 known	 as	 non-structural	 protein	 2	 (NS2).	 One	 type	 of	 vRNP	 is	 a	 polymerase	
complex	composed	of	three	polymerase	proteins:	polymerase	basic	protein	1	(PB1),	
polymerase	basic	protein	2	(PB2)	and	polymerase	acidic	protein	(PA)	(Samji,	2009;	
Brooks	et	al.,	2013;	Haaheim	and	Oxford,	2013)	
																																																						
1	Influenza	C	only	possesses	7	RNA	segments	and	hereby	lacks	the	gene	encoding	for	a	key	surface	
antigen:	neuraminidase	(Brooks	et	al.,	2013)	
2	If	 including	 a	 recently	 discovered	 gene	 encoding	 for	 the	 proapoptotic	 protein,	 PB1-F2,	 the	 total	
number	of	genes	would	be	11	(Chanturiya	et	al.,	2004;	Samji,	2009)	This	gene	is,	however,	absent	in	
certain	species	of	the	virus,	particularly	those	infecting	swine	(Chen	et	al.,	2001).	
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Figure	1.1	Schematic	of	influenza	virus	(Adapted	from	Virology	Blog,	2009)	3		
1.3 Mechanism	of	infection	
Figure	 1.2	 shows	 the	 lifecycle	 of	 influenza.	 After	 transmission	 of	 the	 virus	 into	 a	
host’s	 body,	 the	 virus	 attaches	 itself	 to	 the	 surface	 of	 host	 cell,	 preferably	 	 to	
epithelial	 cells	 in	 the	 respiratory	 tract	 (Brooks	 et	 al.,	 2013;	 Haaheim	 and	Oxford,	
2013)	 This	 attachment	 is	mediated	 by	 HA,	which	 binds	 to	 terminal	 sialic	 acids	 of	
glycolipids	and	glycoproteins	on	the	cell	surface.	HA	specificity	depends	 largely	on	
the	 type	 of	 linkage	 between	 sialic	 acid	 and	 the	 carbohydrates	 bound	 to	
glycoproteins	 or	 glycolipids.	 So-called	 α-2,6	 linkage	 is	 generally	 associated	 with	
human	 influenza	 virus,	 whereas	 α-2,3	 linkage	 is	 mostly	 associated	 with	 avian	 or	
equine	 influenza.	Hemagglutinin	associated	with	swine	 influenza	can	bind	strongly	
																																																						
3	Note	that	this	is	a	general	structure	for	influenza	genera	A	and	B,	not	C.	
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to	 both	 types	 of	 linkages	 (Skehel	 and	 Wiley,	 2000;	 Samji,	 2009;	 Haaheim	 and	
Oxford,	2013).		
	
Figure	1.2	Influenza	virus	lifecycle.	(A)	HA	binds	to	sialic	acid	leading	to	the	formation	of	
an	endosome.	(B)	Fusion	with	endosomal	membrane.	(C)	Transfer	of	viral	RNA	to	host	cell	
nucleus.	 (D)	 Replication	 of	 viral	 RNA.	 (E)	 Exportation	 of	 mRNA	 into	 the	 cytosol.	 (F)	
Translation	of	viral	mRNA	into	viral	proteins.	 (G)	Assembly	of	new	virus.	 (Adapted	from	
Imperial	College	London,	2000)	
Once	 the	 HA	 is	 bound	 to	 the	 cell	 surface,	 the	 cellular	 membrane	 encloses	 itself	
around	 the	 virus	 particle.	 This	 process,	 referred	 to	 as	 receptor-mediated	
endocytosis,	creates	a	vesicle	containing	the	virus	particle	inside	the	cell,	called	an	
endosome.	The	endosome	allows	entry	of	protons	creating	an	acidic	environment.	
This	adjustment	triggers	a	conformational	change	of	HA,	allowing	it	to	fuse	with	the	
endosomal	membrane,	which	exposes	 the	virus	matrix	 to	 the	host	cell	 cytoplasm.	
The	M2	protein,	which	 is	 an	 ion	 channel,	 also	opens	due	 to	 the	 acidic	 conditions	
within	 the	endosome,	allowing	 influx	of	protons,	 creating	acidic	 conditions	within	
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the	virus	particle.	This	 results	 in	 the	disassociation	of	vRNPs	with	M1	protein	and	
ultimately	 the	entry	of	vRNPs	 to	 the	cytoplasm	(Pinto,	Holsinger	and	Lamb,	1992;	
Samji,	2009;	Haaheim	and	Oxford,	2013).		
The	vRNPs	travel	to	the	host	cell	nucleus	after	they	are	released	into	the	cytoplasm.	
Much	 remains	 unknown	 about	 the	 mechanism	 by	 which	 this	 happens.	 What	 is	
known	 is	 that	some	regions	of	 the	NPs	 in	a	vRNP	 function	as	Nuclear	Localisation	
Signals	 (NLSs)	 that	 can	 bind	 to	 the	 cell’s	 nuclear	 import	 cascade	 (Wu,	 Sun	 and	
Pante,	2007).		
Once	 inside	 the	 cell	 nucleus,	 the	 vRNP	 complex	 uses	 its	 own	 enzymes	 to	 make	
positive	sense	cRNA	copies	of	the	negative	sense	vRNA	template.	Unlike	most	RNA	
polymerase,	 this	 particular	 viral	 polymerase	 does	 not	 require	 DNA	 as	 a	 template	
(Alberts	et	al.,	2004;	Crow	et	al.,	2004).	The	vRNP	instead	uses	its	RNA-dependent	
RNA	polymerase	(RdRp)	to	produce	positive	sense	RNA.	The	positive	sense	RNA	can	
then	 either	 be	 used	 as	 a	 template	 to	 produce	 negative	 sense	 RNA	 for	 progeny	
virions	 or	 can	 be	 altered	 to	 function	 as	messenger	 RNA	 to	 recruit	 virus	 proteins	
(Crow	et	al.,	 2004;	Haaheim	and	Oxford,	2013).	 In	 the	 latter	 case,	 for	 the	RNA	 to	
function	as	messenger	RNA,	it	needs	to	travel	from	the	nucleus	to	the	ribosomes	in	
the	cytoplasm	to	be	translated	to	protein.	Eukaryotic	mRNA	needs	to	be	modified	
before	 it	 can	 leave	 the	 nucleus	 and	 therefore	 undergoes	 two	 steps	 prior	 to	 this:	
RNA	capping	and	polyadenylation.	RNA	capping	involves	the	addition	of	a	guanine	
nucleotide	 with	 a	 methyl	 group	 at	 the	 5’	 end	 of	 the	 mRNA	 transcript.	
Polyadenylation	 involves	 the	 trimming	 of	 a	 particular	 sequence	 of	 nucleotides	 at	
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the	3’	end	of	the	mRNA	and	subsequent	addition	of	a	so-called	poly-A	tail,	which	is	
a	series	of	repeated	adenine	nucleotides	(Alberts	et	al.,	2004).	The	viral	genome	of	
influenza	mimics	 the	poly-A	 tail,	however,	 it	does	not	 contain	an	RNA	cap	 (Samji,	
2009).	To	circumvent	this	obstacle,	the	RdRp	complex	utilises	a	mechanism	referred	
to	 as	 ‘cap-snatching’,	 which	 involves	 cleaving	 the	 5’	 end	 of	 cellular	 mRNA	 and	
transferring	 this	 to	 the	 viral	 cRNA	 (Plotch,	 Bouloy	 and	 Krug,	 1979).	 Once	 new	
negative	 sense	 vRNA	 strands	 have	 been	 produced	 from	 the	 cRNA	 templates	 and	
have	 formed	 vRNPs	 they	 are	 exported	 out	 of	 the	 nucleus	 via	 the	 Crm1	 pathway.	
After	 sufficient	 viral	 genetic	 material	 and	 protein	 has	 been	 generated,	 the	 virus	
surface	 proteins	 (M2,	 HA	 and	 NA)	 assemble	 on	 the	 lumen	 of	 the	 host	 cell	
membrane.	 The	other	 viral	 proteins	 assemble	 themselves	 beneath,	 through	 a	 yet	
unclear	and	debated	process.	The	virus	particles	bud	and	are	subsequently	cleaved	
from	the	cellular	membrane	by	NA	(Samji,	2009;	Haaheim	and	Oxford,	2013).		
1.4 Viral	taxonomy	
Virus	classification	starts	at	the	order	taxon,	followed	by	the	family	taxon,	the	genus	
taxon	and,	finally,	the	species	taxon	(Cann,	2012).	
Influenza	viruses	are	single-stranded	ribonucleotide	(ssRNA)	viruses	that	are	part	of	
the	family	Orthomyxoviridae.	This	family	does	not	belong	to	an	assigned	taxonomic	
order	 and	 consists	 of	 six	 genera	 (Cann,	 2012;	 ICTV,	 2012).	 Influenza	 virus	 is	 the	
collective	name	assigned	to	three	genera	of	Orthomyxoviridae:	influenza	viruses	A,	
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B	and	C	(Cox	and	Hashimoto,	2011;	Haaheim	and	Oxford,	2013).	The	first	group	can	
be	divided	into	a	range	of	species	on	which	will	be	elaborated	further	on	in	this	text.	
1.4.1 Influenza	genera	
The	 first	 step	 in	 classifying	 a	 particular	 type	 of	 influenza	 virus	 is	 determining	 the	
genus	(A,	B	or	C).	
As	mentioned	earlier,	influenza	virus	C	lacks	the	gene	for	neuraminidase,	which	is	a	
major	determinant	of	 its	genus.	Further	distinctions	between	genera	can	be	made	
by	antigenic	variations	in	the	matrix	proteins	(M1	and	M2)	and	in	the	Nucleocapsid	
protein	(NP).	Because	these	genes	are	not	cross-reactive,	they	are	all	determinants	
of	the	genus	of	influenza	virus	(A,	B	or	C)	(Brooks	et	al.,	2013).	For	human	infection,	
influenza	A	and	B	are	of	greatest	concern.		
1.4.2 Species:	antigenic	drift	and	antigenic	shift	
To	 further	 understand	 the	 classification	 and	 nomenclature	 of	 influenza	 virus,	
particularly	 type	A,	 one	must	 consider	 the	phenomenon	of	 genetic	 reassortment.	
This	can	occur	in	two	ways,	called	antigenic	drift	and	antigenic	shift.	
Like	most	RNA	viruses,	the	influenza	virus	has	no	genetic	proofreading	mechanism,	
causing	 as	 much	 as	 10%	 of	 a	 virus	 population	 to	 be	 mutants.	 The	 mutations	
occurring	 in	 influenza	 virus	 often	 do	 not	 compromise	 the	 structure	 of	 proteins	
expressed.	 This	 is	 particularly	 true	 for	 the	 surface	 proteins	 HA	 and	 NA,	 where	
mutations	mainly	occur	on	the	outer	regions.	These	also	happen	to	be	the	regions	
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that	 interact	with	 antibodies	 upon	 infection	 of	 a	 host.	 Therefore,	when	 sufficient	
changes	occur	 in	 these	 regions,	 the	 adaptive	 immune	 system	 (1.5.2)	might	 fail	 to	
neutralise	 the	 infectious	agent,	 potentially	 leading	 to	an	epidemic	outbreak.	 Such	
an	accumulation	of	mutations	in	the	genes	coding	for	the	antibody-binding	sites	is	
referred	 to	 as	 antigenic	 drift	 and	 can	 manifest	 itself	 as	 new	 field	 variants	 of	
influenza	virus	(Haaheim	and	Oxford,	2013).	
More	 fundamental	 changes	 occur	 during	 another	mode	 of	 genetic	 reassortment:	
antigenic	 shift.	 This	 can	 occur	when	 two	 different	 influenza	 species	 co-infect	 the	
same	host,	as	 shown	 in	Figure	1.3.	Subsequently,	during	 the	assembly	of	progeny	
virions,	the	paternal	RNA	segments	can	mix.	Particularly	the	crossing	of	HA	and	NA	
encoding	genes	can	offer	the	virus	a	selective	advantage	because	it	can	broaden	the	
range	of	hosts	the	progeny	virus	can	infect.	This	could	be	because	different	varieties	
of	HA	and	NA	have	different	affinities	to	the	previously	mentioned	sialic	acid	linked	
receptors,	which	slightly	differ	per	host	type	(Haaheim	and	Oxford,	2013).	
Influenza	 virus	B	 and	 influenza	 virus	C	do	not	have	 related	 viruses	 existing	 in	 the	
same	 hosts.	 This	 is	 why	 antigenic	 shift	 occurs	 exclusively	 in	 influenza	 virus	 A	
serotypes.	 Therefore,	 only	 influenza	 virus	 A	 has	 designated	 subtypes,	 based	 on	
antigenic	 differences	 exhibited	 by	 HA	 and	 NA	 (Brooks	 et	 al.,	 2013).	 There	 are	
seventeen	 recorded	 subtypes	 of	 hemagglutinin	 (H1-H17)	 and	 ten	 subtypes	 of	
neuraminidase	 (N1-N10)	 (Tong	et	 al.,	 2012).	Only	 four	 subtypes	 of	 hemagglutinin	
(H1,	H2,	H3,	H5)	and	two	subtypes	of	neuraminidase	(N1,	N2)	have	been	recovered	
from	humans	(Brooks	et	al.,	2013).	
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1.4.3 Nomenclature	
The	 nomenclature	 of	 a	 particular	 influenza	 virus	 serotype	 shows	 the	 following	
information	in	the	following	sequence:	type	(A,	B	or	C),	host	animal	of	isolate	(not	
for	human	host),	geographic	origin	of	isolation,	strain	number,	year	of	isolation	and	
–	 only	 in	 the	 case	 of	 influenza	 virus	 A	 -	 the	 particular	 antigenic	 variations	 of	
neuraminidase	and	hemagglutinin.	Hence,	an	influenza	virus	A	isolate	from	a	person	
in	 Brisbane	 in	 2007	 can	 look	 like:	 A/Brisbane/	 1/68(H3N2);	 an	 influenza	 virus	 B	
isolate	can	be	named:	B/Brisbane/60/2008;	and	an	influenza	virus	A	isolate	from	a	
pig	 can	 be	 labelled	 as:	A/swine/lowa/15/30(H1N1)	 (Brooks	 et	 al.,	 2013;	 Haaheim	
and	Oxford,	2013).	
1.4.4 Seasonal	influenza	
Annual	 seasonal	 epidemics	 of	 influenza	 occur	 due	 to	 the	 previously	 explained	
antigenic	drifts	 in	viral	populations,	causing	slight	amino	acid	sequence	changes	 in	
HA	and	NA	epitopes	 (Chowell,	Nishiura	and	Bettencourt,	 2007).	 This	 can	 result	 in	
the	 immune	 system	 not	 recognising	 the	 novel	 surface	 proteins	 and	 can	 cause	
previously	 acquired	 immunity	 to	 become	 ineffective	 (Nicholson,	 Wood	 and	
Zambon,	2003).	
In	 the	 northern	 hemisphere	 influenza	 virus	 typically	 circulates	 from	November	 to	
March.	 Influenza	 usually	 circulates	 between	May	 and	 September	 in	 the	 southern	
hemisphere	 (Edlund	et	al.,	 2011).	However,	 in	 tropical	 regions,	 seasonal	 influenza	
occurs	 all	 year	 around	 and	 therefore,	 some	 argue,	 the	 term	 ‘inter-pandemic’	
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influenza	 is	 technically	 more	 appropriate	 (Lowen	 et	 al.,	 2007;	 Van-Tam	 and	
Sellwood,	2013).		
1.4.5 	Pandemic	influenza	
An	 influenza	 pandemic	 is	 typically	 rare,	 in	 comparison	 to	 seasonal	 outbreaks	 of	
influenza.	 Such	 an	 event	 can	 be	 defined	 as:	 ‘When	 a	 novel	 influenza	 A	 subtype	
spreads	 worldwide’	 (Van-Tam	 and	 Sellwood,	 2013).	 It	 should	 be	 stressed	 that	
seasonal	 influenza	and	pandemic	 influenza	are	not	separate	viral	entities,	but	can	
rather	 be	 seen	 as	 different	 stages	 in	 the	 evolution	 of	 the	 virus.	 For	 instance,	 the	
A(H1N1)	 virus	 which	 emerged	 in	 1918,	 caused	 the	 Spanish	 influenza	 pandemic	
lasting	until	1920	 (Monto	and	Sellwood,	2013).	However,	 seasonal	variants	of	 the	
A(H1N1)	 virus	 kept	 circulating	 until	 1956	 (Van-Tam	 and	 Sellwood,	 2013).	 These	
viruses	were	antigenic	drifted	version	of	the	1918	virus	that	had	lost	virulence,	due	
to	wide-scale	increase	of	immunity	among	the	general	population.		
Referring	 back	 to	 Van-Tam	 and	 Sellwood’s	 definitions	 of	 the	 term	 pandemic,	
‘novel’,	 in	this	context,	 is	used	to	describe	a	type	of	influenza	virus	that	the	public	
has	no	or	little	pre-existing	immunity	against.	Such	a	novel	type	of	virus	can	arise	via	
the	previously	explained	phenomenon	of	antigenic	shift.	Wading	birds	appear	to	act	
as	 reservoirs	 for	 strains	 for	 influenza	 A	 and,	 occasionally,	 through	 close	 contact,	
strains	can	jump	species	directly.	However,	it	is	more	common	that	a	third	species	
acts	as	an	 intermediary,	as	was	seen	 in	 the	2009	swine	 flu	pandemic	 (Monto	and	
Sellwood,	2013).	As	illustrated	by	Figure	1.3,	pigs	can	often	act	as	mixing	vessels	for	
influenza	A	viruses,	enabling	antigenic	shift	(Nicholson,	Wood	and	Zambon,	2003).	
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As	 previously	 discussed,	 this	 is	 because	 pigs	 have	 both	 α-2,6	 linkage	 and	 α-2,3	
linkage	in	the	respiratory	tract,	making	them	susceptible	to	both	avian	and	human	
influenza	(Haaheim	and	Oxford,	2013).	
	
Figure	1.3		Antigenic	shift	in	a	swine	host	
1.5 Immunology	
Immunity,	defined	as	the	active	ability	to	resist	disease,	exists	in	two	forms:	innate	
immunity	 and	 adaptive	 immunity.	 Innate	 immunity,	 also	 known	 as	 natural	
immunity,	is	largely	a	function	of	an	immediate	response	by	phagocytes.	This	class	
of	 white	 blood	 cells	 includes	 natural	 killer	 cells,	 macrophages	 and	 granulocytes;	
which	 engulf	 and	 kill	 most	 pathogens.	 The	 activation	 of	 the	 innate	 immune	
response	triggers	the	adaptive	immune	response	(Madigan	et	al.,	2009).	
Adaptive	immunity	is	arguably	more	complex	and	has	more	relevance	to	the	topic	
of	 vaccines.	 Unlike	 innate	 immunity,	 which	 is	 an	 immediate	 response,	 adaptive	
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Human ﬂu
Avian ﬂu
Pandemic ﬂu
	 																																																																																										Benjamin	A.F.	Bláha	2018	
	 43	
immunity	 is	 acquired	 over	 time	 and	 its	 response	 can	 be	 up	 to	 3	 to	 4	 days	 after	
infection	(Haaheim	and	Oxford,	2013).		
1.5.1 The	innate	immune	response		
Phagocytes	 are	 the	 major	 constituents	 of	 the	 innate	 immune	 response	 and	 can	
recognise	 pathogens	 via	membrane-bound	 Pattern-Recognition	Molecules	 (PRMs)	
also	known	as	Pattern-Recognition	Receptors	(PRRs)	(Madigan	et	al.,	2009;	Kreijtz,	
Fouchier	 and	 Rimmelzwaan,	 2011).	 Such	 a	molecule	 can	 interact	with	 a	 so-called	
Pathogen-Associated	Molecular	Pattern	(PAMP).	For	example,	Toll-Like	Receptor	4	
(TLR-4),	 a	 human	 PRM,	 interacts	 with	 lipopolysaccharide	 (LPS),	 which	 is	 an	
endotoxin	 characteristic	 to	 gram-negative	 bacteria.	 The	 specific	 PRM-PAMP	
interaction	 causes	 a	 transmembrane	 signal	 which	 triggers	 the	 transcription	 of	 a	
variety	of	proteins	 that	allow	the	digestion	of	 the	pathogen.	The	resulting	smaller	
pieces	of	this	digestion	are	called	antigens.	Once	a	phagocyte	presents	these	on	its	
outer	membrane,	the	cell	is	called	an	Antigen-Presenting	Cell	(APC),	which	will	then	
initiate	the	adaptive	 immune	response.	Note	that	not	only	phagocytic	cells	can	be	
APCs.	An	APC	is	simply	a	cell	displaying	an	antigen	(Madigan	et	al.,	2009).	
1.5.2 The	adaptive	immune	response	
A	progenitor	lymphoid	cell	can	give	rise	to	naïve	T-cells	and	naïve	B-cells.	Naïve	T-
cells	bear	T-Cell	Receptors	(TCRs),	which	can	bind	to	specific	antigens;	and	two	co-
receptors:	 CD4	 and	 CD8.	 A	 T-cell	 can	 differentiate	 to	 either	 a	 naïve	 CD4+	 T-cell,	
which	does	not	contain	the	CD8	receptor;	or	to	a	naïve	CD8+	T-cell,	which	lacks	the	
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CD4	receptor.	If	an	endogenous	antigen	binds	to	the	TCR	of	a	naïve	T-cell,	this	cell	
will	 be	 destroyed	 before	 it	matures.	 The	 previously	mentioned	 APCs	 can	 present	
antigens	 using	 one	 of	 two	 receptor	 classes:	 the	 class	 1	 Major	 Histocompatibility	
Complex	proteins	(MHC	I);	or	the	class	2	Major	Histocompatibility	Complex	proteins	
(MHC	II).	MHC	I	receptors	are	found	on	all	nucleated	non-phagocytic	cells,	whereas	
MHC	II	receptors	are	only	present	on	dedicated	phagocytic	APCs	such	as	dendritic	
cells	or	macrophages.	A	naïve	CD8+	T-cell	can	recognise	foreign	antigens	bound	to	
MHC	I	receptors	causing	the	T-cell	to	activate	to	a	cytotoxic-T	cell.	Cytotoxic-T	cells	
destroy	cells	that	are	presented	with	the	same	antigen	that	caused	their	activation.	
A	 naïve	 CD4+	 T-cell	 can	 recognise	 foreign	 antigens	 bound	 to	 MHC	 II	 receptors	
causing	the	T-cell	to	activate	to	a	T-helper	cell.	T-helper	cells	enhance	the	immune	
response	 by	 secreting	 cytokines	 that	 activate	 phagocytes,	 natural	 killer	 (NK)	 cells	
and	B-cells.			
Naïve	mature	B-cells	are	coated	in	pre-made	antibodies	that	can	bind	to	antigens.	A	
naïve	 mature	 B-cell	 initially	 functions	 as	 an	 APC	 by	 endocytosing	 and	 degrading	
these	antigens,	and	presenting	them	on	surface	MHC	II	proteins	to	a	subtype	of	T-
helper	 cells,	 a	 T-helper	 2	 (Th2)	 cell.	 This	 type	 of	 T-cell	 can	 activate	 the	 B-cell	 by	
secreting	cytokines,	interleukin-4	(IL-4)	and	interleukin-5	(IL-5),	causing	the	B-cell	to	
differentiate	into	a	memory	B	cell	or	a	plasma	cell.	Memory	B	cells	can	live	up	to	the	
order	of	years.	When	they	reencounter	the	immunising	agent	that	caused	them	to	
differentiate,	 they	 immediately	 turn	 into	plasma	cells	without	 the	assistance	of	T-
cells.	Plasma	cells	produce	antigen	specific	antibodies.	These	antibodies	can	prevent	
the	 agent	 from	 infecting	 other	 cells	 by	 blocking	 membrane	 proteins,	 by	
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enhancement	of	phagocytosis	(opsonisation)	and	by	recruiting	complement	protein	
that	causes	damage	to	the	infectious	agent	(Madigan	et	al.,	2009).	
1.5.3 Immune	response	to	influenza		
It	 is	 thought	 that	 there	 are	 several	 PRMs	 involved	 in	 the	 innate	 response	 to	
influenza	 virus	 infection.	 Toll-like	 receptor	 7	 (TLR-7),	 present	 in	 mainly	 dendritic	
cells,	 recognises	 single-stranded	 viral	 RNA	 (Kreijtz,	 Fouchier	 and	 Rimmelzwaan,	
2011).	Retinoic	acid	inducible	gene	I	(RIG-I)	recognises	5’-triphosphates	in	genomics	
single	stranded	RNA,	which	appear	after	infection	of	the	host	cell	(Pichlmair	et	al.,	
2006;	 Pang	 and	 Iwasaki,	 2011).	 Toll-like	 receptor	 3	 (TLR-3)	 bind	 double-stranded	
viral	RNA.	These	interactions	induce	a	cascade,	resulting	in	the	production	of	certain	
interferons	 and	 cytokines	 that	 inhibit	 protein	 production	 in	 host	 cells	 and,	
therefore,	 limit	 viral	 replication.	 They	 also	 stimulate	 dendritic	 cells	 and	 thereby	
promote	 antigen	 presentation	 to	 CD4+	 and	 CD8+	 T-cells,	 and	 ultimately	 viral	
clearance	and	immune	memory	(Kreijtz,	Fouchier	and	Rimmelzwaan,	2011).		
It	is	important	to	note	that,	although	the	immune	system	aims	to	protect	the	body	
from	 pathogens,	 paradoxically,	 it	 is	 often	 the	 cause	 of	 illness	 and	 death	 after	
exposure	 to	 these	 pathogens.	 For	 instance,	 it	 is	 thought	 the	 majority	 of	 deaths	
during	 the	 Spanish	 influenza	 pandemic	 were	 caused	 by	 an	 overactive	 immune	
response,	manifesting	in	a	so-called	cytokine	storm	(Nicholson,	Wood	and	Zambon,	
2003).	
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1.5.4 Immunogenicity	
There	 is	 a	 difference	 between	 antigens	 and	 so-called	 immunogens	 and	 the	
distinction	 between	 these	 terms	 is	 very	 relevant	 to	 the	 project.	 Antigens	 are	
substances	 that	 interact	 with	 TCRs	 or	 antibodies.	 This	 does	 not	 mean	 that	 this	
interaction	always	induces	an	immune	response.	It	must	therefore	be	stressed	that	
an	antigen	that	triggers	an	immune	response	is	called	an	immunogen.	
There	 are	 several	 intrinsic	 factors	 that	 determine	 whether	 an	 antigen	 is	
immunogenic.	
The	first	is	molecular	size:	generally,	the	larger	an	antigen,	the	more	likely	it	is	to	be	
immunogenic.	For	example,	haptens,	which	are	low-molecular	weight	compounds,	
can	interact	with	antibodies,	but	do	not	elicit	an	immune	response.	However,	once	
these	are	coupled	to	a	protein	carrier,	and	thereby	forming	a	larger	molecule,	these	
haptens	become	immunogenic.	
Molecular	 complexity	 is	 another	 important	 indication	 of	 immunogenicity.	 Non-
repeating	polymers	such	as	proteins	and	complex	carbohydrates	are	often	effective	
immunogens,	 unlike	 less	 complex	 molecules,	 such	 as	 lipids	 and	 simple	
polysaccharides	(Madigan	et	al.,	2009).	
Another	 important	 indicator	 of	 immunogenicity	 is	 the	 physical	 structure	 of	 the	
molecule.	Generally	 insoluble	macromolecules	or	protein	aggregates	elicit	 greater	
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immune	 response	 than	 the	 individual,	 soluble	 alternatives.	 This	 is	 because	
phagocytes	are	better	at	ingesting	the	former	form.	
There	are	also	several	extrinsic	factors	that	contribute	to	immunogenicity.		The	dose	
of	 immunogen	 is	 a	 very	 important	 factor.	Generally,	 doses	 between	10µg	 and	1g	
are	effective.	Anything	outside	this	range	may	cause	tolerance	and	can	suppress	a	
specific	 immune	 response.	 Another	 extrinsic	 factor	 is	 the	 ability	 of	 the	 immune	
system	to	recognise	an	antigen	as	foreign.	Also,	the	route	of	administration	has	an	
effect	 on	 immunogenicity.	 For	 example,	 orally	 administered	 immunogens	 can	
degrade	significantly	before	being	 taken	up	 into	 the	bloodstream	(Madigan	et	al.,	
2009).		
1.6 Pharmaceutical	interventions	against	influenza	
1.6.1 Antiviral	drugs		
Pharmaceutical	 interventions	 are	 at	 hand	 if	 influenza	 infection	 cannot	 be	
prevented.	There	are	two	types	of	antiviral	drugs	targeted	at	influenza:	M2	channel	
blockers	(adamantanes);	and	neuraminidase	inhibitors	(Van-Tam	and	Lim,	2013).	
M2	channel	blockers	prevent	vRNA	from	entering	a	host	cell.	There	are	two	types	of	
channel	 blockers,	 both	 only	 active	 against	 influenza	 A	 viruses:	 Amantadine	
(Lysovir®,	 Symadine®)	 and	 Rimantadine	 (Flumadine®).	 Side	 effects	 of	M2	 channel	
blockers	 mainly	 involve	 the	 central	 nervous	 system,	 including	 anxiety,	 dizziness,	
concentration	difficulty	and	insomnia	(Sorrell	et	al.,	2011;	Van-Tam	and	Lim,	2013)	
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Neuraminidase	 inhibitors	 prevent	 the	 release	 of	 progeny	 virions	 from	a	 host	 cell.	
(Haaheim	 and	Oxford,	 2013).	 There	 are	 four	 NA	 inhibiting	 compounds:	 zanamivir	
(Relenza®),	 oseltamivir	 (Tamiflu®),	 peramivir	 (Rapiacta®,	 Peramiflu®)	 and	
laninamivir	(Inavir®)	(Van-Tam	and	Lim,	2013).		The	effectiveness	of	these	antivirals	
can	 vary	 widely	 and	 is	 dependent	 on	 the	 strain	 of	 influenza	 itself.	 In	 the	 2009	
pandemic,	 antivirals	 such	 as	 zanamivir	 and	 oseltamivir	 were	 utilised	 in	 the	 early	
stages	of	the	pandemic,	but	to	little	effect	(Kawai	et	al.,	2009).		
1.6.2 Vaccines	
Vaccination	 is	 still	 considered	 the	 gold	 standard	 in	 protecting	 against	 influenza.	
There	are	various	ways	to	prime	the	immune	system	for	future	influenza	infections.	
All	methods	of	 influenza	vaccination	involve	varying	presentations	of	antigens	and	
are	 listed	 below.	 For	 influenza,	 these	 antigens	 are	 almost	 exclusively	HA,	NA	 and	
M2	or	derivatives	of	these	surface	proteins.	
Seasonal	 influenza	vaccines	are	 commonly	a	 trivalent	dose,	 containing	derivatives	
from	 three	 different	 strains	 of	 influenza	 A	 and	 B	 viruses	 to	 account	 for	 annual	
antigenic	drift	(Wolff	and	Reichl,	2008;	WHO,	2009).	However,	the	vaccine	industry	
is	 in	 the	process	 of	moving	 to	 a	 quad-valent	 vaccine	 that	will	 protect	 against	 the	
two	most	common	A	strains	and	two	B	strains	of	influenza.	The	standard	dosage	of	
vaccines	is	typically	15µg	per	strain	(CDC,	2018).		
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1.6.2.1 Live,	attenuated	virus	vaccines	
Modifying	or	reassortment	of	a	‘wild	type’	pathologic	virus,	also	known	as	reverse	
genetics,	produces	a	class	of	vaccines,	referred	to	as	live	attenuated	virus	vaccines	
(Neumann,	Ozawa	and	Kawaoka,	2012).	The	result	is	a	virus	that	maintains	its	ability	
to	 replicate	 and	 cause	 an	 immune	 response	 however,	 usually,	 without	 causing	
disease.	In	the	case	that	disease	is	caused	by	an	attenuated-type	vaccine,	symptoms	
are	 weaker	 and	 are	 generally	 referred	 to	 as	 adverse	 reactions	 (CDC,	 2011).	
Attenuated	viruses	generate	the	strongest	and	longest	acting	immune	response	out	
of	 all	 vaccine	 classes.	 However,	 they	 are	 unsuitable	 for	 immunocompromised	
individuals	 and	 carry	 the	 theoretical	 risk	 of	 pathogenic	 reversion.	 Also,	 it	 is	 very	
difficult	 to	 standardise,	maintain	and	 select	 certain	 strains	 (Madigan	et	al.,	 2009).	
This	is	particularly	difficult	with	influenza	virus,	due	to	its	high	mutability.	
MedImmune	have	licensed	a	live	attenuated	vaccine	that	can	only	replicate	at	25°C.	
This	cold-adapted	virus	is	therefore	isolated	in	the	nasopharynx	and	cannot	spread	
to	the	lungs	(EMA,	2013).		
1.6.2.2 Inactivated	influenza	vaccines	
This	 class	 of	 vaccine	 involves	 the	 expansion	 of	 the	 pathogen	 in	 question	 in	 a	
particular	host.	In	the	case	of	influenza	virus	vaccine	production	this	is	achieved	in	
the	allantoic	 fluid	of	 fertilised	chicken	eggs.	After	harvesting	this	 fluid,	 the	virus	 is	
inactivated,	 disabling	 replication.	 This	 is	 typically	 achieved	 using	 detergents.	 The	
virus	fragments	recovered	from	this	process	are	subsequently	treated	to	ensure	any	
genetic	material	has	been	removed.	The	resulting	inactivated	vaccine	is	specifically	
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referred	to	as	a	split-virion	vaccine	(Nakayama	et	al.,	2012).	If	the	former	fraction	is	
further	purified	to	obtain	a	higher	concentration	of	antigen	(typically	HA	and	NA),	
by	 removing	more	 internal	 viral	 proteins,	 the	 resulting	 vaccine	 is	 referred	 to	 as	 a	
subunit	 vaccine	 (College	 of	 Physicians	 of	 Philadelphia,	 2014;	 Talbot	 et	 al.,	 2015).	
Overall,	 inactivated	 virus	 vaccines	 generally	 yield	 relatively	 short-lived	 immune	
responses	(Madigan	et	al.,	2009).	
1.6.2.3 Virus-like	particle	vaccines	
Virus-like	 particles	 (VLPs)	 are	 structures	 consisting	 of	 multiple	 proteins	 that	 are	
arranged	 to	 collectively	 mimic	 authentic	 native	 viruses.	 Although	 a	 VLP	 typically	
contains	nucleotides	originating	 from	 its	host	expression	 system	 (i.e.	a	genetically	
engineered	 microbe),	 a	 VLP	 is	 not	 considered	 infectious	 because	 it	 lacks	 viral	
genomic	material	(Roldão	et	al.,	2010).	
Compared	to	individual	viral	peptides	or	proteins,	VLPs	present	epitopes	that	have	
more	conformational	similarity	to	the	native	virus.	As	these	multiprotein	structures	
mimic	the	conformation	and	organisation	of	authentic	native	viruses,	 the	 immune	
response	is	expected	to	be	higher	than	for	individual	peptides	or	proteins	(Roldao	et	
al.,	2010).	Most	vaccine	classes	are	formulated	with	adjuvants	to	enhance	immune	
response.	VLPs	usually	have	highly	repetitive	surfaces,	which	allow	cross-linking	on	
specific	B-cell	receptors.	VLPs	can	therefore	induce	strong	B-cell	responses,	without	
requiring	adjuvant	(Jegerlehner	et	al.,	2002;	Roldão	et	al.,	2010).	VLPs	can	also	be	
employed	as	a	scaffold	to	bear	one	or	several	antigens.	This	can	enable	broader	and	
more	efficient	protection.	The	potency	of	such	VLPs	triggers	relatively	high	immune	
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responses,	while	using	lower	amounts	of	antigen,	potentially	reducing	vaccine	costs	
significantly	(Roldão	et	al.,	2010).		
1.6.3 Adjuvants	
Some	antigens,	especially	smaller	targets,	can	be	poorly	 immunogenic	and	require	
further	 assistance	 to	 achieve	 the	 right	 levels	 of	 immuno-stimulation.	 Thus,	
adjuvants	 are	 often	 added	 to	 the	 formulated	 vaccine	 product.	 Adjuvants	 are	
substances	 that	 cause	 a	 non-specific	 immune	 enhancement,	making	 the	 immune	
system	 more	 receptive	 to	 the	 accompanying	 vaccine	 (National	 Research	 Council	
Canada,	 2010).	 Adjuvants	 come	 in	 many	 forms,	 from	 bacterial	 toxins	 to	 non-
biological	agents	such	as	aluminium	hydroxide	(Glaxo	Smith	Kline,	2005).		
1.7 Vaccine	production	
Once	candidate	viral	strains	has	been	selected	based	on	recommendations	from	the	
World	 Health	 Organisation	 (WHO),	 candidate	 high-growth	 seed	 strains	 are	
distributed	to	various	collaborating	centres,	depending	of	the	region	(Gerdil,	2003).	
Manufacturers	 can	use	 these	 recommendations	 to	prepare	a	 range	of	vaccines.	A	
selection	of	methods	of	vaccine	production	is	described	below.		
1.7.1 Fertilised	chicken	egg-derived	vaccine	production	
The	 most	 widely	 used	 method	 for	 vaccine	 production	 involves	 injecting	 live	
influenza	 viruses	 into	 the	 amniotic	 sack	 of	 a	 nine	 to	 twelve-day	 old	 fertilised	 egg	
(WHO,	2009;	Cox	and	Hashimoto,	2011).	Each	egg	typically	yields	one	to	two	doses	
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of	 vaccine	 (Layton	 and	 Lenfestey,	 2005b).	 After	 an	 incubation	 period	 of	 up	 to	 72	
hours,	 the	 virus	 or	 virus	 derivative	 is	 harvested	 (Tree	et	 al.,	 2001;	 Roland,	 2014).		
Eggs	 are	 generally	 used	 to	 produce	 live	 attenuated	 vaccines	 or	 inactivated	 virus	
vaccines	(Palache,	Brands	and	van	Scharrenburg,	1997;	Wolff	and	Reichl,	2008).		
1.7.1.1 Bioprocessing		
The	 following	 describes	 one	 possible	method	 to	 purify	 egg-derived	 vaccines.	 The	
allantoic	 fluid	 of	 the	 embryo	 is	 harvested	 and	 is	 subsequently	 clarified	 by	
centrifugation.	Using	tangential	 flow	ultrafiltration,	the	volume	of	the	supernatant	
is	 reduced.	 The	 retained	 virus	 is	 then	 resuspended	 overnight	 in	 Ca-Mg-saline	
solution.	 This	 suspension	 is	 subsequently	 loaded	 onto	 a	 sucrose	 gradient	 and	
centrifuged,	 which	 allows	 the	 virus	 to	 be	 pooled	 and	 collected	 (Liu	 et	 al.,	 1995).	
There	are,	however,	a	number	of	ways	to	purify	a	vaccine.	For	 instance,	on	 larger	
scales,	 the	 latter	 step	might	 not	 always	 be	 feasible	 and	 can	 be	 substituted	 by	 a	
variety	of	 chromatographic	 steps	 (Wolff	and	Reichl,	2008).	 Figure	1.4	outlines	 the	
methods	to	which	various	downstream	objectives	can	be	achieved.		
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Figure	 1.4	 Downstream	 process	 of	 egg	 and	mammalian	 cell	 derived	 vaccines	 (adapted	
from	Wolff	and	Reichl,	2008).	
1.7.1.2 Advantages	and	disadvantages	
Vaccines	have	been	produced	in	fertilised	eggs	for	a	long	time.	It	is	therefore	a	well-
established	and	widely	approved	process.		
However,	 there	 are	 a	 significant	 number	 of	 disadvantages	 to	 this	 particular	
production	platform.	Due	to	the	general	requirement	of	vaccine	tri-valency	or	quad-
valency;	multiple	eggs	are	required	for	a	single	dose	of	vaccine.	Therefore,	prior	to	
vaccine	production,	a	considerable	number	of	 fertilised	eggs	need	 to	be	supplied.	
The	 supply	 of	 such	 an	 amount	 of	 eggs	 can	 take	 up	 to	 six	 months	 and	 poses	 a	
significant	limit	to	the	scalability	of	vaccine	production	(Gerdil,	2003).	Furthermore,	
post-translation	 mechanisms	 can	 alter	 the	 composition	 of	 wild	 type	 human	 HA	
expressed	in	hens’	eggs	(Oxford	et	al.,	1987,	1991;	Robertson	et	al.,	1987)	leading	to	
relatively	lower	immune	responses	and	decreased	efficacy	of	vaccines	produced	in	
this	fashion	(Wood	et	al.,	1989;	Tree	et	al.,	2001).	Additionally,	residual	egg	albumin	
in	 egg-derived	 vaccines	 is	 known	 to	 cause	 allergic	 reactions	 in	 some	 individuals	
Clariﬁcation Concentration Inactivation
Nuclease TreatmentSeparationPolishing
Centrifugation/ 
Ultraﬁltration/
Precipitation/ 
Membrane 
adsorbance
Centrifugation/
Depth ﬁltration
Formalin/ BEI/ 
beta-PL
Benzonase
Ultra-
centrifugation/ 
Chromatography/ 
Membrane 
adsorbance
Ultraﬁltration/
diaﬁltration
	 																																																																																										Benjamin	A.F.	Bláha	2018	
	 54	
(Nayak,	 Lehmann	 and	 Reichl,	 2005).	 A	 significant	 disadvantage	 is	 that	 this	
production	method	 can	be	highly	unsuitable	 for	 avian	 related	 influenza	A	 vaccine	
production.	For	instance,	the	avian	related	H5N1	influenza	A	strain	of	1997	showed	
a	 mortality	 rate	 of	 70%-100%	 in	 chickens	 (Cox	 and	 Hashimoto,	 2011).	 Chicken	
embryos	 used	 for	 the	 production	 of	 a	 vaccine	 against	 this	 virus	 were	 therefore	
killed	before	significant	amounts	of	vaccine	could	be	produced.		
Much	 of	 the	 industry	 has	 established	 capacity	 in	 egg-based	 vaccine	 production.	
Economic	 drivers	 are	 not	 yet	 present	 to	 warrant	 a	 shift	 from	 this	 established	
process.	The	reasons	for	this	are	a	combination	of	high	costs	and	risk;	and	low	profit	
margins:	The	majority	of	costs	of	developing	and	producing	a	new	vaccine	will	be	
dedicated	to	research	and	development;	and	demonstrating	safety	and	efficacy	 in	
clinical	 trials.	Secondly,	parties	who	buy	 the	vaccine,	predominantly	governments,	
typically	offer	a	buying	price	that	only	covers	the	cost	of	producing	a	single	dose	of	
vaccine.	For	 instance,	 in	 the	2004-2005	 influenza	season	 in	 the	United	States,	 the	
highest	 recorded	wholesale	price	of	 influenza	 vaccines	was	USD	8.50	 (Layton	and	
Lenfestey,	2005a).		
1.7.2 Vaccine	production	in	mammalian	cells	
As	 with	 fertilised	 eggs,	 mammalian	 cells	 are	 generally	 used	 to	 produce	 live	
attenuated	 vaccines,	 inactivated	 virus	 vaccines	 or	 split	 virion	 vaccines	 (Palache,	
Brands	and	van	Scharrenburg,	1997;	Wolff	and	Reichl,	2008).	There	are,	however,	
instances	 where	 subunit	 and	 VLP	 vaccines	 are	 produced	 using	 this	 expression	
	 																																																																																										Benjamin	A.F.	Bláha	2018	
	 55	
system	(SzymczakiewiczMultanowska	et	al.,	2009;	Wu	et	al.,	2010).	A	variety	of	
mammalian	 cell	 lines	 can	 be	 used	 for	 the	 production	 of	 vaccines.	 	 Popular	
expression	systems	are	Madin-Darby	canine	kidney	(MDCK)	cells	and	African	green	
monkey	kidney	(Vero)	cells,	due	to	their	ability	to	produce	high	virus	titres	(Merten	
et	al.,	1996;	Tree	et	al.,	2001).		
1.7.2.1 Bioprocessing		
Mammalian	cells	can	be	cultured	in	serum	or	serum-free	medium.	As	with	eggs,	the	
cells	are	infected	with	virus.	HA	screening	can	be	employed	to	monitor	virus	activity	
during	 growth	 and	 the	 number	 of	 live	 viruses	 can	 be	 measured	 by	 solid	 plaque	
assays	 (Mahy,	 1985;	 Tree	 et	 al.,	 2001).	 Once	 the	 required	 amount	 of	 virus	
production	has	been	determined	and	cultures	have	been	appropriately	diluted,	the	
cultures	are	further	expanded	by	inoculating,	for	example,	roller	bottles	or	spinner	
flasks	 containing	micro-carriers.	 For	 larger	 scale	production,	micro-carriers	 can	be	
used	(Genzel	et	al.,	2004;	Genzel,	Fischer	and	Reichl,	2006;	Chen	et	al.,	2010).		
The	downstream	processing	of	mammalian	 cell-derived	 vaccines	 is	 very	 similar	 to	
that	of	fertilised	egg-derived	vaccines	(Figure	1.4).	
1.7.2.2 Advantages	and	disadvantages	
Vaccine	 production	 in	 mammalian	 cells	 offers	 numerous	 advantages	 to	 vaccine	
production	in	fertilised	eggs.	Mammalian	cell-derived	vaccines	have	been	shown	to	
trigger	 similar	 immune	 responses	 as	 naturally	 circulating	 strains	 (Nerome	 et	 al.,	
1999)	and	have	shown	to	be	safe	and	efficacious	 in	clinical	studies	(Palache	et	al.,	
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1999;	 Percheson	 et	 al.,	 1999).	 Furthermore,	 mammalian	 cell-derived	 vaccine	
production	is	scalable	and	can	employ	the	use	of	well-characterised	and	stable	cell	
lines;	 simplifying	 the	 logistics	 of	 production	 in	 comparison	 to	 the	 use	 of	 eggs.	
Therefore,	processing	time	for	mammalian	cell-derived	vaccines	is	significantly	less	
than	that	of	egg-derived	vaccine	production.		
Generally,	the	use	of	live	influenza	viruses	is	required	in	this	expression	system	and	
poses	 significant	 risks	 with	 respect	 to	 biological	 containment.	 Also,	 the	 risk	 of	
contamination	by	pathological	agents	 is	 increased	when	the	use	of	animal	derived	
products,	such	as	serum,	is	required	(Nims,	2006;	Chen	et	al.,	2008).	Furthermore,	
the	 productivity	 of	 the	 process	 depends	 heavily	 on	 the	 cell	 line	 employed.	 In	
addition,	a	reassortant	virus,	which	contains	genes	from	two	parental	viruses,	often	
needs	 be	 employed	 to	 achieve	 high	 productivity	 (Tree	 et	 al.,	 2001;	 Cox	 and	
Hashimoto,	2011;	Ellis,	Rappuoli	and	Ahmed,	2013).		
1.7.3 Vaccine	production	in	Escherichia	coli		
E.	 coli	 is	 a	 popular	 expression	 system	 for	 a	 variety	 of	 recombinant	 proteins.	
Influenza	 viruses	 cannot	 use	 this	 prokaryotic	 organism	as	 a	 host	 and	 therefore	E.	
coli-derived	vaccines	are	limited	to	those	of	the	subunit	and	VLP	classes.			
One	current	method	being	developed	for	the	production	of	influenza	vaccines	is	the	
production	of	M2e	fusion	proteins	in	E.	coli	(Fiers	et	al.,	2009;	Kim	et	al.,	2013;	Deng	
et	al.,	2015).	M2e	is	the	outer	domain	of	the	M2	protein	and	is	23	amino	acids	long.	
The	 M2	 ectodomain	 is	 highly	 conserved	 and	 cross-reactive,	 making	 it	 a	 good	
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candidate	 for	 a	 universal	 vaccine.	 However,	 low	 immune	 responses	 to	 this	
particular	antigen	not	exerting	any	evolutionary	pressure	on	the	sequence	could	be	
the	cause	of	this	high	conservation.		Because	of	this	low	immune	response,	M2e	has	
to	be	fused	with	more	immunogenic	antigens	such	as	VLPs,	for	example	Hepatitis	B	
core	protein	(HBc),	 formed	by	the	Hepatitis	B	virus	(Fiers	et	al.,	2009;	Deng	et	al.,	
2015);	or	flagellin	(Huleatt	et	al.,	2008).		
1.7.3.1 Bioprocessing		
The	expression	of	M2e-flagellin	fusion	protein	in	E.	coli,	described	by	Huleatt	et	al.	
(2008)	 will	 be	 discussed	 to	 illustrate	 upstream	 production	 of	 microbial-derived	
recombinant	vaccines.		
Initially,	a	DNA	construct	is	created	consisting	of	4	tandem	copies	of	M2e	fused	to	
the	Salmonella	typhimurium	flagellin	fljB	(STF2)	gene.	The	resulting	plasmid	is	then	
inserted	into	competent	E.	coli	cells.	The	transformed	E.	coli	cells	are	subsequently	
expanded	 through	 large-scale	 fermentation,	 which	 is	 a	 well-established	 process		
(Hewitt	et	al.,	2000;	Huleatt	et	al.,	2008).		
At	 the	 end	 of	 the	 fermentation	 process,	 the	 cells	 are	 harvested	 through	
centrifugation.	 The	 sediment	 is	 resuspended	 and	 lysed	 in	 buffer	 containing	
lysozyme	 and	 a	 protease	 inhibitor	 cocktail.	 This	 mixture	 will	 facilitate	 lysis	 while	
minimising	 proteolytic	 cleavage	 of	 the	 product.	 Following	 lysis,	 the	 suspension	 is	
centrifuged	to	separate	cell	debris	and	other	insoluble	materials.	The	supernatant	is	
subsequently	 passed	 through	 a	 depth	 filter	 to	 protect	 chromatographic	 columns	
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further	 downstream.	 The	 first	 chromatographic	 step	 is	 a	 gradient	 ion	 exchange	
separation	 that	 captures	 the	 product.	 To	 remove	 endotoxin,	 Size	 Exclusion	
Chromatography	 is	 used.	 The	 final	 stages	 of	 downstream	 processing	 include	
ultrafiltration	and	sterile	 filtration	 for	 formulation	 (Huleatt	et	al.,	2008;	Wolff	and	
Reichl,	2008;	Josefsberg	and	Buckland,	2012).	The	process	is	summarised	in	Figure	
1.5.	
	
Figure	1.5	Schematic	overview	of	 the	production	process	 for	 the	manufacturing	of	M2e	
fusion	 proteins.	 (A)	 Fermentation.	 (B)	 Harvest	 centrifugation.	 (C)	 Cell	 lysis.	 (D)	
Clarification	 centrifugation.	 (E)	 Depth	 filtration.	 (F)	 Gradient	 ion	 exchange	
chromatography.	(G)	Size	Exclusion	Chromatography.	(H)	Diafiltration.	(I)	Sterile	filtration.		
1.7.3.2 Advantages	and	disadvantages	
E.	coli	is	one	of	the	most	characterised	organisms	in	the	field	of	biochemistry.	Also,	
in	 comparison	 to	 any	 other	 expression	 system,	 E.	 coli	 grows	 fast	 and	 is	 highly	
productive.	These	particular	characteristics	make	E.	coli	an	excellent	candidate	for	
vaccine	production	in	the	event	of	a	pandemic	surge.	Furthermore,	E.	coli	 is	easily	
transformed	and	upstream	production	is	relatively	cost-effective	(Verma,	Boleti	and	
George,	1998).		
However,	 recombinant	 type	 vaccine	 production	 in	 E.	 coli	 can	 also	 result	 in	
unpredictable	 clinical	 efficacy	 and	 safety.	 It	 has	 been	 reported	 that	 after	 the	
vaccination	of	pigs	with	a	fusion	protein	of	M2e	and	influenza	nucleoprotein	(M2e-
NP),	 the	 vaccine	 aggravated	 influenza	 symptoms	 rather	 than	 preventing	 them	
A B C D E F G H I
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(Heinen	 et	 al.,	 2002).	 Furthermore,	 E.	 coli	 produces	 endotoxin,	 which	 can	 cause	
inflammatory	reactions	 if	not	removed	from	a	vaccine.	Finally,	E.	coli	can	be	quite	
restrictive	 as	 an	 expression	 system	 for	 more	 complex	 recombinant	 mammalian	
proteins	because	 it	does	not	possess	the	post-translational	modification	pathways	
required	(Verma,	Boleti	and	George,	1998).	To	date,	no	 licensed	 influenza	vaccine	
has	been	produced	in	E.	coli.		
1.7.4 Vaccine	production	in	insect	cells	
On	 October	 22	 2013	 Protein	 Sciences	 Corporation’s	 “FluBlok”	 seasonal	 influenza	
vaccine	 was	 FDA	 approved	 and	 is	 currently	 marketed	 throughout	 the	 U.S.(FDA,	
2013;	Protein	Sciences	Corporation,	2013).	It	is	the	first	influenza	vaccine	produced	
in	insect	cells.		
1.7.4.1 Bioprocessing		
The	 vaccine	 consists	 of	 trivalent	 recombinant	 hemagglutinin	 (rHA)	 proteins	
produced	in	Spodoptera	frugiperda.	This	is	one	of	the	most	popular	insect	host	used	
in	 industry	 for	 the	 production	 of	 recombinant	 proteins	 (Summers,	 Smith	 and	
Station.,	 1987).	 The	 rHA	 is	 expressed	 in	 the	 insect	 cells	 through	 infection	 with	
baculovirus,	a	popular	 insect	expression	 system	 (Verma,	Boleti	 and	George,	1998;	
Cox	and	Hashimoto,	2011).	First	a	HA	gene	is	cloned	using	RT-PCR	resulting	in	RNA	
being	transcribed	to	cDNA.	The	DNA	is	subsequently	introduced	into	a	baculovirus	
vector	 developed	 by	 Protein	 Sciences	 Corporation	 (Protein	 Sciences	 Corporation,	
2013).	Using	calcium	phosphate	precipitation,	the	vector	is	inserted	into	Spodoptera	
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frugiperda	 Sf9	 cells	 together	 with	 linearised	 genomic	 Autographa	 californica	
nucleopolyhedrovirus	(AcMNPV)	DNA	to	enable	homologous	recombination.		
After	 fermentation,	 the	 infected	 cells	 are	 harvested	 and	 separated	 from	 the	
medium	using	disk	stack	centrifugation.	After	the	pellet	is	collected,	it	is	exposed	to	
a	non-ionic	detergent	 in	order	 to	dissolve	 the	 insect	membranes.	A	depth	 filter	 is	
subsequently	used	to	remove	cell	debris.	This	is	followed	by	three	chromatographic	
processes.	The	first	is	a	cation	exchange	process	(CEX),	which	captures	the	vaccine	
product	 and	 other	 protein	 contaminants.	 The	 second	 process	 is	 Hydrophobic	
Interaction	 Chromatography	 (HIC),	 which	 retains	 rHA	 and	 discards	 protein	
contaminants.	 The	 third	 and	 final	 chromatography	 step	 is	 a	 Q-membrane,	 which	
removes	nucleotides.	Finally,	the	eluate	passes	through	an	ultrafiltration	module	for	
formulation.		The	process	is	summarised	in	Figure	1.6.		
	
	Figure	1.6	Schematic	overview	of	 the	production	process	 for	 the	manufacturing	of	 rHA	
(adapted	 from	Blaha	et	al.,	 2012).	 (A)	 Fermentation.	 (B)	Harvest	 centrifugation.	 (C)	Cell	
lysis.	 (D)	 Clarification	 centrifugation.	 (E)	 Depth	 filtration.	 (F)	 Cation	 exchange	
chromatography.	 (G)	 Hydrogen	 interaction	 chromatography.	 (H)	 Size	 Exclusion	
Chromatography.	(I)	Diafiltration.		
1.7.4.2 Advantages	and	disadvantages	
The	 risk	 of	 contamination	 by	 advantageous	 agents	 in	 insect	 cell	 cultures	 is	
significantly	 lower	 than	 in	 mammalian	 cell	 cultures	 because	 insect	 cells	 do	 not	
require	any	animal-derived	products,	such	as	serum,	for	growth	(Nims,	2006;	Chen	
A B C D E F G IH
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et	al.,	2008).	Furthermore,	the	chance	of	insect	cells	becoming	hosts	for	vertebrate	
viruses	is	relatively	small,	because	of	the	evolutionary	distance	between	mammals	
and	insects	(Kuno	and	Chang,	2005).	The	only	viruses	known	to	propagate	 in	both	
mammals	and	insect	cells	are	arboviruses.	This	virus	does	not	pose	a	serious	risk	to	
the	production	of	vaccines	using	this	expression	system	because	the	susceptibility	
of	Spodoptera	frugiperda	Sf9	to	arboviruses	is	very	low	(Cox	and	Hashimoto,	2011).	
The	only	known	arbovirus	to	cause	a	significant	infection	is	the	mosquito-borne	St.	
Louis	 encephalitis	 virus	 (Verma,	 Boleti	 and	George,	 1998).	 An	 advantage	 that	 the	
arthropod	 expression	 system	has	 over	 prokaryotic	 expression	 systems,	 such	 as	E.	
coli,	 is	 that	 insect	 cells	 are	 able	 to	 perform	 most	 eukaryotic	 post-translational	
alterations,	generally	 resulting	 in	higher	clinical	efficacy.	The	polyhedrin	promoter	
used	 in	 insect-cell	 cultures	 is	 considerably	 stronger	 than	 most	 eukaryotic	
promoters.	 Therefore,	 this	 type	 of	 expression	 system	 produces	 higher	 levels	 of	
protein	than	mammalian	cell	cultures	(Luckow	and	Summers,	1989).	
For	the	purposes	of	human	vaccine	production,	insect	cells	have	more	appropriate	
post-translational	 mechanisms	 than	 E.	 coli.	 However,	 insect	 cells	 process	 mature	
oligosaccharides	 differently	 to	 mammalian	 cells	 and	 do	 not	 recognise	 certain	
proteolytic	cleavage	sites	on	mammalian	proteins	(Hsieh	and	Robbins,	1984;	Kuroda	
et	al.,	1986).	These	drawbacks	could	result	in	lower	clinical	efficacy	of	insect-derived	
vaccines	in	comparison	to	mammalian-derived	vaccines.		
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1.8 Tandem	Core	technology	
This	 thesis	 will	 focus	 on	 the	 development	 of	 a	 production	 process	 for	 a	 novel	
universal	 influenza	 A	 vaccine.	 Universal	 implies	 a	 vaccine	 that	 is	 reactive	 with	
multiple	 types	 of	 influenza	 A,	 accounting	 for	 annual	 antigenic	 drift	 and	
unpredictable	antigenic	shift.			
A	 strategy	 to	 increase	 cross-protection	 against	 variants	 of	 influenza	 virus	 is	 to	
develop	a	vaccine	consisting	of	highly	evolutionary	conserved	epitopes	of	influenza	
virus.	Examples	 of	 such	 epitopes	 are	 the	 aforementioned	M2e	 peptide,	 influenza	
nucleoprotein	(NP)	and	the	stem	of	hemagglutinin	(Fiers	et	al.,	2009;	Abate,	2013;	
Kim	 et	 al.,	 2013;	 IQur,	 2014).	 However,	 the	 absence	 of	 evolutionary	 pressure	 on	
these,	 usually	 structural,	 epitopes	 is	 likely	 due	 to	 a	 lack	 of	 recognition	 by	 the	
immune	system.	Thus,	it	is	often	found	that	such	epitopes	alone	elicit	no	significant	
immune	 response.	 However,	 the	 immunogenicity	 of	 these	 poorly	 immunogenic	
antigens	 can	 be	 increased	 through	 presentation	 on	 the	 surface	 of	 a	 Virus-Like	
Particle.	
Compared	 to	 individual	 viral	 peptides	 or	 proteins,	 such	 as	 M2e,	 VLPs	 present	
epitopes	 in	 such	 a	way	 as	 to	 achieve	 higher	 conformational	 similarity	 to	 a	 native	
virus.		
Hepatitis	B	Core	protein	(HBc),	a	monomer	that	self-assembles	into	VLPs,	has	been	
a	 popular	 carrier	 of	 a	 variety	 of	 heterologous	 epitopes	 derived	 from	 many	
pathogens	 (Roose	et	al.,	 2013).	 This	 fusion-facilitated	 versatility	 of	HBc	 allows	 for	
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the	creation	of	multivalent	VLP-based	vaccines,	i.e.	vaccines	consisting	of	VLPs	that	
present	a	variety	of	heterologous	epitopes.	Such	a	strategy	would	also	be	beneficial	
for	 the	development	of	 a	 universal	 flu	 vaccine	 as	 this	would	 enable	higher	 cross-
protection	 than	employing	 single	epitopes	or	monovalent	 vaccines.	However,	 it	 is	
very	 challenging	 to	 control	 and	 determine	 the	 amount	 of	 each	 heterologous	
epitope	present	in	an	assembled	VLP	for	a	multivalent	vaccine.	
A	way	to	control	the	amount	of	individual	heterologous	epitopes	present	in	a	single	
VLP	is	to	attach	a	flexible	linker	between	two	HBc	monomers	Figure	1.7.	In	this	way,	
attaching	 a	 different	 heterologous	 epitope	 to	 the	major	 insertion	 region	 (MIR)	 of	
each	 monomer,	 results	 in	 the	 expression	 and	 subsequent	 assembly	 of	 VLPs	
presenting	 an	 equal	 amount	 of	 each	 epitope.	 The	 linking	 of	 these	 two	 HBc	
monomers,	 via	 use	 of	 a	 flexible	 linker,	 will	 be	 referred	 to	 as	 Tandem	 Core	
technology	(iQur,	2014).		
The	 formation	 of	 Tandem	 Core-based	 VLPs	 occurs	 through	 the	 assembly	 of	
intermediates	consisting	of	two,	three	and	five	fused	Tandem	Core	dimers	(Holmes	
et	al.,	2015)	
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Figure	 1.7	 Tandem	 Core	 Technology	 overview:	 (A)	 DNA	 sequence	 of	 construct.	 AOX	
promotor	followed	by	two	HBc	units	connected	by	a	flexible	linker	sequence.	Within	each	
HBc	 sequence	 is	 a	 Major	 Immunodominant	 Region	 (MIR)	 sequence,	 allowing	 for	 the	
insertion	 of	 heterologous	 sequences	 of	 interest.	 (B)	 Individual	 tandem	Hepatitis	 B	 core	
(tHBc)	unit.	(C)	Self-assembly	of	tHBc	units	into	a	VLP	(D).		
Tandem	Core	technology	has	several	advantages	over	conventional	VLPs.	Firstly,	 it	
can	hold	large	twin	inserts,	whereas	conventional	VLPs	can	only	be	fused	to	single	
and	small	peptides.	Furthermore,	Tandem	Core	vaccines	will	not	require	the	use	of	
adjuvants.	 Finally,	 Tandem	 Core	 VLPs	 can	 act	 as	more	 agile	 antigen	 presentation	
scaffolds	than	conventional	VLPs,	allowing	for	the	combination	of	multiple	epitopes	
associated	 with	 a	 wide	 variety	 of	 diseases.	 This	 property	 makes	 Tandem	 Core	
technology	a	good	candidate	central	component	for	a	universal	vaccine	production	
platform.	 Even	 though	 Tandem	 Core	 technology	 could	 be	 applied	 for	 the	
presentation	of	epitopes	associated	with	a	wide	array	of	diseases,	the	scope	of	this	
thesis	will	be	restricted	to	the	development	of	a	universal	influenza	vaccine.		
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1.9 Pichia	pastoris	
Tandem	 Core	 VLPs	 have	 another	 important	 advantage	 over	 conventional,	 egg-
derived	vaccines.	VLPs,	in	general,	can	be	produced	in	suspension	cultures,	offering	
the	benefit	of	scalability.	
VLPs	 have	 previously	 been	 successfully	 produced	 in	 suspension	 cultures	 using	 P.	
pastoris	 (Freivalds	 et	 al.,	 2011;	 Jiang	 et	 al.,	 2011).	 Indeed,	 in	 this	 series	 of	
experiments,	a	variety	of	Tandem	Core	VLPs	will	be	expressed	by	P.	pastoris.		
P.	pastoris	 is	a	single-celled	yeast	and,	since	yeasts	are	eukaryotic,	 it	 is	more	likely	
that	 proteins	 typically	 expressed	 in	 a	 eukaryotic	 environment	 are	 appropriately	
translated	and	assembled	in	P.	pastoris	than	in	non-eukaryotic	expression	systems	
such	 as	 E.	 coli.	 However,	 the	 most	 important	 reason	 for	 choosing	 to	 express	
Tandem	 Core	 VLPs	 in	 P.	 pastoris	 rather	 than	 in	 E.	 coli,	 is	 the	 absence	 of	
lipopolysaccharides	(LPS)	in	the	purified	product	(iQur,	2014).	
What	distinguishes	P.	pastoris	 from	many	other	yeast	species,	 like	Saccharomyces	
cerevisiae,	 is	 its	preference	for	respiratory	growth,	 i.e.	 its	use	of	molecular	oxygen	
as	 a	 terminal	 electron	 acceptor	 during	 the	 synthesis	 of	 ATP,	 rather	 than	
fermentative	growth.	A	great	advantage	of	this	is	that	the	carbon	source	is	directly	
turned	to	biomass,	rather	than	to	toxic	by-products,	such	as	ethanol.	This	results	in	
high-density	cell	cultures	(Cregg,	2007).	It	is	worthwhile	to	note	that	despite	this,	a	
general	 challenge	associated	with	P.	pastoris	 is	 low	yields	of	 recombinant	protein	
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when	 compared	 to	 other	 expression	 systems,	 such	 as	 E.	 coli;	 insect	 cells;	 and	
Chinese	Hamster	Ovary	(CHO)	cells	(Weinacker	et	al.,	2013;	Maccani	et	al.,	2014).		
P.	 pastoris	 can	 use	 methanol	 as	 a	 sole	 source	 of	 carbon	 and	 because	 of	 this	
characteristic,	 a	 specific	 set	 of	 genes	 can	 be	 induced	 to	 produce	 the	 following	
metabolic	 enzymes:	 alcohol	 oxidase	 (AOX)	 and	 dihydrosynthase	 (DHAS).	 The	
regulatory	 genes	 involved	 in	 the	 transcription,	 aox1,	 aox2	 and	 das	 respectively,	
constitute	 a	 major	 advantage	 of	 the	 P.pastoris	 expression	 system	 as	 they	 are	
responsible	 for	 approximately	 30%	 of	 protein	 production	 in	 methanol-induced	
cultures,	with	AOX1	accounting	for	the	majority	of	protein	production	(Couderc	and	
Baratti,	1980;	Tschopp	et	al.,	1987;	Krainer	et	al.,	2012).	
P.	pastoris	also	differs	from	other	expression	systems,	such	as	E.	coli,	in	that	vectors	
used	for	genetic	recombination	are	integrated	into	the	host	genome.	This	happens	
via	 homologous	 recombination	 at	 sites	 where	 there	 is	 significant	 homology	
between	sequences	(>0.5	kb)	 (Cregg,	2007).	For	P.	pastoris	 transformations,	these	
sites	 are	 typically	 two	 aligned	 AOX1	 promoter	 (pAOX1)	 sequences	 (Cregg	 et	 al.,	
1985).	
1.9.1 Bioprocessing	–	fermentation	
As	 shown	 in	 Figure	 1.8,	 a	 typical	 bioreactor-based	 fermentation	 of	 P.	 pastoris	
consist	 of	 three	 phases:	 The	 batch	 phase,	 a	 glycerol	 fed-batch	 phase	 and	 the	
induction	phase,	usually	using	methanol.		
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The	 objective	 of	 the	 first	 stage,	 the	 batch	 phase,	 is	 to	maximise	 culture	 biomass	
through	the	consumption	of	glycerol.	As	the	culture	grows,	more	oxygen	is	required	
to	 support	 growth	 and	 cell	 maintenance.	 It	 is	 therefore	 important	 that	 the	
Dissolved	 Oxygen	 (DO)	 content	 is	 controlled	 and	 maintained	 above	 20%.	 This	 is	
typically	achieved	through	a	cascade	of	increased	culture	agitation	followed	by	gas	
blending	 of	 pure	 oxygen	 in	 the	 sparged	 gas.	 The	 batch	 culture	 is	 grown	until	 the	
glycerol	 in	 the	 medium	 has	 been	 completely	 consumed.	 This	 stage	 is	 usually	
reached	 after	 18-24	 hours	 and	 will	 be	 indicated	 by	 a	 rapid	 increase	 in	 DO,	 also	
known	as	a	DO	‘spike’,	or	a	rapid	decrease	in	the	Carbon	Evolution	Rate	(CER).		
	
Figure	1.8:	Typical	fermentation	of	P.	pastoris.	Carbon	Evolution	Rate	(CER)	is	shown	over	
time,	t.	From	left	to	right:	Batch	phase,	fed-batch	phase	and	induction	phase.		
Once	 glycerol	 has	 been	 completely	 consumed	 during	 the	 batch	 phase,	 a	 carbon-
limiting	 glycerol	 feed	 is	 introduced	 for	 at	 least	 4	 hours.	 This	 stage	 serves	 two	
purposes:	 firstly,	 it	 allows	 for	 control	 in	 achieving	 a	 target	 biomass;	 secondly,	 it	
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gradually	 creates	 a	 carbon-limiting	 environment	 to	 facilitate	 adaptation	 to	
methanol	during	the	induction	phase	of	fermentation.	
During	 this	 final	 stage,	heterologous	protein	 is	produced	by	 the	cells.	The	start	of	
the	 induction	 phase	 involves	 the	 adaptation	 of	 the	 cell	 culture	 to	 a	 gradually	
increasing	feed	of	methanol	as	a	sole	carbon	source.	This	gradual	feeding	approach	
is	preferable,	as	an	immediate	addition	of	high	volumes	of	methanol	would	poison	
the	culture.	This	adaptation	period	is	typically	a	few	hours,	while	the	total	induction	
phase	 can	 range	 between	 24	 and	 100	 hours	 in	 duration	 (Invitrogen	 Corporation,	
2002;	Mirro,	 2011).	 Tandem	 Core	 technology,	 expressed	 in	 P.	 pastoris,	 offers	 an	
exciting	proposition	 for	 creating	a	 future	universal	 influenza	vaccine.	However,	 as	
with	 all	 novel	 concepts,	 development	 and	 characterisation	 of	 applying	 this	
technology	 will	 be	 required	 and	 process	 methodologies	 should	 be	 developed	
accordingly.		
1.10 Thesis	aims		
A	wide	variety	of	methods	exist	 for	producing	 influenza	vaccines.	However,	 these	
platforms	cannot	fulfil	public	demand	in	the	event	of	a	pandemic	due	to	limitations	
in	 scalability,	 nor	 do	 these	 produce	 efficacious	 vaccines	 accounting	 for	 antigenic	
drift	and	antigenic	shift.		
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This	 research,	 which	 represents	 a	 component	 of	 research	 performed	 by	 an	 FP74	
consortium	 project,	 will	 focus	 on	 using	 Tandem	 Core	 technology	 to	 develop	 a	
universal	influenza	vaccine.	Using	this	technology,	recombinant	Virus-Like	Particles	
can	be	expressed	in	bioreactor-based	suspension	cultures	of	P.	pastoris,	providing	a	
highly	 scalable	 production	 platform.	 	 To	 realise	 the	 potential	 of	 Tandem	 Core	
technology	as	a	central	component	in	a	universal	vaccine	production	platform,	the	
production	 of	 Tandem	 Core	 VLPs	 in	 bioreactor	 suspension	 cultures	 needs	 to	 be	
extensively	characterised.		
The	specific	objectives	of	this	thesis	are	therefore:		
Initial	process	characterisation	of	novel	Tandem	Core	VLP	constructs	(Chapter	3)	
This	 chapter	 will	 aim	 to	 identify	 critical	 process	 parameters	 associated	 with	
upstream	and	downstream	processing	of	novel	Tandem	Core	VLP	 constructs.	 This	
will	 involve	 investigating	 the	 effects	 of	 changing	 constructs,	 yeast	 phenotype,	
fermentation	modes	and	methods	of	primary	recovery.		
Characterisation,	miniaturisation	 and	optimisation	of	 primary	 recovery	methods	
(Chapter	4)	
The	utilisation	of	scale-down	tools	to	increase	process	throughput	is	a	key	feature	in	
this	thesis	however,	as	the	product	is	intracellular,	appropriate,	low	sample	volume,	
lysis	methods	need	to	be	developed.	This	chapter	will	describe	 research	aimed	to	
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address	the	effects	of	various	primary	recovery	methods,	with	an	emphasis	on	cell	
disruption,	on	the	yield	of	soluble	Tandem	Core	material.	 In	doing	so,	the	chapter	
will	 discuss	 how	 cell	 disruption	 processes	 are	 characterised,	 optimised	 and	
miniaturised.		
Microscale	upstream	process	platform	development	(Chapter	5)	
Having	 developed	 the	 prerequisite	 tools	 to	 implement	 in	 miniaturised	 upstream	
process	 development,	 the	 use	 of	 miniaturised	 fermentation	 platforms	 can	 be	
investigated	to	address	several	key	observations	made	in	chapter	3,	and	to	identify	
appropriate	 scale-down	 platforms	 and	 expression	 techniques	 for	 monitoring	
product	 expression.	 This	 chapter	 will	 therefore	 aim	 to	 develop	 a	 miniaturised	
fermentation	platform	intended	for	rapid	upstream	process	characterisation.		
Characterisation	of	Tandem	Core	Virus-Like	Particle	production	(Chapter	6)	
This	 chapter	 aims	 to	use	miniature	bioreactors,	DoE-based	methodology,	 and	 the	
aforementioned	 scale-down	 cell	 disruption	 tools,	 to	 study	 Virus-Like	 Particle	
production	 in	 a	 bioprocessing	 context	 through	 variance	 of	 previous	 identified	
critical	process	parameters	and	windows	of	operation,	to	maximise	VLP	expression.		
Scale-up	 and	 application	 of	 Tandem	 Core	 Technology	 to	 universal	 influenza	
vaccine	candidates	(Chapter	7)		
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The	previous	chapter	will	have	addressed	the	characterisation	of	VLP	production	at	
miniaturised	scale	using	a	simplified,	non-epitope-exposing,	variant	of	Tandem	Core	
VLP.	 This	 chapter	 aims	 to	 translate	 these	 findings	 to	 industrially	 relevant	 vaccine	
production	 scenarios	 by	 investigating	 the	 effects	 of	 scale-up	 and	 variation	 of	
epitope	insets	that	could	be	utilised	as	a	universal	influenza	vaccine.		
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Chapter	2 Materials	and	methods	
This	chapter	describes	common	materials,	routine	experimental	methodologies	and	
analytical	procedures	used	throughout	this	work.	
2.1 Chemicals	and	media	
All	chemicals	used	were	purchased	from	Sigma	Aldrich	(Gillingham,	UK)	of	analytical	
grade	 or	 higher.	 Bacteriological	 peptone	 and	 yeast	 extract	 were	 purchased	 from	
Oxoid	(Basingstoke,	UK).	Reverse	osmosis	(RO)	water	and	deionized	water	was	used	
throughout	for	media	preparation.	A	summary	table	of	the	media	used	is	provided	
in	10.1.	
2.2 Yeast	strains		
All	 P.	 pastoris	 transformants	 described	 in	 this	 work	 were	 provided	 by	 iQur	 Ltd.	
(London,	UK).	
Two	 phenotypes	 of	 P.	 pastoris	 were	 used	 throughout	 this	 work:	Mut+	 (X33)	 and	
MutS	(KM71h).	
P.	pastoris	Mut+	was	used	to	express	GFP-fused	VLPs	(GFP,e).	P.	pastoris	MutS	was	
used	 to	 express	 the	 following	VLP	 constructs:	 k1,k1;	 LAH3,k1;	HA2.3,	 (M2e)3;	 and	
LAH3,	(M2e)3.	
With	 the	 exception	 of	 the	 k1,k1	 construct,	 amino	 acid	 sequences	 of	 tHBc-VLP	
constructs	were	proprietary	at	the	time	of	this	writing,	and	could	therefore	not	be	
disclosed.	Figure	2.1	shows	the	design	of	the	k1,k1	construct.	
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Figure	2.1	Design	of	the	tHBc-k1,k1	construct.	Amino	acid	sequences	are	depicted	in	the	
Major	Insertion	Regions	(MIRs).	 Image	was	adopted	from	published	work	(Kazaks	et	al.,	
2017).		
2.2.1 Cell	bank	preparation		
2.2.1.1 Master	Cell	Bank	(MCB)	
10µL	 frozen	 seed	 stock	 was	 cultured	 in	 50mL	 Greiner	 (Greiner	 Bio-One,	
Kremsmünster,	Austria),	 skirted	 centrifuge	 tubes	 in	 9990µL	BMGY	media	 [13.8g/L	
yeast	 nitrogen	 base	 with	 ammonium	 sulphate	 and	 without	 amino	 acids,	 12.6g/L	
glycerol,	 100mL/L	 1M	 potassium	 phosphate	 buffer	 pH	 6.0,	 20g/L	 bacteriological	
peptone,	10g/L	yeast	extract	and	2mL/L	biotin	solution]	 for	20	hours	at	30°C,	250	
rpm	in	a	Kuhner®	(Glossop,	UK)	incubator.	The	optical	density	at	600nm	(OD600)	was	
typically	found	to	be	5	at	this	stage.	2mL	of	this	culture	was	subsequently	used	to	
inoculate	 a	 2L	 baffled	 polymer	 reusable	 Nalgene™	 Erlenmeyer	 shake	 flask	
containing	250mL	BMGY.	Post-inoculation,	OD600	values	at	this	stage	were	typically	
around	0.2.	The	culture	was	harvested	after	22-24	hours,	 typically	 reaching	OD600	
values	 between	 60-80,	 indicating	 stationary	 phase.	 The	 harvested	 culture	 was	
diluted	 to	an	OD600	of	36	using	BMGY	and	subsequently	diluted	 to	25	using	100%	
sterile	 glycerol	 to	 achieve	 a	 final	 glycerol	 stock	 concentration	 at	 30%	 (v/v).	 The	
suspension	 was	 vortexed	 briefly	 and	 distributed	 in	 2mL	 aliquots.	 These	 aliquots	
were	gradually	frozen	using	a	Nalgene®	5100-0001	cryo	freezing	container	rack	at	-
80°C	for	24	hours.		
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2.2.1.2 Working	cell	bank	(WCB)	
A	Master	 Cell	 Bank	 (MCB)	 vial	 was	 defrosted	 at	 room	 temperature	 for	 about	 10	
minutes.	 2mL	 of	 each	 tube	 was	 transferred	 to	 a	 reusable	 Nalgene™	 Erlenmeyer	
shake	 flask	 containing	 250mL	 BMGY	 and	 grown	 as	 described	 in	 section	 2.2.1.1.	
OD600	measurements	were	taken	frequently	to	characterise	the	MCB	and	develop	a	
growth	profile	(see	Figure	10.1).	To	assess	MCB	quality,	this	procedure	was	carried	
out	 in	 duplicate.	 The	 harvested	 culture	 was	 processed	 as	 described	 in	 section	
2.2.1.1	and	will	be	referred	to	as	the	Working	Cell	Bank	(WCB).	This	procedure	was	
repeated	without	harvesting	material	to	characterise	the	WCB	(see	Figure	10.2).	
2.2.1.3 	Agar	plate	quality	control	
As	an	additional	quality	control	measure	to	ensure	monocultures	of	transformants,	
agar	 plate-based	 culture	 inspection	was	 performed.	 50µL	 of	 frozen	 cell	 bank	was	
grown	on	YPD	agar	plates	 [20g/L	bacteriological	peptone,	10g/L	yeast	extract	and	
20g/L	agar]	 for	one	week	at	28°C.	Cultures	were	assumed	to	be	of	a	monoculture	
when	 no	 colonies	 with	 different	 morphology	 (colours,	 hyphenation,	 shape	 and	
opacity)	were	observed	(see	Figure	10.3).		
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2.3 Fermentations	
2.3.1 Microwell	fermentations	
As	this	thesis	investigated	the	development	of	microwell	culture	protocols,	a	variety	
of	methods	were	 used	 rather	 than	 a	 single	 protocol.	 The	 commonalities	 of	 these	
procedures	are	described	in	this	section.	
Basal	Salts	Medium	(BSM)	[26.7mL/L	85%phosphoric	acid,	0.93g/L	calcium	sulphate,	
18.2g/L	 potassium	 sulphate,	 14.9g/L	 magnesium	 sulphate	 heptahydrate,	 4.13g/L	
potassium	 hydroxide,	 40g/L	 glycerol,	 20mL/L	 28%	 ammonium	 hydroxide]	 was	
prepared	without	glycerol	to	serve	as	a	variable	induction	medium.	The	volume	of	
glycerol	 was	 substituted	 by	 reverse	 osmosis	 water.	 4.35mL	 of	 PTM1	 trace	 salts	
[6.0g/L	 cupric	 sulphate	 pentahydrate,	 80mg/L	 sodium	 iodide,	 3.0g/L	 manganese	
sulphate	 hydrate,	 0.2g/L	 sodium	molybdate	 dihydrate,	 20mg/L	 boric	 acid,	 0.5g/L	
cobalt	chloride,	20.0g/L	zinc	chloride,	65.0g/L	ferrous	sulphate	heptahydrate,	0.2g/L	
biotin,	5.0mL/L	sulfuric	acid]	was	added	to	1	litre	of	media.	Media	was	adjusted	to	
pH	5.0	and	was	filter	sterilised	using	a	0.22µm	filter.		
An	exponential	inoculum	culture	(OD600=10-30)	was	subjected	to	buffer	exchange	to	
achieve	defined	buffer	conditions	and	inoculum	concentration.	The	buffer	exchange	
was	 performed	 by	 creating	 aliquots	 of	 equal	 volumes	 of	 seed	 culture	 into	 15mL	
Greiner	 tubes	 (Greiner	 Bio-One,	 Kremsmünster,	 Austria)	 and	 centrifuging	 the	
aliquots	 at	 3200g,	 20°C	 for	 10	 minutes.	 The	 supernatant	 was	 discarded	 and	
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appropriate	induction	medium	was	added	to	each	aliquot	to	achieve	a	target	optical	
density	followed	by	vortexing.	
Variable	 volumes	 of	 the	 vortexed	 suspension	 were	 transferred	 to	 24	 well	 pre-
sterilised	deep	square	plates	 (Kinesis,	St	Neots,	UK),	which	was	sealed	with	sterile	
AeraSealTM	film.		
2.3.1.1 Induction	with	Pectin	Digest	Medium		
Some	 microwell	 fermentations	 involved	 induction	 using	 Pectin	 Digest	 Medium	
(PDM).	
PDM5	was	 prepared	 by	 autoclaving	 a	 suspension	 of	 2.7mL	 85%	 phosphoric	 acid,	
8mL	50%	ammonium	hydroxide	and	3.67g	pectin	 from	apple.	The	suspension	was	
cooled	 to	 25°C	 and	 the	 pH	 was	 adjusted	 to	 5.5	 using	 NaOH	 or	 2M	 HCl.	 30mg	
pectolyase	Y-23	 from	Aspergillus	 japonicas	 (MP	Biomedicals,	 Eschwege,	Germany)	
was	added	 to	 the	 suspension.	 The	enzymatic	 reaction	was	 left	 for	33	hours.	BSM	
components	 and	 PTM1	 trace	 salts	 were	 subsequently	 added	 in	 the	 appropriate	
amounts.	 The	 pH	 of	 the	 solution	 was	 adjusted	 to	 5.0	 as	 described	 earlier.	 The	
suspension	 was	 divided	 into	 two	 50mL	 aliquots	 in	 50mL	 centrifuge	 tubes.	 To	
remove	 solids,	 the	 suspension	was	 centrifuged	 at	 4°C	 3200g	 for	 10	minutes.	 The	
pellet	was	discarded. The	supernatant	was	 filter	sterilised	using	a	0.22µm	vacuum	
filter	and	stored	at	4°C.		
																																																						
5	0.5%	(v/v)	MeOH	molar	equivalent	d-Galacturonic	Acid	Methyl	Ester	(dGAME)	
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2.3.2 Shake	flask	cultures	
A	2L	reusable	polymer	baffled	Nalgene™	shake	 flask	containing	250mL	BMGY	was	
inoculated	 with	 1.8mL	 working	 cell	 bank	 (2.2.1.2).	 This	 was	 incubated	 for	 16-20	
hours	at	30°C	and	250	rpm	in	a	Kuhner®	(Glossop,	UK)	incubator.	When	exponential	
phase	 characteristics	 were	 required,	 the	 culture	 was	 grown	 to	 OD600	 values	
between	 10-20.	When	 stationary	 phase	 characteristics	 were	 required	 the	 culture	
was	grown	beyond	and	OD600	value	of	60.	
2.3.3 MutS	250	millilitre	bioreactor	fermentations		
2.3.3.1 Pure	methanol	induction		
A	 250mL	 ambr®	modular	 bioreactor	 system	 (Sartorius,	 Epsom,	 UK)	 was	 used	 for	
studying	P.	pastoris	MutS	fermentations.	Each	bioreactor	unit	(see	Figure	2.2)	had	5	
reservoirs	 of	 which	 reservoir	 A	 contained	 20mL	 50%	 (v/v)	 glycerol	 solution	
supplemented	with	PTM1	trace	salts;	reservoir	B	25mL	10%	ammonium	hydroxide	
solution;	reservoir	C	contained	5mL	sterile	PPG	2000	antifoaming	agent;	5mL	8.5%	
phosphoric	 acid	 was	 added	 to	 reservoir	 D;	 and	 reservoir	 E	 contained	 25mL	
methanol	 with	 PTM1	 trace	 salts.	 The	 bioreactors	 were	 heated	 to	 30°C	 prior	 to	
calibrating	Dissolved	Oxygen	Tension	(DOT)	and	pH.	After	at	 least	3	hours,	2mL	of	
sample	 was	 drawn	 from	 each	 of	 the	 bioreactors	 to	 perform	 offline	 pH	
measurements,	which	were	required	to	complete	pH	calibration.	Bioreactors	were	
deemed	 ready	 for	 inoculation	 at	 DOT=100±5%,	 pH	 4.75-5.0	 and	 T=30±0.1°C.	
Bioreactors	 had	 a	 working	 volume	 of	 100mL	 of	 which	 7mL	 was	 provided	 by	 an	
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appropriately	 diluted	 and	 resuspended6	inoculum	 culture	 to	 achieve	 a	 starting	
bioreactor	 culture	optical	 density	of	 1.0	OD600.	 Throughout	 the	 fermentation	DOT	
was	maintained	at	30%	by	(1)	agitating	the	culture	between	1323	and	3175	rpm,	(2)	
maintaining	an	airflow	 rate	of	0.5vvm	and,	 (3)	when	 required,	additively	blending	
pure	oxygen	with	the	sparged	gas.			
A	20%	drop	in	Carbon	Evolution	Rate	(CER)	and	spike	in	DOT,	indicating	depletion	of	
carbon	 source,	 triggered	 a	 fed-batch	 glycerol	 feed.	 This	 was	 generally	 observed	
between	 18-20	 hours	 after	 bioreactor	 inoculation.	 This	 glycerol	 fed-batch	 phase	
was	 maintained	 for	 a	 fixed	 4	 hours	 at	 a	 constant	 flow	 rate	 between	 11.9-24.4	
millilitres	per	litre	initial	working	volume	per	hour	(mL/Li/h).	20	minutes	prior	to	the	
induction	phase	the	temperature	setpoint	was	varied	between	18.8-31.3°C.		
For	 the	 first	 two	 hours	 of	 the	 induction	 phase	 the	methanol	 flow	 rate	 was	 kept	
constant	 at	 1mL/Li/h.	 After	 this	 the	 feed	 rate	 was	 increased	 by	 10%	 increments	
every	30	minutes	until	the	target	feed	rate	was	reached.	Note	that	the	time	of	each	
final	 increment	 was	 shortened	 accordingly	 to	 achieve	 the	 precise	 final	 value	 of	
QMeOH.	 Also	 note	 that	 this	 feeding	 profile	 did	 not	 apply	 for	 a	 target	 flow	 rate	 of	
0.5mL/Li/h.	This	was	kept	constant	throughout	the	induction	phase.	After	40	hours,	
the	culture	was	cooled	to	12°C	to	minimise	proteolytic	activity.	This	was	followed	by	
harvesting	(2.4.1).			
																																																						
6	In	BSM	medium	supplemented	with	PTM1	trace	salts.	
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2.3.3.2 Mixed	feeding	induction	with	glycerol	
This	method	involved	the	same	procedures	as	described	in	2.3.3.1,	however	there	
were	 several	 differences.	 Instead	 of	 using	methanol,	 mixed	 induction	media	 was	
used	 comprised	 of	 a	 60:40	 ratio	 of	 50%	 (v/v)	 glycerol	 and	 pure	 methanol	
respectively,	plus	12	mL	PTM1	salts	per	 litre	of	 induction	media.	Bioreactors	had	a	
working	volume	of	83.3mL	of	which	6.16mL	was	provided	by	an	 inoculum	culture	
(10-30	OD600)	 to	achieve	a	 starting	bioreactor	 culture	optical	density	of	1.0	OD600.	
Throughout	 the	 fermentation	 DOT	 was	 maintained	 at	 30%	 by	 (1)	 agitating	 the	
culture	 between	 1130	 and	 2826	 rpm,	 (2)	maintaining	 an	 airflow	 rate	 of	 0.51vvm	
and,	(3)	when	required,	blending	pure	oxygen	with	the	sparged	gas,	maintaining	a	
constant	gas	flow	rate.		
The	 induction	phase	was	 followed	 immediately	 after	 the	batch	phase.	 Feeding	of	
induction	 media	 was	 kept	 constant	 at	 5mL/Li/h,	 at	 a	 temperature	 of	 30°C.	
Harvesting	was	performed	after	48	hours	of	induction.	
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Figure	2.2	Overview	of	the	250mL	ambr®	modular	bioreactor	system.	(A)	Peristaltic	pump	
for	harvesting	or	additional	feeding.	(B)	Reservoir	slot.	(C)	Heating	and	cooling	jacket.	(D)	
Computer	 interface.	 (E)	 250mL	 bioreactor	 with	 baffled	 walls.	 (F-J)	 Reservoirs	 A-E.	 (K)	
Removable	 stopper	 for	 inoculation	 procedures.	 (L)	 DO	 sensor.	 (M)	 Impeller	 with	 two	
Rushton	 turbines.	 (N)	 Gas	 sparger.	 (O)	 pH	 and	 temperature	 probe.	 (P)	 Sampling	 and	
addition	lines.	(Q)	Gassing	manifold.		
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2.3.4 MutS	7	litre	bioreactor	fermentations		
A	 7L	 BioFlo®	 New	 Brunswick	 (Eppendorf,	 Stevenage,	 UK)	 was	 used	 for	 initial	
fermentation	 scoping	 studies	 using	 the	 MutS	 pure	 methanol	 induction	 protocol	
(Invitrogen	Corporation,	2002).		
The	initial	working	volume	was	set	at	4L.	The	DOT	setpoint	was	set	at	30%	and	was	
controlled	 in	 a	 sequence	 cascade	 by	 agitating	 the	 impeller	 between	 500	 to	 1200	
rpm	 followed	by	 oxygen	 gas	 blending	 in	 ratio	mode	 at	 a	 constant	 volumetric	 gas	
flow	rate	of	1.5L/min.	Fermentations	were	run	in	batch	mode	for	18-20	hours	until	
a	DOT	 spike	was	observed.	 This	was	 followed	by	a	4	 to	6-hour	 glycerol	 fed-batch	
phase	 at	 a	 constant	 glycerol	 feed	 (50%	 (v/v)	 glycerol	 solution	 supplemented	with	
PTM1	trace	salts)	flow	rate	of	18.15	mL/Li/h.	Following	this	was	the	induction	phase	
at	30°C.	For	the	first	two	hours	of	the	induction	phase	the	methanol	flow	rate	was	
kept	constant	at	1mL/Li/h.	After	this	the	feed	rate	was	increased	by	10%	increments	
every	30	minutes	until	a	target	feed	of	3.0mL/Li/h	rate	was	reached.	The	induction	
phase	was	followed	by	harvesting	as	described	in	2.4.2.	
2.3.5 MutS	30	litre	bioreactor	fermentations		
2.3.5.1 	Pure	methanol	induction		
A	30L	BIOSTAT®	Cplus	(Sartorius,	Epsom,	UK)	stainless	steel	bioreactor	was	used	to	
study	pilot	scale	cultivation	and	 induction	of	MutS	type	P.	pastoris.	The	bioreactor	
was	run	at	12L	working	volume	of	which	500mL	was	provided	by	an	appropriately	
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diluted	and	resuspended7	inoculum	culture	to	achieve	a	starting	bioreactor	culture	
optical	density	of	1.0	OD600.	The	DOT	setpoint	was	set	at	30%	and	was	controlled	in	
a	sequence	cascade	by	agitating	the	impeller	between	468	to	1123	rpm	followed	by	
oxygen	gas	blending	in	ratio	mode	at	a	constant	volumetric	gas	flow	rate	of	0.5vvm.	
pH	 range	 was	 maintained	 between	 4.75-5.0	 and	 pre-induction	 temperature	 at	
30±0.1°C.	 A	 20%	 drop	 in	 CER	 and	 spike	 in	 DOT,	 indicating	 depletion	 of	 carbon	
source,	 triggered	 a	 fed-batch	 glycerol	 feed.	 This	was	 generally	 observed	between	
18-20	 hours	 after	 bioreactor	 inoculation.	 This	 glycerol	 fed-batch	 phase	 was	
maintained	for	a	fixed	4	hours	at	a	constant	glycerol	feed	flow	rate	of	18.15	mL/Li/h.	
20	minutes	prior	to	the	induction	phase	the	temperature	setpoint	was	adjusted	to	
25°C.	 The	 end	 of	 the	 glycerol	 fed-batch	 phase	 triggered	 the	 methanol	 induction	
phase.	For	 the	 first	 two	hours	of	 the	 induction	phase	 the	methanol	 flow	rate	was	
kept	constant	at	1mL/Li/h.	After	this	the	feed	rate	was	increased	by	10%	increments	
every	30	minutes	until	a	target	feed	rate	of	5.5mL/Li/h	was	reached.		
After	40	hours	of	induction	the	culture	was	cooled	to	12°C	to	minimise	proteolytic	
activity.	This	was	followed	by	harvesting	as	described	in	2.4.2.	
2.3.5.2 Mixed	feeding	induction	with	glycerol	
This	method	involved	the	same	procedures	as	described	in	2.3.5.1,	however	there	
were	 several	 differences.	 Instead	 of	 using	methanol,	 mixed	 induction	media	 was	
used	 comprised	 of	 a	 60:40	 ratio	 of	 50%	 (v/v)	 glycerol	 and	 pure	 methanol	
respectively,	plus	12	mL	PTM1	salts	per	 litre	of	 induction	media.	Bioreactors	had	a	
																																																						
7	In	BSM	medium	supplemented	with	PTM1	trace	salts.	
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working	volume	of	10L	of	which	500mL	was	provided	by	an	inoculum	culture	(10-30	
OD600)	 to	 achieve	 a	 starting	 bioreactor	 culture	 optical	 density	 of	 1.0	 OD600.	
Throughout	 the	 fermentation	 DOT	 was	 maintained	 at	 30%	 by	 (1)	 agitating	 the	
culture	between	400	and	1000	rpm,	(2)	maintaining	an	airflow	rate	of	0.51vvm	and,	
(3)	 when	 required,	 blending	 pure	 oxygen	 with	 the	 sparged	 gas,	 maintaining	 a	
constant	gas	flow	rate.		
The	 induction	phase	was	 followed	 immediately	 after	 the	batch	phase.	 Feeding	of	
induction	 media	 was	 kept	 constant	 at	 5mL/Li/h,	 at	 a	 temperature	 of	 30°C.	
Harvesting	was	performed	after	48	hours	of	induction.		
2.3.6 Mut+	7	litre	bioreactor	fermentations		
2.3.6.1 Pure	methanol	induction		
A	 7L	 BioFlo®	 New	 Brunswick	 (Eppendorf,	 Stevenage,	 UK)	 was	 used	 for	 initial	
fermentation	scoping	studies	using	the	Mut+	pure	methanol	induction	protocol.		
The	initial	working	volume	was	set	at	4L.	The	DOT	setpoint	was	set	at	30%	and	was	
controlled	 in	 a	 sequence	 cascade	 by	 agitating	 the	 impeller	 between	 500	 to	 1200	
rpm	 followed	by	 oxygen	 gas	 blending	 in	 ratio	mode	 at	 a	 constant	 volumetric	 gas	
flow	rate	of	1.5L/min.	Fermentations	were	run	in	batch	mode	for	18-20	hours	until	
a	DOT	spike	was	observed.		
This	was	followed	by	a	4-hour	glycerol	fed-batch	phase	at	a	constant	glycerol	feed	
flow	 rate	 of	 18.15	 mL/Li/h.	 The	 induction	 temperature	 was	 subsequently	 varied	
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between	 20-30°C.	 The	 culture	 was	 induced	 with	 methanol,	 supplemented	 with	
12mL/L	PTM1	trace	salts.	The	 initial	 flow	rate	was	maintained	a	3.6	mL/h	per	 litre	
initial	working	volume	(mL/Li/h)	for	2-4	hours	depending	on	the	stability	of	the	DOT	
reading.	 The	 feed	 rate	was	 subsequently	 increased	 to	 7.3	mL/	 Li/h	 for	 another	 2	
hours	 and	 then	 increased	 to	10.9	mL/Li/h	 for	 the	 remainder	of	 the	 fermentation.	
The	induction	phase	was	followed	by	harvesting	as	described	in	2.4.2.	
2.3.6.2 Mixed	feeding	induction	with	sorbitol	
This	method	involved	the	same	procedures	as	described	in	2.3.6.1,	however	there	
were	several	differences.	The	induction	temperature	was	fixed	at	20°C	and	a	mixed	
50:50	 (c-mol:c-mol)	 ratio	 of	 sorbitol	 to	methanol	 feed	was	 introduced	 instead	 of	
pure	methanol.	
2.4 Preparative	methods	
2.4.1 Small-scale	harvesting	
This	 procedure	 applies	 to	 the	 harvesting	 of	 material	 derived	 from	 fermentation	
vessels	of	250mL	or	less.		Fermentation	broth	was	harvested	at	3200	g,	20	min	and	
4°C	using	a	benchtop	5417R	centrifuge	(Eppendorf,	Stevenage,	UK)	 for	samples	of	
50mL	and	a	benchtop	5415R	centrifuge	(Eppendorf,	Stevenage,	UK)	for	samples	of	
2mL	 or	 less.	 	 Supernatant	 was	 discarded	 and	 the	 wet	 pellets	 were	 weighed	 and	
stored	at	-20°C.		
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2.4.2 Large-scale	harvesting	
This	 procedure	 applies	 to	 the	 harvesting	 of	 material	 derived	 from	 7	 and	 30L	
bioreactors.	 	Fermentation	broth	was	harvested	at	3000	g,	20	min	and	4°C	using	a	
Beckman	 Avanti	 J-25	 floor	 centrifuge	 (Beckman	 Coulter,	 High	 Wycombe,	 UK).		
Supernatant	was	discarded	and	the	wet	pellets	were	weighed	and	stored	at	-20°C.		
2.4.3 Cell	disruption	with	High	Pressure	Homogenisation	(HPH)	
Frozen	cell	paste	was	weighed	and	resuspended	in	MOPS	lysis	buffer	[50mM	3-(N-
morpholino)propane	 sulfonic	 acid	 (MOPS)	 ,	 [1mM	 4-(2-aminoethyl)	 benzene	
sulfonyl	 fluoride]	 (AEBSF)	 hydrochloride,	 5U/mL	 benzonase	 (E8263-25KU),	 5mM	
Dithiothreitol	 (DTT)	 in	 reverse	 osmosis	 water	 (R>18.2	 MΩ/cm)	 titrated	 with	 1M	
sodium	hydroxide	to	achieve	a	of	pH	7.5	(@10°C)]	or	TRIS	lysis	buffer	[20mM	Tris	X	,	
(1mM	 4-(2-aminoethyl)	 benzene	 sulfonyl	 fluoride	 (AEBSF)	 hydrochloride,	 5U/mL	
benzonase	 (E8263-25KU),	 5mM	 Dithiothreitol	 (DTT)	 in	 reverse	 osmosis	 water	
(R>18.2	MΩ/cm)	titrated	with	1M	sodium	hydroxide	to	achieve	a	of	pH	8.5	(@10°C)]	
to	achieve	wet	cell	weight	(WCW)	concentrations	of	30	g/L	unless	stated	otherwise.	
40mL	 aliquots	 were	 prepared	 and	 subsequently	 disrupted	 using	 an	 APV	 Gaulin	
Lab40	High	Pressure	Homogeniser	as	stated	between	300-1200	bar,	for	1-5	passes.	
Homogenisation	was	performed	at	T<10°C	with	the	aid	of	a	glycol	cooling	loop.	
To	 each	 homogenised	 sample	 a	 1%	 volumetric	 addition	 of	 Triton	 X-100	 stock	
solution	was	added	to	facilitate	protein	release.	After	a	one-hour	incubation	period	
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at	4°C	a	1%	volumetric	addition	of	EDTA	stock	solution	was	added	to	each	aliquot.	1	
mL	from	each	aliquot	was	collected	for	clarification	and	subsequent	analysis.	
2.4.4 Cell	disruption	with	sonication		
Frozen	 cell	 paste	 was	 weighed	 and	 resuspended	 in	 TRIS	 lysis	 buffer	 (2.4.3).	 A	
SoniPrep	150	(Wolf	Laboratories,	Pocklington,	UK)	was	used	for	cell	disruption	and	
was	operated	at	an	amplitude	of	10	µm	for	 three	6-second	cycles	with	10-second	
cool-down	periods	in	between	cycles.		
After	sonication,	to	each	of	the	samples	10µL	of	1/10	dilution	triton-X100	solution	
was	added	to	achieve	a	0.1%	v/v	concentration.	This	was	left	to	react	for	around	20	
minutes	prior	to	clarification	steps	(see	2.4.10).		
2.4.5 Cell	disruption	with	Adaptive	Focused	Acoustics	(AFA)	
An	E210	AFA	device	(Covaris,	Brighton,	UK)	was	used	to	perform	AFA-mediated	cell	
disruption.	 Experiments	were	 conducted	with	 1mL	 cell	 suspensions	 in	MOPS	 lysis	
buffer,	0.1%	Triton	X-100,	in	12	x	12mm	milliTUBE	vials	(Covaris,	Brighton,	UK),	each	
containing	 an	 integrated	 fiber	 to	 assist	 disruption.	 Alternatively,	 6mL	 Chromacol	
vials	(Thermo	Fisher	Scientific,	Paisley,	UK)	were	used.	The	tubes	were	secured	in	a	
4	x	6	rack.	The	rack	was	placed	into	the	water	bath	of	the	Covaris	system	containing	
degassed	water	at	a	temperature	of	10±	1°C	and	a	submerged	acoustic	transducer.	
Cell	 disruption	 was	 performed	 in	 power	 tracking	 mode,	 automatically	 by	 placing	
each	tube	 in	a	predetermined	sequence	 in	the	focal	zone	of	the	transducer.	A	1%	
volumetric	addition	of	EDTA	stock	solution	was	added	after	sonication.	
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2.4.6 Cell	disruption	with	enzymatic	lysis	
MOPS	 Enzymatic	 Lysis	 buffer	 [4%	 (v/v)	 lyticase	 stock	 solution	 (2000U/mL	 lyticase	
from	Arthrobacter	 luteus	 (L2524),	 100mM	 potassium	 phosphate,	 100mM	 sodium	
hydroxide,	50%	(v/v)	glycerol,	pH	7.5	 in	RO	water)	and	1%	(v/v)	Triton-X100	stock	
solution	in	MOPS	lysis	buffer]	was	heated	in	a	bath	to	25°C.	Frozen	cell	paste	was	
resuspended	in	the	warmed	buffer	to	a	variable	target	biomass	value,	followed	by	a	
1	hour	incubation	at	25°C,	as	per	manufacturer’s	instructions	(Sigma-Aldrich,	2017).		
2.4.7 Chemical	lysis	
Frozen	cell	paste	was	resuspended	and	diluted	to	an	OD600	value	of	5	using	reverse	
osmosis	water	to	a	total	volume	of	1mL	in	1.5mL	micro-centrifuge	tubes.	The	tubes	
were	 subsequently	 centrifuged	 at	 2000	 rpm	 for	 10	 minutes	 using	 a	 benchtop	
Eppendorf	 Centrifuge	 (5415R)	 to	 separate	 cells	 from	 the	 liquor.	 The	 supernatant	
was	discarded	and	the	pellets	were	resuspended	in	100µL	lysis	buffer	(20mM	Tris,	
pH	8.0,	1mM	EDTA,	5mM	DTT,	0.75%	Sodium	Deoxycholate).	The	suspensions	were	
incubated	 at	 room	 temperature	 for	 20	 minutes	 to	 react	 with	 lysis	 buffer	 as	 per	
findings	of	previous	unpublished	works	(data	not	shown).		
2.4.8 Cell	disruption	with	YeastBuster™	
Cell	 pellets	 were	 resuspended	 at	 room	 temperature	 in	 5mL/gWCW	 YeastBuster™	
reagent	 (Merck	 Millipore,	 Watford,	 UK)	 and	 50µL/gWCW	 100X	 THP	 solution.	
Benzonase	 was	 added	 as	 described	 previously	 2.4.3.	 The	 suspensions	 were	
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incubated	at	room	temperature	for	20	minutes	to	react	with	YeastBuster™,	as	per	
manufacturer’s	instructions	(Novagen,	2004).	
2.4.9 Bead	lysis	
Bead	 lysis	 served	 as	 a	 small-scale	 cell	 disruption	 tool	 for	 iQur	 Ltd	 and	 was	
performed	by	IQur	as	outlined	below.	
Pellets	 were	 resuspended	 in	 1.5ml	 MOPS	 lysis	 buffer	 and	 mechanically	 lysed	
through	 bead	 lysis	 (1g	 mixed	 bead	 (2	 part	 0.1mm	 beads	 (0.4g),	 2	 parts	 0.5mm	
beads(0.4g)	 and	 1	 part	 1.5-2mm	 beads	 (0.2g)	 ratio	 2:2:1))	 for	 30	 seconds	 on	 a	
vortex	mixer	followed	by	30	seconds	of	cooling	time	on	ice.	This	cycle	was	repeated	
10	time	per	sample.	
Lysate	was	 separated	 from	beads	 through	manual	 extraction	with	 a	 pipette.	 This	
lysate	 was	 sonicated	 using	 a	 SoniPrep	 150	 device,	 operated	 at	 10000	 amplitude	
microns	for	two	10	second	cycles.		
A	 10%	 Triton	 X100	 stock	 solution	 was	 added	 to	 achieve	 a	 final	 concentration	 of	
0.1%.		
2.4.10 Clarification	
Lysates	were	centrifuged	at	4°C	and	15000	g	for	30	minutes	using	a	benchtop	5415R	
centrifuge	(Eppendorf,	Stevenage,	UK)	for	samples	of	2mL	or	less	for	sample	volume	
of	2mL	or	lower.	A	benchtop	5417R	centrifuge	(Eppendorf,	Stevenage,	UK)	was	used	
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for	 sample	volumes	over	2mL.	The	 supernatant	of	each	 sample	was	with	a	Millex	
0.22µm	33mm	PVDF	syringe	filter	(Merck	Millipore,	Watford,	UK).	A	Millex	0.45µm	
syringe	 filter	was	preceded	by	this	 if	 sample	volumes	were	over	2mL.	Filtrate	was	
stored	at	4-7°C	for	up	to	one	week	for	immediate	analysis;	or	stored	long-term	at	-
20°C.		
2.4.11 Preparative	Size	Exclusion	Chromatography	(SEC)	
Core-positive	material	within	the	size	range	of	20-200nm	was	purified	through	Size	
Exclusion	 Chromatography	 (SEC).	 The	 200nm	 upper	 limit	 was	 assumed	 as	 the	
preceding	 step	 to	 this	 unit	 operation	 was	 consistently	 a	 200nm	 depth-filtration	
step.	The	20nm	lower	limit	was	defined	as	the	assumed	smallest	size	for	a	HBc	VLP.		
Purification	was	 achieved	 by	 passing	 2mL	 of	 clarified	 lysate	 through	 a	 Sepharose	
CL4B	 column	 (XK16/20)	 fitted	on	 an	ÄKTA	pure	pump	 system	 (GE	Healthcare	 Life	
Sciences;	Hatfield,	UK).	The	flow	rate	of	the	mobile	phase	(20mM	Tris	pH	8.4,	5mM	
EDTA,	 1M	 Urea)	 was	 set	 to	 1mL/min.	 Elution	 was	 collected	 between	 10	 and	 14	
minutes,	as	per	recommendation	from	iQur	Ltd.,	and	 is	referred	to	as	the	 ‘pooled	
fraction’	in	Figure	2.3.	
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Figure	2.3	Typical	size	exclusion	profile	for	tHBc-k1,	k1.	Adapted	from	other	works	(Kazaks	
et	al.,	2017).	
2.5 Analytical	methods	
2.5.1 Biomass	quantification	using	Optical	Density	(OD)	
Optical	density	analysis	of	fermentation	samples	was	performed	with	an	Amersham	
Ultrospec	500	Pro	spectrophotometer	(GE	Healthcare	Life	Sciences;	Hatfield,	UK),	at	
an	absorption	wavelength	of	600nm,	using	1mL	of	diluted	fermentation	samples	in	
acrylic	 cuvettes.	 These	 samples	 were	 diluted	 appropriately	 with	 deionised	 water	
until	a	reading	between	0.1-0.5	was	obtained.	The	optical	density	was	determined	
by	multiplying	the	reading	with	the	corresponding	sample	dilution	factor.		
2.5.2 Biomass	quantification	using	Wet	Cell	Weight	(WCW)	
When	 using	 small-scale	 bioreactors	 (V<250mL),	 wet	 cell	 weight	 (WCW)	 was	
determined	 as	 follows.	 In	 a	 pre-weighed	 1.5mL	 Protein	 LoBind	 tube	 (Eppendorf,	
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Stevenage,	 UK),	 a	 1.0mL	 sample	was	 centrifuged	 at	 3200	 g,	 10°C	 for	 10	minutes	
using	 a	 benchtop	 Eppendorf	 Centrifuge	 (5415R).	 The	 supernatant	 was	 either	
discarded	 or	 collected	 for	 subsequent	 analysis.	 The	 weight	 of	 the	 pellet	 was	
determined	by	weighing	the	remaining	pellet	in	the	centrifuge	tube	and	subtracting	
the	weight	of	the	tube.	
When	using	large-scale	bioreactors	(VW,i>10L),	WCW	was	determined	as	follows.	In	
a	pre-weighed	50mL	skirted	Greiner	tube	(Greiner	Bio-One,	Kremsmünster,	Austria)	
50mL	of	sample	was	centrifuged	at	3200	g,	10°C	for	10	minutes	using	a	benchtop	
Eppendorf	 Centrifuge	 (5417R).	 The	 supernatant	was	 either	 discarded	 or	 collected	
for	subsequent	analysis.	The	weight	of	the	pellet	was	determined	by	weighing	the	
remaining	pellet	in	the	centrifuge	tube	and	subtracting	the	weight	of	the	tube.	
2.5.3 Biomass	quantification	using	Dry	Cell	Weight	(DCW)	
Dry	 cell	 weight	 (DCW)	 was	 only	 performed	 for	 small-scale	 fermentations	
(VW,i<100mL).	This	was	done	by	taking	a	pellet	in	a	tube	(see	2.5.2)	and	drying	the	
tube	in	an	oven	at	100°C	for	20-24	hours.	The	weight	of	the	pellet	was	determined	
by	weighing	the	dried	pellet	in	the	centrifuge	tube	and	subtracting	the	weight	of	the	
tube.	
2.5.4 Total	protein	analysis	with	Bicinchoninic	Acid	(BCA)	assay	
Triplicate	 two-fold	 dilution	 series	 of	 25µL	 samples	 were	 prepared	 alongside	 a	
Bovine	 Serum	Albumin	 (BSA)	 standard	 dilution	 series	 in	 a	 96-well	 plate.	 175µl	 of	
working	reagent	(50:1	ratio	of	BCA	solution	to	a	4%	CuSO4	solution)	was	added	to	all	
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wells.	 The	plate	was	wrapped	 in	 foil	 and	 incubated	 for	 30	minutes	 at	 37°C.	 Plate	
reading	 was	 performed	 at	 562nm	 using	 a	 Safire	 II	 multi-plate	 reader	 (Tecan,	
Reading,	UK).	Based	on	a	1mg/mL	protein	upper	detection	limit,	it	was	determined	
which	sample	dilution	factor	is	appropriate	for	iterative	BCA	assays.		
2.5.5 Total	protein	analysis	with	Nanodrop	1000		
Total	 soluble	 protein	 analysis	 of	 unclarified	 and	 clarified	 lysates	 was	 performed	
using	a	Nanodrop	1000	spectrophotometer	 (Thermo	Fisher	Scientific,	Paisley,	UK).	
Triplicate	measurements	were	performed	for	3µL	sample	volumes	at	an	absorbance	
of	280nm	per	manufacturer’s	instructions.	The	extinction	coefficient	was	set	at	1.0	
as	a	default	general	reference	setting.		
2.5.6 Nucleic	acid	analysis	with	Nanodrop	1000	
Nucleic	analysis	of	unclarified	and	clarified	lysates	was	performed	using	a	Nanodrop	
1000	 spectrophotometer	 (Thermo	 Fisher	 Scientific,	 Paisley,	 UK).	 Triplicate	
measurements	were	performed	for	3µL	sample	volumes	at	an	absorbance	of	260nm	
as	per	manufacturer’s	instructions.	
2.5.7 Product	quantification	using	Green	Fluorescent	Protein	(GFP)	
Green	Fluorescent	Protein	 (GFP)	 fused	 to	Tandem	Core	protein,	was	measured	 in	
100µL	triplicate	samples	in	a	96-well	plate	format.	Plate	reading	was	performed	at	
an	excitation	wavelength	of	483nm	and	an	emission	wavelength	of	535nm,	using	a	
Safire	II	multi-plate	reader	(Tecan,	Reading,	UK).	
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2.5.8 Sodium	Dodecyl	Sulphate	Polyacrylamide	Gel	Electrophoresis	(SDS-PAGE)	
12	or	15-slot	pre-cast	NuPage™	4-12%	Bis-Tris	Gels	(Invitrogen,	Carlsbad,	USA)	were	
placed	 in	 an	 XCell	 Surelock®	 Mini-Cell	 (Invitrogen,	 Carlsbad,	 USA).	 200mL	 MOPS	
buffer	(Invitrogen,	Carlsbad,	USA)	was	added	to	the	inner	chamber	of	the	gel	tank.	
500µL	NuPage™	antioxidant	was	added	to	the	inner	chamber.	 
30	µL	of	each	sample	was	transferred	to	a	1.5mL	micro-centrifuge	tube	with	10µL	
NuPage™	 4x	 LDS	 sample	 buffer	 and	 4µL	 NuPage™	 10x	 reducing	 agent.	 All	 tubes	
were	centrifuged	for	30	seconds	to	ensure	that	all	 liquid	resided	at	the	bottom	of	
the	 tubes.	 The	 tubes	were	 vortexed	 and	 heated	 using	 a	 C1000	 TouchÔ	 Thermal	
Cycler	(Bio-Rad,	Watford,	UK)	at	95°C	for	10	minutes	to	denature	protein	content.		
3µL	 of	 pre-stained	 protein	 standard	 was	 added	 to	 the	 first	 lane	 of	 each	 gel.	
Denatured	sample	mixtures	were	applied	to	the	gel	slots	at	10-15µL	depending	on	
the	slot	size.	600mL	MOPS	buffer	was	added	to	the	outer	chamber	of	the	gel	tank.	
Electrophoresis	was	performed	at	200V	for	50	minutes.		
2.5.9 Western	blotting	
After	SDS-PAGE,	the	gels	were	transferred	to	an	XCell™	II	Blot	Module	(Invitrogen,	
Carlsbad,	 USA)	 allowing	 for	 protein	 transfer	 to	 two	 respective	 nitrocellulose	
membranes	 (Invitrogen,	 Carlsbad,	 USA).	 Transfer	 buffer	 was	 prepared	 by	 mixing	
NuPage™	 20x	 Transfer	 Buffer	 (Invitrogen,	 Carlsbad,	 USA)	 with	 749	 mL	 ultrapure	
water,	200mL	pure	ethanol	and	1	mL	NuPage™	antioxidant.	The	transfer	was	run	at	
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10V	for	3	hours.	For	membrane	development,	the	immunostaining	protocol	(section	
2.5.11)	was	followed.	
2.5.10 Dot	blotting		
Samples	 were	 diluted	 in	 MOPS	 lysis	 buffer	 (2.4.3)	 to	 achieve	 total	 protein	
concentrations	of	1mg/mL	at	a	total	volume	of	50µL	in	0.2mL	Protein	LoBind™	PCR	
tubes	(Eppendorf,	Stevenage,	UK)	
Reference	 standard	 (Recombinant	 Hepatitis	 B	 Core	 Antigen,	 Abcam	 AB49013,	
1.0mg/mL)	 was	 diluted	 in	 MOPS	 0.1%	 TX100	 buffer	 to	 achieve	 100µL	 stock	
solutions.	 These	 stock	 solutions	 were	 serial	 diluted	 two-fold	 to	 final	 volumes	 of	
50µL	 to	generate	 reference	curves.	5µL	10X	NuPage™	sample	 reducing	agent	was	
added	to	all	aliquots.	These	were	subsequently	heated	at	95°C	for	10	minutes	using	
C1000	Touch™	Thermal	Cycler	and	subsequently	cooled	for	at	 least	15	minutes	at	
12°C.		
For	each	assay,	a	0.45µm	11.5	x	8.5	cm	nitrocellulose	membranes	was	placed	on	a	
piece	of	filter	paper	(12	x	9cm)	resting	on	a	table.	Using	a	12	x	8	roster	to	serve	as	a	
grid,	samples	were	applied	on	the	membrane	in	2µL	volumes.	Each	membrane	was	
dried	for	at	least	10	minutes	at	room	temperature	post	sample	application.	
For	 membrane	 development,	 the	 immunostaining	 protocol	 (section	 2.5.11)	 was	
followed.	
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Note	 that,	 unless	 stated	 otherwise,	 all	 samples	 were	 analysed	 with	 triplicate	
measurements	to	determine	average	values	and	standard	deviations.		
2.5.11 Immunostaining	
Membranes	 were	 blocked	 in	 5%	 skimmed	 milk	 power	 PBS-T	 (0.05%	 Tween20)	
solution	 for	 1	 hour	 at	 room	 temperature	 or	 overnight	 at	 4-7°C.	 Hepatitis	 B	 virus	
core	 antigen-specific,	 mouse	 monoclonal	 antibody	 (Abcam;	 AB8639;	 Cambridge,	
UK)	 was	 applied	 in	 a	 1:1000	 solution	 in	 2.5%	 Skimmed	 Milk	 Power	 PBS-T	 and	
incubated	 for	 45	 minutes	 at	 room	 temperature	 and	 washed	 three	 times	 for	 5	
minutes	 each	 wash	 with	 PBS-T.	 Secondary	 antibody	 (Abcam;	 A4416-1ML;	
Cambridge,	UK)	was	applied	in	a	1:2000	dilution	in	PBS-T	followed	by	a	30-minute	
incubation	at	room	temperature.	Membranes	were	finally	washed	three	times	for	5	
minutes	 with	 PBS-T	 and	 once	 for	 5	 minutes	 with	 PBS	 to	 rinse	 away	 residual	
detergent.	10mL	of	Bio-Rad’s	Clarity	Western	ECL	substrate	was	used	to	develop	the	
membranes.	 Detection	 was	 performed	 using	 automated	 exposure	 setting	 on	 an	
Amersham	 Imager	 600	 (GE	 Healthcare	 Life	 Sciences;	 Hatfield,	 UK).	 Dot	 blot	
densitometry	was	done	using	ImageQuant	software	followed	by	quantification	with	
four-parameter	logistic	(4PL)	fitting.		
2.5.12 Particle	Size	Distribution	analysis	with	static	light	scattering		
Static	 light	 scattering	 analysis	 was	 performed	 using	 a	Mastersizer	 3000	 (Malvern	
Instruments,	Malvern,	UK).	Samples	were	applied	to	the	Hydro	SV	Dispersion	unit	at	
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1000rpm	until	 laser	obscuration	was	 in	the	5-10%	range.	5	measurements	of	each	
sample	were	taken	to	subsequently	create	an	average	PSD	curve.		
2.5.13 Methanol	analysis	using	High	Performance	Liquid	Chromatography	(HPLC)	
Methanol	 concentrations	 in	 clarified	 supernatant	 samples	 were	 determined	 by	
HPLC	using	a	Dionex	UltiMate3000	HPLC	pump	and	fitted	with	an	Aminex	HPX-87H	
column.	 Columns	 were	 run	 at	 0.6	mL/min	for	 30	minutes	 using	 0.1%	 (v/v)	
trifluoroacetic	 acid	 (TFA)	as	 mobile	 phase,	 a	 column	 temperature	 of	 60	°C,	 an	
injection	volume	of	10	μL	and	monitored	with	an	ERC	Refractomax	520	 refractive	
index	 detector.	Quantitative	 analysis	was	 performed	by	 integration	 of	 peak	 areas	
using	the	external	standard	method	(Ward	et	al.,	2015).		
2.5.14 Neutral	sugar	analysis	using	High	Performance	Liquid	Chromatography	
(HPLC)	
Clarified	 supernatant	 samples	 were	 analysed	 using	 a	 Reagent-FreeÔ	 Ion	
Chromatography	System	(ICS)	 (Thermo	Fisher	Scientific,	Paisley,	UK)	fitted	with	an	
AminoPac	PA10	(2	×	250	mm)	anion	exchange	column,	with	AminoPac	PA10	guard	
column	 (2	×	50	mm),	 an	 eluent	 generator	 with	 a	 KOH	 500	 cartridge,	 and	 an	
electrochemical	 detector	 (gold	 electrode).	 An	 injection	 volume	of	 10	μL	was	used	
and	 a	 7.5	mM	 KOH	 solution	 was	 used	 as	 the	 mobile	 phase	 with	 a	 flow	 rate	 of	
0.25	mL/min	for	 18	min	 at	 30	°C.	 Quantitative	 analysis	 was	 performed	 by	
integration	of	peak	areas	using	the	external	standard	method	(Ward	et	al.,	2017).	 
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2.5.15 Uronic	acid	analysis	using	High	Performance	Liquid	Chromatography	
(HPLC)	
Clarified	 supernatant	 samples	 were	 analysed	 as	 described	 in	 section	 2.5.14	
however,	instead	using	a	mobile	phase	of	5%	(v/v)	1	M	aqueous	sodium	acetate	and	
95%	(v/v)	deionised	water	at	0.25	mL	min−1	for	5	min	at	30	°C	(Ward	et	al.,	2017).	
2.5.16 Transmission	Electron	Microscopy	(TEM)	
TEM	was	performed	by	qualified	operators	of	the	Latvian	Biomedical	Research	and	
Study	Centre.		
2.5.17 Phase-contrast	and	fluorescence	microscopy	
Unclarified	 lysate	 samples	 were	 diluted	 to	 [X]=5-10gwcw/L	 using	 PBS	 and	 stained	
using	a	1:1000	volumetric	addition	BODIPYÒ	in	DMSO.	After	an	incubation	period	of	
15	minutes,	 5µL	 aliquots	of	 stained	 suspension	were	used	 to	prepare	microscopy	
slides.	 Microscopy	 analysis	 was	 done	 in	 bright	 light	 microscopy	 and	 fluorescent	
imaging	modes	using	an	Eclipse	microscope	(Nikon,	Kingston	upon	Thames,	UK).		
	
2.5.18 Statistical	analysis	and	Design	of	Experiments	(DoE)		
All	 statistical	 analysis	 and	model	 generation	was	 done	 using	 JMPÒPro12.0.1	 (SAS	
Institute	Incorporation;	Cary	NC,	USA).	
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Screening	models	were	generated	with	a	minimum	resolution	of	5	 to	estimate	all	
possible	 two-factor	 interactions.	 The	 relative	 contribution	 of	 an	 individual	 factor	
was	defined	as	the	total	of	the	sum	of	squares	(Type	III)	of	each	factor-associated	
term	as	a	percentage	of	the	total	of	the	sum	of	squares	of	all	terms	in	the	screening	
models.		
Central	 Composite	Designs	 (CCDs)	with	on-face	 axial	 points	 (a=1)	 and	 two	 center	
points	 were	 used	 to	 generate	 quadratic	 RSMs.	 Unless	 stated	 otherwise,	 only	
statistically	significant	model	terms	(p<0.05)	were	included	in	each	model	and	were	
selected	using	stepwise	regression.		
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Chapter	3 Initial	process	characterisation	of	novel	Tandem	Core	VLP	
constructs	
3.1 Introduction		
The	 aims	 of	 bioprocess	 development	 are	 to	 create	 processes	 that	 produce	 the	
highest	 possible	 yield	 of	 product,	 at	 the	 highest	 purity,	 at	maximum	 throughput,	
with	the	greatest	level	of	reproducibility	at	a	variety	of	scales,	and,	preferably	at	the	
lowest	possible	cost.		
As	discussed	 in	 the	chapter	1,	when	aiming	 to	 fulfil	 the	above	criteria,	 there	exist	
multiple	 process	 options	 to	 produce	 a	 single	 biopharmaceutical	 compound.	
Although	 the	 scope	 of	 this	 research	 has	 been	 limited	 to	 using,	 specifically,	 P.	
pastoris	 as	 an	 expression	 system	 to	 produce	 Tandem	 Core	 Virus-Like	 Particles	
(VLPs),	a	multitude	of	process	options	still	need	to	be	addressed.		
Firstly,	 one	 must	 consider	 the	 architecture	 of	 the	 plasmid	 to	 be	 tested.	 As	 the	
Tandem	Core	VLP	is	still	novel,	testing	for	appropriate	assembly	and	expression	of	
the	VLP	will	be	required.	In	this	case,	rather	than	choosing	an	immunogenic	fusion	
protein	 associated	 with	 influenza,	 reporter	 proteins,	 such	 as	 Green	 Fluorescent	
Protein	 (GFP)	 or	 Luciferase,	 may	 provide	 better	 insight	 and	 quick	 verification	 of	
tandem-core	protein	presence.	In	this	work,	this	group	of	variables	will	be	referred	
to	as	construct-associated	variables.	
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Secondly,	the	expression	system	needs	to	be	chosen	appropriately.	Variables	in	this	
area	are	the	specific	 type	of	host	cell	 that	would	be	suitable,	 typically	considering	
host	cell	mechanisms	that	will	facilitate	appropriate	formation	of	product;	and	what	
mutations	have	been	introduced	to	achieve	desired	metabolic	effects.	In	this	work,	
this	group	of	variables	will	be	referred	to	as	host	cell-associated	variables.		
Thirdly,	 there	 are	 several	 upstream	 process	 options	 available.	 The	 first	 aspect	 to	
consider	 is	 which	 platform	 is	 most	 suitable.	 In	 upstream	microbial	 bioprocessing	
this	 typically	 involves	 a	 variety	 of	 available	 modes	 of	 fermentation:	 either	
continuous	mode,	batch	mode,	fed-batch	mode,	or	a	combination	of	these	modes	
of	 fermentation.	 A	 subsequent	 aspect	 to	 consider	 is	 how	 the	 chosen	 platform	 is	
operated.	 Operating	 variables	 typically	 include	 operating	 temperature,	 agitation	
rate,	 aeration	 or	 sparge	 rate,	 operating	 pH,	 Dissolved	 Oxygen	 Tension	 (DOT),	
induction	 initiation	 time	 and	 harvest	 time.	 Media	 composition	 also	 needs	
consideration	 and	 can	 be	 controlled	 through	 media	 formulation,	 culture	 feeding	
and	culture	dilution.	For	fed-batch	systems,	feed	flow	rates	need	to	be	considered,	
whereas	with	 continuous	 systems,	 culture	 dilution	 rates	 need	 consideration.	 This	
group	of	options	will	be	referred	to	as	upstream	process-associated	factors.		
Fourthly,	 there	 is	a	multitude	of	options	available	 for	primary	 recovery.	Primarily,	
and	 indeed	 in	 the	 case	 of	 this	 research,	 the	 product	 of	 interest	 needs	 to	 be	
liberated	 from	 the	 cells.	 This	 can	 be	 achieved	 with	 various	 disruption	 methods:	
autolysis,	chemical	 lysis,	enzymatic	 lysis,	bead-facilitated	lysis,	sonication,	adaptive	
focused	 acoustics	 and	 homogenisation.	 Each	 of	 these	 methods	 has	 trade-offs	 in	
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terms	 of	 throughput,	 scalability	 and	 effectiveness.	 Notably,	 sonication	 and	
enzymatic	 lysis	are	not	used	at	pilot	 scale	because	no	 large-scale	apparatus	exists	
for	the	former	and	operational	costs	are	too	high	for	the	latter.	
Subsequently,	a	 suitable	method	must	be	chosen	 to	separate	cell	debris	 from	the	
soluble	product	of	interest.	This	can	be	achieved	through	a	variety	of	combinations	
of	various	modes	of	centrifugation	and	filtration.	Again,	these	modes	of	operation	
have	 various	 operating	 parameters	 associated	 with	 them	 that	 can	 considerably	
affect	 yield,	 purity,	 throughput,	 scalability,	 reproducibility	 and	 cost.	 This	 group	 of	
process	factors	will	be	referred	to	as	primary	recovery-associated	factors.		
Finally,	 the	 recovered	 product	 can	 be	 purified	 in	 numerous	 ways.	 For	 the	
purification	 of	 heterologous	 protein,	 this	 typically	 involves	 removal	 of	 unwanted	
protein	 species	 and	 nucleotides.	 This	 can	 be	 achieved	 through	 numerous	
precipitation	 methods,	 gradient	 centrifugation,	 and	 many	 chromatographic	
methods,	 including	 varieties	 of	 size-exclusion	 chromatography,	 hydrophobic	
interaction	 chromatography	 and	 ion-exchange	 chromatography.	 This	 group	 of	
process	factors	will	be	referred	to	as	downstream	process-associated	factors.	
Due	 to	 the	 sheer	magnitude	of	 options	 available,	 process-design	 limitations	were	
imposed.	Construct-associated	factors	were	limited	to	the	investigation	of	upstream	
process	 effects	 by	 several	 fusion	 protein	 inserts.	 This	 is	 because	 cell-engineering	
specifically	falls	outside	the	scope	of	this	research.	For	the	same	reason,	host	cell-
associated	 factors	were	 limited	 to	 investigating	 relevant	 differences	 in	 the	 use	 of	
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MutS-type	 (slow	 methanol	 metabolising)	 and	 Mut+-type	 (fast	 methanol	
metabolising)	P.	pastoris,	 specifically	and	 respectively	 the	KM71h	and	X33	strains.	
Upstream	process-associated	 factors	were	 limited	 to	 the	use	of	 a	 combination	of	
batch	 mode	 and	 fed-batch	 mode	 fermentations,	 as	 described	 by	 Invitrogen	
(Invitrogen	 Corporation,	 2002).	 The	 chosen	 primary	 recovery-associated	 factors,	
excluding	 extraction	 methods,	 were	 restricted	 to	 bench-top	 centrifugation	 and	
depth	filtration	methods.	Downstream	process-associated	factors	were	constrained	
to	salt	precipitation	methodology	and	to	Size	Exclusion	Chromatography.	These	two	
unit	 operations	 were	 previously	 characterised	 for	 the	 purification	 of	 monomeric	
HBc	protein	(Strods	et	al.,	2015).		
3.1.1 Hypotheses	and	outline	
Due	to	the	relative	novelty	of	this	work,	a	significant	portion	of	previously	discussed	
process-associated	factors	could	not	be	addressed	through	literature	alone.		
This	chapter	therefore	aims	to	identify	critical	process	parameters	and	to	generate	
observations	 through	 addressing	 relatively	 simple	 initial	 hypotheses.	 These	
observations	 can	 be	 used	 to	 (1)	 formulate	 more	 in-depth	 hypotheses	 and	 (2)	
establish	a	base	case	experimental	platform	which,	in	turn,	can	be	used	to	address	
these	matured	hypotheses.		
The	order	of	 the	hypotheses	and	the	associated	research	reported	 in	 this	chapter	
will	 generally	 follow	 the	 same	 sequence	 as	 unit	 operations	 in	 a	 bioprocess:	
addressing	 upstream-associated	 factors,	 by	 investigating	 fermentations;	 followed	
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by	addressing	primary	recovery-associated	factors	by	investigating	various	modes	of	
cell	disruption;	followed	by	addressing	downstream-associated	factors.		
3.2 Pichia	pastoris	Mut+	expressing	Tandem	Core	protein	with	GFP	insert	
Previous	works	have	 shown	 that	Tandem	Core	Hepatitis	B	Virus-Like	Particles	 can	
be	produced	in	both	bacteria	and	plants	(Peyret	et	al.,	2015);	while	other	VLPs,	such	
as	those	based	on	Human	Papilloma	Virus	(HPV),	have	been	produced	in	P.	pastoris		
using	 bioreactors	 (Jiang	 et	 al.,	 2011).	 Initial	 work	 was	 undertaken	 to	 establish	
fermentation	protocols	for	the	correct	expression	and	formation	of	Tandem	Core	in	
P.	pastoris,	and	to	assess	formation	using	a	GFP	reporter	for	analysis.	This	reporter	
protein	 greatly	 increases	 the	 ease	 of	 detecting	 the	 presence	 of	 Tandem	 Core	
protein	throughout	a	bioprocess	in	comparison	to	flu	epitope	inserts,	which	would	
require	more	elaborate	assays	such	as	ELISA’s	or	immuno-densitometry,	and	a	good	
supply	of	reagents.		
This	section	will	report	on	how	P.	pastoris	X33	(Mut+)	was	used	to	express	Tandem	
Core	VLPs	with	 a	 single	GFP	 insert	 on	one	of	 the	Major	 Insertion	Regions	 (MIRs).	
Using	 the	 Mut+	 phenotype	 should	 provide	 strong	 expression	 of	 heterologous	
protein	when	compared	to	its	MutS	variant.	Note	that	a	key	assumption	made	here	
is	that	higher	expression	of	Tandem	Core	protein	will	result	in	higher	VLP	yields.		
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3.2.1 Bench-top	fermentation	of	Pichia	pastoris	Mut+	
The	main	aims	of	this	experiment	were	to	investigate	a	P.	pastoris	X33	fermentation	
to	 identify	critical	process	parameters	and	to	study	Tandem	Core	HBc-GFP	protein	
(tHBc-GFP,e)	expression	and	stability	over	time,	using	Western	blotting.		
All	 stages	of	 fermentation	were	operated	as	described	 in	section	2.3.6.1,	with	the	
following	exceptions:	as	shown	 in	Figure	3.1A,	due	to	an	extended	period	of	poor	
temperature	 control,	 a	 higher	 than	 desired	 temperature	 (43°C)	 resulted	 in	
unfavourable	 conditions	 for	 biomass	 accumulation	 and,	 therefore,	 most	 likely	
prolonged	the	batch	phase	of	the	fermentation,	although	no	product	was	 induced	
at	 this	stage.	Additionally,	 the	glycerol	 fed	batch	phase	 involved	the	use	of	a	50%	
w/w	feed	as	opposed	to	a	50%	volumetric	 feed,	resulting	 in	a	slightly	more	dilute	
feed	 of	 non-inducing	 carbon	 source.	 Furthermore,	 the	 fed	 batch	 phase	was	 4.43	
hours	in	length	and	was	followed	by	a	brief	carbon	starvation	period	to	ensure	the	
absence	of	residual	glycerol	prior	to	induction.	Finally,	an	unintended	pH	drop	was	
observed	during	the	induction	phase	after	approximately	40	hours	of	fermentation.	
This	was	caused	by	depletion	of	base	reservoir	however,	this	did	not	seem	to	have	a	
significant	impact	on	biomass	concentrations.	
OD600	measurements	were	 taken	as	described	 in	section	2.5.1	and	can	be	seen	 in	
Figure	 3.1B.	 In	 addition	 to	 biomass	 monitoring,	 using	 optical	 density,	 multiple	
samples	were	 collected	 from	 the	point	 of	 induction	 throughout	 the	 remainder	 of	
the	fermentation.	
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Collected	fermentation	samples	were	diluted	to	5.0	OD600	using	PBS	for	the	purpose	
of	obtaining	data	relating	to	specific	expression,	rather	than	volumetric	expression.	
Following	centrifugation,	the	pellets	were	chemically	lysed	(section	2.4.7).	Following	
lysis,	 the	 pellets	 were	 vortexed	 and	 50µL	 samples	 were	 taken,	 representing	 the	
total	 protein	 expression	 fraction.	 This	 was	 followed	 by	 centrifugation	 so	 a	 that	
soluble	 protein	 fraction	 could	 be	 studied.	 To	 visualise	 specific	 protein	 expression	
over	time,	Western	blot	analysis	was	used,	as	described	in	sections	2.5.8	and	2.5.9.	
Immunostaining	was	performed	as	described	in	2.5.11.	Sigmafast™	3,3-DAB	tablets	
were	used	for	detection	(see	Figure	3.2).		
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Figure	3.1	Fermentation	data	of	P.	pastoris	Mut+	expressing	tHBc-GFP,e:	(A)	Online	data	
including	agitation	rate,	temperature,	pH	and	dissolved	oxygen	tension	level.	(B)	Offline	
data	including	OD600,	sampling	events	and	carbon	source	feed	rates.		
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Figure	 3.2	 Western	 blots	 of	 reduced	 gels	 of	 collected	 and	 processed	 fermentation	
samples	detected	with	hepatitis	B	core	10e11	antibody	and	stained	with	Sigmafast™	DAB:	
(A)	Total	 tHBc-GFP,e	expression	over	time.	 (B)	Total	soluble	tHBc-GFP,e	expression	over	
time.		
The	fermentation	showed	to	produce	relatively	large	amounts	of	biomass,	reaching	
380g/L	 WCW	 at	 the	 point	 of	 harvest.	 The	 Western	 blot	 results	 also	 show	 that	
induction	 was	 successful.	 The	 full-length	 monomer	 is	 expected	 at	 a	 molecular	
weight	of	around	64kDa	and,	while	this	represents	the	main	band,	it	is	clear	to	see	
that	 some	 truncations	 of	 the	monomer	 are	 visible,	 possibly	 indicating	 proteolytic	
activity.	Furthermore,	the	higher	bands	may	also	indicate	dimer	formations,	though	
this	 is	 difficult	 to	 establish	 with	 the	 existing	 resolution.	 However,	 unfortunately,	
most	 of	 the	 product	 was	 not	 recoverable	 in	 soluble	 form	 at	 any	 time	 of	 the	
fermentation.	 As	 the	Western	 blots	 consistently	 showed	 degradation	 profiles,	 as	
opposed	to	a	single	product	band,	and	as	no	appropriate	reference	hepatitis	B	core	
reference	standard	was	used,	it	was	not	immediately	evident	at	this	point	whether	
tHBc-GFP,e	was	expressed	as	intended.	
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3.2.2 Investigating	alternative	modes	of	induction	and	primary	recovery	
The	previous	section	demonstrated	that	cultivation	and	induction	of	P.	pastoris	X33	
expressing	 tHBc-GFP,e	 was	 possible.	 However,	 the	 majority	 of	 expressed	
heterologous	protein	detected	was	insoluble	and	therefore	it	was	unclear	whether	
VLP	assembly	had	occurred.		Furthermore,	if	VLP	assembly	had	occurred,	VLPs	were	
not	 able	 to	 be	 detected	 due	 to	 potential	 association	 with	 insoluble	 cell	 debris,	
possibly	as	a	result	of	the	method	of	extraction	employed.		
Various	sources	indicate	that	changing	operating	temperature	and	implementing	a	
sorbitol-methanol	mixed	 feeding	 strategies	 can	have	beneficial	 effects	on	process	
yields	and	product	quality	 (Li	et	al.,	 2001;	Xie	et	al.,	 2005;	Celik,	Calik	 and	Oliver,	
2009;	 Zhong	et	 al.,	 2014).	 Figure	 3.2	 showed	 variations	 between	band	 intensities	
and	 profiles	 over	 time,	 particularly	 when	 comparing	 early	 induction	 time	 points	
(t=30.4)	 to	 later	 induction	 time	 points.	 This	 indicates	 that	 induction	 time	 is	 a	
significant	process	parameter.	Furthermore,	other	sources	suggest	that	the	mode	of	
extraction	does	indeed	have	a	significant	effect	on	the	recovery	of	VLPs	(Kee,	Pujar	
and	Titchener-Hooker,	2008;	Gurramkonda	et	al.,	2013).		
Therefore,	based	on	literature,	in	an	attempt	to	improve	soluble	tHBc-GFP,e	yields,	
this	section	will	seek	to	test	the	following	hypotheses:	
1. Induction	temperature	has	a	significant	effect	on	tHBc-GFP,e	expression	and	
quality,	based	on	degradation	profiles.	
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2. The	implementation	of	mixed	feed	induction	has	a	significant	effect	on	tHBc-
GFP,e	expression	and	quality.		
3. Duration	of	induction	time	has	a	significant	effect	on	protein	expression	and	
quality.		
4. tHBc-GFP,e	yields	are	affected	by	different	extraction	methods.	
To	 test	 the	 first	 hypothesis,	 a	 fermentation	was	 operated	 as	 described	 in	 section	
3.2.1,	 however,	 induced	 at	 a	 lower	 temperature	 of	 20°C.	 Fermentation	 data	 is	
shown	in	Figure	10.4	in	the	appendix.	
Looking	 at	 Figure	 3.3,	 and	 comparing	 induction	with	 pure	methanol	 at	 20°C	with	
pure	 methanol	 induction	 at	 30°C	 (as	 described	 in	 section	 3.2.1),	 it	 appears	 that	
higher	 total	 soluble	 tHBc-GFP,e	 expression	 occurs	 at	 higher	 temperatures.	 Higher	
temperatures	are	producing	more	GFP,	however	it	is	unclear	if	the	GFP	is	part	of	the	
VLP	monomer	or	if	it	has	been	cleaved.	
The	Western	blot	in	Figure	3.4B	indicates	that	a	higher	amount	of	full-length	tHBc-
GFP,e	 monomer	 (band	 2,	 ~64kDa)	 has	 become	 insoluble	 at	 a	 low	 temperature	
induction	 process,	 while	 higher	 induction	 temperatures	 seem	 to	 result	 in	 higher	
concentration	 of	 degradation	 product	 (bands	 3	 and	 4).	 Therefore,	 the	 first	
hypothesis	of	this	section	seems	to	be	proven:	 induction	temperature	has	a	effect	
on	tHBc-GFP,e	expression	and	quality.		In	this	case,	lower	temperatures	are	shifting	
more	of	the	product	into	the	insoluble	fraction.		
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Figure	3.3	 Specific	 tHBc-GFP,e	expression	 (RFU/OD600)	 of	harvested	material	 from	 three	
fermentations,	each	with	different	modes	of	induction.	‘Methanol’	refers	to	an	induction	
process	with	 only	methanol	 in	 the	 feed;	 ‘Mixed’	 refers	 to	 an	 induction	 process	with	 a	
mixture	 of	 sorbitol	 and	 methanol	 in	 the	 feed.	 Extractions	 were	 performed	 with	
homogenisation	 or	 with	 sonication	 (*).	 Soluble	 and	 insoluble	 heterologous	 protein	
content	was	quantified	with	a	GFP	assay	as	described	in	section	2.5.7.	
	
Figure	3.4	Fermentation	sample	analysis.	Harvested	material,	each	with	different	modes	
of	 induction.	 Extractions	 were	 performed	 with	 homogenisation	 or	 with	 sonication	 (*).	
Protein	 presence	 in	 clarified	 culture	 media	 was	 also	 studied	 (**).	 (A)	 Reversible	
membrane	stain	of	reduced	SDS-PAGE	gel	showing	soluble	and	insoluble	host	cell	protein	
expression	profiles.	(B)	Western	blot	showing	soluble	and	insoluble	expression	profiles	of	
tHBc-GFP,e.	 Six	 bands	 were	 identified,	 assuming	 u,GFP=27kDa	 (Hink	 et	 al.,	 2000),	
u,HBcAG=21kDA	hetero-Tandem	Core:	(6):	u»21kDa,	(5)	u»	26kDa,	(4)	u»51kDa,	(3)	u»53	
kDa,(2)	u»64	kDa	and	(1)	64<u<191kDa.	
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The	 second	 hypothesis	 was	 addressed	 by	 running	 a	 fermentation	 as	 described	
earlier	in	this	section,	however,	inducing	with	a	1:1	carbon	mole	ratio	of	sorbitol	to	
methanol	 mixture,	 at	 an	 induction	 temperature	 of	 20°C.	 Fermentation	 data	 is	
shown	in	Figure	10.5	in	the	appendix.	
Comparing	 this	 fermentation	with	 the	 previously	 discussed	 process	where	 a	 20°C	
pure	methanol	induction	strategy	was	used,	looking	at	Figure	3.3	and	Figure	3.4,	it	
appears	 the	 addition	 of	 sorbitol	 as	 a	 co-substrate	 does	 not	 obviously	 benefit	 the	
expression	of	 soluble	 tHBc-GFP,e.	 In	 fact,	 expression	of	heterologous	protein,	 per	
cell,	 is	 decreased	 through	 the	 addition	 of	 a	 co-substrate,	 possibly	 due	 to	
competition	 between	 the	 activation	 of	 the	 AOX1	 gene	 and	 cell	 growth	 and	
maintenance.	 This	 could	 have	 resulted	 in	 lower	 specific	 heterologous	 expression.	
Nonetheless,	of	what	little	protein	expression	is	monitored,	a	higher	proportion	of	
expressed	 protein	 appears	 to	 be	 soluble.	 Thus,	 while	 mixed	 feed	 strategies	 can	
indeed	have	an	impact	on	expression	of	heterologous	protein,	the	titres	generated	
did	not	result	in	a	beneficial	improvement.		
The	 third	 hypothesis	 was	 investigated	 by	 analysing	 protein	 expression	 of	 a	 low-
temperature	 fermentation	 over	 time.	 As	 seen	 in	 Figure	 3.5	 and	 Figure	 3.6,	
representing	 specific	 protein	 expression	 over	 time	 in	 the	 previously	 discussed	
fermentation	 with	 a	 20°C	 pure	 methanol	 induction,	 time	 does	 appear	 to	 be	 a	
significant	 factor	 for	 overall	 expression	 of	 tHBc-GFP,e.	 However,	 note	 that	 the	
amount	of	soluble	heterologous	protein,	measured	in	RFUs,	is	consistent	over	time:	
8.27±1.61%	 relative	 to	 the	 total	 amount	 of	 heterologous	 protein	 expressed.	 This	
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data	 would	 suggest	 that	 time	 is	 not	 strictly	 a	 significant	 contributing	 factor	 to	
product	 solubility.	Yet,	 looking	at	 the	corresponding	Western	blot	 (Figure	3.6B),	 it	
seems	that	as	induction	time	progresses,	insoluble	degradation	products	(bands	2,3	
and	4)	accumulate.	This	conflicting	data	between	RFUs	from	GFP	and	Western	blot	
bands	 indicating	 HBc	 positive	 material	 seems	 to	 suggest	 that	 the	 GFP	 insert	 is	
cleaved	from	the	Tandem	Core	scaffold.	However,	this	is	not	a	conclusive	finding.	In	
future	work,	this	theory	could	be	tested	by	employing	GFP-specific	antibodies	in	an	
orthogonal	Western	blot	assay.	Nonetheless,	the	conclusion	of	this	experiment	was	
twofold:	 (1)	 the	hypothesis	 that	 induction	 time	has	a	 significant	effect	on	protein	
expression	and	quality	was	proven;	and	(2)	the	GFP	insert	does	not	provide	suitable	
characteristics	for	bioprocess	characterisation.		
	
Figure	3.5	Time	 course	analysis	of	protein	expression	of	 20°C	pure	methanol	 induction.	
GFP-positive	 protein	 expression	 is	 displayed	 as	 Relative	 Fluorescence	 Units	 (RFUs)	 per	
unit	of	biomass	(OD600).	Total	protein	is	expressed	in	mass	per	unit	of	biomass.	
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Figure	3.6	Protein	analysis	of	fermentation	time	course.	Extractions	were	performed	with	
sonication.	(A)	Reversible	membrane	stain	of	reduced	SDS-PAGE	gel	showing	soluble	and	
insoluble	 host	 cell	 protein	 expression	 profiles.	 (B)	 Western	 blot	 showing	 soluble	 and	
insoluble	expression	profiles	of	tHBc-GFP,e.		
The	 fourth	 hypothesis	 was	 addressed	 by	 comparing	 protein	 extraction	 with	
homogenisation	 (1200	 bar,	 3	 passes)	 (section	 2.4.3),	 to	 protein	 extraction	 with	
sonication	(section	2.4.4).	Figure	3.3	and	Figure	3.4	indicate	that	using	sonication	as	
an	extraction	method,	results	in	lower	overall	yields	and	lower	tHBc-GFP,e	solubility	
compared	to	High	Pressure	Homogenisation.		
In	 addition	 to	 assessing	 the	 above	 hypotheses,	 the	 following	 observations	 were	
made:	 The	banding	profiles	 on	 the	Western	blot	 on	 Figure	 3.4B	 seem	 to	 indicate	
that	 truncation	 of	 heterologous	 protein	 contributes	 to	 insolubility.	 Six	 species,	 or	
breakdown	products,	 of	 expressed	 heterologous	 tHBc-GFP,e	 protein	 fractions	 can	
be	identified,	numbered	as	1	to	6.	As	seen	on	Figure	3.4,	only	species	1,	2	and	6	are	
found	to	be	soluble.	This	suggests	either	certain	truncations	are	inherently	insoluble	
or	 so	 strongly	 hydrophobic	 that	 they	 associate	 with	 cell	 debris	 post	
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homogenisation;	or	that	these	specific	truncated	species	affect	the	assembly,	from	
a	kinetic	perspective,	into	soluble	VLPs.	Following	electron	microscopy	analysis,	no	
proof	was	found	of	VLP	assembly	in	any	of	the	soluble	fractions	of	the	lysed	harvest	
pellets	shown	in	Figure	3.4	(data	not	shown).		
Due	 to	 inconsistencies	 in	 generating	 the	analysed	materials,	 it	 should	be	 stressed	
that	the	findings	in	this	section	are	strictly	indicative,	rather	than	conclusive.		These	
irregularities	 include:	 temporary	 loss	 of	 control	 of	 operating	 parameters	 such	 as	
DOT,	pH	and	 temperature;	different	 induction	 feed	 rates	and	different	harvesting	
times.	Harvesting	times,	ranging	from	70	to	92	hours	post-inoculation,	were	based	
on	 consistent	 target	 OD600	 values	 of	 500	 rather	 than	 consistent	 harvesting	 time,	
which,	after	testing	the	third	hypothesis	of	this	section,	seems	to	have	proven	to	be	
an	incomplete	approach	as	time	was	shown	to	affect	heterologous	expression.	Also	
note	 that	 volumetric	 productivity	 was	 not	 assessed	 as	 all	 final	 harvest	 densities	
were	consistent	approximately	500±31	OD600.		
3.3 Pichia	pastoris	MutS	expressing	Tandem	Core	protein	with	lysine	inserts	
Section	3.2	described	how	attempts	were	made	 to	characterise	 the	production	of	
VLPs	consisting	of	Tandem	Core	protein	units	with	linked	GFP	reporter	as	an	insert	
on	 the	Major	 Insertion	 Region.	 These	 units	were	 expressed	 in	 a	P.	 pastoris	Mut+	
phenotype.	 Results	 show	 that,	 despite	 investigating	multiple	 process	 parameters,	
most	of	 the	expressed	material	 remained	 insoluble	 and	was	often	degraded.	 This	
indicated	 that	VLP	 formation	had	been	problematic.	 In	 addition,	 results	 indicated	
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that	 the	GFP-fused	 protein	 did	 not	 provide	 suitable	 characteristics	 for	 bioprocess	
characterisation.	 Indeed,	no	evidence	was	found	of	VLP	production	by	the	studied	
fermentations	via	electron	microscopy.	This	could	be	because	the	GFP	insert	could	
have	directly	affected	the	assembly	kinetics	of	VLPs,	through	mechanisms	of	steric	
hindrance	 and/or	 hydrophobic	 interactions.	 Secondly,	 the	 rate	 of	 heterologous	
protein	expression,	manipulated	through	varying	modes	of	induction,	was	shown	to	
have	an	effect	on	tHBc-GFP,e	expression	and	solubility.		
Work	 by	 Zlotnik	 et	 al	 indicates	 that	 VLP	 self-assembly	 requires	 regulation,	 as	
uncontrolled	 assembly	 of	 free	 units	 of	 recombinant	 protein	 can	 result	 in	 ‘kinetic	
traps’	 and	 thus	 incomplete	 formation	 of	 capsids	 (Zlotnick	 and	 Mukhopadhyay,	
2011).	 Specifically,	 at	 high	 induction	 rates,	 there	will	 be	multiple	monomers	 that	
will	 seek	 to	 come	 together	 to	 form	an	 intermediate	VLP,	 but	may	never	 create	 a	
fully	formed	capsid.	 Instead,	Zlotnik	suggests	that	by	having	fewer	monomers,	the	
proportion	of	incomplete	intermediate	VLP	will	be	reduced	and	result	in	more	fully	
formed	capsids.	Therefore,	the	MutS	phenotype	of	P.	pastoris	was	utilised	to	assess	
this	theory.		
The	P.	pastoris	MutS	phenotype	has	a	significantly	lower	methanol	metabolism	and	
thus	 also	 a	 lower	 rate	 of	 expressing	 heterologous	 protein	 (Cereghino	 and	 Cregg,	
2000).	As	seen	 in	section	3.2.2,	where	a	mixed	feed	 induction	was	compared	to	a	
pure	methanol	 induction	fermentation,	 lower	specific	expression	seemed	to	result	
in	relatively	higher	ratios	of	soluble	to	insoluble	recombinant	protein.	
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Following	 these	observations,	 the	next	experiments	 tested	whether	Tandem	Core	
protein	 assembly	 is	 hindered	 by	 the	 size	 of	 the	 insert	 placed	 in	 the	MIR.	 It	 was	
noted	that	GFP	appeared	to	cleave	off	 the	Tandem	Core	monomer,	 therefore	this	
was	 replaced	 with	 a	 lysine	 residue	 in	 each	 MIR.	 Secondly,	 if	 VLP	 self-assembly	
requires	 regulation	and	can	be	controlled	 through	 lower	protein	expression	 rates,	
then	 P.	 pastoris	 MutS	 should	 be	 able	 to	 produce	 higher	 levels	 of	 appropriately	
assembled	VLP	than	its	higher	metabolic	counterpart,	Mut+.	
3.3.1 Fermentation	of	Pichia	pastoris	MutS	
Fermentations	of	the	MutS	phenotype	of	P.	pastoris	(KM71h	strain)	were	conducted	
using	a	lysine	residue	insert	at	both	MIRs	on	the	Tandem	Core	VLP.	This	protein	will	
be	referred	to	as	the	k1,k1	construct,	or	tHBc-k1,k1.	Relevant	fermentation	data	is	
shown	in	Figure	10.6	in	the	appendix.	
Prior	 to	 induction,	 the	 fermentation	 processes	 were	 similar	 between	 MutS	 and	
Mut+.	 However,	 the	 induction	 phase	 yielded	 very	 different	 fermentation	
performance,	mostly	relating	to	methanol	consumption.	As	expected,	due	to	lower	
AOX	 expression,	 the	 MutS	 fermentation	 required	 a	 longer	 adaptation	 period	 to	
methanol	and	was	not	capable	of	utilising	this	substrate	at	the	same	rates	as	Mut+	
cultures.	 This	 is	 reflected	 by	 lower	 agitation	 rates	 in	 MutS	 cultures	 during	 the	
induction	phase.	To	accommodate	 lower	methanol	consumption	rates,	preventing	
methanol	toxicity,	an	induction	method	specific	to	the	MutS	genotype	was	used	as	
described	in	section	2.3.4	(Invitrogen	Corporation,	2002).	However,	it	was	expected	
that	lower	methanol	consumption	would	also	result	in	lower	specific	expression	of	
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Tandem	 Core	 protein.	 This	 lower,	 and	 arguably	 more	 controlled,	 expression	 was	
postulated	to	result	in	higher	VLP	yields.		
3.3.2 Initial	DSP	of	VLP	material	
Harvested	material	was	processed	as	described	by	 Figure	3.7,	based	on	protocols	
already	established	 in	 literature	 for	hepatitis	B	 core	VLP	purification.	 (Freivalds	et	
al.,	2011;	Strods	et	al.,	2015)	
	
Figure	3.7	Summary	of	unit	operations	involved	in	purifying	and	characterising	expressed	
material.	 (A)	Homogenisation	at	1200	bar,	3	passes	 (section	2.4.3);	 (B)	centrifugation	at	
15000	 g,	 30	 min,	 4°C;	 (C)	 heat	 treatment	 in	 a	 water	 bath	 at	 55°C,	 30	 minutes;	 (D)	
centrifugation	 at	 15000	 g,	 30	 min,	 22°C;	 (E)	 ammonium	 hydroxide	 precipitation;	 (F)	
centrifugation	 at	 15000	 g,	 30	min,	 4°C;	 (G)	 suspend	 pellet	 in	 PBS;	 (H)	 preparative	 size	
exclusion	column	(section	2.4.11).		
The	use	of	a	heat	treatment	step	allowed	for	the	isolation	of	heat	stable	particles	in	
the	supernatant.	The	implementation	of	ammonium	sulphate	treatment	allowed	for	
the	precipitation	of	VLPs,	which	are	relatively	hydrophobic	 in	comparison	to	other	
soluble	 protein	 species.	 Applying	 a	 final	 size-exclusion	 chromatography	 step,	 as	
described	in	section	2.4.11,	allowed	for	the	isolation	of	particles	in	the	desired	size	
range.		
Pellet Pellet Supernatant
A B C D E F G H
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Figure	3.8B	shows	how	this	sequence	of	purification	steps	was	used	to	successfully	
isolate	 Tandem	 Core	 protein	 with	 no,	 or	 negligible	 amounts	 of,	 truncated	 core-
positive	 species.	 The	 full-length	 monomer	 is	 expected	 at	 molecular	 weight	 of	
around	 42.5kDa.	 Bands	 1	 and	 2	 have	 been	 assumed	 to	 be	 full-length	 tHBc-k1,k1	
proteins,	however;	band	1	is	most	likely	a	dimeric	form	of	this	monomer.	Previous	
work	has	shown	that	this	 intermediate	is	required	for	VLP	assembly	and	would	be	
less	susceptible	to	chemical	reduction	(Holmes	et	al.,	2015).	Hence,	this	dimer	could	
be	 present	 due	 to	 incomplete	 chemical	 reduction	 in	 preparation	 of	 the	 assay.		
Figure	3.9	shows	how	these	same	unit	operations	facilitate	the	removal	of	host	cell	
protein	and	nucleic	acids	(Figure	3.9).	Finally,	Figure	3.10	proves	that	the	expressed	
tHBc-k1,k1	 monomers	 are	 assembling	 into	 Virus-Like	 Particles.	 As	 shown	 by	 the	
profiles	associated	with	clarification	in	Figure	3.8B,	it	would	appear	that	most	of	the	
expressed	 tHBc	 is	 soluble.	 A	 slight	majority	 of	 this	 soluble	material	 is	 heat-stable	
and,	 in	 turn,	 all	 of	 this	 material	 precipitated	 after	 the	 addition	 of	 ammonium	
sulphate.	 This	 last	 step	 eliminated	 a	 significant	 portion	 of	 host	 cell	 protein	 and	
nucleic	 acids,	 as	 shown	 in	 Figure	3.9,	 therefore	proving	 it	 to	be	a	highly	effective	
purification	step.	Although	the	SEC	step	was	shown	to	reduce	the	amount	of	HCP,	it	
is	not	exactly	clear	why	a	large	amount	of	core-positive	material	was	lost	during	to	
this	process.	This	could	possibly	be	due	to	the	detection	of	relatively	small	higher-
order	core-positive	structures,	or	of	 individual	units	of	unassembled	Tandem	Core	
protein	that	are	removed	during	the	SEC	and	pre-SEC	filtration	steps.		
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Figure	3.8	Qualitative	protein	data	of	purification	sequence	as	described	by	Figure	3.7.	(A)	
Membrane	stain	of	a	reduced	SDS-PAGE	gel	showing	host	cell	protein	expression	profiles.	
(B)	Western	blot	showing	expression	profiles	of	tHBc-k1,k1.	Bands	1	and	2	depict	soluble,	
non-truncated	Tandem	Core	protein	species.		
	
Figure	3.9	Mass	balance	of	total	host	cell	protein	and	total	nucleic	acids	in	the	purification	
sequence	described	by	Figure	3.7.		
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Figure	 3.10	 Electron	 microscopy	 image	 of	 k1,k1	 Virus-Like	 Particles	 in	 a	 resuspended	
pellet	after	ammonium	sulphate	precipitation.	VLPs	are	indicated	by	the	arrows.		
3.3.3 Investigating	process	robustness	
The	previous	section	demonstrated	that	tHBc-k1,k1	was	successfully	expressed,	in	a	
soluble	form,	and	was	assembling	into	Virus-Like	Particles.		
However,	not	addressed	were:	 (1)	 the	effect	of	 time	on	 the	expression	of	 soluble	
tHBc-k1,k1	and;	(2)	how	robust	this	process	is	from	a	bioprocessing	perspective.		
To	 address	 this,	 firstly,	 a	 replicate	 fermentation	 run	 was	 attempted,	 the	 original	
fermentation	 being	 depicted	 previously	 in	 Figure	 10.6.	 The	 data	 for	 this	 replicate	
run	 is	 shown	 in	 Figure	 3.11.	 Samples	 were	 taken	 throughout	 the	 fermentation,	
which	were	then	processed	as	described	in	Figure	3.7	until	unit	operation	‘G’,	prior	
to	 Size	 Exclusion	 Chromatography,	 together	 with	 samples	 taken	 throughout	 the	
original	 fermentation.	 Expression	 of	 tHBc-k1,k1	 in	 both	 the	 original	 and	 replicate	
fermentation	were	compared	and	were	 found	 to	differ	 in	band	 intensities	 (Figure	
3.12).		
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Figure	3.11	Data	for	replicate	fermentation	attempt	of	P.	pastoris	MutS	expressing	tHBc-
k1,k1:	 (A)	 Offline	 data	 including	 OD600,	 sampling	 events,	 carbon	 source	 feed	 rates,	
temperature	 and	 pH	 (B)	 Online	 data	 including	 agitation	 rate,	 dissolved	 oxygen	 tension	
level	and	carbon	evolution	rate.		
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Unfortunately,	 the	 fermentations	 could	 not	 be	 operated	 identically	 due	 to	
differences	 in	 discrete	 pump	 increments.	 However,	 this	 presented	 an	 interesting	
opportunity	to	assess	upstream	process	robustness.		
The	main	cause	of	differences	in	metabolic	performance	(CER	and	biomass)	is	most	
likely	due	to	a	9%	increase	in	volumetric	feeding	rates	of	methanol	relative	to	the	
original	fermentation.	This	explains	the	overfeeding-related	CER	profile	seen	in	the	
attempted	 replicate	 fermentation,	 resulting	 from	 methanol	 accumulation.	 This	
profile	is	distinctive	by	an	initial	rapid	increase	in	CER,	between	21	and	24	hours	of	
fermentation,	followed	by	a	rapid	decrease	in	CER	after	25	hours	of	fermentation.		
	
Figure	 3.12	 Qualitative	 protein	 data	 of	 time	 course	 analysis.	 Time	 represents	 the	 time	
post-induction.	 Extractions	were	 performed	 as	 shown	 in	 Figure	 3.7	 up	 until	 step	G.	 (A)	
Reduced	SDS-PAGE	gel	showing	soluble	host	cell	protein	expression	profiles.	(B)	Western	
blot	showing	soluble	expression	profiles	of	tHBc-k1,	k1.		
Overall,	it	seems	that	a	relatively	small	deviation	(9%)	in	pump	flow	rates	can	have	a	
significant	 effect	 on	 the	 fermentation	 process	 described.	 This	 process	 therefore	
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does	not	appear	to	be	very	robust	as	there	is	a	major	issue	with	upstream	process	
reproducibility.		Additionally,	although	ammonium	sulphate	precipitation	facilitated	
significant	removal	of	various	impurities,	it	was	found	that	the	process	could	not	be	
applied	 consistently.	 In	 particular,	 it	 was	 often	 difficult	 to	 isolate	 a	 pellet	 with	
centrifugation	 following	precipitation	 (Figure	3.13).	Therefore,	 future	 investigation	
should	be	carried	out	on	more	robust	platforms	with	tighter	control.	
	
Figure	 3.13	 Close-up	 photo	 of	 50mL	 tubes	 containing	 non-pelleted	 precipitate	
(highlighted	by	arrows)	following	ammonium	sulphate	treatment	and	centrifugation.			
3.4 Summary	
This	chapter	has	shown	that	the	production	of	recombinant	tandem	hepatitis	B	core	
(tHBc)	VLPs	is	possible	in	suspension	culture.		
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Initially,	a	Mut+	phenotype	of	P.	pastoris	was	used	to	express	Tandem	Core	with	a	
single	GFP	 insert	 in	 one	of	 the	MIRs.	No	 evidence	was	 found	 to	 suggest	 that	 the	
expressed	material	was	assembling	 into	VLPs.	This	 could	possibly	be	explained	by	
the	 large	 number	 of	 product	 truncations	 detected	 in	 analyses.	 These	 truncations	
could	have	hindered	the	assembly	of	VLPs.		
It	 was	 found	 that	 induction	 temperature,	 the	 addition	 of	 a	 sorbitol	 co-substrate	
during	induction;	and	that	induction	time	have	a	significant	effect	on	Tandem	Core	
expression	and	quality,	with	low	quality	indicated	by	high	levels	of	truncations.		
It	was	hypothesised	that	 lowering	expression	rates	through	alteration	of	host	cell-
associated	factors,	and	introducing	smaller	inserts,	would	result	in	more	favourable	
conditions	 for	 the	 expression	 and	 assembly	 of	 soluble	 VLPs.	 This	 hypothesis	 was	
tested	 using	 a	P.	 pastoris	MutS	 strain	 expressing	 Tandem	 Core	 protein	with	 two,	
single	 lysine	 inserts.	 Results	 showed	 that,	 using	 this	 strategy,	 soluble	 and	 heat-
stable	VLPs	were	indeed	produced	in	the	appropriate	size	range.		
It	must	be	stressed	that	certain	results	in	this	chapter,	particularly	those	relating	to	
upstream	process-associated	 factors,	are	 strictly	 indicative	 rather	 than	conclusive.	
This	is	owing	to	a	lack	of	consistency	and	reproducibility	in	experiments.	In	addition	
to	this,	minute	changes	to	operating	parameters	such	as	feeding	flow	rates,	caused	
drastic	changes	to	product	quality	attributes.		
To	gain	conclusive	and	quantifiable	results,	these	findings	need	to	be	addressed	in	a	
robust,	 reproducible	 and,	 preferably,	 high-throughput	 fashion.	 This	 could	 be	
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achieved	 through	 the	 use	 of	 miniaturised	 fermentation	 platforms,	 more	
streamlined	 extraction	 processes,	 and	 combined	 with	 experimental	 design	
methodology.		
The	 time	 and	 cost	 benefits	 of	 these	miniaturised	 fermentation	 platforms	 can	 be	
gained	only	by	employing	 complementary	 techniques,	 facilitating	high-throughput	
at	 small	 sample	 volumes.	 As	 indicated	 earlier	 in	 this	 chapter,	 the	 method	 of	
extraction	has	a	significant	effect	on	the	yield	of	soluble	heterologous	material	and,	
since	the	investigated	miniaturised	extraction	platforms	investigated	in	this	chapter	
yielded	 poor	 soluble	 yields,	 this	 is	 something	 that	 needs	 to	 be	 addressed	 in	 the	
subsequent	chapter.		
This	chapter	has	established	the	formation	of	a	VLP	using	the	k1,k1	construct	and	a	
MutS	 phenotype	 strain.	 The	 following	 chapters	 will	 seek	 to	 conduct	 process	
development	on	these	Tandem	Core	VLPs	using	a	high-throughput	methodology	for	
upstream	processing	and	primary	recovery.	As	sample	analysis	has	proven	to	be	a	
limiting	 factor,	 lysis	 methodologies	 will	 be	 first	 investigated,	 which	 will	 facilitate	
sample	analysis	for	high-throughput	fermentation.		
	 	
	 																																																																																										Benjamin	A.F.	Bláha	2018	
	 126	
Chapter	4 Characterisation,	miniaturisation	and	optimisation	of	
primary	recovery	methods		
4.1 Introduction		
Chapter	3	demonstrated	the	significance	of	primary	recovery-associated	factors	 in	
the	recovery	of	soluble	Tandem	Core	material.	Firstly,	it	was	shown	that	the	chosen	
extraction	method	has	a	significant	effect	on	the	yield	of	soluble	material.	Secondly,	
it	was	found	that	small-scale	extraction	methods	did	not	allow	for	the	recovery	of	
relatively	high	soluble	yields	of	core-positive	protein.		
The	 latter	 finding	presented	a	significant	challenge	as	the	benefits	of	miniaturised	
fermentation	 platforms	 can	 only	 be	 gained	 by	 employing	 complementary	
techniques	facilitating	high-throughput	at	small	sample	volumes.	
This	 chapter	will	 therefore	describe	 research	 aimed	at	 structurally	 addressing	 the	
effects	of	primary	 recovery	methods,	with	an	emphasis	on	 cell	 disruption,	on	 the	
yield	of	soluble	Tandem	Core	material.	In	doing	so,	the	chapter	will	discuss	how	cell	
disruption	processes	could	be	characterised,	optimised	and	miniaturised	such	that	
they	 could	 be	 employed	 in	 a	 platform	 approach	 when	 coupled	 with	 miniature	
fermentation,	 or	 situations	 of	 limited	 sample	 volumes.	 Note	 that	 all	 biomass	 (P.	
pastoris	 MutS	 expressing	 k1,k1	 VLPs)	 was	 generated	 from	 a	 single	 batch	 as	
described	in	section	2.3.5.1.	The	majority	of	methodologies	and	results	presented	in	
this	chapter	have	previously	been	published	(Bláha	et	al.,	2017).	
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4.2 Methods	of	cell	disruption		
Cell	disruption	 is	essential	 for	almost	all	 intra-cellular	products.	Most	studies	have	
defined	 total	 cell	 disruption	 (R)	 as	 a	 performance	 criterion	 of	 cell	 disruption	
processes,	 often	 measured	 as	 total	 soluble	 protein	 content.	 However,	 counter-
intuitively,	 maximising	 cell	 disruption	 is	 not	 always	 the	 main	 objective	 of	 cell	
disruption,	as	product	can	associate	with	cell	debris,	such	that	is	becomes	difficult	
to	remove	using	centrifugation.	This	chapter	will	define	cell	disruption	performance	
with	 five	different	performance	criteria:	 (1)	Total	 cell	disruption,	measured	as	 the	
concentration	 of	 total	 soluble	 protein,	 R	 (mg/mL),	 (2)	 specific	 cell	 disruption,	
defined	 as	 the	 amount	 of	 protein	 released	 per	 unit	 of	 suspended	 biomass,	 Rs	
(mg/gWCW)8,	 (3)	 total	 product	 recovery	 expressed	 as	 the	 concentration	 of	 soluble	
Tandem	Core	Hepatitis	B	core	protein	[tHBc]	(µg/mL),	(4)	specific	product	recovery,	
tHBcs	 (µg/gWCW)9	and	 (5)	 product	 purity,	 expressed	 as	 a	 ratio	 of	 total	 recover	
product	 relative	 to	 the	 amount	 of	 total	 release	 soluble	 protein,	 P	 (%)10.	 By	
understanding	 the	 response	 models	 of	 multiple	 performance	 criteria,	 the	 range	
applications	 of	 cell	 disruption	 platforms	 can	 be	 broadened	 as	 well	 as	 create	 a	
performance-based	scaling	methodology.		
																																																						
8	!" = !/ % 		
with	[X]	being	the	concentration	of	biomass	(g/L)	
9	&'()* = &'() /[%]	
10	- = &'() /!	
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4.2.1 High	Pressure	Homogenisation		
The	most	widely-used	method	of	cell	disruption	 in	microbial	bioprocessing	 is	High	
Pressure	Homogenisation	 (HPH)	 (Middelberg,	1995;	Kleinig	and	Middelberg,	1997;	
Klimek-Ochab	et	al.,	2011).	This	method	 involves	passing	a	cell	suspension	at	high	
pressure,	and	often	low	temperature	to	mitigate	heat	effects,	through	an	adjustable	
valve	with	a	restricted	cavity	as	shown	in	Figure	4.1.		
	
Figure	4.1	Schematic	representation	of	a	valve	of	a	high-pressure	homogeniser.	(A)	Valve	
seat,	(B)	impact	ring	and	(C)	valve	rod.			
Through	high-velocity	 impact,	 cavitation,	 fluid	 shear	 and	decompression,	 the	 cells	
are	disrupted	causing	 their	contents	 to	be	 released.	This	process	can	be	repeated	
for	 several	 passes,	 increasing	 the	 levels	 of	 cell	 disruption	 and	 debris	 generated	
(Middelberg,	2000;	Doran,	2013).	Overall	cell	disruption	can	be	described	with	the	
following	equation	(Follows	et	al.,	1971):		
A B
C
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./ 0123012340 = 5678 Equation	4-1 
Where,	Rmax	is	the	maximum	amount	of	releasable	protein	(mg/mL),	R	the	observed	
amount	of	released	protein	(mg/mL),	N	the	discrete	number	of	passes	through	the	
valve,	 k	 a	 temperature	 dependent	 rate	 constant	 and	 is	 specific	 to	 the	 organism	
being	disrupted;	p	 the	operating	pressure	(bar)	and	a	 is	a	measure	of	a	microbe’s	
resistance	to	disruption.	
In	 addition,	 efficiency	 of	 homogenisation	 is	 known	 to	 decrease	 at	 high	 biomass	
suspension	 concentrations	 (Kleinig	 et	 al.,	 1995).	 Therefore,	 for	 a	 given	 organism	
harvested	 at	 fixed	 conditions	 the	 following	 relation	 can	 be	 observed	 for	 cell	
disruption:	
0 = 9(6, 7, [<])	 Equation	4-2 
Where	[X]	is	the	concentration	of	biomass	(gWCW/L)	in	suspension.	
4.2.2 Miniaturised	cell	disruption	platforms	
However,	 High	 Pressure	 Homogenisation	 is	 only	 suitable	 for	 processing	 large	
volumes	 with	 the	 smallest	 representative	 size	 being	 40mL	 using	 an	 APV	 Gaulin	
Lab40	homogeniser	 (Jenning,	 Lippacher	and	Gohla,	2002).	 	 Scale-down	bioprocess	
sequences	often	start	with	the	use	of	microtiter	plates	or	miniaturised	bioreactors	
(Kensy,	 Engelbrecht	 and	Büchs,	 2009b;	 Slinsby	 and	Dewar,	 2015).	 	 HPH	 therefore	
remains	an	incompatible	platform	for	scale-down	bioprocesses,	as	sample	volumes	
are	often	in	the	microliter	range.	
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This	chapter	will	therefore	investigate	scale-down	cell	disruption	platforms.	
4.2.3 Aim	and	objectives	
The	 aim	 of	 this	 chapter	 is	 to	 develop	 a	 miniaturised	 cell	 disruption	 platform	
intended	for	rapid	upstream	process	characterisation.	The	specific	objectives	are	to:	
• Investigate	the	effects	of	 lysis	buffer	components.	This	will	be	necessary	as	
these	 factors	 could	 contribute	 to	 overall	 cell	 disruption,	 product	 release,	
product	stability	and,	once	optimised,	will	be	invariable	between	large-scale	
and	small-scale	(mechanical)	disruption	platforms.		
• Characterise	 high-pressure	 homogenisation	 by	 investigating	 a	 number	 of	
responses.	 This	will	 be	necessary	 to	establish	process	performance	 targets	
for	small-scale	methods.		
• Investigate	the	performance	and	implementation	of	several	small-scale	cell	
disruption	 technologies.	 This	 will	 allow	 for	 the	 selection	 of	 the	 most	
appropriate	platform.		
• Screen	 for	 significant	 process	 factors	 for	 the	 chosen	 small-scale	 cell	
disruption	 platform.	 This	 process	 will	 eliminate	 the	 need	 to	 investigate	
potentially	insignificant	process	factors	during	optimisation	studies,	allowing	
for	a	more	economical	experimental	approach.		
• Characterise	 and	 optimise	 small-scale	 cell	 disruption	 process	 parameters.	
This	 will	 maximise	 process	 the	 output	 of	 key	 quality	 attributes	 and,	 in	 so	
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doing,	 could	 create	 response	 range-overlap	with	 large-scale	 cell	 disruption	
performance.		
• Investigate	scalability	and	mimicry	
4.3 Results	
4.3.1 Buffer	Studies		
Separating	buffer-associated	variables	 from	disruption	process	operation	variables	
will	 allow	 for	 a	 more	 structured	 and	 formalised	 experimental	 approach.	 This	
chapter	will	aim	to	 investigate	the	effects	of	various	non-ionic	detergents	and	salt	
concentrations	on	VLP	recovery.	
Buffer	studies	were	conducted	using	fixed	homogenisation	conditions	(3	passes	at	
1200	bar),	as	described	in	section	2.4.3.		
All	 detergents	 investigated	 in	 this	 chapter	 are	 non-ionic,	 implying	 that	 the	
hydrophilic	region	of	the	molecule	is	uncharged.	Typically	considered	a	mild	class	of	
detergents,	 these	 affect	 lipid	 interactions	 without	 significantly	 affecting	 protein-
protein	 interactions.	 This	 class	 of	 detergents	 is	 predominantly	 used	 to	 isolate	
membrane-associated	 proteins	 by	 forming	micelles	 with	 the	 lipid	 components	 of	
the	membrane	(Shi	et	al.,	2005;	Johnson,	2013).	The	three	detergents	investigated	
are	Triton-X	100,	Polysorbate	80	and	Tween	20	as	these	have	been	studied	for	the	
recovery	of	other	types	of	VLPs	(Shi	et	al.,	2005).	These	non-ionic	detergents	differ	
in	cloud	point,	critical	micelle	concentration,	density	and	molecular	weight.	
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After	determining	the	most	suitable	type	of	detergent,	a	full-factorial	screening	was	
performed	 on	 the	 concentration	 of	 salt,	 the	 concentration	 of	 the	 chosen	 type	 of	
detergent	and	the	concentration	of	biomass	 in	suspension	(also	referred	to	as	the	
concentration	of	solids).		
Figure	 4.2	 shows	 the	 experimental	 procedures	 involved	 in	 studying	 the	 effects	 of	
various	 buffer	 conditions	 on	 a	 variety	 of	 key	 quality	 attributes.	 The	 studied	
attributes	 were	 (1)	 total	 cell	 disruption,	measured	 as	 total	 protein	 concentration	
(section	 2.5.5)	 after	 unit	 operation	 ‘E’;	 (2)	 total	 Tandem	 Core	 material	 recovery,	
estimated	 using	 western	 blotting	 and	 densitometry	 (sections	 2.5.9	 and	 2.5.11),	
measured	 after	 units	 ‘E’	 and	 ‘G’;	 (3)	 particle-size	 distribution	 of	 clarified	 lysate,	
measured	after	unit	operation	‘E’.	Note	that	product	analysis	on	western	blotting	is	
done	 after	 unit	 operation	 ‘E’	 and	 ‘G’.	 The	 rationale	 of	 this	 was	 that	 aggregated	
Tandem	Core	material	would	not	pass	through	a	0.22µm	filter	and	would	therefore	
result	in	a	decreased	signal	on	Western	blot.		
	
Figure	4.2	Summary	of	unit	operations	involved	in	the	analysis	of	buffer-related	variables	
in	cell	disruption	studies.	(A)	Preparation	of	suspension	at	4°C,	relevant	variables	are	the	
concentration	 of	 biomass	 in	 suspension	 ([X]),	 the	 concentration	 of	 salt	 ([NaCl)],	 the	
addition	of	DTT	and	the	addition	of	glycerol.	 (B)	High-pressure	homogenisation	at	10°C,	
relevant	variables	are	the	operating	pressure	and	the	number	of	passes.	 (C)	Addition	of	
non-ionic	detergent	following	a	one-hour	incubation	at	4°C,	relevant	operating	variables	
are	the	type	of	detergent	and	the	concentration	of	detergent.	Crude	 lysate	samples	are	
taken	 after	 this	 incubation.	 (D)	 Centrifugation	 of	 crude	 lysate	 at	 15000g,	 4°C	 for	 30	
minutes.	 (E)	 0.45µm	 &	 0.22µm	 dead-end	 filtration	 of	 supernatant.	 (F)	 Incubation	 of	
supernatant	 at	 4°C,	 investigated	 variable	 is	 the	 incubation	 time,	 samples	 are	 taken	
A B C D E F G
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beyond	this	point	for	particle	size	distribution	analysis.	(G)	0.22µm	dead-end	filtration	of	
incubated	 sample.	 Samples	 were	 taken	 after	 incubations	 to	 study	 the	 effect	 of	
aggregation	on	product	recovery.		
4.3.2 Investigating	the	effect	of	detergent	type	and	quantity	
This	 set	 of	 experiments	 focussed	 on	 the	 effect	 on	 the	 solubility	 of	 Tandem	 Core	
protein	 in	 clarified	 lysate	 (step	 F	 in	 Figure	 4.2)	 resulting	 from	 the	 addition	 of	
different	types	of	detergents	in	lysate	immediately	after	homogenisation	(step	C	in	
Figure	 4.2	 at	 1200	 bar	 for	 3	 passes).	 Note	 that	 this	 addition	 step	 was	 after	
homogenisation,	 rather	 than	 before,	 as	 adding	 detergents	 during	 the	
homogenisation	 process	 could	 result	 in	 the	 formation	 of	 liquid-gas	 interfaces,	
typically	 detrimental	 to	 product	 quality.	 Detergent	 types	 used	 were	 Triton	 X100	
(TX100),	polysorbate	80	 (PS80)	and	Tween	20	at	 final	 lysate	concentrations	of	1%	
and	 0.1%.	 To	 capture	 the	 full	 effect	 of	 detergent-mediated	 solubilisation,	 an	
incubation	period	of	1	hour	was	performed	prior	to	sample	analysis.	Total	product	
and	protein	 released	 in	 crude	 lysate	was	 assessed	 through	Western	blotting	with	
densitometry	analysis	(sections	2.5.9	and	2.5.11)	and	total	protein	analysis	(section		
2.5.5)	 on	 material	 after	 incubation	 in	 step	 C	 in	 Figure	 4.2.	 Using	 similar	
methodology,	 any	 precipitation	 effects	 were	 monitored	 by	 passing	 incubated	
material	through	a	second	0.22um	(step	G	 in	Figure	4.2)	 filter	and	monitoring	any	
decrease	in	protein	concentration.		
Looking	at	Figure	4.3A,	after	72	hours	of	incubation,	there	is	very	little	difference	in	
core-positive	 material	 concentrations	 amongst	 different	 buffer-types.	 Note	 that	
Figure	4.3A	depicts	a	compilation	of	densitometry	data	from	two	membranes,	with	
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two	 separate	 two-point	 calibration	 curves.	 The	 first	 membrane	 contained	 buffer	
conditions	 at	 volumetric	 concentrations	 of	 1%,	 whereas	 the	 second	 membrane	
depicts	 data	 from	 buffer	 concentrations	 of	 0.1%.	 One	 must	 consider	 that	 this	
method	 of	 analysis	 is	 hard	 to	 reproduce	 quantitatively,	 and	 so	 it	 is	 not	
recommended	 that	 the	 two	 concentration-groups	 be	 compared	 directly.	 In	
addition,	 the	 difference	 in	 total	 soluble	 protein	 content	 after	 incubation	 was	
roughly	 the	 same	 in	 all	 buffer	 conditions,	 with	 marginally	 higher	 soluble	 protein	
content	when	using	higher	concentrations	of	TX100.	Therefore,	assuming	that	total	
soluble	protein	content	would	positively	correlate	to	solubility	of	tHBc,	and	bearing	
in	 mind	 that	 total	 protein	 measurement	 data	 was	 more	 robust	 than	 membrane	
densitometry,	TX100	was	chosen	as	the	detergent	for	future	studies.		
	
Figure	4.3	Effects	of	aggregation	in	clarified	lysates	after	additions	of	various	detergents	
at	various	concentrations.	(A)	Product	recovery	data	in	crude	lysate	and	in	clarified	lysate	
after	 44	 hours	 and	 72	 hours	 of	 incubation	 at	 4°C.	 Peak	 area	 was	 determined	 through	
densitometry	analysis	on	Western	blots.	Peak	area	was	converted	to	HBc	concentration	
using	 a	 two-point	 calibration	 curve.	No	 replicate	 data	was	 generated.	 (B)	 Total	 protein	
content	 in	 crude	 lysate	 and	 in	 clarified	 lysate	 after	 1	 hour,	 44	 hours	 and	 72	 hours	 of	
incubation	 at	 4°C.	 Error	 bars	 represent	 triplicate	measurements	 taken	 using	 Nanodrop	
(section		2.5.5).		
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4.3.3 Buffer	characterisation	using	a	DoE	methodology		
The	 previous	 section	 described	 how	 several	 detergents	 contributed	 to	 buffer	
stability,	product	recovery	and	total	cell	disruption.		
However,	 one	 unaddressed	 variable,	 contributing	 to	 the	 aforementioned	 key	
quality	 attributes,	 is	 the	 concentration	 of	 salt.	 Sources	 report	 that	 salt	
concentration	can	have	a	significant	effect	on	the	recovery	of	VLPs	in	storage	(Shi	et	
al.,	2005).		
To	 study	 this	 effect	 in	 combination	with	 the	previous	 studies,	 an	experiment	was	
conducted	 as	 follows:	 after	 determining	 the	 most	 suitable	 detergent,	 a	 4-factor,	
two-level,	 full	 factorial	 experimental	 screening	 design	 with	 3	 midpoints	 was	
executed.	The	factors	chosen	and	their	corresponding	values	are	listed	in	Table	4-1.	
Table	 4-1	 Experimental	 overview	 for	 a	 4-factor,	 two-level,	 full	 factorial	 experimental	
screening	design	with	3	midpoints	to	characterise	homogenisation	conditions.			
STD	 [NaCl]	(mM)	 [TX100]	(%vol.)	 WCW	(g/L)	 t	(h)	
1	 500	 0.1	 150	 1	
2	 0	 0.1	 30	 72	
3	 500	 1.5	 150	 72	
4	 500	 1.5	 30	 72	
5	 0	 1.5	 30	 1	
6	 250	 0.8	 90	 45	
7	 500	 1.5	 150	 1	
8	 0	 15	 150	 1	
9	 500	 1.5	 30	 1	
10	 0	 1.5	 30	 72	
11	 0	 0.1	 150	 1	
12	 500	 0.1	 30	 1	
13	 250	 0.8	 90	 45	
14	 0	 0.1	 30	 1	
15	 0	 1.5	 150	 72	
16	 0	 0.1	 150	 72	
17	 250	 0.8	 90	 45	
18	 500	 0.1	 30	 72	
19	 500	 0.1	 150	 72	
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Several	 responses	were	chosen	to	generate	screening	 results.	Firstly,	 total	 soluble	
protein	 released	 (R	 (mg/mL))	 was	 chosen	 to	 represent	 an	 overall	 level	 of	 cell	
disruption.	 As	 the	 solid	 loading	 percentage	 was	 varied,	 second	 variable	 was	
introduced	to	indicate	a	level	of	cell	disruption	per	unit	of	biomass:	specific	protein	
release	(Rs	(mg/gWCW)).	This	measure	is	relevant	when	wanting	to	make	efficient	
use	 of	 biomass	 input.	 Thirdly,	 overall	 product	 recovery	 was	 measured	 ([HBc]	
(µg/mL)).	 To	 generate	 a	 specific	 response	 for	 total	 protein	 release,	 a	 specific	
measure	of	product	release	was	investigated:	HBcs	(µg/gWCW)).		
Screening	models	were	generated	with	a	minimum	resolution	of	6	 to	estimate	all	
possible	first-degree	polynomial	interactions.		
The	relative	contribution	of	an	individual	factor	was	defined	as	the	total	of	the	sum	
of	 squares	 (Type	 III)	 of	 each	 factor-associated	 first-degree	 polynomial	 term	 as	 a	
percentage	of	the	total	of	the	sum	of	squares	of	all	terms	in	the	screening	models.	
Note	 that	 quadratic	 terms	were	 not	 included	 in	 the	 analysis	 of	 variance	 as	 these	
terms	 are	 aliased	 to	 all	 studied	 factors.	 Table	 4-2	 shows	 the	 level	 of	 overall	
response	 variance	 created	 by	 each	 factor	 in	 this	 screening	 experiment	 when	 all	
possible	first-degree	polynomial	 interactions	are	considered.	The	 left	side	of	Table	
4-3	 shows	 the	 goodness	 of	 fit	 of	 these	models,	 using	 r2.	 The	 robustness	 of	 these	
models	 is	 then	 assessed	 using	 r2	 adjusted.	 The	 same	 table	 subsequently	 shows	
formulae	 for	each	response	model	showing	only	significant	model	 terms	 (p<0.05).	
Similarly,	r2	and	r2	adjusted	of	these	simplified	models	are	shown	on	the	right-hand	
side	of	the	table.		
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For	 total	 cell	 disruption/total	 protein	 extraction	 (R),	 the	 amount	 of	 biomass	 in	
suspension	([X])	was	found	to	be	the	most	highly	contributing	and	significant	factor.	
This	is	unsurprising,	as	biomass	is	the	sole	source	of	protein	in	the	experiment;	no	
biomass	results	in	no	protein	solubilising;	and	more	biomass	results	in	higher	levels	
of	 released	 soluble	 protein,	 hence	 the	 positive	 gradient	 seem	 in	 the	 formula	 in	
Table	 4-3.	 From	 Table	 II	 it	 can	 also	 be	 said	 that	 the	 contribution	 of	 the	
concentration	of	detergent	is	also	relevant.		This	can	be	explained	by	the	significant	
factor	 interaction	 existing	 between	 biomass	 concentration	 and	 detergent	
concentration	seen	 in	Table	4-3.	The	adjusted	 r2	 for	both	 the	complex	model	and	
simplified	model	are	relatively	high	and	close	to	their	corresponding	r2	values.	This	
shows	that	both	models	are	relatively	robust,	not	only	having	a	high	goodness	of	fit	
but	also	high	predictive	ability.		
Table	4-2	shows	that	relative	factor	contributions	for	the	response	for	specific	cell	
disruption	 (Rs)	 differed	 significantly	 from	 the	 response	 R.	 Like	 with	 R,	 major	
response	 variance	 contributions	 are	 due	 to	 variation	 of	 [X]	 and	 [TX].	 However,	 a	
combined	28.54%	of	response	variance	was	caused	by	variance	of	[NaCl]	and	t.	But	
because	 no	 significant	 model	 terms	 were	 associated	 with	 these	 factors,	 despite	
considerably	contributing	to	model	variance,	a	notable	reduction	in	goodness	of	fit	
is	 seen	 in	 simplified	models	 (Table	 4-3).	Moreover,	 the	most	 significant	 factor	 in	
both	 responses	 for	R	 and	RS,	 the	concentration	of	biomass	 ([X]),	has	 the	opposite	
effect.	Maximising	R	requires	maximising	[X],	as	indicated	by	the	positive	gradient	in	
the	 simplified	 model.	 However,	 as	 indicated	 by	 the	 negative	 gradient	 in	 the	
simplified	model	term	for	Rs,	maximising	specific	cell	disruption	requires	minimising	
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[X].	The	negative	correlation	between	Rs	and	[X]	can	be	explained	by	the	fact	that	in	
the	 scenario	 with	 relatively	 less	 biomass,	 more	 kinetic	 energy	 directed	 to	 cell	
disruption	is	available	per	unit	of	biomass.	
As	 seen	 in	 Table	4-2,	 the	 contribution	of	 [X]	 is	 highest	 in	 the	 response	model	 for	
total	product	release	([HBc]).	The	concentration	of	salt	([NaCl]),	however,	has	much	
more	of	an	effect	on	the	release	of	product	than	the	release	of	overall	protein.	The	
negative	effect	of	salt	concentration	on	product	recovery	can	be	explained	by	the	
effect	 of	 product	 “salting	 out”	 at	 higher	 concentrations	 of	 salt	 and	 relatively	
hydrophobic	molecules.		
Variance	 in	HBcs	 levels	are	mainly	caused	by	variance	 in	 [TX],	 followed	by	 [X]	 and	
[NaCl].	 Table	 4-3	 shows	 that	 the	 both	 the	 complex	 and	 simplified	models	 have	 a	
very	high	goodness	of	fit	and	are	both	very	robust.	As	seen	with	[HBc],	the	negative	
model	 terms	 for	 [TX]	 and	 [NaCl]	 could	be	explained	by	salting	out	effects.	Finally,	
like	specific	cell	disruption,	[X]	has	a	negative	effect	on	specific	product	release.		
Table	4-2	Relative	factor	contributions	in	a	four-factor,	two-level,	half-fractional	factorial	
screening	 designs.	 Six	 different	 screenings	 were	 performed:	 Total	 cell	 disruption	 (R);	
specific	 cell	 disruption	 (RS);	 total	 product	 released	 ([HBc]);	 specific	 product	 released	
(HBcs);	and	recovered	product	purity	relative	to	total	protein	concentration	(P).	
Factor	 [X]	(g/L)	 [NaCl]	(mM)	 [TX]	(%)	 t	(h)	
Range	 (30,150)	 (0.1,1.5)	 (0.1,10)	 (1,72)	
%	contribution	
R	(mg/mL)	 84.78%	 2.98%	 8.35%	 3.89%	
Rs	(µg/gWCW)	 41.99%	 11.97%	 29.47%	 16.57%	
[HBc]	(µg/mL)	 68.56%	 13.93%	 14.27%	 3.24%	
HBcs	(µg/gWCW)	 36.52%	 19.82%	 38.26%	 5.39%	
P	(‰)	 27.20%	 11.17%	 55.00%	 6.63%	
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Table	 4-3	Models	 and	 goodness	 of	 fit.	 Screened	 responses	 for	 total	 cell	 disruption	 (R);	
specific	 cell	 disruption	 (RS);	 total	 product	 released	 ([HBc]);	 specific	 product	 released	
(HBcs);	and	recovered	product	purity	relative	to	total	protein	concentration	(P).	Goodness	
of	 fit	 is	given	on	the	 left-hand	side	of	 the	table	 (‘All	 terms’)	using	r2	and	adjusted	r2	 for	
models	 in	 which	 all	 possible	 first-degree	 polynomial	 terms	 have	 been	 considered.	
Following	 this,	 are	 the	 formulae	 describing	 first-degree	 polynomials	 containing	 only	
significant	model	terms	(p<0.05).	Highlighted	in	bold	are	internal	functions.	This	method	
of	displaying	formulae	allows	for	easy	distinction	between	significance	of	model	terms	by	
ranking	them	in	order	of	gradient.	Integrating	the	absolute	experimental	domains	of	each	
corresponding	factor	would	unnecessarily	distort	this	ranking	order.	
	 All	terms	
(Complex	model)	
	 Significant	terms	
(Simplified	model)	
	 R2	 R2	adj.	 Formulae	 R2	 R2	adj.	
R	(mg/mL)	 0.992	 0.951	
! = 17.9 + 8.20F( < ) +2.03F( H< )		 0.933	 0.925	
Rs	(µg/gWCW)	 0.980	 0.878	 !* = 240 − 73.4F < +48.7F( H< ) − 39.3F([<] ∙ [H<])		 0.657	 0.589	
[HBc]	(µg/mL)	 0.966	 0.799	
'() = 37.5 + 17.0F < −7.30F( 62M. ) − 5.06F( H< ) −4.77F([<] ∙ [H<])		 0.905	 0.878	
HBcs	(ng/gWCW)	 0.999	 0.994	
['()]* = 493 − 165F([H<]) +163([<] ∙ [H<]) − 146F([62M.]) −137F([<]) + 97.8F([<] ∙[62M.]) − 65.0F([H<] ∙ O)		 0.951	 0.926	
P	(‰)	 0.985	 0.909	
- = 2.28 − 0.888F H< −0.754F <] ∙ [H< −0.478F 62M. 		 0.836	 0.803	F < = P 4QRSR 		 F H< = TP 4R.UR.V 		 F 62M. = P 4WXRWXR 		 F O = P 4YS.XYX.X 		
Detergent	concentration	was	 found	to	have	the	greatest	effect	on	product	purity,	
(Table	 4-2).	 As	 seen	 with	 [HBc]	 and	 HBcs	 in	 Table	 4-3,	 salt	 and	 detergent	
concentration	both	have	a	negative	effect	on	product	purity,	suggesting	that	certain	
host	 cell	 proteins	 have	 a	 significantly	 higher	 solubility	 than	 the	 expressed	
heterologous	protein	found	in	the	soluble	fraction.	
This	 section	 has	 presented	 the	 effects	 of	 a	 variety	 of	 buffer	 components	 on	 a	
variety	of	performance	criteria.		
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The	 performance	 of	 various	 detergents	 was	 investigated.	 It	 was	 found	 that	
polysorbate	 80	 and	 Triton-X100	 performed	 similarly.	 For	 future	 work,	 the	 choice	
was	made	to	continue	working	with	Triton-X100	as	this	detergent	had	been	used	in	
most	experiments	thus	far.		
Finally,	 within	 the	 ranges	 investigated,	 salt	 concentration	 and	 detergent	
concentration	had	mostly	negative	effects	on	the	five	studied	performance	criteria.	
It	should	be	noted	that	this	is	a	two-level	screening	experiment	and	the	existence	of	
optima	 within	 the	 investigated	 domains	 is	 very	 likely.	 The	 section	 therefore	
recommends	that	future	experiments	re-evaluate	the	ranges	chosen.			
4.4 Homogenisation	characterisation			
After	investigating	the	effects	on	various	key	quality	attributes	by	a	variety	of	lysis	
buffer	 properties,	 the	 next	 objective	was	 addressed:	 characterising	 high-pressure	
homogenisation.		
This	 series	 of	 experiments	 investigated	 the	 number	 of	 passes	 (N),	 the	 operating	
pressure	 (p)	 and	 the	 amount	of	 biomass	 in	 suspension	 ([X]).	 Table	 4-4	 shows	 the	
experimental	 design	 space	 used	 to	 generate	 surface	 response	 models.	
Homogenisation	operating	procedures	were	as	described	in	section	2.4.3.		
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Table	4-4	Design	space	for	a	3-factor,	two-level,	Central	Composite	Design	(CCD)	with	on-
face	axial	points	(a=1)	and	three	centre	points.		
STD	 [X]	(gWCW/L)	 p	(bar)	 N		
1	 50	 300	 1	
2	 50	 300	 5	
3	 50	 1200	 1	
4	 50	 1200	 5	
5	 100	 300	 1	
6	 100	 300	 5	
7	 100	 1200	 1	
8	 100	 1200	 5	
9	 50	 750	 3	
10	 100	 750	 3	
11	 75	 300	 3	
12	 75	 1200	 3	
13	 75	 750	 1	
14	 75	 750	 5	
15	 75	 750	 3	
16	 75	 750	 3	
	
Figure	4.4	High	Pressure	Homogenisation	Response	Surface	Models	at	different	 level	of	
[X]	for	total	cell	disruption	measured	as	total	soluble	protein,	R	(mg/mL).		
Figure	4.4	shows	the	effect	of	biomass	concentration	[X],	operating	pressure	(p)	and	
the	number	of	passes	 (N)	 on	 cell	 disruption	 (R)	expressed	as	 the	 total	 amount	of	
soluble	 total	 protein	 (mg/mL).	 The	 response	 model	 can	 be	 described	 with	 the	
following	 formula:	 R=	 -6.14·10-1N2	 -8.92·10-6	 p2	+	 1.38·10-3	 Np	 +	 1.97·10-4	 p[X]	 +	
4.20N	+	8.4·10-3p	-1.00·10-3[X]	-5.15.	
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As	 indicated	 by	 the	 term	 1.97·10-4	 p[X]	 the	 factor	 interaction	 of	 biomass	
concentration	and	pressure	has	a	positive	effect	on	the	level	of	cell	disruption.	The	
term	 is	 highly	 significant	 (p=0.00253),	 which	 is	 in	 contrast	 with	 the	 assumption	
made	by	others	(Follows	et	al.,	1971),	that	the	effect	of	biomass	concentration	on	
cell	 disruption	 is	 minor.	 This	 difference	 is	 most	 likely	 because	 Follows	 et	 al.	
investigated	 cell	 disruption	 at	 a	 significantly	 higher	 cell	 suspension	 concentration	
range	 (450-750g/L	 vs	 50-100g/L)	 where	 the	 effect	 of	 biomass	 had	 diminished.	
Follows	et	al.	used	a	different	species	of	yeast,	Saccharomyces	cerevisiae,	and	the	
concentrations	 of	 biomass	 used	 are	 considerably	 higher	 than	 would	 be	 used	 for	
practical	 purposes	 since	 higher	 concentrations	 of	 cells	 lead	 to	 lower	 levels	 of	
specific	cell	disruption.		
Unlike	for	pressure,	the	optimum	number	of	passes	seems	to	stay	the	same	as	the	
biomass	concentration	is	changed.	This	is	not	surprising	as	no	term	for	[X]N	exists	in	
the	equation.	However,	the	term	1.38·10-3	Np	indicates	a	positive	factor-interaction	
between	the	number	of	passes	and	pressure,	which	is	expected.		
Finally,	the	two	quadratic	terms	of	N2	and	p2	 indicate	optima	for	pressure	and	the	
number	 of	 passes,	 however	 it	must	 be	 noted	 that	 these	 are	 quadratic	 estimates	
that	are	only	valid	within	the	investigated	range.	The	response	surface	methodology	
in	 this	 series	 of	 experiments	 only	 considers	 linear	 or	 quadratic	 functions,	 not	 for	
instance,	 asymptotic	 functions	which	 are	 very	 common	 in	 biological	 systems	 and	
bioprocesses.	 Therefore,	 supposed	 quadratic	 optima	 found	 at	 the	 end	 of	 the	
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experimental	window,	could	also	 indicate	asymptotic	 limits.	However,	establishing	
this	would	require	further	work	and	does	not	change	the	main	output	of	this	study.		
It	should	also	be	noted	that	cell	disruption	(R)	is	just	one	measure	of	performance	in	
the	 context	 of	 cell	 disruption.	 As	 mentioned	 previously,	 this	 paper	 aims	 to	
investigate	 five	 different	 performance	 criteria	 as	 response	 surfaces.	 Instead	 of	
displaying	 four	 additional	 response	 models,	 Figure	 4.5	 summarises	 the	 factor	
settings	 for	 various	 performance	 optima	 derived	 from	 corresponding	 surface	
models.		
	
Figure	 4.5	 High	 Pressure	 Homogenisation	 performance	 optima	 summary.	 Factor	 values	
and	 optima	 for	 various	 responses:	 R	 (r2=0.98),	 RS	(r2=0.97),	 [TC-HBc]	 (r2=0.92),	 TC-HBcS	
(r2=0.90)	and	P	(r2=0.77).	
Looking	 at	 Figure	 4.5,	 one	 can	 conclude	 that	 different	 operating	 conditions	 are	
required	to	achieve	different	maximum	performance	levels.	For	instance,	maximum	
pressure	 (1200	 bar)	 is	 required	 to	 achieve	maximum	 cell	 disruption	 (R).	 However	
sub-maximal	pressure	(1000	bar)	is	preferable	for	maximum	purity	(P).	Note	that	in	
Figure	 4.5	 biomass	 is	 excluded	 from	 the	 performance	 maxima	 of	 the	 response	
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models	for	specific	product	recovery	(TC-HBCS)	and	purity	(P)	as	this	was	found	to	
have	insignificant	contributions	to	variance	for	these	specific	models	(p>0.05).		 	
In	 summary,	 this	 section	 has	 described	 the	 characterisation	 and	 optimisation	 of	
high-pressure	Homogenisation	 on	 the	 basis	 of	 five	 different	 performance	 criteria.	
Different	 optimum	 operating	 conditions	 were	 established,	 depending	 on	 the	
investigated	performance	criterion.		
4.5 Development	of	small-scale	cell	disruption	methods	
This	section	will	explore	a	variety	of	cell	disruption	platforms	suitable	for	small-scale	
(V£1mL)	use.	However,	 this	 section	will	 focus	mainly	on	enzymatic	 cell	 disruption	
with	lyticase	and	cell	disruption	using	Adaptive	Focussed	Acoustics	(AFA).	Additional	
small-scale	cell	disruption	methods	are	discussed	in	the	appendix	section.		
4.5.1 Enzymatic	lysis	with	lyticase	
Various	sources	have	reported	that	enzymes	can	be	used	to	disrupt	yeast	cells	by	
digesting	 cell	 wall	 components.	 Several	 sources	 report	 that	 the	 enzyme,	 lyticase,	
hydrolyses	beta-glucans	in	fungal	cell	walls,	resulting	in	the	transformation	of	cells	
into	so-called	protoplasts	(Burden,	no	date;	Salazar	and	Asenjo,	2007;	Miyajima	et	
al.,	 2009).	 Lacking	 cell	 walls,	 these	 protoplasts	 are	 much	 more	 susceptible	 to	
mechanical	stress.		
It	was	therefore	hypothesised	that	an	enzymatic	pre-treatment	step	using	 lyticase	
could	be	effective	in	performing	cell	disruption	for	P.	pastoris.		
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To	 assess	 the	 effect	 of	 incubation	 time	 with	 lyticase	 on	 harvested	 material,	 30	
gWCW/L	cells	(from	3.2.1)	was	incubated	in	20mM	Tris-based	lyticase	buffer	(2.4.6).	
Protein	concentrations	in	crude	lysate	were	measured	every	ten	minutes	using	the	
Nanodrop	 method	 described	 in	 section	 2.5.5.	 After	 90	 minutes,	 an	 addition	 of	
Triton-X100	 was	 added	 to	 achieve	 a	 concentration	 of	 0.1%	 (vol.),	 in	 order	 to	
maximise	 disruption	 and	 assess	 this	 augmentation	 effect	 of	 detergent	 on	 cell	
disruption.		
It	 was	 estimated	 that	maximum	 disruption	 through	 enzymatic	 lysis	 had	 occurred	
after	around	20	minutes	but	with	a	higher	degree	of	certainty	after	60	minutes	(see	
Figure	4.6).	After	90	minutes	of	incubation,	subsequent	addition	of	TX100	resulted	
in	 further	disruption	of	cells,	 reflected	by	an	average	31.9%	 increase	 in	measured	
protein	concentration.		
	
Figure	4.6	Enzymatic	cell	disruption	over	time	of	cells	incubated	with	lyticase	at	a	biomass	
concentration	of	30gWCW/L.	Standard	deviations	per	data	point	 represent	 triplicate	 total	
protein	measurements	 of	 crude	 lysate.	 The	 lower	 highlighted	 grey	 area	 represents	 the	
fluctuation	 of	 maximum	 enzymatic	 cell	 disruption	 and	 was	 defined	 as	 the	 overall	
standard	deviation	of	 all	measurements	 taken	between	20-90	minutes.	 The	upper	 grey	
area	represents	the	level	of	cell	disruption	after	90	minutes	of	incubation	and	an	addition	
of	Triton-X100	to	achieve	a	concentration	of	0.1%	(vol.).		
0 10 20 30 40 50 60 70 80 90 100
4.0
4.5
5.0
5.5
6.0
6.5
7.0
7.5
8.0
,me	(min)
R	
(m
g/
m
L)
+	TX100
Maximum	enzyma,c	
disrup,on
	 																																																																																										Benjamin	A.F.	Bláha	2018	
	 146	
The	 efficacy	 of	 lyticase	 as	 a	 disruption	 agent	 was	 further	 assessed	 by	 incubating	
harvested	material	(from	3.3.1)	at	various	cell	densities	in	20mM	Tris-based	lyticase	
buffer	 (2.4.6).	 Samples	 were	 stored	 overnight	 at	 4°C	 prior	 to	 clarification	 as	
described	in	section	2.4.10.	Total	cell	disruption,	R,	was	quantified	as	total	soluble	
protein	release	through	using	Nanodrop	analysis,	as	described	in	section	2.5.5.	The	
results	of	this	experiment	are	shown	in	Figure	4.7.		
	
Figure	 4.7	 Total	 cell	 disruption	 of	 cells	 incubated	 with	 and	 without	 lyticase	 at	 various	
biomass	concentrations.	Cell	disruption	averages	and	standard	deviations	(not	visible)	are	
derived	from	triplicate	measurements	of	total	soluble	protein	in	clarified	lysate	
Figure	4.7	shows	significant	increased	levels	of	total	of	cell	disruption,	at	a	variety	of	
biomass	concentrations	as	a	result	of	incubating	with	lyticase.	It	also	seems	that,	as	
the	 concentration	 of	 biomass	 increases,	 the	 specific	 level	 of	 cell	 disruption,	
indicated	 by	 gradient,	 decreases.	 This	 indicates	 a	 substrate	 dependant	 process,	
typical	of	enzymatic	reactions.	Note	that	a	similar	trend	is	seen	when	no	lyticase	is	
applied.	 The	 absolute	 increase	 of	 observed	 cell	 disruption	 resulting	 from	 an	
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increase	 in	 biomass	 concentration	 can	 be	 attributed	 to	 various	 mechanisms	
including	freeze-thaw-mediated	lysis,	autolysis	and	detergent-mediated	lysis.		
Furthermore,	the	use	of	lyticase	also	allows	for	the	recovery	of	soluble	core-positive	
material	as	shown	in	section	10.3.	
4.5.2 Adaptive	Focused	Acoustics	
Adaptive	 Focused	 Acoustics	 (AFA)	 has	 been	 shown	 to	 be	 a	 suitable	 miniaturised	
platform	for	 the	disruption	of	 the	yeast,	Saccharomyces	cerevisiae	 (Wenger	et	al.,	
2008).	An	AFA	device	generates	acoustic	shock	waves	in	the	kilohertz	(KHz)	region.	
These	 sonic	waves	 cause	 controlled	 cavitation	 at	 a	 focal	 point	within	 the	 sample	
vessel	 (Covaris,	 2011).	 The	 device	 can	 process	 up	 to	 12-96	 samples	 in	 a	 batch,	
enabling	rapid,	high-throughput,	non-contact	cell	disruption.	Figure	4.8	explains	the	
operating	parameters	associated	with	the	Covaris	E210.		
	
Figure	 4.8	 Covaris	 components	 and	 parameters.	 (A1)	 Tank	 containing	 cooled	 degassed	
deionised	water,	 (A2)	acoustic	 transducer,	 (A3)	vial	containing	suspended	cells	and	 (A4)	
acoustic	 focal	 zone.	 (B)	 Covaris	 parameters:	 Duty	 Factor,	DF	 (%),	 refers	 to	 the	 relative	
time	between	 sonic	 bursts,	 hence	Z[ = O\ O] ∙ \^^%.	 Intensity,	 I	 (mV),	 denotes	 the	
amplitude	 of	 the	 sonic	wave.	 Cycles	 per	 burst,	 cpb,	 refers	 to	 the	 amount	 of	 cycles	 per	
acoustic	wave.	In	this	case,	cpb	is	4.	Time,	t	(s),	simply	refers	to	the	total	time	a	sample	is	
exposed	to	sonication	treatment.	[X]	(g/L)	refers	to	the	wet	cell	biomass	concentration	in	
suspension.		
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Process	variables	contributing	to	cell	disruption	can	be	described	as	follows:	
0 = 9(Z[, `, a7b, O, [<])	 Equation	4-3	
Duty	Factor,	DF	(%),	refers	to	the	relative	time	between	sonic	bursts,	hence	
Z[ = O\ O] ∙ \^^		 Equation	4-4	
Intensity,	 I	 (mV),	 denotes	 the	amplitude	of	 the	 sonic	wave.	Cycles	per	burst,	cpb,	
refers	 to	 the	 amount	 of	 cycles	 per	 acoustic	 wave.	 Time,	 t	 (s),	 refers	 to	 the	 total	
acoustic	 exposure	 time.	 [X]	 (g/L)	 refers	 to	 the	 wet	 cell	 biomass	 concentration	 in	
suspension.		
Although	 there	 are	 studies	 showing	 promising	 results	 for	 extracting	 intracellular	
product	 from	 S.	 cerevisiae,	 no	 such	 extensive	 studies	 exist	 for	 AFA-mediated	 cell	
disruption	of	P.	pastoris.		
AFA-mediated	 cell	 disruption	 of	 P.	 pastoris	 was	 investigated	 by	 incubating	
harvested	material	(from	3.3.1)	at	various	cell	densities	in	20mM	Tris-based	lyticase	
buffer	 (2.4.6).	 These	 samples	 were	 subsequently	 transferred	 to	 6mL	 Chromacol	
tubes	and	exposed	to	AFA	treatment	for	0	or	120	seconds	using	maximum	settings	
for	Duty	Factor,	Cycles	Per	Burst	 and	 Intensity	on	Power	Tracking	mode.	 Samples	
were	stored	overnight	storage	at	4°C	prior	 to	clarification.	Total	cell	disruption,	R,	
was	 quantified	 as	 total	 soluble	 protein	 release	 through	 using	 Nanodrop	 analysis	
(section	2.5.5).	The	results	of	this	experiment	are	shown	in	Figure	4.9.		
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Figure	 4.9	 Total	 cell	 disruption	 through	 various	 methods.	 Cell	 disruption	 averages	 and	
standard	 deviations	 (not	 visible)	 are	 derived	 from	 triplicate	 measurements	 of	 total	
soluble	protein	in	clarified	lysate.		
Figure	4.9	shows	that	AFA	treatment	resulted	in	higher	levels	of	cell	disruption	than	
detergent	 treatment	 alone.	 In	 addition,	 it	 shows	 that	 lyticase	 pre-treatment	
augmented	AFA-mediated	cell	disruption.	
In	addition	to	cell	disruption,	Figure	4.10	shows	that	both	modes	of	AFA,	with	and	
without	lyticase	pre-treatment,	result	in	recovery	of	soluble	product.		
0 10 20 30 40 50 60 70 80 90 100
0
2
2
3
4
5
6
7
8
9
[X]	(gWCW/L)
R	
(m
g/
m
L)
Ly#case	&	covaris
Ly#case
Covaris
No	treatment
	 																																																																																										Benjamin	A.F.	Bláha	2018	
	 150	
	
Figure	4.10	Qualitative	dot	blot	analysis	of	 crude	and	clarified	 lysates	 following	 lyticase	
treatment,	 AFA	 treatment	 and	 lyticase	 treatment	 followed	 by	 AFA	 treatment	 at	 a	
biomass	 concentration	 of	 100gWCW/L	 and	 (*)	 50gWCW/L.	 Measurements	 were	
performed	 in	 duplicate.	 Reference	 material	 (hepatitis	 B	 core	 antigen)	 was	 used	 as	 a	
positive	control.		
Due	to	these	results	and	the	automated,	non-contact	character	of	the	platform,	 it	
was	found	that	this	platform	was	the	best	candidate	for	follow-up	research	out	of	
all	the	small-scale	cell	disruption	platforms	investigated.		
4.6 Adaptive	Focused	Acoustics	characterisation		
The	previous	 sections	described	how	Adaptive	 Focused	Acoustics	was	 selected	 as	
the	best	candidate	for	a	small-scale	cell	disruption	platform.		
This	 section	 introduces	 a	 formalised	 approach	 on	 how	 this	 platform	 was	 further	
optimised	through	the	following	steps:	
• Screening	operating	settings	
• Comparing	vessel	designs	
• Investigating	the	use	implementation	of	an	enzymatic	pre-treatment	step		
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In	addition	to	this,	it	should	be	noted	that	unless	stated	otherwise,	milliTUBEs	were	
used	for	all	experiments,	20mM	TRIS	buffer	was	substituted	for	50mM	MOPS	buffer	
and	all	harvested	material	was	produced	by	the	fermentation	described	in	section	
7.4.1.		
4.6.1 Adaptive	Focused	Acoustics	Screening	
In	order	to	eliminate	 insignificant	variables,	an	AFA	screening	was	performed.	The	
Covaris	was	operated	as	described	in	section	2.4.5,	unless	stated	otherwise.	
Table	 4-5	 shows	 the	 results	 of	 the	 first	 screening	 experiment	 which	 was	 a	 five-
factor,	half	fractorial	design	was	used	to	generate	two	factor	screenings.		
Table	4-5	Relative	factor	contributions	 in	a	 five	factor,	 two-level,	half	 fractional	 factorial	
screening	designs.	Two	different	screenings	were	performed:	One	for	R	and	one	for	Rs.	
Factor	 DF	(%)	 cpb	 I	(mv)	 t	(s)	 [X]	(g/L)	
Range	 (0.1,20)	 (50,1000)	 (0.1,10)	 (60,300)	 (10,100)	
%	contribution	
Total	disruption	(R)	 23.5%	 8.6%	 9.9%	 8.7%	 49.1%	
Specific	disruption	
(RS)	
1.6%	 0.1%	 0.3%	 0.3%	 97.7%	
Biomass	([X])	was	found	to	be	the	most	significant	factor	for	both	specific	(Rs)	and	
total	 cell	 disruption	 (R).	 However,	 the	 magnitude	 of	 the	 range	 of	 [X]	 may	 have	
diminished	 the	 significance	 of	 other	 factors	 and	 may	 therefore	 not	 be	
representative.		
Time,	on	the	other	hand,	initially	seems	to	be	insignificant	relative	to	other	factors	
which	was	 in	 contradiction	 to	 other	 sources	 (Wenger	 et	 al.,	 2008).	 This	 could	 be	
because	 the	 effect	 of	 time	 had	 already	 approached	 a	 limit	 and	 is	 not	 significant	
within	the	studied	range.		
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To	account	for	these	two	points	of	discussion,	another	screening	was	performed.		In	
this	 four-factor	 full	 fractional	 screening,	 biomass	 was	 fixed	 at	 [X]=55g/L	 so	
responses	R	and	RS	were	equal.	Additionally,	the	cycles	per	burst	were	found	to	be	
insignificant.	 Therefore,	 in	 further	 experiments	 this	 was	 fixed	 at	 1000	 cpb.	 The	
exposure	 times	were	 lowered,	 as	 it	was	hypothesised	 that	 longer	 exposure	 times	
were	 excessive	 to	 achieving	 disruption	 and	would	 therefore	 not	 show	 significant	
contribution	to	response	variance.	The	results	of	this	screening	are	shown	in	Table	
4-6.	 Following	 two	 screening	experiments	 it	was	 found	 that	biomass,	 duty	 factor,	
intensity	 and	 acoustic	 exposure	 time	were	 significant	 factors.	 Increasing	 acoustic	
exposure	time	did	not	have	a	significant	effect	beyond	60s	so	this	factor	was	fixed	
at	 this	 value,	 while	 other	 significant	 factors	 were	 varied	 to	 generate	 response	
surface	models.		
Table	4-6	Relative	factor	contributions	in	a	four-factor,	two-level,	full-fractional	factorial	
screening	design	
Factor	 DF	(%)	 cpb	 I	(mv)	 t	(s)	
Range	 (0.1,20)	 (50,1000)	 (0.1,10)	 (10,60)	
%	contribution	 Total	cell	disruption	(R=RS)	 40.1%	 0.4%	 38.4%	 21.1%	
4.6.2 Adaptive	Focused	Acoustics	Optimisation			
Figure	4.12	shows	 the	effects	of	different	 types	of	vials,	milliTUBE	and	Chromacol	
vials	 (shown	 in	 Figure	 4.11),	 on	 cell	 disruption	 performance.	 The	 milliTUBE	 vials	
consistently	 outperformed	 Chromacol	 vials	 for	 every	 response.	 Like	
homogenisation,	different	settings	are	required	depending	on	the	chosen	response	
maxima.	
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For	 total	 cell	 disruption	 and	 specific	 cell	 disruption	 (see	 Figure	 4.12A)	 maximum	
performance	values	of	the	Chromacol	configuration	were	found	to	be	slightly	lower	
than	 that	 for	milliTUBE	vials.	However,	 the	values	 for	maximum	product	 recovery	
and	specific	recovery	(Figure	4.12B)	are	significantly	 lower	 in	the	Chromacol	tubes	
when	 compared	 to	milliTUBE	 vials.	 This	 in	 turn,	 results	 in	minimal	 product	 purity	
relative	to	the	milliTUBE	configuration	since	P=[TC-HBc]/R.		
	
Figure	4.11:			Different	tube	types	used	in	adaptive	focused	acoustics	optimisation:			6mL	
Chromacol	tube	(left)	and	1mL	MilliTube	(right).	
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Figure	4.12	Summary	of	Response	Surface	Models	for	Adaptive	Focused	Acoustic	methods.	(A-C)	Maximum	response	ranges	for	various	performance	
criteria.	(A)	On	the	left	y-axis,	the	level	of	total	cell	disruption	(R);	on	the	right	y-axis,	the	specific	level	of	cell	disruption	(Rs).	(B)	On	the	left	y-axis	the	
level	of	total	product	recovery	([TC-HBc]);	on	the	right	y-axis,	the	specific	level	of	product	recovery	(TC-HBcs).	(A,	B)	The	horizontal	grid	lines	display	the	
maximum	model	ranges	of	the	studied	responses	of	High	Pressure	Homogenisation	(HPH).	(C)	Purity	(P)	performance	ranges.	(D)	Different	factor	values	
to	achieve	optima.	Intensity	values	are	superimposed	over	duty	factor	values.	
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Figure	 4.13,	 showing	 Response	 Surface	 Models	 of	 total	 cell	 disruption	 (R)	 using	
milliTUBE	 and	 Chromacol	 vials,	 explains	 these	 differences	 in	 overall	 performance.	
Although	 AFA-mediated	 disruption	 using	 the	 Chromacol	 vials	 does	 influence	
disruption	within	a	certain	range,	as	proven	by	significant	contribution	to	variance	
by	 the	 studies	 factors,	 its	effect	on	overall	disruption	 is	most	 likely	diminished	by	
other	 mechanisms,	 such	 as	 cell	 autolysis	 during	 fermentation,	 osmotic	 shock,	
mechanical	stress	or	heat	lysis	during	buffer	resuspension.	This	is	demonstrated	in	
Figure	4.13	by	a	 relatively	 flat	 response	model	 compared	 to	 that	of	 the	milliTUBE	
configuration.	
	
Figure	4.13:	Effect	of	vial	design.	Response	Surface	Models	at	[X]=100g/L	WCW	and	t=60s	
for	two	configurations	of	AFA-mediated	cell	disruption.	(1)	Using	6mL	Chromacol	vials:	(2)	
1mL	milliTUBE	vials	with	integrated	acoustic	fibres.	
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The	underlying	mechanism	of	these	differences	relates	to	total	vessel	volume,	total	
working	 volume	and	 additional	mechanical	 stress	 through	 the	 addition	of	 an	AFA	
fiber	 in	 the	milliTUBE	 vials.	 Because	 the	 total	 vessel	 volume	 of	 Chromacol	 vial	 is	
significantly	larger	than	that	of	a	milliTUBE	vial,	acoustic	energy	is	dispersed	over	a	
larger	 volume	 resulting	 in	 lower	 levels	 of	 disruption.	 Additionally,	 the	 Chromacol	
vials	 used	 a	 17%	 working	 volume,	 whereas	 milliTUBE	 vials	 were	 filled	 to	 almost	
100%.	This	difference	in	relative	working	volumes	was	a	result	of	standardising	the	
experiments	to	absolute	working	volumes	of	1mL.	Larger	relative	working	volumes	
lead	to	more	efficient	cell	disruption	processes	as	acoustic	energy	is	directed	less	to	
mixing	and	forming	liquid-air	 interfaces	and	more	towards	cavitation	nucleation	in	
the	 lysis	 medium.	 As	 higher	 working	 volumes	 reduce	 mixing	 in	 the	 sample,	 the	
added	integrated	AFA	fiber	facilitates	the	generation	of	high	numbers	of	uniformly	
distributed	 cavitation	 bubbles.	 The	 simultaneous	 collapse	 of	 these	 high-energy	
liquid-gas	 interfaces	 results	 in	higher	 levels	of	mechanical	 energy	and	 thus	higher	
levels	of	cell	disruption	(Covaris	Inc.,	2017).	
Several	sources	report	that	the	enzyme,	 lyticase,	hydrolyses	beta-glucans	found	in	
yeast	and	fungal	cell	walls	form	so-called	protoplasts	(Burden;	Miyajima	et	al.	2009;	
Salazar	 &	 Asenjo	 2007).	 Lacking	 cell	 walls,	 these	 protoplasts	 are	 much	 more	
susceptible	 to	 mechanical	 stress.	 Therefore,	 cell	 suspension	 samples	 were	 pre-
treated	with	lyticase	to	augment	subsequent	AFA-mediated	cell	disruption.		
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Results	 in	 Figure	 4.11	 show	 that	 this	 enzymatic	 pre-treatment	 step	 resulted	 in	
significantly	higher	overall	performance	 in	AFA-mediated	cell	disruption	compared	
to	the	other	small-scale	methods	lacking	this	enzymatic	treatment	step.		
Anand	 et	 al.	 (2007)	 described	 how	 pre-treatment	 of	 Escherichia	 coli	 cells	 with	
guanidium	 hydrochloride,	 affected	 the	 first	 order	 disruption	 rate	 constant,	 k,	 for	
homogenisation.	 Li	 et	 al.	 (2012)	 subsequently	 described	 this	 rate	 constant	 in	 the	
context	 of	 adaptive	 focused	 acoustic	 in	 the	 following	 equation	 at	 fixed	 biomass	
concentration:	
!" #$%#&#$%# = ()		 Equation	4-5	
Where	Rm	is	the	total	maximum	available	amount	of	protein	available	for	release.	R0	
is	the	level	of	protein	release	prior	AFA-mediated	cell	disruption	and	was	found	to	
be	 4.17mg/mL	 for	 untreated	 cells	 and	 16.90mg/mL	 for	 enzymatically	 pre-treated	
cells	 ([X]=100g/L).	 R	 is	 the	 observed	 level	 of	 disruption	 and	 t	 is	 the	 acoustic	
exposure	time	fixed	at	60s.	No	absolute	value	for	Rm	was	obtained	experimentally	
but	as	our	purposes	are	comparative,	Rm	was	chosen	to	be	the	maximum	observed	
level	of	protein	release	from	homogenisation	at	[X]=100g/L	(Rm=29.6mg/mL).		
It	was	expected	that	the	lyticase	pre-treatment	step	would	increase	the	disruption	
rate	constant	due	to	the	weakening	of	cells.	However,	because	of	this	it	was	difficult	
to	determine	how	much	of	the	observed	cell	disruption	was	due	to	non-mechanical	
lysis,	such	as	osmotic	shock,	or	due	to	AFA-mediated	cell	disruption.	Using	the	AFA	
milliTUBE	 configuration,	 we	 found	 that	 the	 disruption	 rate	 constant	 for	 AFA	
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mediated	cell	disruption	preceded	by	 lyticase	 treatment	 (kLY,AFA=	6.82×10-3	 s-1)	was	
2.65	times	higher	than	the	disruption	rate	constant	of	AFA-mediated	cell	disruption	
(kAFA=2.57×10-3	 s-1).	 This	 strongly	 suggests	 that	enzymatic	pre-treatment	augments	
performance	of	AFA-mediated	cell	disruption	by	weakening	cells.		
Because	 of	 this	 pre-treatment,	 maximum	 levels	 of	 AFA-mediated	 cell	 disruption	
almost	matched	maximum	 levels	 achievable	with	 homogenisation.	Moreover,	 the	
performance	of	the	augmented	method	for	maximum	specific	product	recovery	was	
superior	 to	 that	 of	 homogenisation.	 Likewise,	 both	 platforms	 using	 milliTUBE	
achieved	higher	product	purity	levels	than	High	Pressure	Homogenisation.		
4.7 Causes	and	effects	of	micronised	debris		
The	 previous	 section	 demonstrated	 the	 differences	 in	 various	 response	 between	
High	Pressure	Homogenisation	and	various	modes	of	adaptive	focused	acoustics.		
This	 section	aims	 to	explain	 the	mechanisms	 involved	behind	 the	performance	of	
the	discussed	cell	disruption	methods.			
Figure	 4.14A	 shows	 Particle	 Size	 Distribution	 (PSD)	 curves	 of	 various	 unclarified	
lysates	 from	 disrupted	 samples.	 The	 amount	 of	 micro	 debris	 (less	 than	 1µm)	
generated	 through	 High	 Pressure	 Homogenisation	 is	 much	 higher	 than	 that	
generated	through	AFA-mediated	disruption.	These	high	levels	of	micro	debris	are	
associated	 with	 high	 levels	 of	 cell	 disruption,	 however	 also	 impede	 recovery	 of	
	 																																																																																										Benjamin	A.F.	Bláha	2018	
	 159	
product.	 This	 is	demonstrated	 in	 Figure	4.14B	where	homogenisation	 is	 shown	 to	
lead	to	lower	product	purities	than	AFA	despite	higher	levels	of	cell	disruption.		
	
Figure	 4.14:	 Effect	 of	micronised	 debris	 on	 purity.	 (A)	 PSD	 analysis	 derived	 from	 static	
light	 scattering	 analysis	 (2.5.12),	 of	 untreated	 cells	 in	 suspension	 ([X]=50g/L)	 and	
respective	crude	lysates	disrupted	by	homogenisation	(p=1200	bar,	N=5	passes,	T=8±2°C),	
AFA	 (I=10mV,	 DF=20%,	 cpb=1000,	 t=60s,	 T=9±1°C)	 and	 AFA	 preceded	 by	 lyticase	
incubation	 (t=1hr,	 T=25°C).	 (B)	 Modelled	 quantitative	 analysis	 of	 clarified	 lysates	
disrupted	by	AFA,	AFA	preceded	by	 lyticase	 incubation	and	homogenisation.	Two	 levels	
of	 cell	 disruption	 (R)	 and	 product	 purity	 (P)	 are	 given:	 the	 maximum	 values	 of	 the	
respective	 Response	 Surface	 Models	 (Rmax,	 Pmax)	 and,	 superimposed,	 the	 levels	 of	
disruption	 and	 purity	 (Rat	 PSD,	 Pat	 PSD)	 achieved	 at	 the	 same	 disruption	 conditions	
represented	by	the	PSD	curves.	Error	bars	correspond	to	performance	maxima	only.	
1 10
0
40
80
120
Par)cle	Size	(µm)
Vo
lu
m
e	
Fr
eq
ue
nc
y
AFA	&	LY
AFA
A
No	treatment
Homogeniza3on
Ho
mo
ge
niz
a)
on
mT
UB
E
mT
UB
E	&
	En
zym
e
0
10
20
30
40
0
5
10
15
20
R t
ot
	(m
g/
m
L)
Rmax	
Rat	PSD	
P	(%
)
Pmax	
Pat	PSD B
	 																																																																																										Benjamin	A.F.	Bláha	2018	
	 160	
Interestingly,	 the	 enzymatic	 pre-treatment	 step	 does	 not	 significantly	 lead	 to	 a	
change	in	PSD	even	though	it	significantly	increases	levels	of	cell	disruption.	This	is	
probably	why	the	maximum	purity	level	of	milliTUBE	AFA-mediated	cell	disruption	is	
comparable	to	that	of	milliTUBE	AFA-mediated	cell	disruption	preceded	by	lyticase	
treatment.	
The	 generation	 of	 micro	 debris	 during	 homogenisation	 can	 lead	 to	 subsequent	
formation	 of	 aggregates	 as	 seen	 Figure	 4.15A	 and	 Figure	 4.15B.	 The	 fluorescent	
BODIPY	stain	 shows	neutral	 lipids	 in	 intact	 cells	 that	are	adhered	with	cell	debris.	
Such	aggregation	can	severely	limit	the	release	of	the	hydrophilic	product	into	the	
supernatant	upon	subsequent	clarification.		
	
Figure	4.15:	Microscopy	images	of	lysates	([X]=50g/L)	at	101.5x	magnification.	(A1)	Bright	
light	microscopy	 image	of	homogenised	 sample	 (p=1200	bar,	N=5	passes,	T=8±2°C)	 and	
(A2)	corresponding	fluorescent	 image;	arrows	indicate	 intact	cell.	 (B1,	B2)	AFA	(I=10mV,	
DF=20%,	cpb=1000,	t=60s,	T=9±1°C);	arrows	indicate	disrupted	cell.	(C1,	C2)	Lyticase	pre-
treated	 sample;	 arrows	 show	 protoplasted	 cell.	 (D1,	 D2)	 Lyticase	 pre-treated	 sample	
followed	by	AFA	mediated	disruption	(I=10mV,	DF=20%,	cpb=1000,	t=60s,	T=9±1°C).	
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In	 contrast,	 AFA	mediated	 cell	 disruption	 does	 not	 seem	 to	 generate	micronised	
debris.	As	 shown	 in	Figure	4.15B,	a	 cell	disrupted	by	AFA,	 visible	with	bright	 light	
microscopy	 yet	 undetectable	 using	BODIPY	 staining,	 has	 released	 its	 lipid-positive	
content	 out	 of	 the	 cell	 wall	 through	 a	 single	 cavity,	 without	 generating	 large	
amounts	 of	 micronised	 debris.	 Figure	 4.15C	 shows	 what	 appears	 to	 be	 an	
enzymatically	 treated	cell	 that	has	 lost	 its	 characteristic	 shape,	most	 likely	due	 to	
cell	 wall	 disintegration	 by	 lyticase.	 Figure	 4.15D	 shows	 a	 similar	 effect	 on	
enzymatically	treated	cell	subsequently	disrupted	using	AFA.		
4.8 Process	scaling	and	cell	disruption	mimicry	
This	 chapter	 has	 made	 many	 comparisons	 between	 the	 relatively	 large-scale	
industry	 standard	 of	 cell	 disruption,	 High	 Pressure	 Homogenisation,	 and	 various	
modes	of	small-scale,	non-contact	Adaptive	Focused	Acoustics	methods.			
For	 some	 performance	 criteria,	 it	 was	 found	 that	 it	 is	 possible	 for	 AFA	 to	
outperform	High	Pressure	Homogenisation.		
However,	 when	 scaling	 down	 a	 process,	 the	 goal	 is	 often	 not	 to	 outperform	 the	
large-scale	 surrogate,	 but	 to	 mimic	 its	 performance	 as	 closely	 as	 possible.	 To	
achieve	this,	one	must	define	these	performance	criteria.	
This	 section	 considered	 a	 scenario	where	 the	 objective	was	 to	maximise	 product	
purity	 from	 a	 homogenisation	 process	 and,	 using	 enzyme-augmented	AFA,	mimic	
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both	the	level	of	purity	and	the	corresponding	level	of	product	recovery	at	the	same	
homogenisation	parameter	settings.		
First,	operating	ranges	were	defined	by	determining	standard	deviation	windows	of	
(1)	maximum	product	purity,	P,	and	(2)	the	corresponding	level	of	product	recovery,	
[TC-HBc,]	at	maximum	purity	of	High	Pressure	Homogenisation.		
Overlaying	 the	 purity	 and	 product	 recovery	 response	 functions	 for	 enzymatically	
augmented	 AFA	 (‘AUG.	 AFA)’,	 at	 the	 specified	 ranges,	 yielded	 the	 operating	
domains	for	duty	factor	and	intensity	settings.	The	corresponding	operating	window	
is	displayed	in	white	in	Figure	4.16.	
	
Figure	4.16:	Microscale	process	mimicry.	Overlay	plot	of	enzymatically	augmented	AFA-
mediated	 cell	 disruption	 funcions	 of	 purity,	 F(PAUG.	 AFA),	 and	 product	 recovery,	 F([TC-
HBc]AUG.AFA)	at	[X]=50	g/L	and	t=60s.	
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It	 should	 be	 noted	 that	 the	 above	 scenario	 serves	 as	 an	 example	 of	 how	 the	
proposed	 scale-down	methods	 can	 be	 implemented	 to	mimic	 any	 large-scale	 cell	
disruption	 process.	 By	 assigning	 multiple	 performance	 criteria,	 more	 defined	
conditions	can	be	achieved	to	mimic	performance	at	small-scale.	Likewise,	the	same	
methodology	can	be	applied	to	scale-up	a	micro-scale	cell	disruption	process.	This	
suggests	 that	 the	 scale-down	AFA-mediated	 cell	 disruption	 can	be	used	 in	 a	wide	
array	of	applications,	such	as	high-throughput	buffer	development	and	micro-scale	
fermentation	sampling	whilst	retaining	scalable	significance.	
4.9 Summary	
This	 chapter	 presents	 the	 development	 of	 a	 high-performance,	 high-throughput,	
non-contact,	 automated,	 small-scale,	 scalable	 disruption	 tool	 for	 microbial	
bioprocess	development.	This	was	achieved	through	several	steps.	
Firstly,	 the	 effects	 of	 lysis	 buffer	 components	 were	 investigated	 to	 establish	
standardised	buffer	conditions	amongst	different	cell	disruption	platforms.	This	was	
followed	 by	 a	 full	 characterisation	 of	 high-pressure	 homogenisation	 to	 establish	
scale-down	 performance	 targets.	 After	 this,	 various	 small-scale	 disruption	 cell	
disruption	 techniques	were	 compared.	 It	was	 found	 that	 enzymatic	 lysis	with	 the	
enzyme	 lyticase	and	Adaptive	Focused	Acoustics	 (AFA)	provided	the	most	suitable	
characteristics	 for	 further	 investigation.	 Following	 this,	 screening	 and	 subsequent	
optimisation	 experiments	 were	 conducted	 on	 AFA.	 These	 investigations	 were	
carried	 out	 through	 statistical	 screening	 methods,	 the	 development	 of	 twenty	
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Response	 Surface	 Models,	 various	 modes	 of	 microscopy	 and	 particle	 size	
distribution	analysis.		
Significant	process	parameters	 for	AFA	were	 found	 to	be	 acoustic	 exposure	 time,	
biomass	 suspension	 concentration,	 duty	 factor	 and	 intensity.	 After	 performing	
optimisation	experiments	for	these	significant	factors,	it	was	found	that	the	design	
of	 the	 vessel	 in	 which	 samples	 were	 sonicated	 had	 a	 great	 impact	 on	 all	 cell	
disruption	performance	criteria.	Specifically,	it	was	found	that	the	use	of	milliTUBE	
vials	 greatly	 enhanced	 performance	 compared	 to	 using	 Chromacol	 vials.	
Performance	was	subsequently	augmented	using	a	lyticase	pre-treatment	step.	This	
augmentation	 led	 to	 matching	 and	 even	 outperforming	 homogenisation	
performance,	 depending	 on	 the	 performance	 criterion	 investigated.	 The	 resulting	
overlap	 of	 performance	 ranges	 between	 HPH	 and	 AFA-mediated	 cell	 disruption	
allowed	for	small-scale	AFA	performance	mimicry	of	High	Pressure	Homogenisation.	
Performance	mimicry	was	enhanced	by	matching	multiple	performance	criteria,	as	
opposed	to	a	single	criterion,	using	overlay	plot	analysis.	
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Chapter	5 Microscale	upstream	process	platform	development	
5.1 Introduction		
Chapter	 3	 addressed	 the	 need	 for	 miniaturised	 fermentation	 platforms	 to	 study	
upstream	process-associated	factors.	The	same	chapter	also	 identified	a	challenge	
in	the	fact	that	existing	small-scale	extraction	methods	were	either	poorly	scalable,	
non-automatable,	unsuitable	 for	high-throughput	sample	processing	or	 ineffective	
in	recovering	significant	levels	of	soluble	heterologous	product.		
Chapter	4	addressed	this	challenge	through	the	development	of	high-performance,	
high-throughput,	non-contact,	automated,	small-scale,	scalable	disruption	tools	for	
microbial	bioprocess	development.	
Having	 developed	 the	 necessary	 tools	 to	 implement	 in	 miniaturised	 upstream	
process	 development,	 the	 use	 of	 miniaturised	 fermentation	 platforms	 can	 be	
investigated	to	address	several	key	observations	made	in	chapter	3.		
5.2 Aim	and	objectives	
The	aim	of	this	chapter	is	to	develop	a	miniaturised	fermentation	platform	intended	
for	rapid	upstream	process	characterisation	and	to	use	this	platform	to	determine	
critical	process	parameters	for	rapid	upstream	process	characterisation.	Much	work	
has	already	been	conducted	for	E.	coli	growth	in	microtitre	plates,	but	literature	is	
	 																																																																																										Benjamin	A.F.	Bláha	2018	
	 166	
limited	for	P.	pastoris		cultivation	and	protein	expression	(Islam	et	al.,	2008;	Kensy,	
Engelbrecht	and	Büchs,	2009a).	The	specific	objectives	are	therefore	to:	
• Assess	 growth	 kinetics	 in	 microtitre	 plates	 to	 determine	 their	 capacity	 of	
sustaining	biomass	for	P.	pastoris	cultures.	
• Investigate	 bolus	 feeding	 induction	 strategies	 for	 high	 density	 P.	 pastoris	
cultures	
• Investigate	alternative	non-methanol	feeding	strategies	
5.2.1 Batch-mode	growth	kinetics	screening	in	microtitre	plates	
The	 most	 basic	 form	 of	 a	 miniaturised	 fermentation	 characterisation	 platform	 is	
typically	 a	 24	 deep-well	 plate.	 To	maximise	 gas	 transfer,	 square-shaped	wells	 are	
frequently	used.	This	is	because	the	corners	of	the	square	wells	disturb	the	flow	in	a	
way	similar	to	that	of	baffles	in	shake	flasks	or	fermenters	(Duetz	et	al.,	2000). 
The	most	critical	stage	of	upstream	processing	of	Tandem	Core	VLPs	expressed	by	
P.	pastoris	 is	the	induction	phase.	However,	before	this	platform	could	be	used	to	
investigate	 induction	 phase-associated	 factors,	 the	 capacity	 of	 these	 deep	 well	
plates	 to	 sustain	 biomass,	 and	 mimic	 batch-mode	 fermentation,	 had	 to	 be	
investigated.		
This	section	will	hence	aim	to	describe	the	capacity	of	microtitre	plates	to	sustain	
growth	 according	 to	 the	 specific	 growth	 rate,	 µ	 (h-1).	 This	 growth	 rate	 can	 be	
described	by	the	equation:	
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*[,]*) = µ[,]	 	 Equation	5-1	
Where:	
• [X]	is	the	concentration	of	biomass	
• t	is	the	time	(hours)	
• µ	is	the	specific	growth	rate	(per	hour)	
The	amount	of	biomass	at	any	given	time,	t,	can	be	described	as:	
[,]) = [,]&/0)		 Equation	5-2	
Hence:	
ln[4]5 = ln[4]6 + µ8	
∴ µ = ln[4]5 − ln[4]68 	
Therefore,	to	study	this	response,	[X]0	and	t,	needed	to	be	varied.		
In	addition,	the	working	volume,	Vw,	was	also	varied.	The	working	volume	directly	
affects	 the	 Oxygen	 Transfer	 Rate.	 This	 in	 turn	 has	 a	 significant	 effect	 on	 cellular	
metabolism.	This	effect	is	explained	in	more	detail	in	10.4.		
In	this	way,	the	working	volume,	VW,	could	affect	(1)	the	consumption	of	substrate,	
(2)	 the	expression	of	product	and	 (3)	 the	production	of	biomass.	 It	was	 therefore	
hypothesised	 that	 an	 increase	 in	 working	 volume	 would	 result	 in	 a	 decrease	 in	
culture	growth.		
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This	 was	 investigated	 through	 a	 three-factor,	 two-level,	 full-fractional	 factorial	
screening	designs.	Microtitre	plate	batch-mode	fermentations	were	carried	out	as	
described	in	section	2.3.1.	
A	 screening	model,	 consisting	 of	 8	 experimental	 points	 and	 3	 centre	 points,	 was	
generated	 with	 a	 minimum	 resolution	 of	 5	 to	 estimate	 all	 possible	 first-degree	
polynomial	 interactions.	 The	design	 space	and	 corresponding	 response	 values	 are	
shown	in	Table	10-2.	
The	relative	contribution	of	an	individual	factor	was	defined	as	the	total	of	the	sum	
of	 squares	 (Type	 III)	 of	 each	 factor-associated	 first-degree	 polynomial	 term	 as	 a	
percentage	of	the	total	of	the	sum	of	squares	of	all	terms	in	the	screening	models.	
Note	 that	 quadratic	 terms	were	 not	 included	 in	 the	 analysis	 of	 variance	 as	 these	
terms	are	aliased	to	all	studied	factors.	
Table	5-1	shows	the	level	of	overall	response	variance	created	by	each	factor	in	this	
screening	 experiment	 when	 all	 possible	 first-degree	 polynomial	 interactions	 are	
considered.	 The	 left	 side	 of	 Table5-2	 shows	 the	 goodness	 of	 fit	 of	 these	models,	
using	 r2.	 The	 robustness	 of	 these	models	 is	 then	 assessed	 using	 r2	 adjusted.	 The	
same	 table	 subsequently	 shows	 formulae	 for	 each	 response	model	 showing	 only	
significant	 model	 terms	 (p<0.05).	 Similarly,	 r2	 and	 r2	 adjusted	 of	 these	 simplified	
models	are	shown	on	the	right-hand	side	of	this	table.		
As	 seen	 in	 Table	 5-1	 each	 studied	 factor	 has	 different	 levels	 of	 relative	 variance	
contribution	 depending	 on	 the	 response	 investigated.	 Table	 5-2	 shows	 that	 r2	
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consistently	 decreases	 as	 the	 models	 are	 simplified	 through	 elimination	 of	
insignificant	factors;	and	shows	significant	model	terms.		
Table	5-1:	Relative	factor	contributions	in	a	three-factor,	two-level,	full-fractional	factorial	
screening	designs	
Factor	 [X]0	(OD600)	 Vw	(mL)	 t	(h)	
Range	 (20,100)	 (0.5,	2.5)	 (2,30)	
%	contribution	 µ	(h-1)	 3.51%	 44.4%	 52.1%	
	
Table	5-2:	Model	and	goodness	of	fit	for	specific	growth	rate	(µ).	Goodness	of	fit	is	given	
on	 the	 left-hand	side	of	 the	 table	 (‘All	 terms’)	using	 r2	and	adjusted	 r2	 for	 the	model	 in	
which	all	possible	first-degree	polynomial	terms	have	been	considered.	Following	this,	is	
the	 formula	describing	 first-degree	polynomials	 containing	only	 significant	model	 terms	
(p<0.05).	Highlighted	in	bold	are	internal	functions11		
	 All	terms	
(Complex	model)	
	 Significant	terms	
(Simplified	model)	
	 R2	 R2	adj.	 Formula	 R2	 R2	adj.	
µ	(h-1)	 0.948	 0.826	
µ = 4.91 ∙ 10%A − 3.78 ∙ 10%AE ) −3.37 ∙ 10%AE FG + 3.35 ∙ 10%AE FG ∙) 		 0.904	 0.863	
E ,& = 46 − 6040 	 E ) = 8 − 1614 	 E FG = FG − 1.5	
Table	5-2	shows	that	the	specific	growth	rate,	µ,	decreases	as	the	incubation	time	
increases.	 This	 is	 most	 likely	 due	 to	 nutrient	 depletion	 over	 time.	 The	 same	
response	also	has	a	negative	correlation	with	the	working	volume.	This	proves	the	
hypothesis	that	an	increase	in	working	volume	would	result	in	a	decrease	in	culture	
growth.	
	Overall,	 model	 simplification	 for	 this	 response	 resulted	 in	 an	 increase	 in	 model	
robustness,	 represented	 by	 an	 increase	 in	 adjusted	 r2.	 Interestingly,	 the	 initial	
																																																						
11	This	 approach	 to	 displaying	 formulae	 allows	 for	 easy	 distinction	 between	 significance	 of	model	
terms	by	ranking	them	in	order	of	gradient.	Integrating	the	absolute	experimental	domains	of	each	
corresponding	factor	will	unnecessarily	distort	this	ranking	order.	
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concentration	 of	 biomass	 was	 not	 found	 to	 have	 a	 significant	 effect	 on	 specific	
growth	rate	within	the	chosen	range.	However,	this	could	be	due	to	oxygen-limiting	
and	substrate-limiting	effects.	
The	specific	growth	 rate	was	of	 interest	as	one	of	 the	aims	of	 this	 section	was	 to	
determine	 the	 capacity	 of	 this	 fermentation	 platform	 to	 sustain	 biomass.	 For	 a	
fermentation	platform	to	be	deemed	suitable	for	maintaining	or	growing	biomass	at	
any	 particular	 time,	 one	 could	 define	 that	 the	 specific	 growth	 rate	 needs	 to	 be	
equal	 to	 or	 higher	 than	 0	 (µ≥0).	 Therefore,	 the	 factor	 exclusion	 of	 [X]0	 in	 the	
response	 for	 specific	 growth	 rate	 presented	 an	 opportunity	 to	 establish	 a	
generalised	correlation	between	VW	and	t	when	µ=0.	Such	a	correlation	would	allow	
for	the	determination	of	harvest	times	at	various	working	volume,	and	vice-versa,	in	
which	no	overall	culture	death	had	occurred.	
To	investigate	for	how	long	at	what	working	volume	the	wells	were	able	to	sustain	
biomass	(µ=0),	a	correlation	was	established	between	VW	and	t:		
∴ )(0K&) = −4.47FG − 2.63 + 30.14	
Equation	5-3	
The	calculation	of	this	correlation	is	shown	in	section	10.4.3	the	appendix.	A	graphic	
depiction	of	this	correlation	is	shown	in	Figure	5.1.	
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Figure	5.1	Correlation	between	VW	 and	 t	when	µ=0	 in	BMGY	media	within	 the	 range	of	
working	volume	investigated.		
This	 asymptotic	 correlation,	 within	 the	 ranges	 investigated,	 shows	 the	maximum	
incubation	time	at	various	working	volumes.	For	coordinates	outside	the	grey	area	
in	 Figure	 5.1,	 the	 specific	 growth	 rate	 is	 negative,	 indicating	 cell	 death	 due	 to	
substrate	depletion.	As	postulated	earlier,	 increasing	 the	working	volume	 reduces	
the	concentration	of	dissolved	oxygen	in	the	media.	When	oxygen	becomes	limited,	
substrate	 consumption	 rates	 decrease.	 This	 results	 in	 extended	 batch-mode	
fermentation	 times	 at	 decreased	 average	 growth	 rates.	 Ideally,	 this	 correlation	
should	be	verified	outside	the	investigated	ranges	in	future	work.	
Nonetheless,	microtitre	plates	can	be	deemed	a	suitable	platform	for	cultivating	P.	
pastoris	and,	as	shown	in	table	10-2,	can	sustain	cell	densities	of	up	to	140	OD600.		
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5.3 Assessing	methanol	toxicity	
With	 the	aim	of	 creating	a	microtitre	platform,	 characterising	VLP	assembly	 in	 an	
upstream	bioprocess	 environment,	 the	 next	 objective	was	 to	 assess	whether	 this	
platform	could	be	used	as	a	screening	tool	to	study	the	 induction	phase,	 in	which	
methanol	is	introduced.	
The	introduction	of	methanol	into	culture	media	presents	a	two-fold	challenge:	too	
low	concentrations	of	methanol	would	result	in	the	starvation	of	the	cultures	due	to	
a	lack	of	carbon	source,	whereas	too	high	concentrations	of	methanol	would	result	
in	 culture	death	due	 to	 toxicity.	As	mentioned	 in	 chapter	 1,	 in	 typical	 bioreactor-
based	fermentations	of	P.	pastoris,	this	issue	is	usually	mitigated	through	the	use	of	
continuous	 feeding	 of	 methanol,	 often	 combined	 with	 sophisticated	 feedback	
control	 systems.	 However,	 in	 microtitre	 based	 platforms,	 no	 such	 control	
mechanisms	 are	 available.	 Therefore,	 a	 major	 conceptual	 challenge	 in	 the	
implementation	 of	 microtitre	 plate-based	 fermentations	 in	 upstream	 process	
development	 for	P.	pastoris,	 is	 translating	continuous	 feeding	 into	bolus	additions	
of	methanol.		
To	 choose	appropriate	 ranges	 in	 subsequent	 screening	experiments,	 the	effect	of	
methanol	concentration	was	studies	on	both	MutS	and	Mut+	cultures.	The	protocol	
for	this	is	described	in	section	2.3.1.		
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Figure	5.2	Effect	of	methanol	concentration	on	growth	rates	after	24	hours	of	induction	of	
P.	pastoris	MutS	and	Mut+	cultures.	Starting	cultures	were	standardised	to	OD600=8;	and	
standard	deviations	and	averages	were	derived	from	duplicate	measurements.		
As	seen	in	Figure	5.2,	for	the	Mut+	phenotype,	it	seems	that	a	minimum	methanol	
concentration	 of	 0.313	%	 vol.	 is	 required	 to	 avoid	 culture	 starvation.	 The	 growth	
rate	 decreases	 between	 5.00	 and	 10.0%	 vol.	 methanol.	 Negative	 specific	 growth	
rates	were	observed	at	the	latter	concentration,	indicating	toxicity.		
Note	 that	 the	 error	 in	 some	measurements	 its	 quite	 high,	 obscuring	 trends.	 This	
error	 could	 have	 possibly	 been	 introduced	 by	 differences	 in	 media	 evaporation	
between	wells.	 The	 effect	 of	methanol	 on	 the	MutS	 phenotype	 is	 less	 conclusive,	
but	seems	to	not	introduce	the	same	level	of	variance	as	with	the	Mut+	phenotype.	
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In	 addition,	 methanol	 toxicity	 seems	 to	 occur	 at	 lower	 ranges	 than	 the	 Mut+	
phenotype,	between	1.25	and	2.50%	vol.	methanol.		
However,	both	profiles,	assuming	a	One-Factor-at-a-Time	(OFAT)	approach,	do	not	
take	 variance	 of	 time	 and	 initial	 biomass	 into	 account.	 The	 additions	 of	 these	
variables	 will	 be	 investigated	 in	 the	 next	 section	 using	 a	 DoE-based	 screening	
approach.	
5.4 Induction	screening	in	microtitre	plates	
Methanol	toxicity	profiles	were	assessed	for	both	P.	pastoris	phenotypes	in	section	
5.3.	 Understanding	 the	 differences	 in	 the	 manifestation	 of	 methanol	 toxicity	
between	 the	 two	studied	phenotypes	allowed	 for	 suitable	 range	determination	 in	
subsequent	 microtitre	 plate-based	 screening	 experiments	 for	 induction	 phase-
associated	factors.	
5.4.1 Initial	induction	screening	results	
The	 previous	 sections	 have	 investigated	 (1)	 the	 capacity	 of	 microtitre	 plates	 to	
sustain	biomass	and	mimic	bioreactor	batch-mode	performance	and	(2)	the	effects	
of	methanol	concentrations	on	the	growth	of	both	phenotypes	of	P.	pastoris.		
This	 section	will	 perform	 screening	 experiments	 to	 determine	whether	microtitre	
plates	are	a	suitable	platform	to	study	induction	processes	for	P.	pastoris	cultures.		
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In	 addition	 to	 the	 specific	 growth	 rate,	 studied	 in	 section	 5.2.1,	 this	 section	 will	
therefore	 also	 investigate	 (1)	 the	 total	 level	 of	 expression	of	 tHBc	protein,	 [tHBc]	
(ng/mL)	and	(2)	the	specific	expression	of	tHBc	protein,	tHBcs	(ng/mL/AU).			
These	aims	were	examined	through	a	three-factor,	two-level,	full-fractional	factorial	
screening	designs.	Microtitre	plate	fermentations	were	carried	out	as	described	 in	
section	2.3.1.	Primary	recovery	was	performed	as	described	in	sections	2.4.1,	2.4.6	
and	2.4.10.	Product	analysis	was	performed	with	dot	blots	(2.5.10	and	2.5.11).		
The	design	 space	and	corresponding	 response	values	are	 shown	 in	Table	10-3	 for	
the	 Mut+	 phenotype	 and	 in	 Table	 10-4	 for	 the	 MutS	 phenotype.	 Based	 on	 the	
methanol	toxicity	profiles	shown	in	Figure	5.2,	the	methanol	concentrations	chosen	
for	the	Mut+	phenotype	were	higher	than	for	the	MutS	phenotype.		
The	 relative	 contribution	 of	 an	 individual	 factor	 was	 determined	 as	 described	 in	
5.2.1.	Table	5-3	and	Table	5-4	show	the	 level	of	overall	response	variance	created	
by	 each	 factor	 in	 screening	 experiments	 for	 Mut+	 and	 MutS	 phenotypes	
respectively.	 The	 left	 side	of	Table	5-5	and	Table	5-6-	Mut+	and	MutS	phenotypes	
respectively-	show	the	goodness	of	fit	of	these	models,	using	r2.	The	robustness	of	
these	 models	 was	 subsequently	 assessed	 using	 r2	 adjusted.	 The	 same	 tables	
subsequently	 show	 formulae	 for	 each	 response	 model	 showing	 only	 significant	
model	 terms	 (p<0.05).	 Similarly,	 r2	 and	 r2	 adjusted	 of	 these	 simplified	models	 are	
shown	on	the	right-hand	side	of	these	tables.		
	 																																																																																										Benjamin	A.F.	Bláha	2018	
	 176	
Table	5-3:	Relative	factor	contributions	in	a	three-factor,	two-level,	full-fractional	factorial	
screening	 designs	 investigating	 induction	 of	 P.	 pastoris	 Mut+	 with	 pure	 methanol	 in	
microtitre	plates:	Specific	growth	rate	(µ)	total	heterologous	protein	expression	([tHBc]),	
specific	 heterologous	 protein	 expression	 (tHBcS),	 initial	 biomass	 concentration	 ([X]0),	
initial	methanol	concentration	([MeOH])	and	induction	time	(t).	*:	Curvature	detected	in	
screening	response	model.	
Factor	 [X]0	(OD600)	 [MeOH]	(%	vol.))	 t	(h)	
Range	 (18,	90)	 (0.5,	5.0)	 (2,30)	
%	contribution	
µ	(h-1)*	 32.3%	 0.748%	 67.0%	
[tHBc]*	
(µg/mL	 21.9%	 5.30%	 72.8%	
tHBcs	
(µg/mL/OD600)	 58.6%	 5.91%	 35.5%	
	
Table	 5-4:	 Similar	 to	 Table	 5-3,	 this	 table	 shows	 the	 relative	 factor	 contributions	 of	 a	
screening	 design	 investigating	 induction	 of	 P.	 pastoris	 MutS	 with	 pure	 methanol	 in	
microtitre	plates.	
Factor	 [X]0	(OD600)	 [MeOH]	(%	vol.)	 t	(h)	
Range	 (18,	90)	 (0.3,	1.0)	 (2,30)	
%	contribution	
µ	(h-1)*	 47.4%	 0.282%	 52.3%	
[tHBc]*	
(µg/mL)	 48.0%	 3.91%	 48.0%	
tHBcs	
(µg/mL/OD600)	 46.3%	 7.38%	 46.3%	
	
Table	5-5:	Models	and	goodness	of	fit	for	screening	responses	investigating	induction	of	
P.	 pastoris	Mut+	with	 pure	methanol	 in	microtitre	 plates:	 Specific	 growth	 rate	 (µ)	 total	
heterologous	 protein	 expression	 ([tHBc]),	 specific	 heterologous	 protein	 expression	
(tHBcS),	initial	biomass	concentration	([X]0),	initial	methanol	concentration	([MeOH])	and	
induction	time	(t).	Goodness	of	fit	is	given	on	the	left-hand	side	of	the	table	(‘All	terms’)	
using	 r2	 and	 adjusted	 r2	 for	models	 in	which	 all	 possible	 first-degree	 polynomial	 terms	
have	 been	 considered.	 Following	 this,	 are	 the	 formulae	 describing	 first-degree	
polynomials	containing	only	significant	model	terms	(p<0.05).	
	 All	terms	
(Complex	
model)	
	 Significant	terms	
(Simplified	model)	
	 R2	 R2	adj.	 Formulae	 R2	 R2	adj.	
µ	(h-1)	 0.885	 0.618	 µ = −0.147 + 0.170	E ) −0.0970E ,& ∙ ) + 0.0939 ,& 		 0.877	 0.825	
[tHBc]	(µg/mL)	 0.734	 0.113	 )NOP = 53.9 + 23.7E ) 	 0.514	 0.460	
tHBcS	
(µg/mL/OD600)	
0.995	 0.984	 )NOPQ = 2.89 − 2.25E ,& +1.45E ) − 1.14E ,& ∙ ) 		 0.921	 0.888	E ,& = 46 − 5436 	 E ) = 8 − 1614 	
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Table	 5-6:	 Similar	 to	 Table	 5-5,	 this	 table	 shows	 the	 models	 and	 goodness	 of	 fit	 for	
screening	responses	investigating	induction	of	P.	pastoris	MutS.	
	 All	terms	
(Complex	
model)	
	 Significant	terms	
(Simplified	model)	
	 R2	 R2	adj.	 Formulae	 R2	 R2	adj.	
µ	(h-1)	 0.935	 0.782	 µ = −0.119 + 0.131E ) −0.121E ,& ∙ ) + 0.119E ,& 		 0.931	 0.902	
[tHBc]	(µg/mL)	 0.921	 0.736	 [)NOP] = 2.07 + 2.84E ) +2.84E ,& ∙ ) + 2.84E ,& 		 0.871	 0.816	
[tHBc]	
(µg/mL/OD600)	
0.924	 0.749	 NOPQ = 0.0415 + 0.0570E ) +0.0570E ,& ∙ ) + 0.0570E ,& 		 0.829	 0.756	E ,& = 46 − 5436 	 E ) = 8 − 1614 	
In	the	case	of	both	phenotypes,	the	concentration	of	methanol	seems	to	have	little	
effect	 on	 any	 of	 the	 responses.	 However,	 this	 seems	 to	 be	 conflicting	 the	 data	
shown	 in	 Figure	5.2,	where	 the	 concentration	of	methanol	 shows	 to	have	a	 clear	
effect	 on	 the	 growth	 rate.	 There	 are	 several	 possible	 explanations	 for	 this.	 By	
looking	at	the	measured	concentrations	of	hepatitis	B	core-positive	material	Table	
10-4	 one	 could	 conclude	 that	 the	 lack	 of	 observed	 expression	 suggests	 that	 the	
design	 space	 was	 not	 appropriately	 chosen	 for	 MutS	 phenotype.	 For	 both	
phenotypes,	many	 responses	models	 indicated	 curvature.	 Also	 noteworthy	 is	 the	
fact	 that,	 contrary	 to	 the	 MutS	 cultures,	 expression	 of	 tHBc	 was	 consistently	
observed	in	each	run	for	the	Mut+	phenotype	(Table	10-3)	However,	the	screening	
methodology	 described	 here	 excludes,	 by	 definition,	 the	 implementation	 of	
quadratic	 terms	 in	 response	 models	 since	 it	 is	 not	 possible	 to	 attribute	 this	
curvature	to	a	single	factor.	The	omission	of	the	hypothetically	significant	quadratic	
model	terms	could	explain	the	observed	poor	goodness	of	fit	for	µ	and	[tHBc].	It	is	
highly	 likely	 that	 the	 effect	 of	methanol	 concentration	 can	be	described	 as	 solely	
quadratic	since,	as	discussed	earlier,	relatively	 low	concentrations	result	 in	culture	
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starvation,	whereas	too	high	concentrations	result	in	toxic	conditions.	However,	the	
same	 could	 be	 hypothesised	 for	 time,	 t,	 and	 initial	 biomass	 concentration,	 ([X0]).	
Regarding	 the	 hypothesis	 of	 the	 existence	 of	 an	 optimum	 for	 initial	 biomass	
concentration,	 one	 could	 imagine	 that	 the	 quadratic	 relationship	 of	 the	 ratio	 of	
biomass	 concentration	 to	 methanol	 concentration	 is	 highly	 significant:	 relatively	
high	ratios	would	result	 in	relatively	rapid	substrate	depletion	followed	by	culture	
stagnation,	while	relatively	low	ratios	could	result	in	the	culture	to	be	overwhelmed	
by	 methanol	 resulting	 in	 cell	 death.	 An	 optimum	 for	 harvesting	 time	 could	 be	
explained	 by	 the	 fact	 that	 P.	 pastoris,	 like	 many	 microorganisms,	 is	 known	 to	
require	a	minimum	period	of	adaptation	to	metabolically	adjust	to	the	introduction	
of	a	different	carbon	source	(Invitrogen	Corporation,	2002),	this	affecting	all	of	the	
studied	responses,	whilst	 too	 long	 incubation	times	would,	again,	 result	 in	culture	
stagnation	due	to	depletion	of	carbon	source.		
5.4.2 Second	induction	screening	
Results	 from	the	previous	section	(5.4.1)	suggested	to	 investigate	different	ranges	
for	 the	 design	 space	 for	 the	 MutS	 phenotype	 induction	 screening.	 Therefore,	 a	
second	 screening	 was	 conducted	 in	 which	 the	 following	 hypotheses	 were	
addressed:	
The	only	observed	instances	of	expression	were	found	in	runs	in	which	both	initial	
biomass	concentrations	and	incubation	time	were	relatively	high	(Table	10-4).	This	
effect	 could	be	a	 result	 of	 a	 relatively	 long	adaptation	period	 to	methanol	 in	 this	
fermentation	platform.	Therefore,	an	increase	in	both	concentration	of	biomass	and	
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incubation	 time	 could	 yield	 higher	 expression	 for	 the	MutS	 phenotype	 induced	 in	
microtitre	plates.		
• If	 the	 above	 strategy	 indeed	 would	 improve	 the	 levels	 of	 heterologous	
protein	 expression,	 then	 it	 should	 also	 be	 ensured	 that	 no	 carbon	 source	
depletion	 occurs	 after	 the	 adaptation	 period	 to	 methanol.	 Therefore,	 a	
slightly	 higher	 and	 a	 wider	 range	 of	 methanol	 concentration	 –
accommodating	 for	 higher	 levels	 of	 biomass	 and	 incubation	 times-	 could	
yield	better	expression	of	tHBc	for	the	MutS	phenotype	induced	in	microtitre	
plates.		
To	further	 investigate	the	limitations	for	the	design	space	for	the	Mut+	phenotype	
the	following	hypotheses	were	formulated:		
• The	 previous	 section	 (5.4.1)	 showed	 good	 expression	 of	 heterologous	
protein	 for	 the	Mut+	phenotype.	 In	addition,	all	 the	observed	growth	rates	
were	negative.	This,	just	like	with	the	MutS	phenotype	this	could	be	due	to	
the	requirement	of	relatively	long	adaptation	times	to	methanol.	Also,	it	was	
shown	 that	 time	 had	 a	 positive	 effect	 on	 specific	 growth	 rate,	 volumetric	
expression	and	specific	expression.	 	Hence,	an	 increase	 in	 incubation	times	
could	yield	higher	expression	for	the	Mut+	phenotype	induced	in	microtitre	
plates.	
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• As	harvest	time	increases,	lower	cell	density	cultures	were	shown	to	express	
volumetrically	 more	 product	 than	 higher	 cell	 density	 cultures.	 This	 is	
probably	 because	 higher	 cell	 density	 cultures	 require	 higher	 amounts	 of	
substrate	(MeOH)	for	cell	maintenance.	Hence,	lowering	the	initial	biomass	
concentration	 at	 induction	 could	 yield	 higher	 expression	 for	 the	 Mut+	
phenotype	induced	in	microtitre	plates.	
• The	existence	of	toxic	methanol	concentrations	for	Mut+	phenotypes	has	
previously	been	established	(Figure	5.2)	at	fixed	initial	biomass	
concentrations	and	incubation	times.	Section	5.4.1	partially	aimed	to	study	
how	this	toxicity	was	affected	through	variation	of	initial	biomass	
concentrations	and	incubation	times.		However,	no	obvious	toxic	effects	
were	observed.	To	establish	a	screening	range	limitation	for	methanol,	the	
range	of	methanol	concentration	needs	to	be	widened	until	toxic	effects	are	
observed.		
Table	 10-5	 and	 Table	 10-6	 show	 the	 second	 set	 of	 screenings’	 design	 spaces	 and	
corresponding	response	values	for	the	Mut+	and	MutS	phenotype	respectively	and	
Table	5-8	show	the	corresponding	analysis	of	variance	and	Table	5-9	and	Table	5-10	
show	the	corresponding	screening	models.	
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Table	 5-7:	 Relative	 factor	 contributions	 in	second	 three-factor,	 two-level,	 full-fractional	
factorial	screening	designs	investigating	induction	of	P.	pastoris	Mut+	with	pure	methanol	
in	 microtitre	 plates:	 Specific	 growth	 rate	 (µ)	 total	 heterologous	 protein	 expression	
([tHBc]),	 specific	 heterologous	 protein	 expression	 (tHBcS),	 initial	 biomass	 concentration	
([X]0),	initial	methanol	concentration	([MeOH])	and	induction	time	(t).	
Factor	 [X]0	(OD600)	 [MeOH]	(%	vol.))	 t	(h)	
Range	 (9,	45)	 (2.5,	7.5)	 (16,46)	
%	contribution	
µ	(h-1)	 24.74%	 48.78%	 26.48%	
[tHBc]	
(µg/mL	 41.23%	 26.61%	 32.16%	
tHBcs	
(µg/mL/OD600)	 35.25%	 31.89%	 32.86%	
	
Table	 5-8:	 Similar	 to	 Table	 5-7,	 this	 table	 shows	 the	 relative	 factor	 contributions	 of	 a	
screening	 design	 investigating	 induction	 of	 P.	 pastoris	 MutS	 with	 pure	 methanol	 in	
microtitre	plates.	*:	Curvature	detected	in	screening	response	model.		
Factor	 [X]0	(OD600)	 [MeOH]	(%	vol.)	 t	(h)	
Range	 (90,	135)	 (0.5,	2.5)	 (16,46)	
%	contribution	
µ	(h-1)	 51.87%	 22.54%	 25.60%	
[tHBc]	
(µg/mL)*	 63.41%	 30.94%	 5.65%	
tHBcs	
(µg/mL/OD600)	 71.75%	 4.84%	 23.41%	
	
Table	 5-9:	 Models	 and	 goodness	 of	 fit	 for	 second	 screening	 designs	 investigating	
induction	 of	 P.	 pastoris	 Mut+	 in	 microtitre	 plates:	 Specific	 growth	 rate	 (µ)	 total	
heterologous	 protein	 expression	 ([tHBc]),	 specific	 heterologous	 protein	 expression	
(tHBcS),	initial	biomass	concentration	([X]0),	initial	methanol	concentration	([MeOH])	and	
induction	time	(t).	Goodness	of	fit	is	given	on	the	left-hand	side	of	the	table	(‘All	terms’)	
using	 r2	 and	 adjusted	 r2	 for	models	 in	which	 all	 possible	 first-degree	 polynomial	 terms	
have	been	considered.		
	 All	terms	
(Complex	
model)	
	 Significant	terms	
(Simplified	model)	
	 R2	 R2	adj.	 Formulae	 R2	 R2	adj.	
µ	(h-1)	 0.993	 0.978	
µ = 0.0185 − 0.0134E R/SN +0.0126E R/SN ∙ ) +0.0118E R/SN ∙ ,& −0.0107E R/SN ∙ ,& ∙ ) −0.00684E ,& ∙ ) 		 0.993	 0.986	
[tHBc]	(µg/mL)	 0.956	 0.852	 )NOP = 0.430 + 0.306E ,& ∙ ) 		 0.251	 0.168	
[tHBc]	
(µg/mL/OD600)	
0.961	 0.869	 NOPQ = 0.0431 − 0.0541E ,& 		 0.163	 0.067	
E ,& = 46 − 2718 	 E R/SN = TUVW − 52.5 	 E ) = 8 − 3115 	
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Table	 5-10:	 Similar	 to	 Table	 5-9,	 this	 table	 shows	 the	 models	 and	 goodness	 of	 fit	 for	
screening	responses	investigating	induction	of	P.	pastoris	MutS.	
	 All	terms	
(Complex	
model)	
	 Significant	terms	
(Simplified	model)	
	 R2	 R2	adj.	 Formulae	 R2	 R2	adj.	
µ	(h-1)	 0.989	 0.963	
µ = 5.92 ∙ 10%X − 3.76 ∙10%YE ,& + 2.65 ∙ 10%YE ,& ∙) + 	2.53 ∙ 10%YE R/SN − 1.63 ∙10%YE R/SN ∙ ) − 8.81 ∙ 10%XE ) 		 0.982	 0.963	
[tHBc]	(µg/mL)	 0.833	 0.442	 )NOP = 8.30 − 1.52E ,& +1.40E R/SN ∙ ,& −		 0.754	 0.692	
[tHBc]	
(µg/mL/OD600)	
0.939	 0.797	
NOPQ = 0.0761 − 0.0235E ,& +0.0128E R/SN ∙ ,& 		
	
0.823	 0.779	
E ,& = 46 − 112.522.5 	 E R/SN = TUVW − 1.5	 E ) = 8 − 3115 	
Based	 on	 the	 data	 generated	 for	 the	 second	 screening	 for	 the	Mut+	 phenotype,	
several	 deductions	 can	 be	made	 as	 a	 result	 of	 changing	 screening	 ranges	 for	 the	
investigated	process	parameters.	
Comparing	 the	data	sets	generated	 for	 the	 first	and	second	screening	 (Table	10-3	
and	10-5	respectively),	a	significant	contrast	becomes	apparent.	The	chosen	ranges	
in	 the	 first	 screening	 resulted	 in	 predominantly	 high	 expression,	 yet	 negative	
growth	 rates	 for	all	observations.	The	second	screening	 shows	 the	exact	opposite	
result.	 The	 observed	 expression	 is	 so	 low	 that	 it	 is	 indistinguishable	 from	 noise,	
reflected	by	the	lack	of	significant	model	terms	shown	in	Table	5-9	while	for	all	but	
one	 run	 show	 positive	 growth	 rates12.	 It	 therefore	 seems	 that,	 for	 the	 Mut+	
phenotype	within	the	chosen	design	space,	there	is	an	inverse	relationship	between	
growth	rate	and	expression.		
																																																						
12	This	outlier	can	be	explained	by	the	requirement	of	slightly	longer	adaptation	times	to	higher	–or	
even	toxic-	concentrations	of	methanol	(comparing	pattern	‘+--’with	‘+-+’).	
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This	fact	that	the	majority	of	all	variation	in	growth	rate	response	(Table	5-7)	is	due	
to	 variation	 in	 methanol	 concentration	 indicates	 that,	 at	 higher	 methanol	
concentrations,	 growth	 -rather	 than	 heterologous	 protein	 expression-	 is	
preferential	 for	 the	Mut+	 phenotype.	 As	 suggested	 by	 other	 research	 (Chiruvolu,	
Cregg	 and	 Meagher,	 1997;	 Krainer	 et	 al.,	 2012),	 this	 could	 be	 explained	 by	 the	
elevated	 requirement	 of	 alcohol	 oxidase	 at	 increased	 levels	 of	 methanol.	 This	
creates	a	scenario	in	which	more	resources	are	allocated	to	the	synthesis	of	alcohol	
oxidase	rather	than	the	heterologous	protein	of	 interest.	 It	 is	 therefore	crucial	 for	
the	 remainder	 of	 this	 research	 to	 bear	 in	 mind	 that	 increased	 induction,	
counterintuitively,	 does	 not	 necessarily	 result	 in	 higher	 levels	 of	 heterologous	
production.		
In	 addition	 to	 the	 nutrient	 competition-effect,	 described	 above,	 another	 possible	
explanation	 for	 the	 observation	 that	 low	 levels	 of	 recombinant	 protein	 are	
associated	 with	 high	 growth	 and	 vice	 versa,	 is	 the	 consumption	 of	 heterologous	
protein	 as	 a	 carbon	 source.	 Therefore,	 at	 limiting	 levels	 of	 carbon	 source	 (i.e.	
methanol),	P.	pastoris	would	consume	any	heterologous	protein	already	expressed,	
whereas	 at	 high	 levels	 of	 methanol,	 the	 required	 overexpression	 of	 AOX	 and	
increased	growth	 rates	preventing	 toxicity,	 could	 result	 in	 limited	 resources	being	
redirected	to	the	synthesis	of	AOX	rather	than	heterologous	protein.	The	result	of	
these	two	scenarios	is	that	there	could	be	a	tight	window	of	operation	for	methanol	
feeding,	 one	 that	 would	 be	 particularly	 difficult	 to	 control	 with	 bolus	 methanol	
feeding.		
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In	summary,	to	address	the	hypotheses	stated	at	the	start	of	this	section	regarding	
the	 Mut+	 phenotype:	 Extending	 the	 incubation	 time	 has	 likely	 led	 to	 P.	 pastoris	
Mut+	 to	 adapt	 to	 higher	 specific	 levels	 of	methanol,	 i.e.	 the	 amount	 of	methanol	
available	per	unit	of	biomass.	However,	this	adaptation,	unexpectedly,	did	not	lead	
to	 higher	 heterologous	 protein	 expression,	 but	 rather	 higher	 growth	 rates.	 In	
addition,	 methanol	 toxicity	 was	 shown	 to	 occur	 at	 low	 cell	 concentrations,	 high	
methanol	concentrations	and	at	relatively	early	induction	times.		
Extending	the	 incubation	time,	 increasing	the	concentration	of	 initial	biomass	and	
widening	 the	 range	of	methanol	 concentration	has	 resulted	 in	 significantly	higher	
levels	of	both	expression	and	cell	growth	for	the	MutS	phenotype.		
This	 illustrates	 an	 important	 difference	 between	Mut+	 and	MutS	 phenotypes.	 For	
MutS	 phenotypes	 the	 correlation	 between	 specific	 growth	 rate	 and	 heterologous	
protein	 expression	 has	 a	 propensity	 to	 be	 positive,	 whereas	 for	 the	 Mut+	
phenotypes	this	correlation	tends	to	be	inversed.		
This	difference	can	be	explained	through	Figure	5.3,	which	is	a	simplified	version	of	
an	 illustration	 of	 the	 methanol	 utilisation	 pathway	 by	 Krainer	 et	 al.	 (2012)	 and	
incorporates	 the	 explanation	 by	 Chiruvolu,	 Cregg	 and	 Meagher	 (1997)	 of	 the	
previous	mentioned	nutrient-competetion	effect	between	recombinant	protein	and	
AOX	proteins.	MutS	 is	known	to	express	considerably	 less	AOX	protein	 than	Mut+.	
This	 means	 that	 nutrient	 resources,	 such	 as	 a	 limited	 carbon	 source,	 would	 be	
available	 for	 the	 production	 of	 recombinant	 protein	 in	MutS	 at	 equal	 expression	
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stimuli.	 This	 could	 explain	 why,	 in	 all	 the	 screenings	 performed,	 volumetric	
expression	levels	of	tHBc	are	highest	in	the	MutS	phenotype.	
	
Figure	 5.3	 Diagram	 of	 the	 methanol	 utilisation	 pathway	 in	 P.	 pastoris	 demonstrating	
nutrient	 competetion	 affecting	 heterologous	 protein	 expression.	 Green	 arrows	 indicate	
positive	 stimuli;	 the	 red	 arrow	 shows	 a	 negative	 stimulus.	 ‘R’	 represents	 the	 overall	
nutrient	supply	available	to	a	cell.	(1)	Expression	of	AOX	protein(s)	through	aox	gene(s).	
(2)	 Expression	 of	 heterolgous	 protein,	 dependent	 on	 nutrient	 availibility	 and	 induction	
stimulus.	(3)	Degradation	of	heterologous	protein.		
This	section	has	demonstrated	how	microtitre	plates	were	used	to	screen	induction	
stage	 fermentation	 for	 two	 phenotypes	 of	 P.	 pastoris.	 Key	 differences	 between	
induction	 behaviour	 of	 the	 two	 strains	 were	 observed	 and	 it	 was	 demonstrated	
that,	 within	 the	 chosen	 design	 space,	 the	MutS	 phenotype	 produced	 the	 highest	
volumetric	yields	of	tHBc	(see	tables	10.3-10.6).	
With	 regards,	 to	 the	 suitability	 of	 microtitre	 plates	 used	 to	 study	 induction	
processes,	 three	 central	 limitations	were	 identified	 for	both	 strains	of	P.	pastoris:	
(1)	 the	 requirement	 for	 an	 adaptation	 period	 to	 methanol,	 (2)	 the	 substrate	
depletion	 of	 methanol	 and	 (3)	 methanol	 toxicity.	 To	 address	 these	 limitations,	
either	 a	 continuous	 feeding	 mechanism	 needed	 to	 be	 implemented	 or	 a	 bolus	
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feeding	optimisation	strategy	needed	to	be	developed.	The	former	system	was	not	
available	 in	the	microtitre	plate	system	and	the	latter	approach	would	require	the	
addition	 of	 significantly	 more	 factors	 added	 to	 screening	 (and	 eventually	
optimisation)	experimental	designs,	such	as	the	 interval	 length	between	the	bolus	
additions	and	the	total	 length	of	 induction	(or	the	total	amount	of	bolus	additions	
given).	Because	P.	pastoris	 cultures	are	 shown	 to	 require	an	adaptation	period	 to	
methanol,	 it	 would	 most	 likely	 be	 necessary	 to	 implement	 separate	 screening	
experiments	for	phases	where	the	cultures	are	not	adapted	to	methanol	and	when	
the	 cultures	 are	 adapted	 to	 methanol.	 Also,	 because	 the	 screening	 experiments	
shown	 in	 this	 chapter	 so	 far	 have	 not	 eliminated	 a	 single	 studied	 factor	 as	 being	
insignificant,	 the	 previous	 screened	 factors	 in	 addition	 to	 the	 proposed	 bolus-
associated	 factors	 would	 amount	 to	 a	 high	 number	 of	 runs13	that	 could	 be	
considered	uneconomical	from	a	time-management	point	of	view.			
5.5 Investigating	alternative	feeding	with	pectin	and	pectin	derivatives	
The	 previous	 section	 demonstrated	 the	 limitations	 that	 induction	 with	 pure	
methanol	 imposes	 on	 method	 development	 for	 microtitre	 plate-based	 upstream	
process	platforms	for	P.	pastoris.		
This	 section	 aims	 to	 address	 these	 issues	 with	 a	 question	 that	 seems	 to	 remain	
largely	 unanswered:	 how	 does	 P.	 pastoris	 assimilate	 methanol	 in	 its	 natural	
environment	in	the	first	place?	
																																																						
13	(25+3)·2·2=140	runs	for	screening	experiments,	assuming	2-level	screening	designs	with	3	centre	
points	 for	 two	 phases	 of	 induction	 (adapted	 and	 non-adapted)	 for	 both	 phenotypes	 of	 Pichia	
pastoris.	
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P.	pastoris	was	first	isolated	from	a	French	chestnut	tree	and	was	often	found	as	a	
contaminating	yeast	species	in	wine	production	(BioGrammatics,	2013).	This	implies	
that	 these	microorganisms	 obtain	 nutrients	 from	 plant	 derivatives.	 In	 fact,	 many	
methylotrophic	yeasts	obtain	methanol	indirectly	from	a	plant	polymer:	pectin.	This	
happens	 through	 the	 conversion	 of	 pectin	 by	 pectin	 methyl	 esterase	 (PME)	 to	
carboxylated	 polymers	 and	 free	 methanol	 	 (Lee,	 Jae-Dong	 and	 Komagata,	 1980;	
Nakagawa	et	al.,	2005),	as	shown	in	Figure	5.4.	
	
Figure	5.4	Reaction	diagram	of	the	enzymatic	conversion	of	a	methyl	ester	on	pectin	to	a	
carboxylated	polymer	and	free	methanol	by	pectin	methyl	esterase.		
Previous	 research	has	 also	 suggested	 that	 esters	 are	 converted	 to	methanol	 in	P.	
pastoris		through	an	unidentified	pathway	(Krainer	et	al.,	2012).		Taking	this	and	the	
phylogenetic	 similarity	 to	 other	 methylotrophic	 yeasts	 into	 account,	 it	 was	
hypothesised	that	P.	pastoris	may	be	able	to	metabolise	pectin	to	obtain	methanol.		
If	this	hypothesis	were	proven	to	be	true,	pectin,	or	its	derivatives,	could	be	used	as	
an	 indirect	 induction	 agent.	 This	would	mitigate	 the	methanol	 feeding-associated	
limitations	of	microtitre	plate-based	induction	of	P.	pastoris	previously	discussed	in	
section	5.4.2	and	the	methanol	toxicity	issues	in	unintended	accumulation	events.		
R O
O
CH3
H2O CH3OH
PME
R OH
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5.5.1 Micro	fermentations	of	pectin	digest			
It	should	be	stressed	that	in	this	series	of	experiments	methanol	is	still	the	inducing	
agent	 and	 that	 pectin	 would	 effectively	 act	 as	 molecular	 storage	 of	 methanol.	
Therefore,	 it	 had	 to	 be	 determined	 how	 much	 pectin	 would	 be	 appropriate	 to	
produce	a	significant	induction	response.	
Pectin	 is	 polymer	 of	 D-galacturonic	 acid	 and	 D-galacturonic	 acid	 methyl	 ester	
(Mohnen,	2008).	The	level	of	esterification,	denoted	in	%,	indicates	the	proportion	
of	 molecules	 in	 a	 pectin	 polymer	 that	 are	 D-galacturonic	 acid	 methyl	 ester.	 D-
galacturonic	acid	methyl	ester	(dGAME),	specifically,	has	been	postulated	to	be	the	
methanol	donating	group	within	pectin.		
It	 was	 shown	 in	 Figure	 5.2	 that	 a	minimum	 observed	 concentration	 of	methanol	
required	to	sustain	a	culture	was	0.313%.	Therefore,	an	equivalent	amount	of	0.5	%	
vol.	methanol	was	prepared	with	pectin	 from	apple.	This	equivalent	was	 found	to	
translate	to	3.67g/L	pectin,	assuming	a	70%	level	of	esterification.		
However,	 pectin	 is	 poorly	 soluble	 in	 water	 and	 turns	 to	 gels	 at	 higher	
concentrations	 (data	 not	 shown).	 Increased	 viscosity	would	 provide	 unfavourable	
culturing	conditions,	as	this	would	lower	oxygen	transfer	conditions.	An	approach	to	
solubilise	 pectin	 was	 to	 heat	 pectin	 under	 alkaline	 conditions	 and	 subsequently	
depolymerise	pectin	using	pectin	lyase	(PNL)	as	shown	in	Figure	5.5.		
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Figure	5.5	PNL-mediated	depolymerisation	of	pection	(left)	to	dGAME	(right).		
To	study	 if	pectin	could	 induce	P.	pastoris	 indirectly,	Pectin	Digest	Medium	(PDM;	
0.5%	vol.	MeOH	equivalent	dGAME)	was	prepared	as	described	in	2.3.1.1.		
Harvest	 times	 (t)	 and	 initial	biomass	 concentrations	 ([X0])	were	varied	 in	a	 similar	
screening-type	 fashion	 as	 described	 in	 previous	 section	 for	 both	 the	 Mut+	
phenotype	(Table	10-7)	and	the	MutS	phenotype	(Table	10-8).	
Table	10-9	and	Table	10-10	show	the	level	of	overall	response	variance	created	by	
each	 factor	 in	 screening	experiments	 for	Mut+	and	MutS	phenotypes	 respectively.	
The	 left	 side	 of	 Table	 10-11	 and	 Table	 10-12	 -	 Mut+	 and	 MutS	 phenotypes	
respectively-	show	the	goodness	of	fit	of	these	models,	using	r2.	The	robustness	of	
these	 models	 was	 subsequently	 assessed	 using	 r2	 adjusted.	 The	 same	 tables	
subsequently	 show	 formulae	 for	 each	 response	 model	 showing	 only	 significant	
model	 terms	 (p<0.05).	 Similarly,	 r2	 and	 r2	 adjusted	 of	 these	 simplified	models	 are	
shown	on	the	right-hand	side	of	these	tables.	
Mut+	 showed	 positive	 growth	 rates	 after	 each	 experimental	 run,	 with	 low	
expression	of	heterologous	protein.	However,	MutS	showed	slight	negative	growth	
rates,	 with	 significant	 expression	 of	 heterologous	 protein.	 This	 contrast	 between	
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the	two	phenotypes	 is	seen	 in	previous	sections	and	can	also	be	explained	by	the	
previously	discussed	nutrient	competition-effect	depicted	in	Figure	5.3.	
Overall	 the	 use	 of	 PDM	 shows	 to	 induce	 P.	 pastoris	 proving	 the	 hypothesis	 that	
pectin	derivatives	can	be	used	to	induce	heterologous	protein	expression.		
However,	PDM	is	an	undefined	enzymatic	digest.	Previous	work	has	shown	that	the	
saponification	 of	 citrus	 pectin	 through	 alkalisation	 could	 result	 in	 complete	 de-
esterification	(Zhan,	Janssen	and	Mort,	1998).	It	was	therefore	not	definitive	if	the	
observed	effects	were	due	to	the	action	of	methanol	liberation	by	PME	on	dGAME	
polymers.	 
5.5.2 	Micro	fermentations	of	pectin	monomers	
The	previous	 section	described	how	Pectin	Digest	Media	was	used	 successfully	 to	
induce	heterologous	protein	expression	in	two	phenotypes	of	P.	pastoris.		
This	 section	 describes	 using	 defined	 media	 conditions	 to	 test	 the	 hypothesis	 of	
monomeric	dGAME	being	able	to	 induce	heterologous	protein	expression	through	
PME	 activity.	 To	 explain	 the	 effect	 of	 other	 pectin	 digest	 components	 and	 to	
provide	a	benchmark	of	expression,	d-galacturonic	acid	 (dGA)	and	methanol	were	
also	considered.	
Molecularly	 equivalent	 amounts	 to	 1%	 MeOH	 (vol.)	 of	 dGA	 and	 dGAME	 were	
prepared	in	BSM.	Several	mixtures	were	prepared	in	which	2-level	combinations	of	
the	 three	 substrates	 were	 combined.	 To	 gain	 an	 indication	 of	 specific	 substrate	
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consumption	rates,	different	 levels	of	 initial	biomass	were	used	for	 induction.	The	
induction	was	carried	out	as	described	in	section	2.3.1.	
Figure	 5.6	 shows	 the	 levels	 of	 expression	 and	 substrate	 consumption	 for	 each	
possible	condition.	Expression	was	measured	using	dot	blotting	(2.5.10)	followed	by	
immunostaining	 and	 linear	 signal	 analysis	 (2.5.11).	 Residual	 dGA	 was	 measured	
using	uronic	acid	analysis	as	described	 in	 section	2.5.15,	and	 residual	dGAME	and	
methanol	 were	 quantified	 using	 chromatographic	 methods	 described	 in	 section	
2.5.14.	
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Figure	5.6	Metabolic	analysis	of	P.	pastoris	MutS	in	several	defined	media	conditions:	Basal	Salts	Media	(BSM),	d-galacturonic	acid	in	Basal	Salts	Media	
(dGA),	d-galacturonic	acid	methyl	ester	in	Basal	Salts	Media	(dGAME),	methanol	in	Basal	Salts	Media	(MeOH),	d-galacturonic	acid	and	methanol	in	Basal	
Salts	Media	(MeOH	+	dGA),	and	d-galacturonic	acid	methyl	ester	and	methanol	in	Basal	Salts	Media	(MeOH	+dGAME).	Expression	and	susbtrate	
concentrations	after	20	hours	of	fermentation	at	two	different	starting	biomass	concentrations:	(A)	Expression	of	tHBc-k1,k1;	(B)	dGA	concentrations;	(C)	
dGAME	concentrations;	and	(D)	MeOH	concentrations.
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The	 data	 shows	 that	 induction	 was	 only	 observed	 in	 cultures	 with	 methanol	
addition	(Figure	5.6A).	In	all	cultures	in	which	methanol	was	introduced,	significant	
levels	 of	 methanol	 were	 consumed	 (Figure	 5.6B).	 No	 apparent	 induction	 was	
observed	 in	 cultures	 containing	 dGAME	 alone	 (Figure	 5.6A)	 nor	 was	 dGAME	
consumed	 (Figure	 5.6C),	 disproving	 the	 hypothesis	 that,	 at	 least	 under	 these	
conditions,	dGAME	can	be	used	to	induce	AOX.		
In	fact,	dGA	and	dGAME	seem	to	inhibit	the	uptake	of	methanol,	as	shown	in	Figure	
5.6D.	 This	 could	 be	 explained	 by	 the	 effect	 that	 under	 acidic	 conditions14	an	
equilibrium	 exists	 between	 dGAME	 on	 one	 end;	 and	 dGA	 and	 methanol	 on	 the	
other	 end	 Figure	 5.7.	 This	 could	 allow	 dGA	 (and	 dGAME)	 to	 act	 as	 a	 ‘buffer’	 for	
methanol.		
	
Figure	5.7	Equilibirum	between	d-galacturonic	acid	and	d-galacturonic	acid	methyl	ester.	
A	reaction	mechanism	of	this	equilibrium	is	shown	in	Figure	10.10	in	the	appendix.		
																																																						
14	Late	 stage	 induction	 cultures	 in	microtitre	 plates	would	 be	 significantly	 below	 pH	 5	 due	 to	 the	
consumption	of	ammonia.	
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One	 reason	 induction	was	not	observed	using	defined	pectin	derivatives	 could	be	
that	dGAME	is	too	small	a	molecule	for	PMEs	to	act	on	to	release	methanol.	Indeed,	
a	 review	 suggest	 that	 PMEs	 exclusively	 act	 on	 chains	 of	 galacturonic	 acid	 and	
galacturonic	acid	methyl	ester	(Manmohit	Kalia,	2015).	Therefore,	it	is	hypothesised	
that	galacturonic	acid	methyl	ester	can	only	be	used	as	an	indirect	inducing	agent	in	
polymer,	or	at	 least	oligomeric	form.	However,	further	work	would	be	required	to	
demonstrate	this.	
5.6 Summary	
This	 chapter	 studied	 the	 use	 of	 microtitre	 plates	 to	 develop	 a	 miniaturised	
fermentation	platform	intended	for	rapid	upstream	process	characterisation.	
It	was	found	that	microtitre	plates	can	be	used	to	grow	P.	pastoris	for	the	purposes	
of	 increasing	 biomass	 in	 complex	 media.	 However,	 induction	 of	 heterologous	
protein	in	microtitre	plates	proved	to	be	more	challenging	due	to	the	requirement	
for	 an	 adaptation	 period	 to	 methanol,	 the	 substrate	 depletion	 of	 methanol	 and	
methanol	toxicity.	
Nonetheless,	 several	 critical	 process	 parameters	 were	 confirmed:	 Initial	 biomass	
concentration	at	induction,	harvest	time	and	methanol	concentration	in	media.		
Also,	 significant	differences	 in	growth	and	 induction	characteristics	between	MutS	
and	 Mut+	 phenotypes	 were	 identified.	 For	 the	 MutS	 phenotype	 the	 correlation	
between	 specific	 growth	 rate	 and	 heterologous	 protein	 expression	 tended	 to	 be	
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positive,	 whereas	 for	 the	 Mut+	 phenotype	 this	 correlation	 was	 inversed.	 It	 was	
postulated	 this	 was	 due	 to	 an	 intracellular	 nutrient	 competition	 effect	 between	
expression	of	AOX	protein	and	heterologous	protein.		
To	address	the	issues	associated	with	pure	methanol-based	induction	in	microtitre	
plates,	 the	use	of	pectin	digest	as	an	 indirect	 induction	agent	was	 studied.	 It	was	
found	that	 the	use	of	 this	novel	media	resulted	 in	 the	expression	of	heterologous	
protein,	however,	 it	was	determined	that	this	effect	was	not	due	to	the	proposed	
metabolism	of	d-galacturonic	methyl	ester	by	pectin	methyl	esterase.	Investigating	
the	mechanism	of	induction	by	PDM	needs	to	be	assessed	in	future	work	but	could	
likely	 be	 attributed	 to	 the	 release	 of	 free	 methanol	 during	 the	 saponification	
process	of	pectin	or	due	to	pectin	methyl	esterases	acting	exclusively	on	polymeric	
forms	of	d-galacturonic	methyl	ester.		
While	 microtitre	 plates	 have	 proved	 useful	 in	 previous	 published	 work	 to	 be	 an	
effective	 screening	 tool	 for	upstream	processing,	 in	 the	case	of	methylotrophic	P.	
pastoris	they	have	a	 limited	utility.	This	 is	because	the	methanol	 induction	system	
needs	 to	 be	 tightly	 regulated	 and	 controlled,	 which	 cannot	 be	 achieved	 through	
bolus	 additions.	 Therefore,	 the	 next	 chapter	 will	 explore	 miniature	 bioreactor	
systems	that	are	capable	of	tighter	parameter	regulation.		
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Chapter	6 Characterisation	of	Tandem	Core	Virus-Like	particle	
production	
6.1 Introduction	
Several	 critical	 process	 parameters	 were	 identified	 in	 chapter	 3	 and	 5,	 including	
temperature;	harvest	time;	initial	biomass	concentration;	and	induction	strategies.		
Chapter	4	shows	how	microscale	sample	processing	techniques	were	developed	to	
enable	 high-throughput	 sample	 processing	 in	 upstream	 process	 development	 at	
miniaturised	 scales.	 Subsequently,	 chapter	 5	 aimed	 to	 investigate	 the	 use	 of	
microtiter	plates	for	the	purpose	of	upstream	process	characterisation.	However,	it	
was	 found	 that	 (1)	 the	 oxygen	 transfer	 rates	 required	 for	methanol	 induction	 in	
microtitre	 plates	 was	 limiting	 and	 (2)	 this	 platform	 lacked	 several	 crucial	 control	
mechanisms	required	for	the	induction	of	heterologous	protein	of	P.	pastoris.	Such	
a	platform	would	therefore	be	difficult	to	scale-up	to	attain	practical	and	industrial	
relevance.		
To	address	these,	this	chapter	will	describe	how	upstream	process	characterisation	
was	 performed	using	 a	 novel,	miniaturised,	 disposable	 and	 automated	bioreactor	
system,	the	ambr®	250.	
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6.2 Aim	and	objectives	
This	chapter	aims	to	use	miniature	bioreactors	and	the	aforementioned	scale-down	
cell	 disruption	 tools	 to	 study	 VLP	 production	 in	 a	 bioprocessing	 context	 through	
variance	of	 previous	 identified	 critical	 process	parameters.	 The	 specific	 objectives	
are:	
• Model	metabolic	effects	due	to	process	variance.		
• Characterise	specific	expression	of	Tandem	Core	material		
• Characterise	volumetric	expression	of	Tandem	Core	material		
• Investigate	methanol	toxicity	
• Optimise	the	VLP	production	process	
• Establish	a	correlation	between	VLP	assembly	and	tHBc	expression	
6.3 Experimental	Approach	
To	better	understand	VLP	expression	in	P.	pastoris,	the	k1,k1	construct	investigated	
in	 chapter	 3	will	 provide	 a	 good	 base	 case	 for	 the	 purpose	 of	 Tandem	 Core	 VLP	
assembly	in	this	chapter.	
This	chapter	will	address	the	variance	of	CCPs	identified	in	chapters	3	and	5	through	
three	 response	 categories:	 metabolic	 effects,	 specific	 expression	 and	 volumetric	
expression.		
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6.3.1 Metabolic	effects	studied	in	the	miniature	bioreactor	system	
To	 gain	 understanding	 in	 the	 fermentation	 process,	 several	 metabolic	 responses	
were	studied	in	the	ambr®	system,	these	are:	the	concentration	of	biomass	[X],	the	
Carbon	Evolution	Rate	(CER),	and	the	Respiratory	Quotient	(RQ).	
6.3.1.1 Concentration	of	biomass	
Using	 the	 concentration	 of	 biomass	 to	monitor	 fermentation	 processes	 has	 been	
covered	 extensively	 in	 previous	 chapters.	 This	 chapter	 will	 use	 wet	 cell	 weight	
(2.5.2)	and	dry	cell	weight	(2.5.3)	to	measure	biomass	in	an	offline	fashion.		
6.3.1.2 Carbon	Dioxide	Evolution	Rate	
The	 Carbon	 Dioxide	 Evolution	 Rate	 (CER)	 is	 the	 net	 quantity	 of	 carbon	 dioxide	
observed	in	the	exhaust	gas	of	a	fermentation	process,	expressed	as	the	amount	of	
millimoles	of	carbon	dioxide	per	litre	of	working	volume	per	hour.	Hence:		
!"# = %&'() ∙ [!,-]/01 ∙ [2]&' [2]/01 − [!,-]&' 	
Where:	
• %&'	is	the	sparge	rate	(m3/h)	
• ()	is	the	working	volume	(m3)	
• 	[!,-]/01	is	the	concentration	of	exhaust	carbon	dioxide	(mmol/L)	
• [!,-]&'	is	the	concentration	of	sparged	carbon	dioxide	(mmol/L)	
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• 2/01	is	the	concentration	of	exhaust	inert	gas15	(mmol/L)	
• 2&'	is	the	concentration	of	sparged	inert	gas	(mmol/L)	
CER	 analysis	 is	 typically	 used	 to	 indicate	 the	 metabolic	 status	 of	 a	 fermentation	
process	through	online	measurements	(Omstead,	1990).		
In	 this	 series	of	experiments,	CER	will	 be	used	 (1)	 as	a	method	of	monitoring	 the	
activity	 and	 growth	 of	P.	 pastoris,	 (2)	 as	 a	 trigger	 for	 automatically	 initiating	 the	
glycerol	 fed-batch	 phase	 and	 (3)	 comparing	 performance	 between	 scales	 in	 the	
subsequent	chapter.		
6.3.1.3 Respiratory	Quotient	(RQ)	
The	Respiratory	Quotient	has	typically	been	used	as	an	online	means	to	indicate	the	
carbon	source	being	utilised	by	a	microbe	at	any	given	time	(Omstead,	1990).	The	
RQ	 is	defined	as	 the	ratio	between	the	carbon	dioxide	produced	by	a	culture	and	
the	amount	of	oxygen	consumed	by	it.	Hence:	
#5 = [!,-][,-] = 67 = !"#,8#	
6.3.2 Specific	expression		
Specific	expression	is	defined	as	the	amount	of	heterologous	protein	expressed	per	
unit	of	biomass.	In	the	case	of	this	study	this	specifically	means	the	amount	of	tHBc	
per	gram	of	wet	cell	weight:	tHBcS	(µg/gWCW).		
																																																						
15	Usually	argon	or	molecular	nitrogen	
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One	objective	of	this	chapter	is	to	characterise	VLP	assembly.	To	do	this,	the	specific	
expression	of	tHBc	must	be	characterised	in	different	states.	As	shown	in	Figure	6.1,	
this	 was	 done	 by	 measuring	 (1)	 how	 much	 tHBc	 was	 recovered	 after	
homogenisation,	 (2)	how	much	of	 this	material	was	soluble;	and	 (3)	how	much	of	
this	material	was	in	the	correct	size	range	of	a	VLP.	These	‘states’	of	tHBc,	which	are	
categorised	 by	 the	 downstream	 fractions	 in	 which	 tHBc	 is	 recovered,	 will	
henceforth	be	referred	to	as	‘total’	(or	‘crude’),	‘soluble’	and	‘VLP’	(Figure	6.1)	
	
	
Figure	6.1	Overview	of	VLP	production.	(Top)	unit	operations	involved	from	left	to	right:	
Fermentation	 and	 harvesting,	 cell	 disruption,	 clarification,	 and	 purification.	 (Bottom)	
Outputs	of	respective	unit	operations:	(1)	Biomass,	(2)	lysate	containing	cell	debris,	host	
cell	 protein	 and	 total	 produced	 tHBc;	 (3)	 clarified	 lysate	 containing	 soluble	 host	 cell	
protein	 and	 soluble	 tHBc;	 (4)	 size-exclusion	 chromatography	 fractions	 containing	 tHBc	
and	host	cell	protein	in	within	the	20-220µm	size	range.		
Total	expression	 is	defined	as	the	quantity	of	 tHBc	measured	 in	crude	 lysate	after	
cell	disruption	(Step	2,	Figure	6.1).	Soluble	expression	 is	defined	as	the	amount	of	
tHBc	measured	in	clarified	lysate	after	clarification	(Step	3,	Figure	6.1).	Finally,	the	
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amount	of	 tHBc	 assumed	 to	be	mostly	 assembled	VLP	was	measured	 after	 a	 size	
exclusion	 purification	 step	 (Step	 4,	 Figure	 6.1).	 It	 must	 be	 emphasised	 that	 the	
chromatography	fractions	also	contained	host	cell	protein,	and	states	of	tHBc	other	
than	tHBc	assembled	into	Virus-Like	Particles.	Quantification	of	tHBc	was	performed	
as	described	in	sections	2.5.10	and	2.5.11.		
6.3.3 Design	of	Experiments	
This	chapter	will	be	addressing	the	use	of	more	sophisticated	tools	than	microtiter	
plates	 for	 upstream	 process	 characterisation.	 However,	 to	 gain	 higher	 level	 of	
process	control,	a	significant	trade-off	had	to	be	made	for	experimental	throughput.	
Bioreactor	 fermentation	 processes	 are	 considerably	 more	 expensive	 and	 time	
consuming	 than	 microtiter	 plate-based	 fermentation.	 Therefore,	 to	 mitigate	 the	
reduced	throughput,	more	economic	use	of	experiments	was	crucial.	Hence,	Design	
of	Experiment-based	response	surface	methodology	was	used	for	upstream	process	
characterisation.		
	Figure	 6.2	 shows	 an	 experimental	 overview	 of	 the	 procedures	 involved	 in	 this	
chapter	to	study	the	above	responses.		
The	effects	of	temperature,	Ti	(°C),	methanol	flow	rate,	QMeOH	(mL/Li/h)	and	finally,	
glycerol	flow	rate,	QGY	(mL/Li/h)	on	responses	were	studied	by	generating	response	
surface	models.	Central	Composite	Design	 (CCD)	with	off-face	axial	points	 (a=1.1)	
and	three	centre	points	were	used	to	generate	quadratic	response	surface	models.	
Varying	glycerol	flow	rates	allowed	for	introducing	automated	variation	in	biomass	
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prior	 to	 culture	 induction	 without	 relying	 on	 offline	 data.	 Note	 that,	 the	 centre	
points	of	this	design	space	were	based	on	Invitrogen’s	protocol	for	P.	pastoris	MutS	
induction	(Invitrogen	Corporation,	2002).		
Models	 were	 generated	 using	 stepwise	 regression	 to	 maximise	 the	 number	 of	
model	terms	while	minimising	RMSE	values.		
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Figure	6.2	Experimental	overview.	Input:	(top	left)	Central	Composite	Design	for	QGY,	QMeOH,	and	T	after	40	hours	of	induction;	(top	right)	expansion	and	
centre	 points	 of	 CCD	 used	 to	 investigate	 response	 variance	 over	 time	 at	 0,	 8,	 24	 and	 40	 hours	 of	 induction.	 Outputs:	 Metabolic	 data	 including			
respiratory	 quotient,	 Carbon	 Dioxide	 Evolution	 Rate	 and	 biomass	 concentration;	 and	 specific	 expression	 of	 various	 fractions	 of	 tHBc.		
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6.3.4 Methodology	
Figure	 6.3	 describes	 the	 workflow	 used	 in	 this	 series	 of	 experiments.	 Step	 A	
described	the	inoculum	culture	required	to	generate	biomass	for	unit	operation	B,	
the	 fermentation	 unit	 operation.	 Variation	 of	 process	 parameters	 of	 this	 unit	
operation,	particularly	the	induction	phase,	will	be	the	focus	of	this	chapter.	Beyond	
step	B,	where	 the	workflow	diverges,	 the	 top	 row	 represents	unit	 the	operations	
involved	 in	 developing	 surface	 response	models;	 the	 bottom	 row	 represents	 the	
unit	 operations	 involved	 in	 developing	 time	 course	 profiles	 of	 each	 investigated	
response.	The	main	differences	between	the	top	and	bottom	processing	sequences	
are	 (1)	 the	 use	 of	 small	 sample	 volumes	 (40mL	 and	 1.8mL	 respectively),	 (2)	 the	
method	of	cell	disruption	(HPH	vs	 lyticase	treatment	followed	by	AFA)	and	(3)	the	
absence	of	a	size-exclusion	chromatography	step	in	the	bottom	sequence.	
		
Figure	 6.3	 Overview	 of	 methodology.	 (A)	 Shakeflask	 culture	 as	 described	 in	 2.3.2.	 (B)	
Fermentation	 process	 (2.3.3.1),	 varied	 as	 described	 by	 Figure	 6.2.	 (C)	 Centrifugation	
(2.4.1),	pellet	is	recovered.	(D1)	Homogenisation	at	3	passes	and	500	bar,	as	described	in	
2.4.3.	(D2)	Lyticase	incubation	as	described	in	2.4.6.	(D3)	AFA	as	described	in	2.4.5,	with	
Chromacol	tubes.	(E)	Centrifugation	(2.4.10),	supernatant	is	recovered.	(F)	0.45µm	dead-
end	 filtration.	 (G)	 0.22µm	 dead-end	 filtration.	 Sample	 1	 represents	 total	 expression	 of	
tHBc.	Sample	2	 represents	expression	of	soluble	 tHBc.	Sample	3	 represents	 the	 fraction	
containing	VLP-assembled	tHBc.	
Sample 1 
Sample 3 
Sample 1 
Sample 2 
A B
C D1 FE G
Sample 2 
C D2 ED3 G
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The	 latter	 is	because	the	sample	volume	did	not	permit	preparative	size-exclusion	
chromatography.	 Table	 10-13	 describes	 the	 design	 space	 used	 in	 the	 chapter	 to	
study	nine	responses.	The	models	for	these	responses	are	summarised	in	Table	6-1.	
Table	6-1	Models	and	goodness	of	fit	for	final	biomass	concentration	([X]),	Carbon	Dioxide	
Evolution	Rate	(CER),	Respiratory	Quotient	(RQ),	specific	total	expression	of	core	protein	
(Ytot.,	spec.),	 specific	 expression	of	 soluble	 core	protein	 (Ysol.,	spec.),	 specific	 expression	of	VLP-
sized	core	protein	(YVLP,	spec.),	volumetric	total	expression	of	core	protein	(Ytot.,	vol.),	volumetric	
expression	 of	 soluble	 core	 protein	 (Ysol.,	vol.)	 and	 volumetric	 expression	 of	 VLP-sized	 core	
protein	 (YVLP,	vol.).	 Goodness	 of	 fit	 is	 given	 on	 the	 left-hand	 side	 of	 the	 table	 (‘All	 terms’)	
using	r2	and	adjusted	r2	 for	models	 in	which	all	possible	 first-degree	and	second-degree	
polynomial	terms	have	been	considered.	Following	this,	are	the	formulae	describing	first-	
and	second-degree	polynomials	containing	a	reduced	number	model	terms	at	the	lowest	
model	RMSE.	Highlighted	in	bold	are	internal	functions.	
	 All	terms	
(Complex	model)	 	
Significant	terms	
(Simplified	model)	
	 R2	 R2	adj.	 Formulae	 R2	 R2	adj.	
[X]	(gWCW/L)	 0.871	 0.705	
! = 235 − 29.1*(,-./0 ∙ 2) −25.3*(2) − 23.3*(	25) +17.4	*(,-./0) + 11.4*(,9:)		 0.866	 0.786	
CER	
(mmoL/L/h)	 0.964	 0.917	
;<= = 46.8 + 20.8*(,-./0) −10.6*(,-./0 ∙ 2) − 8.08(2) −6.75*(	25) − 3.56*(,-./05) +3.00*(,9: ∙ 2)		 0.962	 0.940	
RQ	 0.796	 0.533	
=A = 0.554 + 0.0362*(,9:) +0.0300*(,-./05) + 0.0278*(2) +0.0242*(	25)	 − 0.0166*(,-./0)		 0.743	 0.626	
Ytot.,	spec.	
(µg/gWCW)	 0.596	 0.0771	
BCDC.,FGHI. 	= 4.17 − 1.36*(,9:5) −1.34*(,-./05)	 + 0.975*(2) +0.872*(,-./0))		 0.558	 0.411	
Ysol.,	spec.	
(µg/gWCW)	 0.590	 0.0632	
BFDJ.,FGHI. = 5.41	 − 2.02*(,-./05) −1.78*(,9:5) + 1.12*(,-./0) +1.05*(2)		 0.554	 0.405	
YVLP,	spec.	
(µg/gWCW)	 0.558	 -0.00945	
BKLM,FGHI. = 4.03 − 1.25*(,-./05) +1.08*(2) + 1.02*(,-./0) −0.922*(	25)		 0.476	 0.302	
Ytot.,	vol.	(µg/L)	 0.561	 -0.00307	
BCDC.,NDJ. = 980 − 304*(,9:5)	 +228*(,-./0) − 223*(,-./05) −167*(	25) + 137*(2)		 0.539	 0.329	
Ysol.,	vol.	(µg/L)	 0.5690	 0.0149	
BFDJ.,NDJ. = 1.35 ∙ 10O − 383*(,9:5) −344(	25) − 338(,-./05) +290*(,-./0)		 0.526	 0.370	
YVLP,	vol.	
(µg/gWCW)	 0.508	 0.0167	
BKLM,NDJ. = 1005 + 273* ,-./0 −359* 	25 + 153* 	2 −205* ,-./05 		 0.444	 0.259	*(,-./0) = ,-./0 − 32 	 * APQ = ,9: − 18.155 	 * 2 = 2 − 255 	
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6.4 Metabolic	responses	
Figure	6.6	shows	the	time	course	profiles	of	metabolic	responses:	biomass,	CER	and	
RQ.	Each	of	these	responses	is	discussed	individually	through	additional	analysis	of	
surface	response	methodology	in	subsequent	subsections.		
6.4.1 Effect	of	methanol	uptake	
To	 understand	 the	majority	 of	 the	metabolic	 responses,	 the	 uptake	 of	methanol	
must	 be	 understood.	 Figure	 6.4	 shows	 that	 there	 is	 an	 uptake	 limit	 of	 residual	
methanol	in	the	media	by	the	methylotrophic	culture	and	that	this	limit	occurs	at	an	
undefined	value	between	QMeOH=5.5mL/Li/h	and	QMeOH=8.0mL/Li/h.	The	 Invitrogen	
P.	 pastoris	 fermentation	 protocol	 recommends	 not	 to	 exceed	 a	 2%	 residual	
methanol	concentration	as	 this	will	 induce	toxicity	 (Invitrogen	Corporation,	2002).	
At	 the	 same	 time	 point	 that	 this	 residual	 concentration	 is	 reached,	 a	 decline	 in	
growth	rate	(Figure	6.5A),	a	reduction	in	CER	(Figure	6.5D)	and	an	increase	in	RQ	is	
observed	(Figure	6.5G).	
The	 methanol	 uptake	 rate	 also	 seems	 negatively	 affected	 by	 the	 induction	
temperature,	as	shown	in	Figure	6.4C.		
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Figure	 6.4	 Time	 course	 profiles	 of	 residual	 methanol	 concentrations:	 (A)	 Residual	
methanol	 concentrations	 at	 various	 methanol	 flow	 rates.	 Note	 that	 these	 flow	 rates,	
displayed	as	a	 line	are	shown	on	the	right	y-axis	and	the	residual	accumulation	by	area	
plot	on	the	left	axis.	(B)	Residual	methanol	concentrations	at	various	glycerol	flow	rates.	
(C)	Residual	methanol	concentrations	at	various	induction	temperatures.	
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6.4.2 Biomass	
Within	the	ranges	of	the	central	composite	design,	the	methanol	flow	rate	seems	to	
have	a	positive	effect	on	the	concentration	of	biomass	(Figure	6.6A&B).		
The	 effect	 of	 glycerol	 flow	 rate	 in	 the	 fed	 batch	 phase	 seems	 to	 have	 a	 slight	
positive	 effect	 on	 the	 biomass	 yield	 after	 40	 hours	 of	 induction	 (Figure	 6.6C&D),	
however,	 as	 indicated	 by	 the	 convergence	 of	 growth	 curves	 in	 Figure	 6.5B,	 as	
induction	time	is	increased	the	effect	of	initial	biomass	concentration,	and	thus	the	
effect	of	QGY,	diminishes.	
Temperature	 seems	 to	 have	 a	 negative	 effect	 on	 overall	 biomass	 concentrations	
(Figure	6.6E&F).	This	could	be	explained	by	the	fact	that	alcohol	oxidase	activity	is	
increased	 at	 higher	 temperatures	 (Couderc	 and	 Baratti,	 1980).	 This	 results	 in	 the	
formation	 of	 a	 toxic	 metabolite,	 formaldehyde,	 which	 in	 turn	 could	 lead	 to	 cell	
death.	Other	studies	have	indeed	shown	that	lower	induction	temperatures	lead	to	
a	decrease	in	stress	responses,	in	turn	leading	to	higher	biomass	concentrations	(M	
Dragosits	et	al.,	2009).	
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Figure	6.5	Time	course	profiles	of	metabolic	responses:	Biomass	(A-C),	Carbon	Dioxide	Evolution	Rate	(D-F)	and	Respiratory	Quotient	(G-I).			These	
responses	are	a	result	of	varying	the	following	factors:	Methanol	flow	rate	(A,	D,	G);	Glycerol	flow	rate	(B,	E,	H);	and	induction	temperature	(C,	F,	I).	
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Figure	 6.6	 Response	 Surface	 Model	 for	 biomass,	 [X].	 (A-B)	 Effect	 of	 QGY	 and	 T	 at	 (A)	
QMeOH=0.5mL/Li/h	 and	 (B)	 QMeOH=5.5mL/Li/h.	 (C-D)	 Effect	 of	 QMeOH	 and	 T	 at	 (C)	
QGY=11.9mL/Li/h	and	(D)	QGY=24.4mL/Li/h.	 (E-F)	Effect	of	QGY	and	QMeOH	at	 (E)	T=18.75°C	
and	(F)	T=31.25°C		
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6.4.3 The	impact	of	variables	on	the	CER	
Methanol	 feed	 rate	 has	 a	 positive	 effect	 on	 CER	 in	 the	 investigated	 design	 space	
(Figure	6.7A&B).	However,	as	with	biomass	when	the	range	of	methanol	feed	rate	
was	 extended	 to	 promote	 toxic	 conditions,	 a	 drop	 in	 carbon	 evolution	 rate	 was	
observed	 in	 later	 stages	 of	 induction	 (Figure	 6.5D).	 Indeed,	 the	quadratic	 term	 in	
formula	in	Table	6-1	indicates	that	there	is	an	optimum	methanol	flow	rate	outside	
the	investigated	range	beyond	the	higher	end	of	the	flow	rate	levels.	
Glycerol	 flow	 rate	 seems	 to	 have	 a	 negative	 effect	 on	 CER,	 interacting	 with	
induction	temperature.		
The	 induction	 temperature	 also	 has	 a	 negative	 effect	 on	 the	 CER,	 the	 lower	 the	
temperature,	 the	higher	 the	CER.	However,	 the	model	 indicates	 that	 temperature	
may	 have	 an	 optimum	 outside	 the	 investigated	 range.	 However,	 this	 value	 is	
beyond	the	 lower	end	of	 the	 investigated	temperature	settings	and	would	 impact	
on	product	expression.	
In	addition,	note	the	high	goodness	of	fit	of	the	model	in	Table	6-1	and	the	high	‘r2	
adjusted’	value,	indicating	that	the	model	has	high	predicative	capacity.	This	model	
is	therefore	useful,	not	just	for	the	production	of	recombinant	vaccines,	but	for	the	
performance	 prediction	 of	 any	 P.	 pastoris	 culture,	 assuming	 negligible	 effects	
introduced	by	 varying	 the	heterologous	protein	of	 interests	 (i.e.	 stress	 responses,	
nutrient	competition	and	protein	recycling).	
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Figure	6.7	Response	Surface	Model	for	Carbon	Dioxide	Evolution	Rate,	CER.	(A-B)	Effect	of	
QGY	and	T	at	(A)	QMeOH=0.5mL/Li/h	and	(B)	QMeOH=5.5mL/Li/h.	(C-D)	Effect	of	QMeOH	and	T	
at	 (C)	 QGY=11.9mL/Li/h	 and	 (D)	 QGY=24.4mL/Li/h.	 (E-F)	 Effect	 of	 QGY	 and	 QMeOH	 at	 (E)	
T=18.75°C	and	(F)	T=31.25°C		
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6.4.4 Respiratory	quotient	
The	 respiratory	 quotient	 is	 significantly	 influenced	 by	 methanol	 flow	 rates.	 As	
shown	 in	 Figure	 6.8A-C	 there	 seems	 to	 be	 a	 minimum	 RQ	 occurring	 around	
3.55mL/Li/h.	Note	that	the	toxic	effect	of	methanol	 introduced	through	the	1.45α	
expansion	point	has	not	been	incorporated	into	this	model,	but	is	shown	in	Figure	
6.5C.	 In	 this	 last	 graph,	 a	 slight	 increase	 in	 RQ	 is	 seen	 towards	 the	 end	 of	 the	
fermentation.	
Increases	in	the	glycerol	flow	rate	seem	to	cause	an	increase	in	the	RQ	in	Figure	6.8.	
However,	this	effect	is	not	very	noticeable	in	Figure	6.5.	Temperature	also	seems	to	
have	a	largely	positive	effect	on	the	value	of	RQ,	with	the	minimum	existing	around	
22.04°C.		
The	value	of	 the	RQ	can	be	explained	as	 follows.	When	methanol	 is	only	used	for	
maintenance	and	not	being	fixed	as	biomass:	
2"#$%# + 3%( → 4#(% +	2"%(	
Hence:	,- = 2 3 = 0.67	
This	principle	is	demonstrated	in	the	case	of	the	induction	at	QMeOH=0.5mL/Li/h	(see	
Figure	 6.5A	 &	 G),	 where	 no	 significant	 growth	 is	 observed	 and	 the	 RQ	 is	 indeed	
around	0.67.		
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However,	when	methanol	 is	being	 fixed	as	biomass,	as	 is	 the	case	during	growth,	
this	 value	 can	 become	 lower	 as	 shown	 by	 a	 simplified	 version	 of	 Equation	 10-4,	
where	 the	 assumption	 is	 made	 that	 carbon	 fixation	 via	 protein	 expression	 is	
negligible16:	
"#$%# + 3 ∙ %( + 5 ∙ 6#7%# → 8 ∙ "#9%:6; + < ∙ "%( + = ∙ #(%	
Hence,	when	8 > 0,	,- = < 3 < 0.67	
																																																						
16	This	 seems	 like	 a	 reasonable	 assumption	 as	 the	 maximum	 observed	 specific	 expression	 in	 this	
research	is	around	60µg/gDCW.	
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Figure	6.8	Response	Surface	Model	for	respiratory	quotient,	RQ.	(A-C)	Effect	of	QGY	and	T	
at	 (A)	 QMeOH=0.5mL/Li/h,	 (B)	 QMeOH=3.55mL/Li/h	 (response	 minimum)	 and	 (C)	
QMeOH=5.5mL/Li/h.	 (D-E)	 Effect	 of	 QMeOH	 and	 T	 at	 (D)	 QGY=11.9mL/Li/h	 and	 (E)	
QGY=24.4mL/Li/h.	(F-H)	Effect	of	QGY	and	QMeOH	at	(F)	T=18.75°C,	(G)	T=22.04°C	(response	
minimum)	and	(H)	T=31.25°C		
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6.5 Specific	expression	of	Tandem	Core	protein		
6.5.1 Specific	total	core	protein	
Figure	 6.9	 shows	 the	 response	 surface	 model	 for	 specific	 total	 core	 protein	
expression.	Optima	were	 established	 for	methanol	 flow	 rate	 (QMeOH=3.65mL/Li/h)	
and	glycerol	flow	rate	(QGY=18.15mL/Li/h)	and	a	positive	correlation	was	established	
between	 temperature	 and	 specific	 expression.	 The	 existence	 of	 an	 optimum	
methanol	flow	rate	for	this	response	can	explained	by	the	fact	that	methanol	acts	as	
a	 carbon	 source	 required	 for	 growth,	 yet	 is	 toxic	 at	 higher	 concentrations.	 The	
optimum	 glycerol	 feed	 rate	 in	 the	 fed	 batch	 phase	 is	 aliased	 to	 the	 optimum	
biomass	concentration	at	the	start	of	the	induction	phase.		
The	existence	of	 an	optimum	biomass	 concentration	at	 the	 start	of	 the	 induction	
phase	 has	 a	 similar	 explanation	 as	 the	 existence	 for	 an	 optimum	methanol	 flow	
rate:	 too	 low	 biomass	 concentration	 relative	 to	 residual	 methanol	 concentration	
could	result	in	cell	toxicity,	whereas	too	high	concentrations	of	biomass	relative	to	
residual	methanol	concentration	would	result	in	nutrient	competition	and	reduced	
specific	induction	stimulus.		
The	positive	correlation	of	temperature	to	expression	of	tHBc	could	be	explained	by	
the	previous	postulation,	made	 in	 section	6.4.2,	 that	higher	 temperatures	 lead	 to	
lower	 levels	 of	 biomass	 through	 alcohol	 oxidase	 hyperactivity.	 A	 decrease	 in	
biomass	 at	 the	 same	 volumetric	 induction	 stimulus	would	 lead	 to	 higher	 specific	
expression.		
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Figure	6.9	Response	Surface	Model	for	specific	total	core	protein	expression,	Ytotal,	spec	.	(A-
C)	 Effect	 of	 QGY	 and	 T	 at	 (A)	 QMeOH=0.5mL/Li/h,	 (B)	 QMeOH=3.65mL/Li/h	 (response	
maximum)	and	(C)	QMeOH=5.5mL/Li/h.	(D-E)	Effect	of	QMeOH	and	T	at	(D)	QGY=11.9mL/Li/h	
and	(E)	QGY=24.4mL/Li/h.	(F-G)	Effect	of	QGY	and	QMeOH	at	(F)	T=18.75°C,	(G)	T=31.25°C.	
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6.5.2 Specific	soluble	core	protein		
Specific	 soluble	 tHBc	 is	 relevant	as	 this	 is	 the	 state	of	Tandem	Core	material	 that	
can	either	be	immunogenic	unassembled	or	assemble	into	a	VLP.		
As	seen	in	Figure	6.10,	the	trends	observed	for	specific	soluble	tHBc	expression	are	
very	similar	to	that	for	specific	total	core	protein	expression.			
	
Figure	6.10	Response	Surface	Model	for	specific	soluble	core	protein	expression,	Ysol.,	spec.	
(A-C)	 Effect	 of	 QGY	 and	 T	 at	 (A)	 QMeOH=0.5mL/Li/h,	 (B)	 QMeOH=3.60mL/Li/h	 (response	
maximum)	and	(C)	QMeOH=5.5mL/Li/h.	(D-E)	Effect	of	QMeOH	and	T	at	(D)	QGY=11.90mL/Li/h	
and	QGY=24.40mL/Li/h;	and	(E)	QGY=18.15mL/Li/h	(response	maximum).	(F-G)	Effect	of	QGY	
and	QMeOH	at	(F)	T=18.75°C,	(G)	T=31.25°C.			
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6.5.3 Time	course	profiles	of	specific	expression	responses	
Figure	6.11	shows	time	course	profiles	of	total	and	soluble	expression	as	a	result	of	
variation	 of	 methanol	 flow	 rate,	 glycerol	 flow	 rate	 and	 induction	 temperature.	
Small-scale	sample	processing	and	analysis	was	performed	as	described	in	sections	
6.3.4,	2.5.10	and	2.5.11.	
Increasing	methanol	flow	rate	resulted	in	higher	expression	over	time	of	total	tHBc	
and	 increased	 amount	 of	 soluble	 tHBc	 expression.	 However,	 this	 correlation	 for	
soluble	tHBc	changed	beyond	QMeOH=5.5mL/Li/h.	At	QMeOH=8.0mL/Li/h,	virtually	no	
production	 of	 soluble	 protein	 was	 seen	 after	 24	 hours	 of	 induction,	 whilst	 total	
expression	was	the	highest	observed	at	this	time	point.	This	could	suggest	that,	at	
very	 high	 induction	 stimulus	 the	 resulting	 expression	 of	 tHBc	 is	 either	 incorrect,	
resulting	 in	 truncated	 heterologous	 protein,	 or	 is	 too	 high	 to	 permit	 assembly	 of	
soluble	multimeric	structures.	In	addition,	this	flow	rate	caused	observed	methanol	
toxicity	 at	 24	 hours	 after	 induction.	 This	 is	 indicated	 by	 a	 decreased	 growth	 rate	
(Figure	 6.5A),	 a	 decreased	 CER	 (Figure	 6.5D)	 and	 an	 increasing	 RQ	 (Figure	 6.5G)	
coinciding	with	a	residual	media	methanol	concentration	over	2%	vol.	(Figure	6.4A),	
which	 has	 been	 shown	 by	 previous	 work	 to	 be	 the	 limit	 toxicity	 threshold	
concentration	 of	 residual	 methanol	 (Invitrogen	 Corporation,	 2002).	 Methanol	
toxicity	could	have	triggered	various	stress	responses	including	the	up-regulation	of	
proteases,	which	would	 have	 resulted	 in	 truncation	 of	 tHBc,	 contributing	 to	 poor	
solubility	 or	 poor	 identification	 by	 dot	 blot,	 and	 poor	 assembly.	 In	 addition,	
methanol	 can	 weaken	 hydrophobic	 interactions	 between	 protein	 (Hwang	 et	 al.,	
	 																																																																																										Benjamin	A.F.	Bláha	2018	
	 220	
2011).	 This	 in	 turn	 can	affect	 the	assembly	of	 tHBc	 into	 soluble	material	 (such	as	
VLPs)	 as	 this	 action	 is	 based	 on	 hydrophobic	 interactions	 (Holmes	 et	 al.,	 2015;	
Peyret	et	al.,	2015).		
The	effect	of	glycerol	 flow	 rate	 in	 the	 fed	batch	phase,	 leading	 to	higher	biomass	
concentrations	 at	 the	 start	 of	 the	 induction	 phase,	 does	 not	 seems	 to	 have	 a	
significant	effect	on	the	solubility	of	expressed	tHBc	at	later	stages	of	induction.		
Temperature	 seemed	 to	 have	 a	 positive	 effect	 on	 the	 total	 specific	 expression	 of	
tHBc,	yet	a	negative	effect	on	soluble,	recoverable	heterologous	protein	expression.	
It	has	been	 reported	 that	 the	protein	 folding	 stress	 is	 increased	at	high	 induction	
temperatures	and	that	higher	titres	of	correctly	 folded	protein	are	often	achieved	
below	30°C	 (M	Dragosits	et	al.,	2009;	 Li	et	al.,	2011;	Anasontzis	et	al.,	2014).	The	
higher	 temperatures	 could	 have	 therefore	 led	 to	 increased	 misfolding	 and	
hydrophobicity	of	expressed	tHBc,	such	that,	either	during	the	induction	process	or	
during	 the	 cell	 disruption	 process,	 expressed	 Tandem	 Core	 material	 associated	
more	 readily	 with	 host	 cell	 protein	 or	 cell	 debris.	 This	 would	 have	 led	 to	 the	
formation	of	aggregates	entrapping	core-positive	material,	hindering	recovery.	
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Figure	6.11	(A	and	B)	Expression	at	various	methanol	flow	rates	of	total	and	soluble	tHBc	
respectively.	(C	and	D)	Expression	at	various	glycerol	flow	rates	of	total	and	soluble	tHBc	
respectively.	(E	and	F)	Expression	at	various	induction	temperatures	of	total	and	soluble	
tHBc	respectively
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6.5.4 Specific	VLP-core	protein	material	analysis	
Material	from	the	clarified	supernatant	was	passed	through	a	SEC	column	in	order	
to	identify	material	that	is	of	the	correct	size	range	for	the	VLP.	As	shown	in	Figure	
6.12,	 there	 are	 a	 number	 of	 differences	 between	 specific	 expression	 of	 VLP	 and	
soluble	and/or	total	specific	tHBc	expression.	Firstly,	for	VLP-fitting	tHBc	there	is	no	
apparent	 effect	 for	 the	 glycerol	 feed	 rate.	 Secondly,	 the	 induction	 temperature	
seems	 to	 have	 a	 significantly	 higher	 effect	 of	 specific	 VLP	 expression	 and	 also	
demonstrates	an	optimum	value.	Note	that	similar	trends	have	been	observed	for	
volumetric	expression	of	VLP	protein	(Figure	10.14).	
	
Figure	 6.12	 Response	 Surface	 Model	 for	 specific	 VLP	 core	 protein	 expression,	 YVLP,	 sol.	
Effect	of	QMeOH	and	T.	Effect	of	QGY	was	found	to	be	negligible	
To	understand	VLP	assembly	a	correlation	between	soluble	tHBc	and	the	proportion	
of	soluble	tHBc	assembled	into	VLP-size	is	shown	in	Figure	6.13.		
When	 looking	 at	 this	 figure,	 it	 appears	 that	 the	 higher	 the	 expression	 of	 soluble	
tHBc	 is,	 the	 lower	 the	 proportion	 of	 assembled	 VLPs	 to	 soluble	 tHBc	 is.	 Just	 like	
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several	 findings	 in	 chapter	 3,	 supporting	 this	 data	 is	 the	 finding	 that	 VLP	 self-
assembly	requires	regulation,	as	relatively	high	and	uncontrolled	expression	of	free	
units	of	 tHBc	can	 result	 in	kinetic	 traps	and	 thus	 incomplete	 formation	of	 capsids	
(Zlotnick	 and	Mukhopadhyay,	 2011).	 Note	 that	 some	 degree	 of	 caution	must	 be	
taken	when	 interpreting	 the	 data	 in	 Figure	 6.13.	 This	 is	 because	 a	 VLP-to-soluble	
tHBc	ratio	above	1	is	unrealistic.	The	reason	the	existence	of	ratios	higher	than	1,	is	
most	 likely	 due	 to	 a	 non-specific	 binding	 effect	 of	 HCPs	 during	 immunoblotting	
detection.	 Hence,	 there	 would	 be	 less	 non-specific	 binding	 in	 relatively	 pure	
samples	 (i.e.	 SEC-derived	 sampled)	 resulting	 in	 higher	 levels	 of	 detection	 in	 an	
immunoassay.		
	
Figure	 6.13	 Correlation	 between	 specific	 soluble	 expression	 of	 tHBc	 (x-axis)	 and	 the	
relative	proportion	of	soluble	tHBc	assembled	into	VLP-sized	particles	(y-axis).	Each	point	
in	represents	harvested	material	of	the	17	fermentation	runs	discussed	in	this	chapter.		
	
	 																																																																																										Benjamin	A.F.	Bláha	2018	
	 224	
Overall,	 it	 seems	 that	 there	 is	 a	 very	 small	window	within	which	 soluble	 Tandem	
Core	 protein	 successfully	 assembles	 into	 VLPs	 per	 unit	 of	 biomass.	 One	 way	 to	
address	 this	 limitation	 would	 be	 minimise	 specific	 expression	 of	 tHBc	 while	
maximising	the	concentration	of	biomass.	Lowering	the	induction	temperature	and	
methanol	flow	rate	has	been	shown	to	achieve	this	effect.	However,	such	a	strategy	
would	drastically	 increase	downstream	processing	load	as	relatively	more	material	
would	have	to	be	removed	to	purify	VLPs.		
6.6 Response-specific	optima		
As	seen	in	previous	sections,	different	optimum	settings	are	appropriate	depending	
on	the	response	studied.	These	optima	are	summarised	in	Figure	6.14.	
Looking	at	Figure	6.14A,	when	 trying	 to	maximise	biomass	and	metabolic	activity,	
indicated	 by	 [X]	 and	 CER	 respectively,	 higher	methanol	 flow	 rates	 are	 preferable	
(QMeOH=5.5mL/Li/h).	However,	when	aiming	to	maximise	specific	expression	of	tHBc,	
regardless	of	its	state,	a	slightly	lower	flow	rate	is	required	(QMeOH~3.5mL/Li/h).	This	
setting	 is	 slightly	higher	when	aiming	 to	maximise	volumetric	expression	 since,	as	
mentioned	previously,	this	output	is	also	a	function	of	biomass.	
	Figure	 6.14B	 shows	 the	 different	 glycerol	 flow	 rate	 setting	 required	 to	 achieve	
different	optima.	Unsurprisingly,	 to	maximise	biomass	at	 the	end	of	 the	 induction	
phase	 the	 biomass	 at	 the	 start	 of	 the	 induction	 phase	 has	 to	 be	 maximised,	 as	
indicated	 by	 the	 highest	 possible	 feed	 setting	 within	 the	 range	 investigated.	 The	
opposite	is	seen	when	aiming	to	maximise	the	carbon	evolution	rate	and	minimising	
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the	respiratory	quotient.	Glycerol	flow	rate	optima	were	found	to	be	at	the	design	
midpoints	 for	 all	 expression	 responses,	 except	 for	 VLP-fitting	 tHBc.	 In	 the	 latter	
case,	the	glycerol	flow	rate	was	not	found	to	have	a	significant	effect.		
Figure	 6.14C	 shows	 that	 to	 maximise	 biomass	 and	 metabolic	 activity,	 lower	
temperatures	 are	 preferable.	 For	 the	 lowest	 possible	 respiratory	 quotient,	 an	
optimum	 operating	 temperature	 of	 22°C	 was	 established.	 Interestingly,	 the	
maximum	 investigated	 temperature	was	 found	 to	 be	 the	 optimum	 for	 both	 total	
and	soluble	specific	expression	of	tHBc.	However,	for	maximum	specific	expression	
of	VLPs,	 a	 significantly	 lower	 temperature	was	 required.	 This	 again	 suggests,	 that	
for	 the	 production	 of	 VLPs,	 more	 control	 is	 required	 than	 simply	 upregulating	
expression	of	heterologous	protein.	
There	 are	 therefore	 trade-offs	 to	 be	 made	 when	 determining	 the	 fermentation	
protocol	 for	 the	 production	 of	 Tandem	 Core	 VLPs	 in	 P.	 pastoris.	 Lower	
temperatures	 seem	more	 favourable	 for	 increasing	 the	 concentration	of	biomass.	
This,	 however,	 lowers	 specific	 expression	 but,	 in	 turn,	 seems	 to	 promote	 the	
specific	 expression	 of	 soluble	 Tandem	 Core	 material.	 On	 the	 other	 hand,	 high	
specific	 expression	of	 Tandem	Core	protein,	 regardless	 of	 its	 state,	 is	 achieved	 at	
higher	 induction	 temperatures.	 A	 downside	 of	 this	 approach	 is	 a	 decrease	 in	
biomass	 and	 product	 solubility.	 For	 the	 purpose	 of	 this	 work,	 the	 aim	 was	 to	
maximise	 the	 volumetric	 production	 of	 VLPs.	 Optimum	 settings	 for	 this	 were	 an	
induction	temperature	of	around	25°C	and	a	methanol	feed	rate	above	4.5	mL/Li/h.	
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Figure	6.14	Summary	of	response	optima	for	(A)	methanol	flow	rate	settings,	(B)	glycerol	
flow	 rate	 settings	 and	 (C)	 induction	 temperature	 settings.	 The	 symbols	@ 	and	 –@	
represent	 the	 centre	 face	 expansion	 coordinates	 of	 the	 design	 space,	 whereas	 0	
represents	the	midpoint	coordinates.		
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6.7 Summary		
Through	time	course	analysis	and	response	surface	methodology	the	production	of	
the	 k1,k1	 construct	 in	 P.	 pastoris	 	 has	 been	 characterised.	 This	 characterisation	
yielded	several	key	findings.	
Metabolic	 responses,	 [X],	 CER	 and	 RQ,	 required	 significantly	 different	 optimum	
operating	conditions	than	specific	expression	responses	and	volumetric	responses.	
Assuming	 these	 models	 are	 not	 highly	 specific	 to	 the	 protein	 of	 interest	 being	
expressed,	 such	 data	 could	 translate	 to	many	 processes	 employing	P.	 pastoris	 to	
produce	heterologous	protein	in	general.	
Methanol	toxicity	was	studied	and	it	was	found	that	induction	feed	rates	can	be	set	
significantly	 higher	 than	 recommended	 by	 industry	 standard	 protocols	 for	 these	
constructs.	
Analysis	of	specific	expression	responses	showed	that	models	for	expression	of	total	
and	 crude	 tHBc	 were	 very	 much	 alike.	 However,	 the	 model	 for	 specific	 VLP-
assembled	 tHBc	 was	 very	 different.	 This	 indicated	 that	 maximising	 expression	 of	
tHBc	was	 not	 synonymous	 to	maximising	 the	 production	 of	 VLPs.	 It	 was,	 in	 fact,	
shown	that	a	relatively	narrow	window	for	specific	tHBc	expression	exists	in	which	a	
significant	part	of	Tandem	Core	units	assembles	into	Virus-Like	Particles.	There	are	
several	 suggested	 theories	 as	 to	 why	 tHBc	 expression	 and	 VLP	 assembly	 are	 not	
directly	proportional.	These	are:		
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1. Higher	 expression	 rates	 could	 result	 in	 kinetic	 traps,	 resulting	 in	
unassembled	intermediate	material.	
2. Expressed	 material	 is	 expressed	 disproportionately	 high	 to	 chaperone	
proteins,	 resulting	 in	 expression	 of	misfolded	 and	 truncated	 Tandem	Core	
units,	which	are	either	insoluble	or	incapable	of	assembling	into	a	VLP.	
3. Stress	responses	due	to	accumulation	of	heterologous	protein	as	a	result	of	
internalisation.	
4. Stress	responses	due	to	starvation	or	intoxication	of	culture.	
Finally,	 volumetric	 production	 of	 VLPs	 was	 studied.	 This	 response	 was	 the	 most	
relevant	response	for	applied	vaccine	production	and	was	used	a	base	for	process	
scale-up.	This	will	be	covered	in	the	next	chapter.		
6.8 Discussion	
Aside	from	the	metabolic	responses,	it	should	be	stressed	that,	due	to	low	r2	values,	
some	of	 the	models	displayed	 in	 this	 chapter	cannot	 serve	 in	a	predictive	 fashion	
but,	rather	indicate	several	principle	differences	discussed	previously,	including	the	
difference	between	tHBc	expression	and	VLP	assembly.		
The	noise	of	expression	models	could	be	significantly	reduced	by:	
1. Using	more	sensitive	assays.	
2. Including	sample	process	automation	to	rule	out	manual	errors	
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3. Run	all	fermentation	processes	parallel	instead	of	in	campaign	mode.	Doing	
so	would	rule	out	any	issues	related	to	storage	and	age	of	pellets			
In	addition,	future	work	should	address	the	following	points:	
1. Harvest	time	should	be	included	in	all	the	response	models.		
2. Rates	of	tHBc	expression	and	VLP	assembly	could	provide	more	meaningful	
insight	to	the	assembly	process	than	concentrations	at	fixed	time	points.	
3. Response	surface	methodology	for	residual	methanol	should	be	included	to	
identify	 factor	 interactions	 affecting	 substrate	 consumption	 and	 induction	
stimuli.	
4. RNA	 measurements	 would	 provide	 a	 better	 measure	 of	 heterologous	
protein	expression	than	measuring	tHBc	concentrations	in	crude	lysate.	
However,	in	summary,	this	approach	has	increased	our	understanding	of	the	design	
space	 for	 VLP	 production	 in	 P.	 pastoris,	 and	 permits	 for	 fine	 tuning	 of	 the	
fermentation	depending	on	the	desired	optimum	response.		
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Chapter	7 Scale-up	and	application	of	Tandem	Core	technology	to	
universal	influenza	vaccine	candidates		
7.1 Introduction	
Thus	far,	this	work	has	characterised	the	production	of	Tandem	Core	VLPs	using	the	
k1,	 k1	 VLP	 construct;	 and	 at	 small-scale,	 using	 the	 ambr®250	modular	 bioreactor	
system.		
For	this	research	to	attain	practical	and	 industrial	relevance,	 in	particular	with	the	
aim	of	creating	a	universal	influenza	vaccine,	these	findings	need	to	be	translated	to	
VLP	production	(1)	with	Tandem	Core	VLPs	presenting	influenza	epitopes	and	(2)	at	
larger	scales.		
7.2 Aims	and	objectives	
This	 chapter	 aims	 to	 investigate	 how	 the	 previous	 findings	 translate	 to	 applied	
industrial	scenarios.	Thus,	the	following	objectives	were	set:	
• Investigate	effects	of	varying	inserts:	This	chapter	will	investigate	the	effects	
on	 fermentation	 processes	 and	 product	 yields	 as	 a	 result	 of	 changing	
epitopes	on	the	Tandem	Core	VLP	exterior.	
• Investigate	 effects	 of	 scale-up:	 To	 attain	 industrial	 relevance	 it	 must	 be	
demonstrated	that	the	established	processes	can	be	scaled-up.	
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• Investigate	 the	 effects	 of	 alternative	 feeding	 strategies	 on	 yield	 and	
scalability.		
7.3 Variation	of	inserts	with	universal	influenza	epitopes	
The	 k1,	 k1	 VLP	 constructs	 utilises	 lysine	 residues	 in	 the	 major	 insertion	 regions	
(MIR)	of	the	Tandem	Core	sub-unit.	However,	this	work	seeks	to	replace	the	lysine	
residues	 with	 small	 conserved	 regions	 of	 influenza	 that	 might	 be	 useful	 in	 a	
universal	vaccine.	Thus	far,	the	effect	of	changing	the	insert	on	VLP	production	and	
assembly	has	yet	to	be	characterised	and	therefore,	this	section	aims	to	scope	the	
effects	 of	 changing	 inserts	 on	 the	 Tandem	 Core	 scaffold	 on	 upstream	 process	
requirements.	This	was	done	by	inducing	various	transformants	of	P.	pastoris	MutS	
expressing	 different	 Tandem	Core	 constructs	 at	 identical	 fermentation	 conditions	
and	subsequently,	studying	metabolic	responses	and	product	titers.		
7.3.1.1 Pure	methanol	 induction	 yields	 lower	 observable	 titres	 for	more	 complex	
inserts	
Several	 constructs	 were	 created	 to	 monitor	 the	 effect	 on	 upstream	 processing.	
These	constructs	are	summarised	below.	
• k1,	 k1:	 As	 mentioned	 earlier,	 this	 represents	 the	 most	 simplified	 VLP	
construct,	 containing	 only	 single	 lysine	 inserts	 in	 the	MIRs.	 This	 construct	
has	also	been	investigated	in	the	previous	chapter.	
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• LAH3,	k1:	This	construct	consists	of	a	lysine	insert	in	one	of	the	MIRs	on	the	
scaffold	and	a	variant	of	Lower	Alpha	Helix	(LAH)	of	the	hemagglutinin	stalk.	
Previous	 research	 has	 shown	 that	 this	 epitope	 provides	 the	 desired	
immunogenic	 response	 and	 can	 be	 placed	 onto	 a	 hepatitis	 B	 core	 VLP	
scaffold	(Krammer	and	Palese,	2013;	Chen	et	al.,	2015).		
• HA2.3,	 (M2e)3:	 This	 construct	 displays	 two	 different	 influenza-specific	
epitopes.	 The	 first	 epitope	 is	 HA2.3,	which	 comprises	 the	 long-alpha	 helix	
structural	domain,	plus	an	extended	amino	acid	sequence	(Barbey-Martin	et	
al.,	 2002).	 (M2e)3	 represents	 a	 triplet	 sequence	 of	 an	 evolutionarily	
conserved	 region	 ectodomain	 of	 the	 M2	 channel	 in	 influenza	 viruses.	
Previous	 studies	 have	 shown	 induced	M2e-specific	 CD4	 T	 immunity	 when	
M2e	was	presented	on	a	VLP	(Deng	et	al.,	2015).	This	section	will	investigate	
two	Pichia	transformants:	one	with	a	relative	high	copy	number	(‘HC’);	and	
one	with	a	relatively	low	copy	number	(‘LC’)17.	
• LAH3,	 (M2e)3:	 This	 construct	 displays	 the	 previously	 discussed	 epitopes	
(M2e)3	and	LAH3.		
Using	 a	 pure	 methanol	 induction	 protocol	 (section	 2.3.3.1),	 at	 30°C,	 QMeOH=5.0	
mL/Li/h	 and	 QGY=13.15	 mL/Li/h,	 no	 significant	 differences	 in	 final	 biomass	 at	 40	
hours	 induction	 were	 observed	 between	 transformants	 (Figure	 7.2).	 Minor	
differences	between	CER	and	RQ	were	observed	Figure	7.1.	These	variances	could	
relate	to	the	differences	in	product	stability,	meaning	less	stable	products	could	be	
																																																						
17	These	 copy	numbers	were	determined	qualitatively	 and	were	based	on	differences	 in	 antibiotic	
resistance	provided	by	the	vectors	used	for	transformation	(data	not	shown).		
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recycled	 as	 a	 carbon	 source,	 or	 differences	 in	 the	 copy	 numbers	 of	 heterologous	
genes	 of	 these	 transformants,	 as	 demonstrated	 by	 two	 transformants	 containing	
the	same	HA2.3,	 (M2e)3	construct	with	different	copy	numbers	 in	Figure	7.1	(light	
blue	vs	dark	blue).	However,	substantial	differences	between	specific	expression	of	
VLPs	were	observed	in	Figure	7.2.	It	was	found	that	transformants	expressing	single	
and	 relatively	 smaller	 inserts	 (k1,	 k1	 and	 LAH,	 k1)	 had	 the	 highest	 specific	 yields.	
However,	 it	 should	 be	 noted	 that	 the	 chosen	 induction	 method	 was	 based	 on	
maximising	total	specific	tHBc	expression,	rather	than	maximising	total	specific	VLP	
production	as	the	assembly	kinetics	for	each	novel	VLP	was	unknown.		
Therefore,	 it	 was	 postulated	 that	 assembly	 of	 Tandem	 Core	 protein	 with	 larger	
inserts	would	be	more	challenging	at	relatively	high	total	expression	rates	than	for	
Tandem	Core	protein	with	relatively	small	inserts.		
	
Figure	 7.1	 Representative	 metabolic	 anlaysis	 of	 different	 VLP	 constructs:	 (A)	 Carbon	
Dioxide	Evolution	Rates	and	(B)	Respiratory	Quotients.		
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Figure	7.2	Quantitative	analysis	of	harvested	material	of	different	VLP	constructs:	 (Left)	
Biomass	 after	 40	 hours	 of	 pure	methanol	 induction.	 (Right)	 Specific	 yields	 of	 different	
constructs.	
This	explains	why	the	LAH3,	k1	construct,	containing	an	influenza	epitope,	was	able	
to	assemble	 into	VLPs	at	comparable	titres	to	the	k1,	k1	construct	using	the	same	
induction	 conditions.	 Nonetheless,	 the	 aim	 of	 this	 research	 was	 to	 develop	 an	
influenza	 vaccine	 offering	 the	 broadest	 possible	 cross-protectiveness	 against	
influenza	variants.	Therefore,	to	maximise	the	potential	of	Tandem	Core	technology	
it	 was	 preferable	 to	 employ	 two	 inserts	 simultaneously,	 ideally	 using	 the	 HA2.3,	
(M2e)3	construct.	However,	as	shown	by	the	data	above	this	was	not	possible	using	
a	pure	feeding	strategy	at	these	induction	settings.		
7.3.1.2 Mixed	feeding	induction	provides	better	yields	for	more	complex	inserts		
In	 an	 attempt	 to	 lower	 the	 specific	 expression	 of	 tHBc	 protein	 to	 facilitate	 the	
assembly	of	more	complex	Tandem	Core	units,	a	mixed	feeding	induction	protocol	
was	 implemented	 in	which	glycerol	was	 introduced	simultaneously	with	methanol	
during	 the	 induction	 phase.	 The	mixed	 feeding	 induction	 protocol	 is	 described	 in	
section	2.3.3.2.	The	aim	of	this	strategy	was	(1)	to	create	a	carbon	rich	environment	
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such	 that	 cellular	 stress	 factors	 were	 not	 induced;	 and	 (2)	 to	 lower	 the	 specific	
expression	of	tHBc	through	partial	repression	of	AOX	genes	and	increased	levels	of	
biomass	generation	(Hartner	and	Glieder,	2006).		
The	HA2.3,(M2e)3	 (HC)	 construct	was	used	 for	 this	 study,	 as	 it	provided	 the	most	
complex	version	of	insert	combination	available	and	would,	therefore,	according	to	
the	 previously	 stated	 hypothesis,	 prove	 to	 be	 the	 most	 challenging	 version	 of	
Tandem	Core	protein	to	assemble	into	a	VLP.		
The	data	generated	from	this	mixed	feeding	approach	was	compared	to	harvested	
material	 derived	 from	 pure	 methanol	 induced	 fermentation	 for	 the	 low-copy	
HA2.3,(M2e)3	construct.		
As	 shown	 in	 Figure	 7.3A,	 a	 mixed	 feeding	 strategy	 resulted	 in	 higher	 metabolic	
activity	 as	 a	 result	 of	 higher	 biomass	 generation.	 As	 reported	 by	 several	 sources,	
this	can	be	explained	by	the	 fact	 that	 the	maximum	specific	growth	rate	 is	higher	
when	glycerol	is	used	as	a	carbon	source	than	when	methanol	is	used	as	a	carbon	
source	 (Orman,	Çelık	and	Ozdamar,	2009;	Looser	et	al.,	2014).	The	utilisation	of	a	
different	 carbon	 source	 is	 confirmed	 through	 analysis	 of	 the	 RQ	 shown	 in	 Figure	
7.3B,	which	 shows	 consistently	 higher	 values	 throughout	 the	 induction	 phase	 for	
mixed	feed	induction	than	the	pure	methanol	induction	cultures.	This,	 in	turn,	can	
be	explained	by	the	fact	that	the	RQ	for	glycerol	consumption	(RQGY=0.86)	is	higher	
than	for	the	consumption	of	methanol	(RQMeOH=0.67).		
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Figure	7.3		Metabolic	analysis	of	HA2.3,	(M2e)3	constructs	with	different	copy	numbers	at	
different	 induction	 modes.	 (A)	 Carbon	 Dioxide	 Evolution	 Rates.	 Event	 A	 shows	 the	
approximate	 time	of	 	 the	glycerol	 fed-batch	phase	 for	pure	methanol	 feeding	 induction	
processes	 and	 the	 start	 of	 innduction	 for	 the	mixed	 feeding	 induction	process.	 Event	B	
shows	the	time	for	the	start	of	induction	for	the	pure	feeding	processes.	(B)	Respiratory	
Quotients.	 The	 orange	 curves	 denote	 the	 responses	 of	 the	 mixed	 feeding	 induction	
process,	whereas	 the	 blue	 curves	 denote	 the	 responses	 for	 the	 pure	 feeding	 induction	
processes	at	high	copy	numbers	(dark	blue)	and	low	copy	numbers	(light	blue).		
Time	 course	 analysis	 of	 VLP-sized	HA2.3,	 (M2e)3	 expression,	 shown	 in	 Figure	 7.4,	
restated	the	earlier	conclusion	(Figure	7.2),	that	low	titers	are	observed	when	using	
the	pure	methanol-based	induction	method	described	above.	 In	fact,	 it	was	found	
that	beyond	24	hours,	a	loss	of	specific	productivity	occurred.	Furthermore,	Figure	
10.15	shows	how	the	same	pure	methanol-based	induction	method	was	applied	for	
the,	 simpler,	 k1,k1	 VLP	 construct,	 yielding	 significantly	 different	 results.	 This	
suggests	that	VLP	expression	and	assembly	is	highly	dependent	on	the	construct.	
On	the	other	hand,	when	comparing	the	titres	from	a	mixed	feed	induction	to	pure	
methanol	 induction	of	 the	 same	VLP	 construct	 (HA2.3,	 (M2e)3),	 specific	 titres	 are	
significantly	 higher	 throughout	 the	 entire	 induction	 phase.	 This	 implies	 the	
induction	process	has	to	be	optimised	for	each	individual	VLP-construct.		
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Figure	 7.4	 Size	 Exclusion	 Chromatography	 (2.4.11)	 fractions	 of	 bead-lysed	 (2.4.9)	
HA2.3(M2e)3	 construct	 ( ± 65kDa)	 using	 pure	 methanol	 induction.	 Two-minute	
chromatography	fractions	were	collected	after	10	minutes	for	an	additional	20	minutes.	
(A-D)	 Coomassie	 stains	 of	 reduced	 gels.	 (E-H)	 Western	 blots	 (1-minute	 exposure).	
Fermentation	samples	were	collected	at	0	hours	(A	&	E),	8	hours	(B	&	F),	24	hours	(C	&	G)	
and	40	hours	(D	&	H)	of	induction.	SEC	and	Western	blotting	procedures	were	performed	
by	iQur	Ltd.	
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Figure	 7.5	 Size	 Exclusion	 Chromatography	 (2.4.11)	 fractions	 of	 bead-lysed	 (2.4.9)	
HA2.3(M2e)3	 construct	 (±65kDa)	 using	 glycerol	 mixed	 feed	 induction.	 Two-minute	
chromatography	fractions	were	collected	after	10	minutes	for	an	additional	20	minutes.		
(A-D)	 Coomassie	 stains	 of	 reduced	 gels.	 (E-H)	 Western	 Blots	 (1-minute	 exposure).	
Fermentation	samples	were	collected	after	1.5	hours	(A	&	E),	9	hours	(B	&	F),	31	hours	(C	
&	 G)	 and	 48	 hours	 (D	 &	 H)	 of	 induction.	 SEC	 and	 Western	 blotting	 procedures	 were	
performed	by	iQur	Ltd.	
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7.4 Effects	of	scale-up	
So	 far,	 this	 chapter	 has	 investigated	 two	 categories	 of	 induction	 modes	 at	
miniaturised	 scales	 of	 fermentation:	 pure	 methanol-based	 induction	 and	
glycerol/methanol	mixed	feed	induction.	This	section	will	compare	the	scalability	of	
each	 of	 these	 induction	 modes.	 The	 processes	 were	 scaled	 120-fold:	 from	
miniaturised	bioreactor	scale	(VT=250mL)	to	pilot	plant	scale	(VT=30L).	
Process	scale-up	was	performed	using	constant	power	per	volume	input	at	constant	
relative	 gas	 flow	 rates.	 The	 power	 input	 is	 calculated	 as	 follows	 (Junker,	 2004;	
Schmidt,	2005):	
B = BCDEFGH	Equation	7-1	
Where:	
• I	is	the	gassed	power	input	(W)	
• IJ	is	the	non-gassed	power	input	(W)	
• K	is	the	fermentation	broth	density	(kg/m3)		
• 6	is	the	impeller	agitation	speed	(rpm)	
• L	is	the	impeller	diameter	(m3)	
Maintaining	 constant	 power	 per	 volume	 input	 is	 achieved	 through	 the	 following	
correlation:	
BMNM = BONO		 Equation	7-2	
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Where	the	numbered	subscripts	are	associated	with	different	vessels.		
For	simplicity,	geometric	similarity	was	assumed.	Hence,	 impeller	agitation	speeds	
at	large-scale	were	determined	though	maintaining	constant	6$L(.	
7.4.1 Challenging	scale-up	of	pure	methanol	cultures	
A	 high-yield	 process	 for	 VLP	 production	 of	 k1,	 k1-VLPs	 was	 established	 in	 the	
previous	 chapter	 and	 was	 chosen	 as	 the	 fermentation	 process	 to	 scale-up	 to	
investigate	pure	methanol	 induction	 scalability.	 The	 induction	parameters	 for	 this	
scaled-down	process	were:	T=25°C,	QGY=13.15mL/Li/h	and	QMeOH=5.0mL/Li/h.		
Figure	 7.6A	 shows	 the	 near-identical	 off-gas	 carbon	 dioxide	 profiles	 during	 the	
batch	phase	and	induction	phase.	However,	during	the	glycerol	fed-batch	phase	the	
observed	carbon	dioxide	concentration	in	the	exhaust	gas	was	significantly	higher	at	
large-scale	than	at	small-scale.	An	explanation	for	this	is	the	fact	that	two	different	
gas	 blending	 modes	 were	 used	 for	 the	 two	 scales.	 The	 addition	 of	 pure	 oxygen	
through	gas	blending	typically	comes	into	play	during	the	glycerol	fed-batch	phase	
to	maintain	the	increasing	oxygen	uptake	rate	of	the	culture.	At	small-scale,	oxygen	
blending	was	performed	through	addition	of	oxygen	through	varying	the	total	gas	
flow	rate,	whereas	at	large-scale,	this	mode	of	blending	was	not	available.	Instead,	
at	 large-scale,	 oxygen	 was	 blended	 while	 maintaining	 a	 constant	 gas	 flow	 rate.	
Because	the	gas	flow	rate	was	increased	at	small-scale,	a	lower	gas	concentration	of	
carbon	dioxide	was	observed.	However,	aside	from	different	off-gas	carbon	dioxide	
profiles,	 the	 difference	 in	 gas	 blending	 modes	 also	 seems	 to	 have	 resulted	 in	
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different	biomass	concentration	through	the	induction	period.	One	possible	reason	
for	 this	 is	 that	 the	 smaller	 scale	 bioreactors	 have	 reduced	mass	 transfer	 capacity	
due	to	surface	tension	effects.	
Figure	 7.6C	 shows	 specific	 total	 and	 soluble	 tHBc	 yields	 over	 time.	 The	
corresponding	fermentation	samples	were	processed	using	the	lyticase-augmented	
AFA	method	(sections	2.4.6	and	2.4.5)	followed	by	dot	blot	analysis	(sections	2.5.10	
and	2.5.11).	For	the	first	24	hours	of	induction,	total	specific	expression	seems	to	be	
highly	similar	between	the	two	scales	however,	beyond	this	time,	a	drop	in	specific	
expression	 is	seen	at	the	 larger	scale.	This	could	be	explained	by	the	fact	that	the	
larger	 scale	 fermentation	 attained	 higher	 biomass	 concentrations,	 hence	 more	
resources	would	have	had	to	have	been	allocated	to	cell	maintenance,	rather	than	
heterologous	protein	expression	and	this	high	biomass	concentration	would	result	
in	a	lower	specific	expression,	as	one	term	is	divided	by	the	other.	
Finally,	 volumetric	 productivity	 profiles	 were	 established	 (Figure	 7.6D)	 and	 were	
found	 to	 follow	 similar	 trends	 to	 specific	 productivity	 profiles.
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Figure	7.6	Fermentation	data	of	process	scale-up	of	P.	pastoris		expressing	tHBc-k1,k1	using	pure	methanol-based	heterologous	protein	induction.	(A)	
Carbon	dioxide	concentrations	measured	in	off-gas.	(B)	wet	cell	weight	biomass	concentrations.	(C)	Total	specific	expression	of	tHBc.	(D)	Total	volumetric	
expression	of	tHBc.	
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7.4.2 Investigating	scalability	of	mixed	feeding	induction		
The	 previous	 section	 discussed	 the	 challenges	 observed	 when	 scaling	 up	 a	 pure	
methanol-based	induction	process.	It	was	hypothesised	that	these	differences	arose	
during	 the	 glycerol	 fed-batch	 phase,	 where	 gas	 blending	 is	 most	 critical.	 On	 the	
other	hand,	a	mixed	feeding	protocol	omits	this	fed-batch	phase	and,	therefore,	did	
not	require	significant	levels	of	pure	oxygen	gas	blending.		
It	 was	 hypothesised	 that	 scaling	 up	 the	 mixed	 feed	 induction	 process	 (section	
7.3.1.2)	would	yield	higher	process	similarity	at	large-scale	than	scaling	up	the	pure	
methanol	based	induction	process	(section	7.4.1).		
Figure	 7.7	 shows	 high	 similarities	 between	 both	 investigated	 scales	 in	 off-gas	
carbon	dioxide	profiles	and	biomass	concentration	profiles.	Slightly	lower	values	for	
both	responses	are	observed	at	large-scale	as	the	induction	phase	progresses.	This	
could	be	explained	by	a	slightly	longer	lag	phase	at	the	30L	scale,	possibly	caused	by	
differences	in	inoculum	culture	concentration	(data	not	shown).	
Qualitative	 product	 analysis	 shown	 in	 Figure	 7.8	 shows	 near-identical	 expression	
profiles	 of	 total	 and	 soluble	 specific	 expressed	 tHBc	 in	 harvested	 material	 at	 48	
hours	 of	 induction.	 This	 similarity	 is	 emphasised	 when	 using	 log	 scaling	 Figure	
10.16.	This	suggests	that:	(1)	the	studied	mixed	feeding	induction	process	is	highly	
scalable	and,	(2)	it	 is	more	scalable	than	the	investigated	pure	methanol	induction	
process.		
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Figure	7.7	 Fermentation	data	of	process	 scale-up	of	 P.	pastoris	 	 expressing	 tHBc-HA2.3,	
(M2e)3	 using	 mixed	 feeding	 induction	 (section	 2.3.5.2).	 Large-scale	 data,	 at	 30L	 total	
working	 volume,	 is	 shown	 in	 blue.	 Small-scale	 data,	 at	 250mL	 total	working	 volume,	 is	
shown	 in	 orange.	 Carbon	 dioxide	 concentrations	 ([CO2])	 was	 measured	 in	 off-gas	 and	
biomass	concentrations	([X])	were	determined	through	wet	cell	weight	analysis	 (section	
2.5.2).		
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Figure	 7.8	 Qualitative	 protein	 data	 of	 large-scale	 and	 small-scale	 fermentations,	 both	
using	 the	 same	 mixed	 feeding	 induction	 protocol.	 For	 the	 large-scale	 fermentation	
(VT=30L),	samples	were	taken	at	0,	9,	31	and	48	hours	of	induction.	Samples	for	the	small-
scale	 fermentation	 (VT=250mL)	 were	 taken	 at	 48	 hours	 of	 induction.	 Extractions	 were	
performed	with	homogenisation.	(A)	Membrane	stain	of	reduced	SDS-PAGE	gel	showing	
host	 cell	 protein	 expression	 profiles	 in	 crude	 and	 clarified	 lysates.	 (B)	 Western	 blot	
showing	 heterologous	 protein	 expression	 profiles	 of	 tHBc-HA2.3,(M2e)3	 (±65kDa)	 in	
crude	and	clarified	lysates.		
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7.5 Impact	of	varying	inserts	on	large-scale	fermentation	
The	previous	sections	in	this	chapter	have	discussed	the	effects	of	variation	of	the	
epitopes	 inserted	 on	 the	 MIR	 of	 the	 VLP	 scaffold	 on	 product	 titres	 and	 other	
bioprocess-related	 responses,	 such	 as	metabolic	 activity	 and	 respiratory	 quotient	
profiles;	 the	 suitability	 of	 two	 different	modes	 of	 induction	 for	 the	 expression	 of	
different	VLP	constructs;	and	the	process-scalability	of	these	two	different	modes	of	
induction.	 In	 comparison	 to	 pure	 methanol	 based-induction,	 it	 was	 found	 that	
mixed	feeding	 induction	was	more	suitable	 for	VLP-constructs	with	more	complex	
inserts,	such	as	tHBc-HA2.3,	(M2e)3	and	resulted	in	a	more	scalable	process.		
The	final	objective	of	this	thesis	was	to	use	these	findings	in	such	a	way	that	these	
would	 have	 a	 practical	 application.	 Therefore,	 this	 section	 aimed	 to	 combine	 the	
findings	by	investigating	the	effects	of	titres	of	different	VLP	constructs	containing	
different	combinations	candidate	influenza	epitopes,	produced	at	large-scale	using	
the	most	 scalable	 induction	method,	which,	 as	 discussed	 earlier	was	 found	 to	 be	
mixed	feeding.	The	candidate	VLP	constructs	for	a	universal	influenza	vaccine	were:	
(1)	k1,	LAH3;	(2)	k1,	(M2e)3	and	(3)	HA2.3,	(M2e)3.		
Figure	7.9	 shows	 that	 the	differences	between	metabolic	 responses	 are	 relatively	
small	 when	 changing	 inserts	 on	 the	 MIR	 of	 VLPs	 when	 employing	 a	 mixed	 feed	
induction	process.		
However,	expression	profiles	shown	in	Figure	7.10	were	very	different	between	the	
VLP	constructs.	This	figure	suggests	that	as	the	cumulative	insert	size	increases,	the	
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specific	 yield	 of	 VLP-fitting	 tHBc	 decreases.	 Figure	 7.11	 confirms	 this	 finding	 and	
shows	the	quantitative	analysis	of	VLP	yields.	Figure	7.10	and	Figure	7.11	also	show	
that	the	investigated	mixed	feeding	processes	do	not	achieve	as	high	yields	as	the	
optimised	pure	methanol-based	induction	process	used	to	produce	k1,	k1.		
	
	
Figure	7.9	Carbon	dioxide	concentration	profiles	in	fermentation	exhaust	gas	and	biomass	
concentration	 profiles	 for	 k1,LAH3,	 k1,(M2e)3	 and	 HA2.3,(M2e)3	 constructs	 during	 30L	
mixed	 feed	 induction.	 Unfortunately,	 no	 carbon	 dioxide	 concentration	 profiles	 were	
obtained	for	the	k1,(M2e)3	construct.	A	component	of	these	results	has	previously	been	
published	(Kazaks	et	al.,	2017).		
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Figure	7.10	Qualitative	analysis	of	expression	of	different	 tHBc	constructs	 showing	VLP-
sized	Tandem	Core	material	through	western	blot	analysis	as	described	in	sections	2.5.8,	
2.5.9	 and	 2.5.11.	 All	 samples	 were	 standardised	 to	 a	 concentration	 of	 50µg/mL	 total	
protein.	Fermentations	for	the	k1,LAH3	(±48kDa);	k1,(M2e)3	(±58kDa)	and	HA2.3,(M2e)3	
(±65kDa)	 were	 performed	 at	 30L	 total	 volume	 and	 using	 a	 mixed	 feeding	 induction	
protocol.	The	k1,k1	construct	(±42.5kDa);	represents	the	yields	of	Tandem	Core	material	
produced	through	the	pure	feeding	induction	process	as	described	in	section	7.4.1.	(Top)	
Reverse	stained	membrane	of	SDS-PAGE	gel	showing	host	cell	protein	expression	profiles	
in	 crude	 lysate	 (A),	 clarified	 lysates	 (B)	 and	 VLP-sized	 material	 fractions	 (C).	 (Bottom)	
Western	 blot	 (1-hour	 exposure)	 showing	 heterologous	 protein	 expression	 profiles	 in	
crude	lysate	(A),	clarified	lysates	(B)	and	VLP-sized	material	fractions	(C).	
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Figure	7.11	Quantitative	analysis	of	expression	of	different	tHBc	constructs	showing	VLP-
sized	 Tandem	 Core	 material	 through	 dot	 blot	 analysis	 as	 described	 in	 section	 2.5.10.	
Fermentations	for	the	k1,LAH3;	k1,(M2e)3	and	HA2.3,(M2e)3	were	performed	at	30L	total	
volume	and	using	a	mixed	feeding	induction	protocol.	The	k1,	k1	construct	represents	the	
yield	of	VLP-sized	Tandem	Core	material	produced	through	the	pure	methanol	induction	
process	 as	 described	 in	 section	 7.4.1.	 Note	 that	 dot	 blot	 analysis	was	 performed	 using	
linear	 fitting	 (r2=0.96,	 n=18)	 rather	 than	 four	 parameter	 logistic	 fitting.	 This	 was	 done	
because	 4PL	 analysis	 could	 not	 capture	 the	 higher-end	 concentration	 of	 the	 harvested	
and	 processed	 material	 from	 the	 k1,k1	 fermentation.	 This	 could	 result	 in	 slight	 over-
estimation	of	lower-end	sample	concentrations	and	slight	underestimation	of	higher-end	
sample	concentrations.	
7.6 Summary	
This	chapter	has	demonstrated	that	there	is	no	universal	fermentation	process	for	
the	production	of	the	investigated	VLP	constructs:	different	fermentation	processes	
must	be	investigated	and	established	for	different	VLP	constructs.	It	seems	that	the	
implementation	of	more	complex	inserts	on	the	VLP	exterior	requires	lower	specific	
total	 tHBc	 expression.	 It	 was	 postulated	 that,	 aside	 from	 lowering	 induction	
temperature,	this	could	be	achieved	by	employing	a	glycerol	mixed	feed	induction	
process.	 Indeed,	for	an	 influenza	vaccine,	providing	broad	cross-protection	against	
influenza	 variants,	 larger	 and	 more	 complex	 inserts	 are	 required.	 It	 was	
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demonstrated	 that	higher	VLP	 titres	 containing	 these	 inserts	were	achieved	using	
mixed	 feed	 induction	 when	 compared	 to	 the	 previously	 studied	 pure	 methanol-
based	induction	processes.		
Overall,	 the	 results	 initially	 demonstrated	 in	 the	 ambr®	 250	 system	 have	 been	
confirmed	at	pilot	scale	using	the	30L	fermenter	and	have	netted	similar	results.	
The	 scale-up	 of	 an	 optimised	 pure	methanol-based	 induction	 process	 proved,	 to	
some	 degree,	 problematic.	 The	 issues	 that	 arose	 mainly	 resulted	 from	 the	
requirement	of	oxygen	gas	blending	during	 the	glycerol	 fed-batch	phase.	Because	
mixed	feed	induction	omitted	this	phase	in	its	process,	the	resulting	process	scale-
up	was	much	more	successful.		
Using	this	mixed	feeding	strategy,	the	expression	of	three	candidate	Tandem	Core	
VLPs	presenting	 various	 influenza	 epitopes,	was	 investigated	 at	 pilot	 scale.	 It	was	
again	 shown	 that	 the	 implementation	 of	more	 complex	 inserts	 resulted	 in	 lower	
VLP	titres.	To	fully	understand	why	will	require	further	study,	but	insert	complexity	
may	have	a	role	to	play.		
Comparing	 the	 yields	 of	 these	 mixed	 feeding	 induction	 fermentations	 with	 the	
aforementioned	 (and	 poorly	 scalable)	 optimised	 pure	 methanol	 based	 induction	
process	suggested	that	there	was	significant	room	for	process	improvement.	
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Chapter	8 Conclusions	and	future	work	
8.1 Conclusions		
This	chapter	summarises	the	main	findings	of	this	thesis	with	respect	to	the	specific	
aims	identified	in	section	1.10.	
Chapter	3	showed	that,	by	lowering	expression	rates	through	changing	the	host	cell	
phenotype	 and	 the	 introduction	 of	 smaller	 inserts	 of	 the	 Tandem	 Core	 scaffold,	
soluble	 and	 heat-stable	 VLPs	 were	 successfully	 produced	 in	 the	 appropriate	 size	
range.	 This	 chapter	 also	 identified	 a	 relatively	 large	 number	 of	 critical	 process	
parameters,	 therefore	 recognising	 the	 need	 for	 robust,	 high-throughput	
miniaturised	 fermentation	 platforms,	 more	 effective	 extraction	 processes;	 ideally	
combined	with	experimentally	economic	experimental	design	methodology.		
The	 time	 and	 cost	 benefits	 of	 such	miniaturised	 fermentation	 platforms	 could	 be	
gained	 only	 by	 employing	 complementary	 techniques	 facilitating	 high-throughput	
processing	 at	 small	 sample	 volumes.	 Chapter	 4	 therefore	 focused	 on	 the	
development	 of	 a	 high-performance,	 high-throughput,	 non-contact,	 automated,	
small-scale,	 scalable	 disruption	 tool	 for	microbial	 bioprocess	 development.	 It	was	
found	that	Adaptive	Focused	Acoustics	(AFA)	on	enzymatically	pre-treated	samples	
provided	 the	 most	 suitable	 platform	 fulfilling	 these	 criteria.	 Development	 and	
optimisation	 of	 this	 method	 led	 to	 matching	 and	 even	 outperforming	
homogenisation	 performance,	 depending	 on	 the	 performance	 criterion	
investigated.	 The	 resulting	overlap	of	performance	 ranges	between	High	Pressure	
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Homogenisation	 and	 AFA-mediated	 cell	 disruption	 allowed	 for	 small-scale	 AFA	
performance	 mimicry	 of	 High	 Pressure	 Homogenisation.	 The	 utility	 of	 this	 work	
means	 that,	 for	microbial	 cultures	with	 sizeable	 cell	walls,	 such	 as	P.	 pastoris,	 an	
efficient	scale-down	tool	is	now	available	adding	to	the	processing	tools	set.		
It	was	found	in	chapter	5	that	methanol-based	induction	of	P.	pastoris	in	microtitre	
plates	 proved	 to	 be	 challenging	 predominantly	 due	 to	 reduced	 mass	 transfer	
capacity	 and	 due	 to	 the	 tight	 regulation	 required	 of	 methanol	 induction.	 As	 an	
alternative,	 the	use	of	pectin	digest	as	an	 indirect	 induction	agent	was	 studied.	 It	
was	 found	 that	 the	 use	 of	 this	 novel	 media	 resulted	 in	 the	 expression	 of	
heterologous	protein,	however,	 it	was	determined	that	 this	effect	was	not	due	to	
the	proposed	metabolism	of	d-galacturonic	methyl	ester	by	pectin	methyl	esterase.	
Hence,	it	was	found	that	microtiter	plates	provided	an	unsuitable	platform	for	rapid	
upstream	process	development	for	methylotrophic	induction.	Nonetheless,	several	
critical	 process	 parameters	 were	 confirmed:	 initial	 biomass	 concentration	 at	
induction,	harvest	time	and	methanol	concentration	in	media.		
The	 effects	 of	 variance	 of	 these	 critical	 process	 parameters	 were	 studied	 to	 a	
greater	 extent	 using	 miniaturised	 bioreactors	 in	 chapter	 6.	 Metabolic	 responses,	
such	 as	 final	 biomass	 concentration,	 required	 significantly	 different	 optimum	
operating	 conditions	 than	 specific	 product	 expression	 responses	 and	 volumetric	
responses.	This	tightly	controlled	system	allowed	for	a	better	understanding	to	be	
developed	between	tHBc	expression	and	the	formation	of	VLPs.	 It	was	 found	that	
maximising	expression	of	heterologous	protein	was	not	synonymous	to	maximising	
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the	production	of	VLPs.	 It	was,	 in	 fact,	shown	that	a	relatively	narrow	window	for	
specific	 tHBc	 expression	exists	 in	 which	 a	 significant	 part	 of	 Tandem	 Core	 units	
assembles	into	VLPs.		
Chapter	 7	 showed	 that	 different	 fermentation	 processes	 are	 appropriate	 for	
different	constructs.	It	was	demonstrated	that	higher	titres	for	complex	VLPs	were	
achieved	using	mixed	feeding	induction	rather	than	pure	methanol-based	induction.	
In	 addition,	 the	 scale-up	 of	 an	 optimised	 pure	methanol-based	 induction	 process	
proved	 problematic.	 The	 issues	 that	 arose	 mainly	 resulted	 from	 the	 requisite	 of	
oxygen	 gas	 blending	 during	 the	 glycerol	 fed-batch	 phase.	 Because	mixed	 feeding	
induction	omitted	this	phase	in	its	process,	the	resulting	process	scale-up	was	more	
successful.	 Using	 this	 mixed	 feeding	 strategy,	 the	 expression	 of	 three	 influenza	
vaccine	 candidates	 was	 investigated	 at	 pilot	 scale.	 It	 was	 again	 shown	 that	 the	
implementation	of	more	complex	inserts	resulted	in	lower	VLP	titres.		
8.2 Future	work	
Although	 chapter	 3	 showed	 how	 critical	 process	 parameters	 were	 identified	
associated	 with	 fermentation	 primary	 recovery,	 relatively	 little	 investigation	 was	
performed	on	the	development	of	high-throughput	analytical	techniques	that	could	
distinguish	 between	 assembled	 and	 unassembled	 Tandem	 Core	material.	 A	main	
assumption	 in	 this	 thesis	 has	 been	 that	 Tandem	 Core-positive	 material	 within	 a	
particular	size	range	represented	assembled	VLP.	However,	it	must	be	stressed	that	
this	 provides	 but	 an	 approximation	 as	 the	method	 does	 not	 distinguish	 between	
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VLPs	and	Tandem	Core-positive	aggregates	corresponding	to	the	same	size	as	a	VLP.	
Future	work	 should	 therefore	 focus	 on	 the	 development	 of	 alternative	 analytical	
techniques.	Nonetheless,	for	preparative	purposes,	Size	Exclusion	Chromatography	
is	 a	 highly	 scalable	 purification	 technique	 and	 therefore	 has	merit.	 It	 is	 therefore	
also	 recommended	 that	 the	 employed	 SEC	 method	 is	 improved	 to	 maximise	
recovery	of	VLPs.		
The	 results	 in	 chapter	 4	 demonstrated	 that	 AFA-mediated	 cell	 disruption	 can	 be	
employed	in	high-throughput	miniaturised	fashion.	This	technology	could	therefore	
be	 used	 as	 a	 tool	 for	 a	 wide	 variety	 of	 applications	 including	 lysis	 buffer	
development,	 strain	 selection,	 fermentation	 process	 development	 and	 whole	
bioprocess	 integration.	 It	 is	 therefore	 recommended	 that	 future	work	 focuses	 on	
broadening	the	range	of	applications	for	AFA.	It	should	be	noted	that,	 in	doing	so,	
certain	conditions	could	render	lyticase	less	effective.	Therefore,	it	is	recommended	
that	in-depth	studies	are	dedicated	to	establishing	the	limitations	of	implementing	
lyticase	pre-treatment	in	cell	disruption	processes	of	P.	pastoris.	Factors	to	be	taken	
into	consideration	may	include	media	pH,	salt	concentration,	temperature,	and/or	
various	economic	criteria;	such	as	cost	and	throughput.	
AFA	has	also	demonstrated	its	effectiveness	in	cell	disruption	and	product	recovery	
in	 comparison	 to	 the	 industry	 standard	 of	 cell	 disruption,	 High	 Pressure	
Homogenisation,	 at	 small-scale.	 Cell	 disruption	 of	 P.	 pastoris	 using	 AFA	 could	 be	
implemented	 at	 industrial	 scale	 using	 continuous	 flow	 systems	 as	 pilot	 scale	 AFA	
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units	now	exists	 that	could	offer	better	 recovery	with	 less	micronised	debris.	This	
could	have	significant	implications	for	the	development	of	continuous	bioprocesses.		
Chapter	 5	 focused	 on	 the	 development	 of	 microscale	 fermentation	 platforms.	
Although	 the	experiments	 show	that	growth	and	 induction	can	be	achieved	using	
microtitre	plates,	 tighter	process	controls	are	 required,	particularly	 relating	 to	 the	
introduction	of	methanol	 into	media.	 	Future	work	should	therefore	 focus	on	two	
areas:	 (1)	 the	 implantation	 of	 more	 sophisticated	 microscale	 fermentation	
platforms,	such	as	the	ambr®	15	micro	bioreactor	(Sartorius	AG,	Goettingen,	DE)	or	
the	Micro-Matrix	 system	 (Applikon	 Biotechnology	 B.V.,	 Delft,	 NL);	 and	 (2)	 further	
investigation	 of	 indirect	 AOX	 induction	 through	 the	 introduction	 of	 pectin	
oligomers.		
Chapter	 6	 showed	 that	 tHBc	 expression	 and	 VLP	 assembly	 are	 not	 directly	
proportional.	To	prove	and	assess	the	effect	of	disproportionately	high	rates	of	tHBc	
expression	in	comparison	to	the	required	chaperone	proteins,	an	adaptation	to	the	
methodology	described	by	Damasceno	et	al.	(2007)	could	be	employed.	This	would	
involve	the	co-overexpression	of	chaperones	such	as	immunoglobin	binding	protein	
(BiP)	 and	Protein	Disulphide	 Isomerase	 (PDI).	Higher	 levels	of	 co-expression	 could	
prove	 to	be	 favourable	 for	VLP	 assembly.	 In	 addition,	 cellular	 stress	 responses	 to	
either	high	levels	of	tHBc	internalisation	or	high	methanol	concentrations	could	be	
correlated	 to	 stress-associated	 protein	 expression	 as	 described	 by	 others	 (Martin	
Dragosits	et	al.,	2009).		
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Although	 the	 number	 of	 factors	 in	 the	 experimental	 design	was	 limited	 to	 three,	
response	 surface	models	 could	 be	 generated	where	 time,	 pH	 and	DOT	 levels	 are	
included.	Time	was	not	included	in	the	response	models	for	VLP	production	as	this	
would	require	 large	sampling	volumes	throughout	the	fermentations18,	and	would	
significantly	reduce	bioreactor	working	volumes.	However,	if	better	analytical	tools	
are	developed	to	detect	VLPs,	these	could	be	combined	with	the	developed	scale-
down	AFA-based	 cell	 disruption	platform	 to	 eliminate	 the	need	 for	 large	 samples	
volumes	and	to	increase	experimental	throughput.	Acidity	was	also	not	considered	
a	priority	factor	as	the	trace	salts	the	Basal	Salts	Media	tended	to	precipitate	above	
a	pH	of	5.5,	significantly	limiting	the	upper	range	of	the	experimental	design	space.	
However,	 there	could	be	benefits	 in	studying	the	effect	of	 increased	acidity	as	pH	
values	below	3	could	inhibit	protease	activity	triggered	by	stress	responses,	thereby	
minimising	 the	 formation	 of	 truncated	 heterologous	 protein	 (Invitrogen	
Corporation,	2002).	DOT	was	also	not	considered	a	priority	factor,	as	an	increase	in	
DOT	 would	 mainly	 result	 in	 an	 increase	 in	 excess	 oxygen	 concentrations.	 Also,	
assuming	 a	 scenario	 in	 which	 high	 DOT	 levels	 are	 most	 favourable,	 maintaining	
relatively	 high	 DOT	 levels	 would	 become	 problematic	 when	 scaling	 up	 a	
fermentation	 process.	 Nonetheless,	 the	 effect	 of	 variance	 of	 DOT	 levels	 on	
heterologous	protein	expression	by	P.	pastoris	 	has	 reported	to	be	significant	and	
would	be	worthwhile	to	investigate	(Invitrogen	Corporation,	2002;	Lee	et	al.,	2003).	
Chapter	 7	 showed	 the	 benefits	 of	 implementing	 mixed	 feeding	 induction.	 A	
secondary	 consequence	 of	 adapting	 this	 approach	would	 be	 the	 exclusion	 of	 the	
																																																						
18	Due	to	the	minimum	sample	volume	required	for	preparative	SEC	
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glycerol	 fed-batch	phase.	This	would	 reduce	 the	number	of	 factors	 to	be	 studied,	
making	it	more	feasible	to	study	the	additional	factors	of	interest	discussed	above.	
It	 should	 also	 be	 stressed	 that	 the	 scale-up	 of	 processes	 discussed	 in	 chapter	 7	
assumed	 geometric	 similarity	 of	 miniature	 and	 pilot	 scale	 bioreactors	 for	 the	
purpose	 of	 simplicity.	 In	 reality,	 there	 are	 dissimilarities	 between	 these	 vessel	
geometries.	Therefore,	to	improve	process	scalability,	accounting	for	the	geometric	
differences	 between	 the	 vessels	 could	 account	 for	 better	 scale-up.	 Additionally,	
alternative	 scaling	 strategies	 could	 also	 be	 investigated,	 for	 instance,	maintaining	
constant	oxygen	transfer	capacity	has	proven	to	be	an	effective	basis	 for	scale-up	
when	vessel	geometry	is	dissimilar	(Islam	et	al.,	2008).		
This	work	has	 shown	 that	upstream	process	development	 is	highly	dependent	on	
the	VLP	construct	involved.	Future	work	could	therefore	explore	the	fundamentals	
of	VLP	assembly	and	its	change	with	insert	variation.	However,	the	requirement	of	
reassessing	 the	 suitability	 of	 a	 bioprocess	 after	 candidate	 epitope	 selection	
significantly	 impedes	 vaccine	 development.	 To	 move	 towards	 a	 more	 flexible	
vaccine	 development	 platform,	 a	 universal	 vaccine	 production	 process,	 such	
variance	 needs	 to	 be	 eliminated	 or	 reduced.	 This	 could	 be	 achieved	 by	
implementing	 a	 different	 VLP-production	 strategy	 altogether,	 in	 which	 a	
standardised	VLP	scaffold	is	produced	in	a	single	fermentation	process	followed	by	
epitope	conjugation	in	a	separate	unit	operation	post-purification.	The	investigated	
k1,	 k1	 construct	 would	 in	 fact	 be	 suitable	 for	 lysine	 residue-based	 conjugation.	
Future	 work	 in	 this	 scenario	 would	mainly	 involve	 optimising	 such	 a	 conjugation	
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step,	which	is	arguably	less	complex	and	less	time	consuming	than	the	optimisation	
of	fermentation	processes.	
Finally,	to	improve	volumetric	yields	it	could	be	beneficial	to	develop	transformants	
that	secrete	Tandem	Core	protein	and	prevent	VLP	assembly	intracellularly	so	that	
VLP	assembly	 can	be	controlled	outside	 the	cell	 in	a	 separate	unit	operation.	VLP	
assembly	of	hepatitis	B	core	protein	outside	cells	has	indeed	been	demonstrated	in	
previous	 works	 (Ludgate	 et	 al.,	 2016).	 Such	 an	 approach	 would	 be	 beneficial	
because	 it	would	 (1)	 reduce	 intracellular	proteolytic	degradation	of	 tHBc	 resulting	
from	a	variety	of	possible	 cellular	 stress	 responses,	 (2)	allow	 for	highly	 controlled	
assembly	of	VLPs	and	(3)	eliminate	the	need	of	a	cell	disruption	method.	The	latter	
unit	operation	has	been	proven	 in	 this	work	 to	have	 the	potential	 to	 significantly	
impede	 VLP	 recovery	 due	 to	 the	 generation	 of	 micronised	 debris.	 This	 secretory	
assembly	 could	 possibly	 be	 achieved	 by	 developing	 a	 construct	 that	 contains	 a	
fused	 SUMO-tag	 attached	 to	 the	 existing	 tHBc	 sequence.	 This	 SUMO	 tag	 would	
prevent	VLP	assembly	until	it	is	cleaved	by	specific	proteases	as	described	by	others	
(Panavas,	Sanders	and	Butt,	2009).		
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Chapter	10 Appendix	
10.1 Supplementary	data	(Chapter	2)	
10.1.1 Media	components	
Table	10-1	Fermentation	media	components	
10X	YNB	(Yeast	Nitrogen	Base	with	ammonium	sulphate	and	without	amino	acids)	
Yeast	Nitrogen	Base	(YNB)	with	ammonium	
sulphate	and	without	amino	acids	
69	g	
RO	water	 500	ml	
500X	B	(0.02%	Biotin)	
Biotin	 20	mg	
0.05	M	NaOH	 100	ml	
10X	GY	(10%	Glycerol)	
Glycerol	 100	ml		
RO	water	 900	ml	
BMGY	Medium	(Buffered	Glycerol-complex	medium)	
Yeast	Extract		 10	g/l	
Peptone	 20	g/l	
1M	potassium	phosphate,	pH	6.0	 100	ml/l	
10X	YNB	 100	ml/l	
500X	B			 2	ml/l	
10X	GY	 100	ml/l	
PTM1	Trace	Salts	
Cupric	sulphate	5	H2O	 6.0	g/l	
Sodium	iodide	 0.08	g/l	
Manganese	sulphate	7	H2O	 3.0	g/l	
Sodium	molybdate	2	H2O	 0.2	g/l	
Boric	acid		 0.02	g/l	
Cobalt	chloride	 0.5	g/l	
Zinc	chloride	 20.0	g/l	
Ferrous	sulphate	7	H2O	 65.0	g/l	
Biotin	 0.2	g/l	
Sulphuric	acid	 5.0	ml/l	
Fermentation	Basal	Salts	
Phosphoric	acid,	85	%	 26.7	ml/l	
Calcium	sulphate	 0.93	g/l	
Potassium	sulphate		 18.2	g/l	
Magnesium	sulphate	7	H2O	 14.9	g/l	
Potassium	hydroxide	 4.13	g/l	
Glycerol	 40.0	g/l	
Antifoam	(PPG2000	Foam	Control	Agent)	 1	ml/l	
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10.1.2 Cell	bank	data	
	
Figure	 10.1	Growth	 profile	 of	master	 cell	 bank	Pichia	 pastoris	 KM71H	 expressing	 tHBc-
k1,k1.		
	
Figure	10.2	Growth	profile	of	working	cell	bank	Pichia	pastoris	KM71H	expressing	tHBc-
k1,k1.	
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Figure	 10.3	 Non-contaminated	 agar	 culture	 of	 working	 cell	 bank	 Pichia	 pastoris	 X33	
expressing	tHBc-GFP,e	at	28°C,	1	week.		
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10.2 Supplementary	data	(Chapter	3)	
10.2.1 Fermentation	graphs	
	
Figure	10.4	Low-temperature	induction	fermentation	data	of	P.	pastoris	Mut+	expressing	
tHBc-GFP,e:	 (A)	 Online	 data	 including	 agitation	 rate,	 temperature,	 pH	 and	 dissolved	
oxygen	tension	level.	(B)	Offline	data	including	OD600,	sampling	events	and	carbon	source	
feed	rates.		
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Figure	 10.5	 Mixed	 feeding	 induction	 fermentation	 data	 of	 P.pastoris	 Mut+	 expressing	
tHBc-GFP,e:	 (A)	 Online	 data	 including	 agitation	 rate,	 temperature,	 pH	 and	 dissolved	
oxygen	tension	level.	(B)	Offline	data	including	OD600	and	carbon	source	feed	rates.		
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Figure	10.6	Fermentation	data	of	P.	pastoris	MutS	expressing	tHBc-k1,k1:	(A)	Offline	data	
including	 OD600,	 sampling	 events,	 carbon	 source	 feed	 rates,	 temperature	 and	 pH	 (B)	
Online	data	including	agitation	rate,	dissolved	oxygen	tension	level	and	carbon	evolution	
rate.	
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10.3 Supplementary	data	(Chapter	4)	
10.3.1 Chemical	lysis	with	YeastBusterTM	
YeastBusterTM	 is	 a	 protein	 extraction	 reagent	 produced	 by	 Novagen®	 with	 a	
proprietary	 mix	 of	 mild	 detergents,	 protein	 stabilisation	 buffer	 reducing	 agent	
called	tris(hydroxypropyl)phosphine	(THP).	 It	has	reportedly	been	used	to	perform	
extractions	of	proteins	from	Pichia	pastoris	 through	‘gentle	conditions’	 	 (Novagen,	
2004).		
As	 this	 agent	 has	 previously	 been	 used	 to	 disrupt	 Pichia	 pastoris,	 it	 was	
hypothesised	 that	 YeastBusterTM	 could	 be	 effective	 in	 extracting	 soluble	 core-
positive	material	from	harvested	cells.		
The	effectiveness	of	YeastBusterTM	as	a	disruption	agent	was	assessed	by	incubating	
harvested	material	(3.3.1)	at	various	cell	densities	in	(1)	YeastBusterTM	(2.4.8)	and,	
for	comparative	purposes,	(2)	lyticase	buffer	(2.4.6).	Note	that	the	lyticase	mix	also	
contained	0.1%	Triton-X100	prior	to	incubation.		
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Figure	10.7	Total	protein	concentration	of	crude	and	clarified	lysates	of	cells	incubated	in	
1mL	YeastbusterTM	(section	2.4.8)	at	various	biomass	concentrations	([X]).	Averages	and	
standard	deviations	are	derived	 from	triplicate	measurements	on	duplicate	 samples	 for	
both	 crude	 and	 clarified	 lysates.	 Total	 protein	 quantification	was	determined	using	 the	
Nanodrop	method	(section	2.5.5).		
Figure	10.7	shows	total	protein	concentrations	of	both	crude	and	clarified	lysates	of	
cells	 incubated	 with	 YeastbusterTM	 at	 various	 biomass	 concentrations.	 The	 data	
shows	that	YeastbusterTM	is	capable	of	disrupting	cells	and	that	the	total	amount	of	
total-	 and	 soluble	 protein	 released	 by	 YeastbusterTM	 increases	 as	 the	 biomass	
concentration	increases.	However,	the	proportion	of	soluble	protein	to	total	protein	
measured	decreases	as	the	concentration	of	biomass	increases.	
The	data	 shows	 that	YeastbusterTM	 is	 suitable	 for	disrupting	P.	pastoris.	However,	
the	 aim	 of	 using	 this	 agent	 is	 to	 recover	 soluble	 core-positive	material.	 This	 was	
assessed	 using	 qualitative	 product	 analysis,	 which	 shown	 in	 Figure	 10.8	 and	 was	
performed	 on	 crude	 and	 clarified	 lysates	 using	 dot	 blot	 analysis	 as	 described	 in	
sections	2.5.10	and	2.5.11.	
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Figure	 10.8	 Qualitative	 analysis	 of	 crude	 and	 clarified	 lysates	 following	 lyticase	 (LY)	
(2000U/mL)	 treatment	 (2.4.6)	 and	 YeastbusterTM	 (YB)	 treatments	 (2.4.8)	 at	 various	
concentrations	of	biomass	at	a	total	lysis	volume	of	1mL.	Measurements	were	performed	
in	duplicate.	Reference	material	(hepatitis	B	core	antigen)	was	used	as	a	positive	control	
(not	shown).		
Figure	 10.8	 shows	 no	 detectable	 recovery	 of	 soluble	 core-positive	material	when	
YeastbusterTM	 is	used.	This	demonstrates	that,	despite	being	capable	of	disrupting	
Pichia	 pastoris,	 certain	 unknown	 characteristics	 of	 YeastbusterTM	 cause	 core-
positive	material	to	become	insoluble.	The	use	of	YeastbusterTM	as	an	agent	for	cell	
disruption	in	future	experiments	was,	therefore,	not	recommended.		
10.3.2 Sonication	
Cells	can	be	disrupted	through	 intense	 localised	shockwaves	created	by	ultrasonic	
waves.	 These	waves	 can	be	produced	by	 sonication	devices	 such	 as	 the	 SoniPrep	
150	(MSE,	2017).	This	method	of	disruption	has	been	used	for	the	disruption	for	a	
variety	of	microbial	expression	systems	(Chakrabarti	et	al.,	2001;	Hemsworth	et	al.,	
2014),	 including	P.	 pastoris.	 Section	 2.4.4	 shows	 how	 the	 SoniPrep	 150	was	 used	
throughout	this	 thesis.	 It	was	therefore	hypothesised	that	 this	method	could	be	a	
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suitable	extraction	method	for	the	recovery	of	soluble	core-positive	material	 from	
harvested	cells.		
Total	cell	disruption	through	sonication	of	harvested	material	(3.2.1)	was	compared	
to	material	disrupted	through	lyticase	as	described	in	section	2.4.6.	This	comparison	
is	shown	in	Figure	10.9.	
	
Figure	 10.9	 Comparison	 of	 lyticase-mediated	 cell	 disruption	 versus	 SoniPrep-mediated	
cell	 disruption	 with	 and	 without	 the	 addition	 of	 Triton-X100	 after	 cell	 disruption.	
Triplicate	measurements	were	performed	on	clarified	lysate	using	the	Nanodrop	method	
(section	2.5.5).		
It	seems	that	total	 levels	of	cell	disruption	achieved	through	sonication	are	similar	
to	those	achieved	through	incubation	with	lyticase.	However,	section	3.2.2	had	also	
shown	 that	 the	 implementation	 of	 sonication	 resulted	 in	 a	 loss	 of	 soluble	 core-
positive	material.	 It	has	been	speculated	that	this	could	be	due	to	heating	effects.	
Furthermore,	 this	 method	 of	 cell	 disruption	 relies	 heavily	 on	 manual	 operation,	
presents	 an	 increased	 risk	 of	 sample	 cross-contamination	 and	 is	 not	 suitable	 for	
automation.	 Therefore,	 sonication	 with	 the	 SoniPrep	 150	 was	 not	 considered	 an	
ideal	scale-down	cell	disruption	platform.	
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10.4 Supplementary	data	(Chapter	5)	
10.4.1 Theory	of	the	effect	of	working	volume	on	growth	and	expression	
A	 change	 in	working	 volume	 (Vw)	 leads	 to	 a	 change	 in	 the	 oxygen	mass	 transfer	
coefficient,	kLa,	as	shown	in	the	following	correlation	(Doran,	1996):		
"#$ = & '( 	 	 Equation	10-1	
In	 turn,	 the	 oxygen	 mass	 transfer	 coefficient	 affects	 the	 Oxygen	 Transfer	 Rate	
(OTR),	which	describes	 the	amount	of	oxygen	made	available	per	unit	of	 volume,	
per	unit	of	time.	This	correlation	is	shown	in	the	following	equation	(Klöckner	and	
Büchs,	2012;	Kirk	and	Szita,	2013):	
)*+ = "#$ ,∗ − ,# 		 	 Equation	10-2	
Where:	
• OTR	represents	the	Oxygen	Transfer	Rate	(mmol/L/h)	
• C∗	represents	 maximum	 concentration	 of	 dissolved	 oxygen	 at	 equilibrium	
(mmol/L)	
• C4	represents	the	observed	concentration	of	oxygen	in	the	culture	(mmoL/L)	
The	OTR	is	important	as	it	can	be	used	to	define	whether	a	culture	is	being	supplied	
with	 sufficient	 oxygen,	 through	 comparison	with	 the	Oxygen	Uptake	 Rate	 (OUR).	
This	is	because	a	for	a	culture	to	grow	the	OTR	must	be	equal	to	or	greater	than	the	
OUR.	
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The	OUR	describes	 the	 rate	of	oxygen	 consumption	by	a	 culture,	which	 in	 turn	 is	
dependent	on	the	specific	growth	rate	as	shown	in	the	following	equation:		
)5+ = 678/): 8 + <[8]		 Equation	10-3	
Where:	
• OUR	represents	the	Oxygen	Uptake	Rate	(mmol/L/h)	
• YA/BC 	represents	the	yield	of	biomass	over	oxygen		
• m 	represents	 a	 maintenance	 coefficient	 and	 can	 be	 determined	
experimentally	
The	 yield	 of	 biomass	 over	 oxygen	 can	 be	 calculated	 using	 Equation	 10-4.	 This	
equation	is	a	representation	of	the	metabolism	of	a	culture.	
CEHGOHNJ + a ∙ OM + b ∙ HOOPNQ → c ∙ CHTOUNV + d ∙ COM + e ∙ HMO + f ∙ CZH[O\N]	
Equation	10-4	
Where:	
• CEHGOHNJ	represents	the	molecular	formula	of	the	carbon	source	used		
• CHTOUNV	represents	the	molecular	formula	of	the	biomass	produced19	
• CZH[O\N]	represents	the	molecular	formula	of	the	product	expressed20	
																																																						
19	In	 the	 case	 of	 Pichia	 pastoris	 this	 is	 found	 to	 be	 CH1.761	N0.143	O0.636	S0.002	at	 atmospheric	 oxygen	
levels		(Carnicer	et	al.,	2009)	
	
20	Based	on	amino	acid	sequence	and	assuming	negligible	levels	of	glycosylation,	for	tHBc-k1,k1	this	
was	determined	to	be	CH1.902	N0.284	O0.302	S0.007	
	 																																																																																										Benjamin	A.F.	Bláha	2018	
	 303	
10.4.2 Design	space	for	growth	kinetics	screening	in	microtitre	plates	
Table	 10-2	 Growth	 kinetics	 screening	 in	 microtitre	 plates:	 Design	 space	 (left)	 and	
corresponding	response	values	(right).		
Pattern	 Vw(mL)	 [X]0	(OD600)	 t	(h)	 [X]t	(OD600)	 µ	(h-1)	
−−−	 0.5	 20	 2	 27.2	 1.54•10-1	
−−+	 0.5	 20	 30	 58.4	 3.57•10-2	
−+−	 0.5	 100	 2	 140	 1.70•10-1	
−++	 0.5	 100	 30	 108	 2.44•10-3	
+−−	 2.5	 20	 2	 21.2	 2.91•10-1	
+−+	 2.5	 20	 30	 62.8	 3.81•10-1	
++−	 2.5	 100	 2	 105	 2.53•10-2	
+++	 2.5	 100	 30	 98.4	 -5.38•10-4	
000	 1.5	 60	 16	 94.8	 2.86•10-2	
000	 1.5	 60	 16	 95.6	 2.91•10-2	
000	 1.5	 60	 16	 94.8	 2.86•10-2	
10.4.3 Calculation	for	correlation	between	incubation	time	and	working	volume		
µ = 4.91 ∙ 10dM − 3.78 ∙ 10dMf t − 3.37 ∙ 10dMf Vj + 3.35 ∙ 10dMf Vj ∙ t = 0	
∴ 1.46 − 1.13f t − 1.01f Vj + f Vj ∙ f t = 0	
∴ f t − 1.01 f Vj − 1.13 = −0.319	
∴ f t = −0.319f Vj − 1.13 + 1.01	
f t = t − 1614 	∪ 	f Vj = Vj − 1.5	
∴ o(6qr) = dt.tu'(d:.vw + wr. xt		 	 Equation	10-5	
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10.4.4 Design	space	and	model	summaries	for	 induction	screenings	 in	microtitre	
plates	
Table	10-3	Growth	and	expression	kinetics	screening	in	microtitre	plates	during	methanol	
induction	 of	 P.	 pastoris	 Mut+:	 Design	 space	 (left)	 and	 corresponding	 response	 values	
(right).		
Pattern	 [MeOH]	
(%	vol.)	
[X]0	
(OD600)	
t	(h)	 [X]t	
(OD600)	
µ	(h-1)	 [tHBc]	
(ng/mL)	
tHBcs	
(µg/mL/OD600)	
−−−	 0.5	 18	 2	 5.54	 -5.89•10-1	 8.12	 1.47	
+−−	 5	 18	 2	 6.50	 -5.09•10-1	 24.7	 0.380	
−+−	 0.5	 90	 2	 65.6	 -1.58•10-1	 25.5	 0.389	
++−	 5	 90	 2	 63.2	 -1.77•10-1	 27.1	 0.429	
0	 2.75	 54	 16	 29.2	 -3.84•10-2	 76.2	 2.61	
0	 2.75	 54	 16	 31.6	 -3.35•10-2	 76.6	 2.42	
0	 2.75	 54	 16	 27.2	 -4.29•10-2	 80.0	 2.94	
−−+	 0.5	 18	 30	 10.0	 -1.96•10-2	 89.7	 8.96	
+−+	 5	 18	 30	 12.8	 -1.14•10-2	 85.2	 6.66	
−++	 0.5	 90	 30	 41.6	 -2.57•10-2	 38.3	 0.920	
+++	 5	 90	 30	 53.2	 -1.75•10-2	 61.7	 1.16	
	
Table	10-4	Growth	and	expression	kinetics	screening	in	microtitre	plates	during	methanol	
induction	 of	 P.	 pastoris	 MutS:	 Design	 space	 (left)	 and	 corresponding	 response	 values	
(right).		
Pattern	 [MeOH]	
(%	vol.)	
[X]0	
(OD600)	
t	
(h)	
[X]t	(OD600)	 µ	(h-1)	 [tHBc]	
(ng/mL)	
tHBcs	
(µg/mL/OD600)	
−−−	 0.3	 18	 2	 6.26	 -5.28•10-1	 0	 0	
+−−	 1.0	 18	 2	 6.48	 -5.11•10-1	 0	 0	
−+−	 0.3	 90	 2	 79.2	 -6.39•10-2	 0	 0	
++−	 1.0	 90	 2	 87.2	 -1.58•10-2	 0	 0	
0	 0.65	 54	 16	 26.8	 -4.38•10-2	 0	 0	
0	 0.65	 54	 16	 27.2	 -4.29•10-2	 0	 0	
0	 0.65	 54	 16	 31.6	 -3.35•10-2	 0	 0	
−−+	 0.3	 18	 30	 9.6	 -2.10•10-2	 0	 0	
+−+	 1.0	 18	 30	 12.8	 -1.14•10-2	 0	 0	
−++	 0.3	 90	 30	 46.4	 -2.21•10-2	 13.7	 0.295	
+++	 1.0	 90	 30	 56	 -1.58•10-2	 9.02	 0.161	
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Table	 10-5	 Second	 screening	 of	 growth	 and	 expression	 kinetics	 screening	 in	microtitre	
plates	 during	 methanol	 induction	 of	 P.	 pastoris	 Mut+:	 Design	 space	 (left)	 and	
corresponding	response	values	(right).		
Pattern	 [MeOH]	
(%	vol.)	
[X]0	
(OD600)	
t	
(h)	
[X]t	(OD600)	 µ	(h-1)	 [tHBc]	
(ng/mL)	
tHBcs	
(µg/mL/OD600)	
−−−	 2.5	 9	 16	 23.2	 5.92•10-2	 0.506	 2.18•10-2	
+−−	 7.5	 9	 16	 4.92	 -3.77•10-2	 1.99	 4.04•10-1	
−+−	 2.5	 45	 16	 71.2	 2.87•10-2	 0.0292	 4.11•10-4	
++−	 7.5	 45	 16	 63.6	 2.16•10-2	 0.172	 2.71•10-3	
000	 5	 27	 31	 50	 2.05•10-2	 0.445	 8.90•10-3	
000	 5	 27	 31	 53.6	 2.29•10-2	 0.450	 8.40•10-3	
000	 5	 27	 31	 49.2	 2.00•10-2	 0.0841	 1.71•10-3	
−−+	 2.5	 9	 46	 28.8	 2.53•10-2	 0.0499	 1.73•10-3	
+−+	 7.5	 9	 46	 24.4	 2.17•10-2	 0.399	 1.63•10-3	
−++	 2.5	 45	 46	 72	 1.02•10-2	 0.387	 5.38•10-3	
+++	 7.5	 45	 46	 74.4	 1.09•10-2	 0.215	 2.89•10-3	
	
Table	10-6	Second	screening	of	growth	and	expression	kinetics	in	microtitre	plates	during	
methanol	 induction	of	P.	pastoris	MutS:	Design	space	 (left)	and	corresponding	 response	
values	(right).	
Pattern	 [MeOH]	
(%	vol.)	
[X]0	
(OD600)	
t	
(h)	
[X]t	
(OD600)	
µ	(h-1)	 [tHBc]	
(ng/mL)	
tHBcs	
(µg/mL/OD600)	
−−−	 0.5	 90	 16	 96	 4.03•10-3	 11.4	 1.19•10-1	
+−−	 2.5	 90	 16	 109.2	 1.21•10-2	 7.13	 6.53•10-2	
−+−	 0.5	 135	 16	 116.8	 -9.05•10-3	 4.55	 3.90•10-2	
++−	 2.5	 135	 16	 134	 -4.65•10-4	 6.85	 5.11•10-2	
000	 1.5	 112.5	 31	 114.8	 6.75•10-4	 8.10	 7.05•10-2	
000	 1.5	 112.5	 31	 114.8	 6.75•10-4	 10.7	 9.35•10-2	
000	 1.5	 112.5	 31	 109.2	 -9.92•10-4	 9.05	 8.29•10-2	
−−+	 0.5	 90	 46	 93.2	 7.60•10-4	 10.8	 1.16•10-1	
+−+	 2.5	 90	 46	 95.2	 1.22•10-3	 8.49	 8.91•10-2	
−++	 0.5	 135	 46	 118.8	 -2.78•10-3	 5.95	 5.01•10-2	
+++	 2.5	 135	 46	 137.2	 3.51•10-4	 8.31	 6.06•10-2	
	
	
	
	
	 																																																																																										Benjamin	A.F.	Bláha	2018	
	 306	
Table	 10-7	 Growth	 and	 expression	 kinetics	 screening	 in	 microtitre	 plates	 during	 PDM	
induction	 of	 P.	 pastoris	 Mut+:	 Design	 space	 (left)	 and	 corresponding	 response	 values	
(right).		
Pattern	 [X]0	
(OD600)	
t	(h)	 [X]t	
(OD600)	
µ	(h-1)	 [tHBc]	
(µg/mL)	
tHBcs	
(µg/mL/OD600)	
−−	 10.8	 16	 18	 3.19•10-2	 0.975	 0.0542	
+−	 54	 16	 58	 4.47•10-3	 0	 0	
00	 32.4	 30	 36	 3.51•10-3	 0	 0	
00	 32.4	 30	 35.6	 3.14•10-3	 0	 0	
−+	 10.8	 46	 16.4	 9.08•10-3	 2.34	 0.142	
++	 54	 46	 56.8	 1.10•10-3	 0	 0	
	
Table	 10-8	 Growth	 and	 expression	 kinetics	 screening	 in	 microtitre	 plates	 during	 PDM	
induction	 of	 P.	 pastoris	 MutS:	 Design	 space	 (left)	 and	 corresponding	 response	 values	
(right).		
Pattern	 [X]0	
(OD600)	
t	(h)	 [X]t	
(OD600)	
µ	(h-1)	 [tHBc]	
(µg/mL)	
tHBcs	
(µg/mL/OD600)	
−−	 108	 16	 100.8	 -4.31•10-3	 3.13	 0.0311	
+−	 162	 16	 146.4	 -6.33•10-3	 4.85	 0.0331	
00	 135	 30	 120	 -3.93	•10-3	 9.60	 0.0800	
00	 135	 30	 118	 -4.49•10-3	 10.8	 0.0911	
−+	 108	 46	 98	 -2.11•10-3	 10.6	 0.108	
++	 162	 46	 147.6	 -2.02•10-3		 6.16	 0.0417	
	
Table	10-9:	Relative	factor	contributions	in	a	two-factor,	two-level,	full-fractional	factorial	
screening	 designs	 investigating	 induction	 of	 P.	 pastoris	 Mut+	 in	 microtitre	 plates	 using	
defined	media	containing	pectin	derivatives.	*:	Curvature	detected	in	screening	response	
model.	
Factor	 [X]0	(OD600)	 t	(h)	
Range	 (10.8,54.0)	 (16,	46)	
%	contribution	
µ	(h-1)	 60.53%	 39.47%	
[tHBc](µg/mL)	 77.59%	 22.41%	
tHBcs(µg/mL/OD600)	 74.89%	 25.11%	
	
Table	 10-10	 Relative	 factor	 contributions	 in	 a	 two-factor,	 two-level,	 full-fractional	
factorial	screening	designs	investigating	induction	of	P.	pastoris	MutS	in	microtitre	plates	
using	 defined	 media	 containing	 pectin	 derivatives.	 *:	 Curvature	 detected	 in	 screening	
response	model.	
Factor	 [X]0	(OD600)	 t	(h)	
Range	 (108,162)	 (16,	46)	
%	contribution	
µ	(h-1)	 14.72%	 85.28%	
[tHBc](µg/mL)	 29.32%	 70.68%	
tHBcs(µg/mL/OD600)	 43.32%	 56.68%	
	 																																																																																										Benjamin	A.F.	Bláha	2018	
	 307	
Table	 10-11	 dGAME	 Models	 and	 goodness	 of	 fit	 for	 second	 screening	 designs	
investigating	 induction	 of	 P.	 pastoris	 Mut+	 in	 microtitre	 plates	 using	 defined	 media	
containing	pectin	derivatives.	
	 All	terms	
(Complex	
model)	
	 Significant	terms	
(Simplified	model)	
	 R2	 R2	adj.	 Formulae	 R2	 R2	adj.	
µ	(h-1)	 0.863	 0.657	 µ = 8.87 ∙ 10dy − 8.70 ∙ 10dyf X{ 	 0.467	 0.333	
[tHBc]	(µg/mL)	 0.801	 0.501	 tHBc = 0.552 − 0.828f X{ 	 0.598	 0.498	
[tHBc]	
(µg/mL/OD600)	
0.808	 0.520	
HBc~ = 3.27 ∙ 10dM − 4.92 ∙10dMf X{ 		
	
0.576	 0.470	
f X{ = X{ − 32.421.6 	
	
Table	 10-12	 dGAME	 Models	 and	 goodness	 of	 fit	 for	 second	 screening	 designs	
investigating	 induction	 of	 P.	 pastoris	 MutS	 in	 microtitre	 plates	 using	 defined	 media	
containing	pectin	derivatives.	
	 All	terms	
(Complex	
model)	
	 Significant	terms	
(Simplified	model)	
	 R2	 R2	adj.	 Formulae	 R2	 R2	adj.	
µ	(h-1)	 0.972	 0.929	 µ = −3.83 ∙ 10dy − 1.64 ∙ 10dyf t 	 0.816	 0.770	
[tHBc]	(µg/mL)	 0.551	 -0.124	 tHBc = 7.56 − 2.10f t 	 0.337	 0.171	
[tHBc]	
(µg/mL/OD600)	
0.715	 0.285	 HBc~ = 6.46 ∙ 10dM − 2.06 ∙ 10dMf t 		 0.312	 0.141	
f X{ = X{ − 13527 	 f t = t − 3115 	
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10.4.5 	Reaction	mechanism	of	d-galacturonic	acid	and	methanol	
	
Figure	 10.10	 Reaction	 mechanism	 of	 d-galacturonic	 acid	 and	 methanol	 under	 acidic	
conditions	
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10.5 Supplementary	data	(Chapter	6)	
10.5.1 Volumetric	total	core	protein	
	
Figure	10.11	Response	Surface	Model	 for	volumetric	total	core	protein	expression,	Ytotal,	
vol.	 (A-C)	 Effect	 of	 QGY	 and	 T	 at	 (A)	 QMeOH=0.5mL/Li/h,	 (B)	 QMeOH=3.65mL/Li/h	 (response	
maximum)	and	(C)	QMeOH=5.5mL/Li/h.	(D-E)	Effect	of	QMeOH	and	T	at	(D)	QGY=11.90mL/Li/h	
and	QGY=24.40mL/Li/h;	and	(E)	QGY=18.15mL/Li/h	(response	maximum).	(F-H)	Effect	of	QGY	
and	QMeOH	at	(F)	T=18.75°C,	(G)	T=27.04°C	and	(H)	T=31.25°C.	
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10.5.2 Volumetric	expression	responses	
	
Figure	10.12	Response	Surface	Model	for	volumetric	soluble	core	protein	expression,	Ysol,	
vol.	 (A-C)	 Effect	 of	 QGY	 and	 T	 at	 (A)	 QMeOH=0.5mL/Li/h,	 (B)	 QMeOH=3.86mL/Li/h	 (response	
maximum)	and	(C)	QMeOH=5.5mL/Li/h.	(D-E)	Effect	of	QMeOH	and	T	at	(D)	QGY=18.15mL/Li/h	
(response	maximum);	and	(E)	QGY=11.90mL/Li/h	and	QGY=24.40mL/Li/h.	(F-H)	Effect	of	QGY	
and	QMeOH	at	(F)	T=18.75°C,	(G)	T=26.10°C	and	(H)	T=31.25°C.	
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Figure	10.13	Time	course	profiles	of	volumetric	tHBc	expression:	(A	and	B)	Expression	at	
various	methanol	flow	rates	of	total	and	soluble	tHBc	respectively.	(C	and	D)	Expression	
at	various	glycerol	flow	rates	of	total	and	soluble	tHBc	respectively.	(E	and	F)	Expression	
at	various	induction	temperatures	of	total	and	soluble	tHBc	respectively.	
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Figure	10.14	Response	Surface	Model	for	volumetric	VLP	core	protein	expression,	YVLP,	vol.	
Effect	of	QMeOH	and	T.	Effect	of	QGY	was	found	to	be	negligible.		
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Table	10-13:	Central	composite	design	for	induction	optimisation.	Design	space	(left)	and	corresponding	response	values	(right).		
Design	space	 Metabolic	responses	 Specific	expression	(µg/gWCW)	 Volumetric	expression(µg/L)	
Standard	
order	
Pattern	 QMeOH	
(mL/Li/h)	
QGY	
(mL/Li/h)	
T	(°C)	 [X]	
(gWCW/L)	
CER	
(mmol/L/h)	
RQ	 Ytot.,	spec.	
	
Ysol.,	spec.	 YVLP,	spec.	 Ytot.,	vol.	 Ysol.,	vol.	 YVLP.,	vol.	
1	 −−−	 1	 13.15	 20	 180	 16.7	 0.568	 1.93·10-1	 1.87·10-2	 3.76·10-1	 34.7	 3.36	 67.6	
2	 −−+	 1	 13.15	 30	 181	 18.5	 0.570	 1.43	 4.05·10-1	 2.58	 259	 73.2	 466	
3	 −+−	 1	 23.15	 20	 203	 14.6	 0.647	 6.70·10-2	 3.05·10-2	 1.67·10-1	 13.6	 6.19	 33.8	
4	 −++	 1	 23.15	 30	 209	 18.6	 0.675	 5.39·10-1	 5.39·10-1	 1.32	 113	 113	 275	
5	 +−−	 5	 13.15	 20	 257	 78.5	 0.522	 9.09·10-1	 9.82·10-2	 2.09	 234	 25.3	 537	
6	 +−+	 5	 13.15	 30	 139	 28.0	 0.589	 2.60	 2.42	 3.13	 361	 336	 435	
7	 ++−	 5	 23.15	 20	 270	 69.4	 0.611	 1.33	 1.28	 8.08·10-1	 360	 347	 218	
8	 +++	 5	 23.15	 30	 162	 40.7	 0.704	 7.85·10-1	 1.18	 1.18	 127	 192	 191	
9	 000	 3	 18.15	 25	 238	 45.7	 0.551	 3.56	 3.79	 2.93	 845	 900	 696	
10	 000	 3	 18.15	 25	 240	 46.5	 0.574	 2.75	 3.95	 3.17	 660	 949	 762	
11	 000	 3	 18.15	 25	 228	 45.3	 0.546	 3.14	 4.96	 4.12	 714	 1.13·103	 937	
12	 0α0	 3	 24.4	 25	 250	 48.9	 0.558	 2.57	 4.08	 4.34	 642	 1.02·103	 1.08·103	
13	 α00	 5.5	 18.15	 25	 279	 76.7	 0.534	 5.85	 7.87	 7.52	 1.63·103	 2.19·103	 2.10·103	
14	 0-α0	 3	 11.9	 25	 217	 45.8	 0.546	 4.00	 5.58	 5.45	 870	 1.21·103	 1.18·103	
15	 00α	 3	 18.15	 31.25	 178	 31.7	 0.632	 8.37	 9.65	 7.49	 1.49·103	 1.72·103	 1.33·103	
16	 00-α	 3	 18.15	 18.75	 228	 44.9	 0.538	 1.97	 2.77	 1.67	 448	 63.1	 381	
17	 -α00	 0.5	 18.15	 25	 168	 9.86	 0.655	 7.97	 1.06	 6.02·10-1	 134	 178	 101	
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10.6 Supplementary	data	(Chapter	7)	
	
Figure	10.15	Size	Exclusion	Chromatography	(2.4.11)	fractions	of	bead-lysed	(2.4.9)	k1,	k1	
construct	 (42.5kDa)	 using	 pure	 methanol	 induction.	 Two-minute	 chromatography	
fractions	were	collected	after	10	minutes	for	an	additional	20	minutes.	(A-D)	Coomassie	
stains	 of	 reduced	 gels.	 (E-H)	Western	Blots	 (1-minute	 exposure).	 Fermentation	 samples	
were	collected	at	0	hours	(A	&	E),	8	hours	(B	&	F),	24	hours	(C	&	G)	and	40	hours	(D	&	H)	
of	induction.	SEC	and	Western	blotting	procedures	were	performed	by	iQur	Ltd.	
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Figure	 10.16	 Log-scaled	 fermentation	 data	 of	 process	 scale-up	 of	 Pichia	 pastoris	
expressing	 tHBc-HA2.3,	 (M2e)3	 using	 mixed	 feeding	 induction.	 Large-scale	 data,	 at	 30L	
total	working	volume,	is	shown	in	blue.	Small-scale	data,	at	250mL	total	working	volume,	
is	 shown	 in	orange.	Carbon	dioxide	concentrations	 ([CO2])	was	measured	 in	off-gas	and	
biomass	concentrations	([X])	were	determined	through	wet	cell	weight	analysis.				
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